1	ONCOLOGY	NNP	O	ONCOLOGY	nn	2	SENT_1	[p1l726t81r912b105],
2	REPORTS	NNS	O	report	_	0	SENT_1	[p1l921t81r1065b105],
3	16	CD	NUMBER	16	num	5	SENT_1	[p1l1087t81r1123b105],
4	:	:	O	:	_	0	SENT_1	[p1l1087t81r1123b105],
5	533-541	CD	NUMBER	533-541	dep	2	SENT_1	[p1l1144t81r1262b109],
6	,	,	O	,	_	0	SENT_1	[p1l1144t81r1262b109],
7	2006	CD	DATE	2006	appos	5	SENT_1	[p1l1280t81r1344b105],

1	Evaluation	NN	O	evaluation	_	0	SENT_2	[p1l180t184r527b238],
2	of	IN	O	of	_	0	SENT_2	[p1l549t184r614b238],
3	the	DT	O	the	det	9	SENT_2	[p1l630t185r727b238],
4	epidermal	JJ	O	epidermal	amod	9	SENT_2	[p1l749t184r1071b252],
5	growth	NN	O	growth	nn	9	SENT_2	[p1l1093t185r1317b252],
6	factor	NN	O	factor	nn	9	SENT_2	[p1l1338t184r1528b238],
7	receptor	NN	O	receptor	nn	9	SENT_2	[p1l1549t189r1816b252],
8	gene	NN	O	gene	nn	9	SENT_2	[p1l1837t201r1980b252],
9	mutation	NN	O	mutation	prep_of	1	SENT_2	[p1l373t274r662b328],
10	and	CC	O	and	_	0	SENT_2	[p1l684t275r802b328],
11	copy	NN	O	copy	nn	12	SENT_2	[p1l823t290r971b342],
12	number	NN	O	number	prep_of	1	SENT_2	[p1l991t275r1243b328],
13	in	IN	O	in	dep	1	SENT_2	[p1l1264t274r1324b327],
14	non-small	JJ	O	non-small	amod	17	SENT_2	[p1l1346t275r1660b328],
15	cell	NN	O	cell	nn	17	SENT_2	[p1l1681t275r1787b328],
16	lung	NN	O	lung	nn	17	SENT_2	[p1l537t365r677b432],
17	cancer	NN	O	cancer	pobj	13	SENT_2	[p1l698t380r908b418],
18	with	IN	O	with	dep	1	SENT_2	[p1l929t364r1068b418],
19	gefitinib	NN	O	gefitinib	nn	20	SENT_2	[p1l1090t364r1353b432],
20	therapy	NN	O	therapy	pobj	18	SENT_2	[p1l1375t365r1622b432],

1	KATSUHIKO	NNP	PERSON	KATSUHIKO	nn	2	SENT_3	[p1l60t505r301b534],
2	ENDO	NNP	PERSON	ENDO	_	0	SENT_3	[p1l313t505r439b539],
3	,	,	O	,	_	0	SENT_3	[p1l313t505r439b539],
4	HIDEFUMI	NNP	PERSON	HIDEFUMI	nn	5	SENT_3	[p1l460t505r663b534],
5	SASAKI	NNP	PERSON	SASAKI	dep	2	SENT_3	[p1l675t505r835b539],
6	,	,	O	,	_	0	SENT_3	[p1l675t505r835b539],
7	MOTOKI	NNP	ORGANIZATION	MOTOKI	nn	8	SENT_3	[p1l856t505r1021b534],
8	YANO	NNP	ORGANIZATION	YANO	appos	5	SENT_3	[p1l1033t505r1163b539],
9	,	,	O	,	_	0	SENT_3	[p1l1033t505r1163b539],
10	YOSHIHIRO	NNP	PERSON	YOSHIHIRO	nn	11	SENT_3	[p1l1185t505r1412b534],
11	KOBAYASHI	NNP	PERSON	KOBAYASHI	appos	5	SENT_3	[p1l1424t505r1679b539],
12	,	,	O	,	_	0	SENT_3	[p1l1424t505r1679b539],
13	HARUHIRO	NNP	LOCATION	HARUHIRO	nn	14	SENT_3	[p1l1700t505r1918b534],
14	YUKIUE	NNP	LOCATION	YUKIUE	appos	5	SENT_3	[p1l1931t505r2100b539],
15	,	,	O	,	_	0	SENT_3	[p1l1931t505r2100b539],

1	HIROSHI	NNP	LOCATION	HIROSHI	nn	2	SENT_4	[p1l325t554r493b583],
2	HANEDA	NNP	LOCATION	HANEDA	_	0	SENT_4	[p1l504t554r690b588],
3	,	,	O	,	_	0	SENT_4	[p1l504t554r690b588],
4	ERIKO	NNP	PERSON	ERIKO	nn	5	SENT_4	[p1l711t554r837b583],
5	SUZUKI	NNP	PERSON	SUZUKI	conj_and	2	SENT_4	[p1l850t554r1012b588],
6	,	,	O	,	_	0	SENT_4	[p1l850t554r1012b588],
7	OSAMU	NNP	PERSON	OSAMU	nn	8	SENT_4	[p1l1034t554r1182b583],
8	KAWANO	NNP	PERSON	KAWANO	conj_and	2	SENT_4	[p1l1194t554r1382b583],
9	and	CC	O	and	_	0	SENT_4	[p1l1405t554r1464b583],
10	YOSHITAKA	NNP	PERSON	YOSHITAKA	nn	11	SENT_4	[p1l1486t554r1727b583],
11	FUJII	NNP	PERSON	FUJII	conj_and	2	SENT_4	[p1l1739t554r1835b583],

1	Department	NNP	O	Department	_	0	SENT_5	[p1l403t609r599b646],
2	of	IN	O	of	_	0	SENT_5	[p1l611t608r647b637],
3	Surgery	NNP	O	Surgery	nn	4	SENT_5	[p1l657t608r786b646],
4	II	NNP	O	II	prep_of	1	SENT_5	[p1l798t609r835b643],
5	,	,	O	,	_	0	SENT_5	[p1l798t609r835b643],
6	Nagoya	NNP	ORGANIZATION	Nagoya	nn	10	SENT_5	[p1l846t609r975b646],
7	City	NNP	ORGANIZATION	City	nn	10	SENT_5	[p1l987t608r1057b646],
8	University	NNP	ORGANIZATION	University	nn	10	SENT_5	[p1l1068t608r1243b646],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_5	[p1l1254t608r1390b637],
10	School	NNP	ORGANIZATION	School	appos	4	SENT_5	[p1l1403t608r1527b643],
11	,	,	O	,	_	0	SENT_5	[p1l1403t608r1527b643],
12	1	CD	NUMBER	1	num	13	SENT_5	[p1l1542t609r1554b637],
13	Kawasurni	NNP	LOCATION	Kawasurni	appos	10	SENT_5	[p1l1569t608r1757b643],
14	,	,	O	,	_	0	SENT_5	[p1l1569t608r1757b643],

1	Mizuho	NNP	O	Mizuho	nn	3	SENT_6	[p1l657t657r871b692],
2	—	NNP	O	—	nn	3	SENT_6	[p1l657t657r871b692],
3	cho	NN	O	cho	_	0	SENT_6	[p1l657t657r871b692],
4	,	,	O	,	_	0	SENT_6	[p1l657t657r871b692],
5	Mizuho	NNP	O	Mizuho	nn	7	SENT_6	[p1l882t657r1077b692],
6	—	CD	NUMBER	—	num	7	SENT_6	[p1l882t657r1077b692],
7	ku	NN	O	ku	appos	3	SENT_6	[p1l882t657r1077b692],
8	,	,	O	,	_	0	SENT_6	[p1l882t657r1077b692],
9	Nagoya	NNP	LOCATION	Nagoya	appos	7	SENT_6	[p1l1088t658r1217b695],
10	467-8601	CD	NUMBER	467-8601	num	9	SENT_6	[p1l1228t657r1383b686],
11	,	,	O	,	_	0	SENT_6	[p1l1391t681r1398b692],
12	Japan	NNP	LOCATION	Japan	nsubj	13	SENT_6	[p1l1408t658r1503b695],
13	Received	VBD	O	receive	rcmod	7	SENT_6	[p1l628t712r783b741],
14	February	NNP	DATE	February	tmod	13	SENT_6	[p1l793t712r943b750],
15	23	CD	DATE	23	num	14	SENT_6	[p1l955t712r1006b747],
16	,	,	DATE	,	_	0	SENT_6	[p1l955t712r1006b747],
17	2006	CD	DATE	2006	num	14	SENT_6	[p1l1018t712r1109b747],
18	;	:	O	;	_	0	SENT_6	[p1l1018t712r1109b747],
19	Accepted	JJ	O	accepted	dep	3	SENT_6	[p1l1133t712r1289b750],
20	May	NNP	DATE	May	tmod	19	SENT_6	[p1l1300t713r1375b750],
21	16,2006	CD	DATE	16,2006	num	20	SENT_6	[p1l1391t712r1531b747],

1	Abstract	JJ	O	abstract	_	0	SENT_7	[p1l9t906r371b968],
2	.	.	O	.	_	0	SENT_7	[p1l9t906r371b968],

1	Several	JJ	O	several	amod	2	SENT_8	[p1l410t907r680b968],
2	studies	NNS	O	study	nsubj	4	SENT_8	[p1l721t907r969b967],
3	have	VBP	O	have	aux	4	SENT_8	[p1l1008t907r1176b967],
4	suggested	VBN	O	suggest	_	0	SENT_8	[p1l1218t907r1575b985],
5	that	IN	O	that	complm	26	SENT_8	[p1l1611t907r1747b967],
6	epidermal	JJ	O	epidermal	amod	12	SENT_8	[p1l1784t907r2147b985],
7	growth	NN	O	growth	nn	12	SENT_8	[p1l10t1010r255b1088],
8	factor	NN	O	factor	nn	12	SENT_8	[p1l290t1010r494b1071],
9	receptor	NN	O	receptor	nn	12	SENT_8	[p1l527t1019r815b1088],
10	(	CD	NUMBER	(	num	12	SENT_8	[p1l851t1011r1125b1085],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_8	[p1l851t1011r1125b1085],
12	)	NN	O	)	nsubj	26	SENT_8	[p1l851t1011r1125b1085],
13	gene	NN	O	gene	nn	14	SENT_8	[p1l1164t1029r1325b1088],
14	mutation	NN	O	mutation	dep	12	SENT_8	[p1l1361t1010r1694b1082],
15	,	,	O	,	_	0	SENT_8	[p1l1361t1010r1694b1082],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_8	[p1l1728t1011r1950b1071],
17	gene	NN	O	gene	nn	18	SENT_8	[p1l1986t1029r2147b1088],
18	amplification	NN	O	amplification	nsubj	26	SENT_8	[p1l11t1113r491b1191],
19	,	,	O	,	_	0	SENT_8	[p1l11t1113r491b1191],
20	and	CC	O	and	_	0	SENT_8	[p1l524t1113r645b1173],
21	some	DT	O	some	det	23	SENT_8	[p1l679t1132r856b1174],
22	other	JJ	O	other	amod	23	SENT_8	[p1l889t1113r1065b1174],
23	biomarkers	NNS	O	biomarker	nsubj	26	SENT_8	[p1l1094t1113r1481b1174],
24	may	MD	O	may	aux	26	SENT_8	[p1l1514t1132r1660b1191],
25	be	VB	O	be	cop	26	SENT_8	[p1l1691t1113r1771b1173],
26	predictors	NNS	O	predictor	ccomp	4	SENT_8	[p1l1802t1113r2146b1191],
27	of	IN	O	of	_	0	SENT_8	[p1l10t1216r86b1277],
28	gefitinib	NN	O	gefitinib	nn	29	SENT_8	[p1l118t1216r422b1294],
29	sensitivity	NN	O	sensitivity	prep_of	26	SENT_8	[p1l463t1216r855b1294],
30	.	.	O	.	_	0	SENT_8	[p1l463t1216r855b1294],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l892t1218r1012b1276],
2	analyzed	VBD	O	analyze	_	0	SENT_9	[p1l1051t1216r1369b1294],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_9	[p1l1404t1217r1630b1277],
4	mutation	NN	O	mutation	dobj	2	SENT_9	[p1l1666t1216r1985b1277],
5	and	CC	O	and	_	0	SENT_9	[p1l2024t1216r2149b1276],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_9	[p1l8t1320r233b1380],
7	copy	NN	O	copy	nn	8	SENT_9	[p1l270t1338r439b1397],
8	number	NN	O	number	conj_and	4	SENT_9	[p1l476t1319r749b1379],
9	in	IN	O	in	_	0	SENT_9	[p1l784t1319r850b1378],
10	22	CD	NUMBER	22	num	12	SENT_9	[p1l888t1320r971b1378],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_9	[p1l1010t1319r1591b1397],
12	—	NN	O	—	prep_in	4	SENT_9	[p1l1010t1319r1591b1397],
13	treated	VBN	O	treat	partmod	12	SENT_9	[p1l1010t1319r1591b1397],
14	non-small	JJ	O	non-small	amod	17	SENT_9	[p1l1627t1319r1984b1380],
15	cell	NN	O	cell	nn	17	SENT_9	[p1l2021t1319r2148b1379],
16	lung	NN	O	lung	nn	17	SENT_9	[p1l9t1422r159b1500],
17	cancer	NN	O	cancer	dobj	13	SENT_9	[p1l190t1441r415b1482],
18	(	CD	NUMBER	(	num	21	SENT_9	[p1l445t1423r774b1497],
19	NSCLC	NN	O	nsclc	nn	21	SENT_9	[p1l445t1423r774b1497],
20	)	NN	O	)	nn	21	SENT_9	[p1l445t1423r774b1497],
21	cases	NNS	O	case	dep	17	SENT_9	[p1l807t1441r984b1482],
22	and	CC	O	and	_	0	SENT_9	[p1l1017t1422r1139b1482],
23	their	PRP$	O	they	poss	24	SENT_9	[p1l1167t1422r1325b1482],
24	relation	NN	O	relation	dobj	13	SENT_9	[p1l1352t1422r1615b1483],
25	to	TO	O	to	_	0	SENT_9	[p1l1644t1431r1708b1483],
26	the	DT	O	the	det	27	SENT_9	[p1l1738t1422r1841b1482],
27	survival	NN	O	survival	prep_to	24	SENT_9	[p1l1874t1422r2148b1482],
28	of	IN	O	of	_	0	SENT_9	[p1l10t1525r86b1586],
29	patients	NNS	O	patient	prep_of	27	SENT_9	[p1l116t1525r420b1603],
30	.	.	O	.	_	0	SENT_9	[p1l116t1525r420b1603],

1	We	PRP	O	we	nsubj	3	SENT_10	[p1l457t1527r577b1585],
2	also	RB	O	also	advmod	3	SENT_10	[p1l616t1525r756b1586],
3	studied	VBD	O	study	_	0	SENT_10	[p1l797t1525r1054b1585],
4	143	CD	NUMBER	143	advmod	3	SENT_10	[p1l1098t1525r1217b1585],
5	gefitinib	NN	O	gefitinib	dobj	3	SENT_10	[p1l1259t1525r1792b1603],
6	—	CD	NUMBER	—	num	5	SENT_10	[p1l1259t1525r1792b1603],
7	na	TO	O	na	infmod	5	SENT_10	[p1l1259t1525r1792b1603],
8	'	''	O	'	_	0	SENT_10	[p1l1259t1525r1792b1603],
9	1	CD	NUMBER	1	dobj	3	SENT_10	[p1l1259t1525r1792b1603],
10	've	VBP	O	have	rcmod	9	SENT_10	[p1l1259t1525r1792b1603],
11	Japanese	JJ	MISC	japanese	amod	13	SENT_10	[p1l1829t1527r2147b1603],
12	NSCLC	NN	O	nsclc	nn	13	SENT_10	[p1l8t1628r284b1689],
13	cases	NNS	O	case	dobj	10	SENT_10	[p1l319t1647r519b1688],
14	.	.	O	.	_	0	SENT_10	[p1l319t1647r519b1688],

1	The	DT	O	the	det	4	SENT_11	[p1l553t1628r684b1688],
2	ErbB2	NN	O	erbb2	nn	4	SENT_11	[p1l717t1628r940b1688],
3	copy	NN	O	copy	nn	4	SENT_11	[p1l975t1647r1139b1706],
4	number	NN	O	number	nsubj	15	SENT_11	[p1l1173t1628r1437b1688],
5	was	VBD	O	be	auxpass	7	SENT_11	[p1l1468t1647r1598b1688],
6	also	RB	O	also	advmod	7	SENT_11	[p1l1634t1628r1768b1689],
7	studied	VBN	O	study	rcmod	4	SENT_11	[p1l1805t1628r2051b1688],
8	in	IN	O	in	_	0	SENT_11	[p1l2083t1628r2148b1687],
9	59	CD	NUMBER	59	num	10	SENT_11	[p1l10t1731r91b1793],
10	gefitinib	NN	O	gefitinib	prep_in	7	SENT_11	[p1l119t1731r626b1809],
11	—	CD	NUMBER	—	dobj	7	SENT_11	[p1l119t1731r626b1809],
12	na	TO	O	na	infmod	11	SENT_11	[p1l119t1731r626b1809],
13	'	''	O	'	_	0	SENT_11	[p1l119t1731r626b1809],
14	1	CD	NUMBER	1	dep	12	SENT_11	[p1l119t1731r626b1809],
15	've	VBP	O	have	_	0	SENT_11	[p1l119t1731r626b1809],
16	NSCLC	NN	O	nsclc	nn	17	SENT_11	[p1l651t1732r927b1792],
17	cases	NNS	O	case	dobj	15	SENT_11	[p1l955t1750r1155b1791],
18	.	.	O	.	_	0	SENT_11	[p1l955t1750r1155b1791],

1	In	IN	O	in	_	0	SENT_12	[p1l1182t1733r1252b1790],
2	gefitinib	JJ	O	gefitinib	amod	3	SENT_12	[p1l1278t1731r1834b1809],
3	—	NN	O	—	prep_in	13	SENT_12	[p1l1278t1731r1834b1809],
4	treated	VBN	O	treat	partmod	3	SENT_12	[p1l1278t1731r1834b1809],
5	patients	NNS	O	patient	dobj	4	SENT_12	[p1l1858t1731r2149b1809],
6	,	,	O	,	_	0	SENT_12	[p1l1858t1731r2149b1809],
7	the	DT	O	the	det	8	SENT_12	[p1l9t1834r111b1894],
8	presence	NN	O	presence	nsubjpass	13	SENT_12	[p1l138t1853r440b1912],
9	of	IN	O	of	_	0	SENT_12	[p1l469t1834r544b1895],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_12	[p1l564t1835r785b1895],
11	mutation	NN	O	mutation	prep_of	8	SENT_12	[p1l812t1834r1118b1895],
12	was	VBD	O	be	auxpass	13	SENT_12	[p1l1145t1853r1275b1894],
13	associated	VBN	O	associate	_	0	SENT_12	[p1l1306t1834r1659b1895],
14	with	IN	O	with	_	0	SENT_12	[p1l1687t1834r1838b1894],
15	a	DT	O	a	det	18	SENT_12	[p1l1867t1853r1903b1894],
16	higher	JJR	O	higher	amod	18	SENT_12	[p1l1928t1834r2149b1912],
17	response	NN	O	response	nn	18	SENT_12	[p1l8t1956r311b2015],
18	rate	NN	O	rate	prep_with	13	SENT_12	[p1l346t1946r475b1997],
19	to	TO	O	to	_	0	SENT_12	[p1l511t1946r575b1998],
20	gefitinib	NN	O	gefitinib	prep_to	18	SENT_12	[p1l612t1937r904b2015],
21	and	CC	O	and	_	0	SENT_12	[p1l943t1937r1065b1997],
22	a	DT	O	a	det	25	SENT_12	[p1l1101t1956r1137b1997],
23	longer	RBR	O	longer	amod	25	SENT_12	[p1l1171t1937r1393b2015],
24	overall	JJ	O	overall	amod	25	SENT_12	[p1l1428t1937r1667b1998],
25	survival	NN	O	survival	conj_and	18	SENT_12	[p1l1705t1937r2004b2009],
26	,	,	O	,	_	0	SENT_12	[p1l1705t1937r2004b2009],
27	but	CC	O	but	_	0	SENT_12	[p1l2037t1937r2149b1997],
28	the	DT	O	the	det	31	SENT_12	[p1l9t2040r111b2100],
29	increased	VBN	O	increase	amod	31	SENT_12	[p1l140t2040r466b2100],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_12	[p1l492t2041r712b2101],
31	gene	NN	O	gene	conj_but	13	SENT_12	[p1l740t2059r900b2118],
32	copy	NN	O	copy	nn	33	SENT_12	[p1l929t2059r1093b2118],
33	number	NN	O	number	nsubj	34	SENT_12	[p1l1122t2040r1386b2100],
34	was	VBD	O	be	rcmod	31	SENT_12	[p1l1412t2059r1542b2100],
35	not	RB	O	not	neg	34	SENT_12	[p1l1572t2049r1701b2101],
36	.	.	O	.	_	0	SENT_12	[p1l1572t2049r1701b2101],

1	In	IN	O	in	_	0	SENT_13	[p1l1730t2042r1800b2099],
2	gefitinibna	NN	O	gefitinibna	prep_in	18	SENT_13	[p1l1828t2040r2145b2118, p1l9t2148r212b2203],
3	'	''	O	'	_	0	SENT_13	[p1l1828t2040r2145b2118, p1l9t2148r212b2203],
4	1	CD	NUMBER	1	nsubj	5	SENT_13	[p1l1828t2040r2145b2118, p1l9t2148r212b2203],
5	've	VBP	O	have	rcmod	2	SENT_13	[p1l1828t2040r2145b2118, p1l9t2148r212b2203],
6	cases	NNS	O	case	dobj	5	SENT_13	[p1l252t2162r478b2215],
7	,	,	O	,	_	0	SENT_13	[p1l252t2162r478b2215],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_13	[p1l516t2144r750b2204],
9	mutation	NN	O	mutation	nsubjpass	18	SENT_13	[p1l789t2143r1127b2204],
10	but	CC	O	but	_	0	SENT_13	[p1l1166t2143r1286b2203],
11	not	RB	O	not	_	0	SENT_13	[p1l1324t2152r1443b2204],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_13	[p1l1481t2144r1714b2204],
13	gene	NN	O	gene	conj_negcc	9	SENT_13	[p1l1754t2162r1928b2221],
14	copy	NN	O	copy	nn	15	SENT_13	[p1l1969t2162r2147b2221],
15	number	NN	O	number	dep	13	SENT_13	[p1l9t2246r287b2306],
16	was	VBD	O	be	auxpass	18	SENT_13	[p1l323t2265r459b2306],
17	significantly	RB	O	significantly	advmod	18	SENT_13	[p1l502t2246r962b2324],
18	correlated	VBN	O	correlate	_	0	SENT_13	[p1l1001t2246r1371b2307],
19	with	IN	O	with	_	0	SENT_13	[p1l1408t2246r1568b2306],
20	gender	NN	O	gender	prep_with	18	SENT_13	[p1l1607t2246r1878b2324],
21	,	,	O	,	_	0	SENT_13	[p1l1607t2246r1878b2324],
22	pathological	JJ	O	pathological	amod	23	SENT_13	[p1l1914t2246r2145b2324, p1l9t2349r266b2427],
23	subtypes	NNS	O	subtype	conj_and	20	SENT_13	[p1l309t2349r662b2427],
24	,	,	O	,	_	0	SENT_13	[p1l309t2349r662b2427],
25	and	CC	O	and	_	0	SENT_13	[p1l702t2349r832b2409],
26	smoking	NN	O	smoking	nn	27	SENT_13	[p1l873t2349r1190b2427],
27	status	NN	O	status	conj_and	20	SENT_13	[p1l1233t2358r1470b2409],
28	.	.	O	.	_	0	SENT_13	[p1l1233t2358r1470b2409],

1	The	DT	O	the	det	4	SENT_14	[p1l1510t2349r1650b2409],
2	ErbB2	NN	O	erbb2	nn	4	SENT_14	[p1l1690t2349r1929b2409],
3	copy	NN	O	copy	nn	4	SENT_14	[p1l1970t2368r2147b2427],
4	number	NN	O	number	nsubjpass	8	SENT_14	[p1l9t2452r289b2512],
5	was	VBD	O	be	auxpass	8	SENT_14	[p1l325t2471r462b2512],
6	not	RB	O	not	neg	8	SENT_14	[p1l502t2461r618b2513],
7	significantly	RB	O	significantly	advmod	8	SENT_14	[p1l658t2452r1123b2530],
8	correlated	VBD	O	correlate	_	0	SENT_14	[p1l1162t2452r1535b2513],
9	with	IN	O	with	_	0	SENT_14	[p1l1572t2452r1734b2512],
10	the	DT	O	the	det	12	SENT_14	[p1l1771t2452r1880b2512],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_14	[p1l1919t2453r2148b2513],
12	mutation	NN	O	mutation	prep_with	8	SENT_14	[p1l9t2555r315b2616],
13	or	CC	O	or	_	0	SENT_14	[p1l349t2574r419b2616],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_14	[p1l450t2556r671b2616],
15	copy	NN	O	copy	nn	16	SENT_14	[p1l704t2574r869b2633],
16	number	NN	O	number	conj_or	12	SENT_14	[p1l903t2555r1167b2615],
17	in	IN	O	in	_	0	SENT_14	[p1l1199t2555r1264b2614],
18	59	CD	NUMBER	59	num	19	SENT_14	[p1l1298t2555r1379b2616],
19	cases	NNS	O	case	prep_in	8	SENT_14	[p1l1415t2574r1615b2615],
20	.	.	O	.	_	0	SENT_14	[p1l1415t2574r1615b2615],

1	In	IN	O	in	_	0	SENT_15	[p1l1650t2557r1720b2614],
2	conclusion	NN	O	conclusion	prep_in	9	SENT_15	[p1l1754t2555r2149b2627],
3	,	,	O	,	_	0	SENT_15	[p1l1754t2555r2149b2627],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_15	[p1l8t2659r228b2719],
5	mutation	NN	O	mutation	nsubj	9	SENT_15	[p1l256t2658r563b2719],
6	was	VBD	O	be	cop	9	SENT_15	[p1l591t2677r721b2718],
7	a	DT	O	a	det	9	SENT_15	[p1l754t2677r789b2718],
8	better	JJR	O	better	amod	9	SENT_15	[p1l815t2658r1013b2718],
9	predictor	NN	O	predictor	_	0	SENT_15	[p1l1039t2658r1352b2736],
10	of	IN	O	of	_	0	SENT_15	[p1l1380t2658r1454b2719],
11	clinical	JJ	O	clinical	amod	12	SENT_15	[p1l1478t2658r1730b2718],
12	outcome	NN	O	outcome	prep_of	9	SENT_15	[p1l1759t2667r2054b2719],
13	in	IN	O	in	_	0	SENT_15	[p1l2083t2658r2149b2717],
14	gefitinib	NN	O	gefitinib	nn	15	SENT_15	[p1l10t2761r566b2839],
15	—	NN	O	—	prep_in	12	SENT_15	[p1l10t2761r566b2839],
16	treated	VBN	O	treat	partmod	15	SENT_15	[p1l10t2761r566b2839],
17	patients	NNS	O	patient	dobj	16	SENT_15	[p1l587t2761r854b2839],
18	than	IN	O	than	_	0	SENT_15	[p1l880t2761r1028b2821],
19	the	DT	O	the	det	23	SENT_15	[p1l1051t2761r1154b2821],
20	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_15	[p1l1178t2762r1398b2822],
21	gene	NN	O	gene	nn	23	SENT_15	[p1l1423t2780r1582b2839],
22	copy	NN	O	copy	nn	23	SENT_15	[p1l1608t2780r1773b2839],
23	number	NN	O	number	prep_than	16	SENT_15	[p1l1797t2761r2080b2821],
24	.	.	O	.	_	0	SENT_15	[p1l1797t2761r2080b2821],

1	Introduction	NN	O	introduction	_	0	SENT_16	[p1l9t2967r478b3028],

1	Lung	NN	O	lung	nn	2	SENT_17	[p1l8t3177r193b3253],
2	cancer	NN	O	cancer	nsubj	3	SENT_17	[p1l231t3194r463b3235],
3	has	VBZ	O	have	_	0	SENT_17	[p1l497t3175r612b3235],
4	a	DT	O	a	det	7	SENT_17	[p1l652t3194r688b3235],
5	high	JJ	O	high	amod	7	SENT_17	[p1l722t3175r880b3253],
6	mortality	NN	O	mortality	nn	7	SENT_17	[p1l916t3175r1242b3253],
7	rate	NN	O	rate	dobj	3	SENT_17	[p1l1278t3184r1411b3235],
8	in	IN	O	in	_	0	SENT_17	[p1l1448t3175r1515b3235],
9	many	JJ	O	many	amod	11	SENT_17	[p1l1551t3194r1745b3253],
10	developed	JJ	O	developed	amod	11	SENT_17	[p1l1783t3175r2149b3253],
11	countries	NNS	O	country	prep_in	7	SENT_17	[p1l9t3278r344b3339],
12	.	.	O	.	_	0	SENT_17	[p1l9t3278r344b3339],

1	Gefitinib	NN	O	gefitinib	nsubj	2	SENT_18	[p1l380t3278r689b3339],
2	inhibits	VBZ	O	inhibit	_	0	SENT_18	[p1l725t3278r980b3338],
3	tyrosine	NN	O	tyrosine	nn	4	SENT_18	[p1l1016t3278r1293b3356],
4	kinase	NN	O	kinase	nsubj	8	SENT_18	[p1l1327t3278r1546b3338],
5	(	CD	NUMBER	(	num	8	SENT_18	[p1l1584t3279r1749b3353],
6	TK	NN	O	tk	nn	8	SENT_18	[p1l1584t3279r1749b3353],
7	)	NN	O	)	nn	8	SENT_18	[p1l1584t3279r1749b3353],
8	activity	NN	O	activity	xcomp	2	SENT_18	[p1l1788t3278r2043b3356],
9	of	IN	O	of	_	0	SENT_18	[p1l2079t3278r2153b3339],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	8	SENT_18	[p1l8t3382r228b3442],
11	by	IN	O	by	_	0	SENT_18	[p1l251t3381r336b3459],
12	reversibly	RB	O	reversibly	advmod	13	SENT_18	[p1l360t3381r704b3459],
13	competing	VBG	O	compete	prepc_by	2	SENT_18	[p1l731t3381r1092b3459],
14	with	IN	O	with	_	0	SENT_18	[p1l1118t3381r1270b3441],
15	ATP	NN	ORGANIZATION	atp	prep_with	13	SENT_18	[p1l1294t3382r1455b3441],
16	at	IN	O	at	_	0	SENT_18	[p1l1482t3390r1542b3441],
17	the	DT	O	the	det	21	SENT_18	[p1l1564t3381r1667b3441],
18	ATP	NN	O	atp	nn	21	SENT_18	[p1l1692t3381r2147b3459],
19	—	NN	O	—	nn	21	SENT_18	[p1l1692t3381r2147b3459],
20	binding	NN	O	binding	nn	21	SENT_18	[p1l1692t3381r2147b3459],
21	cleft	NN	O	cleft	prep_at	13	SENT_18	[p1l9t3484r162b3544],
22	within	IN	O	within	_	0	SENT_18	[p1l191t3484r410b3544],
23	the	DT	O	the	det	25	SENT_18	[p1l440t3484r543b3544],
24	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_18	[p1l573t3485r793b3545],
25	protein	NN	O	protein	prep_within	21	SENT_18	[p1l822t3484r1087b3562],
26	.	.	O	.	_	0	SENT_18	[p1l822t3484r1087b3562],

1	Good	JJ	O	good	amod	3	SENT_19	[p1l1119t3484r1309b3545],
2	clinical	JJ	O	clinical	amod	3	SENT_19	[p1l1339t3484r1591b3544],
3	responses	NNS	O	response	nsubjpass	6	SENT_19	[p1l1620t3503r1954b3562],
4	have	VBP	O	have	aux	6	SENT_19	[p1l1986t3484r2147b3544],
5	been	VBN	O	be	auxpass	6	SENT_19	[p1l8t3587r174b3647],
6	observed	VBN	O	observe	_	0	SENT_19	[p1l211t3587r530b3648],
7	most	RBS	O	most	advmod	8	SENT_19	[p1l566t3596r737b3648],
8	frequently	RB	O	frequently	advmod	6	SENT_19	[p1l773t3587r1137b3665],
9	in	IN	O	in	_	0	SENT_19	[p1l1174t3587r1241b3646],
10	women	NNS	O	woman	prep_in	6	SENT_19	[p1l1278t3606r1559b3659],
11	,	,	O	,	_	0	SENT_19	[p1l1278t3606r1559b3659],
12	in	IN	O	in	_	0	SENT_19	[p1l1595t3587r1661b3646],
13	nonsmokers	NNS	O	nonsmoker	conj_and	10	SENT_19	[p1l1698t3587r2149b3659],
14	,	,	O	,	_	0	SENT_19	[p1l1698t3587r2149b3659],
15	in	IN	O	in	_	0	SENT_19	[p1l9t3690r76b3749],
16	patients	NNS	O	patient	prep_in	13	SENT_19	[p1l111t3690r381b3768],
17	with	IN	O	with	_	0	SENT_19	[p1l419t3690r573b3750],
18	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	16	SENT_19	[p1l609t3690r1238b3762],
19	,	,	O	,	_	0	SENT_19	[p1l609t3690r1238b3762],
20	and	CC	O	and	_	0	SENT_19	[p1l1274t3690r1397b3750],
21	in	IN	O	in	_	0	SENT_19	[p1l1431t3690r1497b3749],
22	Japanese	JJ	MISC	japanese	amod	23	SENT_19	[p1l1532t3692r1841b3768],
23	patients	NNS	O	patient	conj_and	10	SENT_19	[p1l1876t3690r2146b3768],

1	(	NN	O	(	_	0	SENT_20	[p2l11t20r203b94],
2	1-4	CD	NUMBER	1-4	num	3	SENT_20	[p2l11t20r203b94],
3	)	NN	O	)	dep	1	SENT_20	[p2l11t20r203b94],
4	.	.	O	.	_	0	SENT_20	[p2l11t20r203b94],

1	Unfortunately	RB	O	unfortunately	advmod	12	SENT_21	[p2l240t19r754b97],
2	,	,	O	,	_	0	SENT_21	[p2l240t19r754b97],
3	the	DT	O	the	det	4	SENT_21	[p2l788t19r892b79],
4	addition	NN	O	addition	nsubj	12	SENT_21	[p2l930t19r1215b80],
5	of	IN	O	of	_	0	SENT_21	[p2l1251t19r1326b80],
6	gefitinib	NN	O	gefitinib	prep_of	4	SENT_21	[p2l1357t19r1650b97],
7	to	TO	O	to	_	0	SENT_21	[p2l1687t28r1752b80],
8	traditional	JJ	O	traditional	amod	9	SENT_21	[p2l1788t19r2148b80],
9	chemotherapy	NN	O	chemotherapy	prep_to	6	SENT_21	[p2l9t122r497b200],
10	did	VBD	O	do	aux	12	SENT_21	[p2l529t122r637b182],
11	not	RB	O	not	neg	12	SENT_21	[p2l667t131r777b183],
12	add	VB	O	add	_	0	SENT_21	[p2l808t122r930b182],
13	any	DT	O	any	det	14	SENT_21	[p2l961t141r1082b200],
14	benefit	NN	O	benefit	dobj	12	SENT_21	[p2l1112t122r1353b182],
15	to	TO	O	to	_	0	SENT_21	[p2l1382t131r1446b183],
16	patient	NN	O	patient	nn	17	SENT_21	[p2l1477t122r1713b200],
17	survival	NN	O	survival	prep_to	12	SENT_21	[p2l1745t122r2019b182],
18	for	IN	O	for	prep	12	SENT_21	[p2l2050t122r2150b183],

1	Correspondence	NN	O	correspondence	_	0	SENT_22	[p2l12t517r561b594],
2	to	TO	O	to	dep	1	SENT_22	[p2l590t529r668b577],
3	:	:	O	:	_	0	SENT_22	[p2l590t529r668b577],
4	Dr	NN	O	dr	nn	6	SENT_22	[p2l698t524r778b576],
5	Hidefumi	NNP	PERSON	Hidefumi	nn	6	SENT_22	[p2l800t523r1088b577],
6	Sasaki	NNP	PERSON	Sasaki	dep	1	SENT_22	[p2l1113t523r1326b587],
7	,	,	O	,	_	0	SENT_22	[p2l1113t523r1326b587],
8	Department	NNP	O	Department	appos	6	SENT_22	[p2l1348t524r1705b593],
9	of	IN	O	of	_	0	SENT_22	[p2l1727t523r1793b577],
10	Surgery	NNP	O	Surgery	nn	11	SENT_22	[p2l1814t523r2049b593],
11	II	NNP	O	II	prep_of	8	SENT_22	[p2l2072t524r2140b587],
12	,	,	O	,	_	0	SENT_22	[p2l2072t524r2140b587],
13	Nagoya	NNP	ORGANIZATION	Nagoya	nn	17	SENT_22	[p2l8t621r250b691],
14	City	NNP	ORGANIZATION	City	nn	17	SENT_22	[p2l272t620r403b691],
15	University	NNP	ORGANIZATION	University	nn	17	SENT_22	[p2l426t620r753b691],
16	Medical	NNP	ORGANIZATION	Medical	nn	17	SENT_22	[p2l775t620r1029b674],
17	School	NNP	ORGANIZATION	School	appos	11	SENT_22	[p2l1053t620r1287b685],
18	,	,	O	,	_	0	SENT_22	[p2l1053t620r1287b685],
19	1	CD	NUMBER	1	num	20	SENT_22	[p2l1316t621r1338b673],
20	Kawasumi	NNP	ORGANIZATION	Kawasumi	appos	11	SENT_22	[p2l1367t620r1719b685],
21	,	,	O	,	_	0	SENT_22	[p2l1367t620r1719b685],
22	Mizuho	NNP	O	Mizuho	nn	24	SENT_22	[p2l1740t620r2140b684],
23	—	CD	NUMBER	—	num	24	SENT_22	[p2l1740t620r2140b684],
24	cho	NN	O	cho	appos	11	SENT_22	[p2l1740t620r2140b684],
25	,	,	O	,	_	0	SENT_22	[p2l1740t620r2140b684],
26	Mizuho	NNP	O	Mizuho	nn	28	SENT_22	[p2l8t713r373b777],
27	—	CD	NUMBER	—	num	28	SENT_22	[p2l8t713r373b777],
28	ku	NN	O	ku	appos	11	SENT_22	[p2l8t713r373b777],
29	,	,	O	,	_	0	SENT_22	[p2l8t713r373b777],
30	Nagoya	NNP	LOCATION	Nagoya	appos	11	SENT_22	[p2l394t714r636b784],
31	467-8601	CD	NUMBER	467-8601	num	30	SENT_22	[p2l656t713r946b767],
32	,	,	O	,	_	0	SENT_22	[p2l962t758r974b778],
33	Japan	NNP	LOCATION	Japan	nn	34	SENT_22	[p2l994t714r1170b784],
34	E	NNP	O	E	appos	11	SENT_22	[p2l8t806r235b860],
35	—	CD	NUMBER	—	num	36	SENT_22	[p2l8t806r235b860],
36	mail	NN	O	mail	dep	34	SENT_22	[p2l8t806r235b860],
37	:	:	O	:	_	0	SENT_22	[p2l8t806r235b860],
38	hisasaki@med.nagoya—cu.ac.jp	NN	O	hisasaki@med.nagoya—cu.ac.jp	dep	11	SENT_22	[p2l262t806r1230b877],

1	Key	NN	O	key	nn	2	SENT_23	[p2l8t1005r141b1080],
2	words	NNS	O	word	_	0	SENT_23	[p2l171t1003r408b1064],
3	.	.	O	.	_	0	SENT_23	[p2l171t1003r408b1064],

1	‘	NN	O	‘	dep	23	SENT_24	[p2l171t1003r408b1064],
2	epidermal	JJ	O	epidermal	amod	6	SENT_24	[p2l437t1008r747b1079],
3	growth	NN	O	growth	nn	6	SENT_24	[p2l775t1009r993b1079],
4	factor	NN	O	factor	nn	6	SENT_24	[p2l1020t1009r1201b1063],
5	receptor	NN	O	receptor	nn	6	SENT_24	[p2l1226t1017r1482b1079],
6	mutation	NN	O	mutation	dep	1	SENT_24	[p2l1508t1009r1803b1073],
7	,	,	O	,	_	0	SENT_24	[p2l1508t1009r1803b1073],
8	epidermal	JJ	O	epidermal	amod	13	SENT_24	[p2l1830t1008r2139b1079],
9	growth	NN	O	growth	nn	13	SENT_24	[p2l9t1106r232b1176],
10	factor	NN	O	factor	nn	13	SENT_24	[p2l264t1106r449b1161],
11	receptor	NN	O	receptor	nn	13	SENT_24	[p2l479t1114r741b1177],
12	copy	NN	O	copy	nn	13	SENT_24	[p2l772t1123r922b1177],
13	number	NN	O	number	appos	6	SENT_24	[p2l955t1106r1217b1170],
14	,	,	O	,	_	0	SENT_24	[p2l955t1106r1217b1170],
15	non	JJ	O	non	amod	16	SENT_24	[p2l1248t1106r1564b1161],
16	—	NN	O	—	appos	6	SENT_24	[p2l1248t1106r1564b1161],
17	small	JJ	O	small	amod	20	SENT_24	[p2l1248t1106r1564b1161],
18	cell	NN	O	cell	nn	20	SENT_24	[p2l1597t1106r1710b1160],
19	lung	NN	O	lung	nn	20	SENT_24	[p2l1742t1106r1880b1176],
20	cancer	NN	O	cancer	dep	16	SENT_24	[p2l1914t1123r2140b1170],
21	,	,	O	,	_	0	SENT_24	[p2l1914t1123r2140b1170],
22	gefitinib	NN	O	gefitinib	nsubj	23	SENT_24	[p2l10t1199r269b1269],
23	advanced	VBD	O	advance	_	0	SENT_24	[p2l9t1296r348b1356],
24	NSCLC	NNP	O	NSCLC	nsubj	40	SENT_24	[p2l384t1297r668b1357],
25	(	CD	NUMBER	(	num	24	SENT_24	[p2l710t1296r835b1371],
26	3	CD	NUMBER	3	num	27	SENT_24	[p2l710t1296r835b1371],
27	)	NN	O	)	tmod	24	SENT_24	[p2l710t1296r835b1371],
28	,	,	O	,	_	0	SENT_24	[p2l710t1296r835b1371],
29	although	IN	O	although	mark	35	SENT_24	[p2l873t1296r1188b1374],
30	overexpression	NN	O	overexpression	nsubjpass	35	SENT_24	[p2l1225t1296r1775b1374],
31	of	IN	O	of	_	0	SENT_24	[p2l1813t1296r1890b1357],
32	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_24	[p2l1920t1297r2147b1357],
33	protein	NN	O	protein	prep_of	30	SENT_24	[p2l6t1399r251b1477],
34	was	VBD	O	be	auxpass	35	SENT_24	[p2l286t1418r415b1459],
35	seen	VBN	O	see	dep	27	SENT_24	[p2l455t1418r604b1459],
36	in	IN	O	in	_	0	SENT_24	[p2l639t1399r704b1458],
37	relatively	RB	O	relatively	advmod	38	SENT_24	[p2l737t1399r1062b1477],
38	high	JJ	O	high	amod	39	SENT_24	[p2l1097t1399r1250b1477],
39	frequencies	NNS	O	frequency	prep_in	35	SENT_24	[p2l1284t1399r1679b1477],
40	(	VBP	O	(	ccomp	23	SENT_24	[p2l1719t1399r1835b1474],
41	5	CD	NUMBER	5	number	42	SENT_24	[p2l1719t1399r1835b1474],
42	)	CD	NUMBER	)	dobj	40	SENT_24	[p2l1719t1399r1835b1474],
43	.	.	O	.	_	0	SENT_24	[p2l1719t1399r1835b1474],

1	We	PRP	O	we	nsubj	5	SENT_25	[p2l1870t1401r1988b1460],
2	and	CC	O	and	_	0	SENT_25	[p2l2025t1399r2147b1459],
3	others	NNS	O	other	conj_and	1	SENT_25	[p2l8t1501r232b1561],
4	have	VBP	O	have	aux	5	SENT_25	[p2l271t1501r442b1561],
5	shown	VBN	O	show	_	0	SENT_25	[p2l484t1501r719b1561],
6	that	IN	O	that	complm	18	SENT_25	[p2l757t1501r896b1561],
7	the	DT	O	the	det	9	SENT_25	[p2l933t1501r1042b1561],
8	somatic	JJ	O	somatic	amod	9	SENT_25	[p2l1085t1501r1367b1561],
9	mutation	NN	O	mutation	nsubjpass	18	SENT_25	[p2l1407t1501r1737b1561],
10	in	IN	O	in	_	0	SENT_25	[p2l1775t1501r1843b1560],
11	the	DT	O	the	det	13	SENT_25	[p2l1881t1501r1991b1561],
12	TK	NN	O	tk	nn	13	SENT_25	[p2l2030t1503r2147b1560],
13	domain	NN	O	domain	prep_in	9	SENT_25	[p2l8t1604r275b1665],
14	of	IN	O	of	_	0	SENT_25	[p2l312t1604r389b1665],
15	the	DT	O	the	det	16	SENT_25	[p2l420t1604r526b1664],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	13	SENT_25	[p2l563t1605r789b1665],
17	is	VBZ	O	be	auxpass	18	SENT_25	[p2l826t1604r881b1664],
18	associated	VBN	O	associate	ccomp	5	SENT_25	[p2l921t1604r1291b1665],
19	with	IN	O	with	_	0	SENT_25	[p2l1327t1604r1485b1664],
20	the	DT	O	the	det	21	SENT_25	[p2l1521t1604r1628b1664],
21	sensitivity	NN	O	sensitivity	prep_with	18	SENT_25	[p2l1668t1604r2037b1682],
22	of	IN	O	of	_	0	SENT_25	[p2l2076t1604r2152b1665],
23	NSCLC	NNP	ORGANIZATION	NSCLC	prep_of	21	SENT_25	[p2l7t1707r294b1768],
24	to	TO	O	to	aux	25	SENT_25	[p2l333t1716r400b1768],
25	gefitinib	VB	O	gefitinib	xcomp	18	SENT_25	[p2l440t1707r752b1785],
26	(	CD	NUMBER	(	num	28	SENT_25	[p2l793t1707r996b1782],
27	6-8	CD	NUMBER	6-8	num	28	SENT_25	[p2l793t1707r996b1782],
28	)	NN	O	)	dobj	25	SENT_25	[p2l793t1707r996b1782],
29	.	.	O	.	_	0	SENT_25	[p2l793t1707r996b1782],

1	The	DT	O	the	det	6	SENT_26	[p2l1035t1707r1172b1767],
2	most	RBS	O	most	advmod	3	SENT_26	[p2l1211t1716r1387b1768],
3	frequently	RB	O	frequently	advmod	4	SENT_26	[p2l1424t1707r1802b1785],
4	reported	VBN	O	report	amod	6	SENT_26	[p2l1839t1707r2147b1785],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_26	[p2l7t1811r233b1871],
6	mutations	NNS	O	mutation	nsubj	9	SENT_26	[p2l270t1810r624b1871],
7	are	VBP	O	be	cop	9	SENT_26	[p2l665t1829r770b1870],
8	either	RB	O	either	advmod	9	SENT_26	[p2l808t1810r1014b1870],
9	deletion	NN	O	deletion	_	0	SENT_26	[p2l1050t1810r1342b1871],
10	or	CC	O	or	_	0	SENT_26	[p2l1379t1829r1452b1871],
11	single	JJ	O	single	amod	14	SENT_26	[p2l1490t1810r1701b1888],
12	amino	NN	O	amino	nn	14	SENT_26	[p2l1741t1810r1960b1871],
13	acid	NN	O	acid	nn	14	SENT_26	[p2l2000t1810r2148b1870],
14	substitutions	NNS	O	substitution	conj_or	9	SENT_26	[p2l10t1913r441b1974],
15	in	IN	O	in	_	0	SENT_26	[p2l470t1913r535b1973],
16	exon	NN	O	exon	prep_in	14	SENT_26	[p2l561t1932r727b1974],
17	18	CD	NUMBER	18	num	16	SENT_26	[p2l762t1914r860b1985],
18	,	,	O	,	_	0	SENT_26	[p2l762t1914r860b1985],
19	19	CD	NUMBER	19	conj_or	9	SENT_26	[p2l894t1914r993b1985],
20	,	,	O	,	_	0	SENT_26	[p2l894t1914r993b1985],
21	or	CC	O	or	_	0	SENT_26	[p2l1019t1932r1090b1974],
22	21	CD	NUMBER	21	conj_or	9	SENT_26	[p2l1116t1914r1191b1973],
23	clustered	VBN	O	cluster	partmod	22	SENT_26	[p2l1226t1913r1536b1974],
24	around	IN	O	around	_	0	SENT_26	[p2l1564t1913r1801b1974],
25	the	DT	O	the	det	27	SENT_26	[p2l1826t1913r1929b1974],
26	ATPbinding	NN	O	atpbinding	nn	27	SENT_26	[p2l1956t1914r2144b1973, p2l6t2016r269b2094],
27	pocket	NN	O	pocket	prep_around	23	SENT_26	[p2l302t2016r534b2094],
28	of	IN	O	of	_	0	SENT_26	[p2l567t2016r642b2077],
29	the	DT	O	the	det	31	SENT_26	[p2l670t2016r773b2076],
30	TK	NN	O	tk	nn	31	SENT_26	[p2l807t2018r921b2076],
31	domain	NN	O	domain	prep_of	27	SENT_26	[p2l955t2016r1232b2077],
32	.	.	O	.	_	0	SENT_26	[p2l955t2016r1232b2077],

1	In	FW	O	in	nn	2	SENT_27	[p2l1265t2018r1337b2076],
2	vitro	FW	O	vitro	nsubjpass	25	SENT_27	[p2l1371t2018r1555b2088],
3	,	,	O	,	_	0	SENT_27	[p2l1371t2018r1555b2088],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_27	[p2l1587t2017r1807b2077],
5	mutation	NN	O	mutation	appos	2	SENT_27	[p2l1841t2016r2147b2077],
6	has	VBZ	O	have	aux	8	SENT_27	[p2l7t2119r119b2179],
7	been	VBN	O	be	auxpass	8	SENT_27	[p2l145t2119r308b2179],
8	reported	VBN	O	report	_	0	SENT_27	[p2l332t2119r621b2197],
9	to	TO	O	to	aux	10	SENT_27	[p2l646t2128r710b2180],
10	confer	VB	O	confer	xcomp	8	SENT_27	[p2l737t2119r957b2180],
11	enhanced	VBN	O	enhance	amod	13	SENT_27	[p2l982t2119r1307b2179],
12	TK	NN	O	tk	nn	13	SENT_27	[p2l1332t2121r1446b2179],
13	activity	NN	O	activity	dobj	10	SENT_27	[p2l1473t2119r1728b2197],
14	in	IN	O	in	_	0	SENT_27	[p2l1755t2119r1820b2178],
15	response	NN	O	response	prep_in	13	SENT_27	[p2l1845t2138r2146b2197],
16	to	TO	O	to	dep	15	SENT_27	[p2l7t2231r78b2283],
17	the	DT	O	the	det	23	SENT_27	[p2l120t2222r236b2282],
18	epidermal	JJ	O	epidermal	amod	23	SENT_27	[p2l278t2222r674b2300],
19	growth	NN	O	growth	nn	23	SENT_27	[p2l717t2222r992b2300],
20	factor	NN	O	factor	nn	23	SENT_27	[p2l1033t2222r1267b2283],
21	(	CD	NUMBER	(	num	23	SENT_27	[p2l1309t2223r1549b2297],
22	EGF	NN	ORGANIZATION	egf	nn	23	SENT_27	[p2l1309t2223r1549b2297],
23	)	NN	O	)	dep	15	SENT_27	[p2l1309t2223r1549b2297],
24	and	CC	O	and	_	0	SENT_27	[p2l1594t2222r1729b2282],
25	increased	VBD	O	increase	conj_and	8	SENT_27	[p2l1770t2222r2147b2282],
26	sensitivity	NN	O	sensitivity	dobj	25	SENT_27	[p2l10t2325r361b2403],
27	to	TO	O	to	_	0	SENT_27	[p2l389t2334r453b2386],
28	the	DT	O	the	det	29	SENT_27	[p2l482t2325r586b2385],
29	inhibition	NN	O	inhibition	prep_to	25	SENT_27	[p2l615t2325r950b2386],
30	by	IN	O	by	_	0	SENT_27	[p2l976t2325r1061b2403],
31	gefitinib	NN	O	gefitinib	prep_by	25	SENT_27	[p2l1091t2325r1380b2403],
32	(	CD	NUMBER	(	number	33	SENT_27	[p2l1412t2325r1767b2400],
33	6,7,9,10	CD	NUMBER	6,7,9,10	num	34	SENT_27	[p2l1412t2325r1767b2400],
34	)	NN	O	)	dobj	8	SENT_27	[p2l1412t2325r1767b2400],
35	.	.	O	.	_	0	SENT_27	[p2l1412t2325r1767b2400],

1	Thus	RB	O	thus	advmod	6	SENT_28	[p2l1796t2325r1990b2397],
2	,	,	O	,	_	0	SENT_28	[p2l1796t2325r1990b2397],
3	it	PRP	O	it	nsubj	6	SENT_28	[p2l2018t2325r2065b2385],
4	is	VBZ	O	be	cop	6	SENT_28	[p2l2092t2325r2145b2385],
5	highly	RB	O	highly	advmod	6	SENT_28	[p2l7t2428r226b2506],
6	likely	JJ	O	likely	_	0	SENT_28	[p2l256t2428r450b2506],
7	that	IN	O	that	complm	13	SENT_28	[p2l479t2428r609b2488],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_28	[p2l636t2429r856b2489],
9	mutation	NN	O	mutation	nsubj	13	SENT_28	[p2l885t2428r1191b2489],
10	is	VBZ	O	be	cop	13	SENT_28	[p2l1220t2428r1273b2488],
11	a	DT	O	a	det	13	SENT_28	[p2l1306t2447r1341b2488],
12	critical	JJ	O	critical	amod	13	SENT_28	[p2l1370t2428r1607b2488],
13	determinant	NN	O	determinant	ccomp	6	SENT_28	[p2l1637t2428r2049b2488],
14	of	IN	O	of	_	0	SENT_28	[p2l2078t2428r2153b2489],
15	the	DT	O	the	det	16	SENT_28	[p2l7t2531r110b2591],
16	patient	NN	O	patient	poss	18	SENT_28	[p2l134t2531r416b2609],
17	's	POS	O	's	_	0	SENT_28	[p2l134t2531r416b2609],
18	response	NN	O	response	prep_of	13	SENT_28	[p2l441t2550r742b2609],
19	to	TO	O	to	_	0	SENT_28	[p2l766t2540r831b2592],
20	gefitinib	NN	O	gefitinib	prep_to	18	SENT_28	[p2l857t2531r1167b2609],
21	.	.	O	.	_	0	SENT_28	[p2l857t2531r1167b2609],

1	Other	JJ	O	other	amod	2	SENT_29	[p2l130t2633r337b2693],
2	biomarkers	NNS	O	biomarker	nsubjpass	8	SENT_29	[p2l371t2633r783b2693],
3	of	IN	O	of	_	0	SENT_29	[p2l824t2633r901b2693],
4	NSCLC	NNP	ORGANIZATION	NSCLC	prep_of	2	SENT_29	[p2l933t2634r1220b2694],
5	have	VBP	O	have	aux	8	SENT_29	[p2l1258t2633r1428b2693],
6	also	RB	O	also	advmod	8	SENT_29	[p2l1468t2633r1611b2693],
7	been	VBN	O	be	auxpass	8	SENT_29	[p2l1648t2633r1820b2693],
8	studied	VBN	O	study	_	0	SENT_29	[p2l1860t2633r2145b2693],
9	.	.	O	.	_	0	SENT_29	[p2l1860t2633r2145b2693],

1	Some	DT	O	some	det	2	SENT_30	[p2l10t2737r202b2797],
2	studies	NNS	O	study	nsubj	3	SENT_30	[p2l240t2736r473b2796],
3	reported	VBD	O	report	_	0	SENT_30	[p2l508t2736r797b2814],
4	that	IN	O	that	complm	32	SENT_30	[p2l830t2736r959b2796],
5	downstream	JJ	O	downstream	nsubj	32	SENT_30	[p2l993t2736r1415b2797],
6	signaling	VBG	O	signal	partmod	5	SENT_30	[p2l1451t2736r1762b2814],
7	molecules	NNS	O	molecule	dobj	6	SENT_30	[p2l1797t2736r2144b2797],
8	(	RB	O	(	advmod	9	SENT_30	[p2l10t2839r518b2917],
9	particularly	RB	O	particularly	amod	7	SENT_30	[p2l10t2839r518b2917],
10	,	,	O	,	_	0	SENT_30	[p2l10t2839r518b2917],
11	the	DT	O	the	det	15	SENT_30	[p2l556t2839r669b2899],
12	Akt	NN	MISC	akt	nn	15	SENT_30	[p2l709t2839r848b2899],
13	signaling	NN	O	signaling	nn	15	SENT_30	[p2l889t2839r1238b2917],
14	pathway	NN	O	pathway	nn	15	SENT_30	[p2l1278t2839r1659b2917],
15	)	NN	O	)	conj_and	7	SENT_30	[p2l1278t2839r1659b2917],
16	,	,	O	,	_	0	SENT_30	[p2l1278t2839r1659b2917],
17	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_30	[p2l1697t2840r1932b2900],
18	gene	NN	O	gene	nn	19	SENT_30	[p2l1972t2858r2146b2917],
19	amplification	NN	O	amplification	appos	15	SENT_30	[p2l9t2942r490b3020],
20	,	,	O	,	_	0	SENT_30	[p2l9t2942r490b3020],
21	and	CC	O	and	_	0	SENT_30	[p2l518t2942r640b3002],
22	the	DT	O	the	det	23	SENT_30	[p2l666t2942r769b3002],
23	expression	NN	O	expression	dobj	6	SENT_30	[p2l797t2942r1166b3020],
24	of	IN	O	of	_	0	SENT_30	[p2l1194t2942r1268b3003],
25	the	DT	O	the	det	28	SENT_30	[p2l1289t2942r1393b3002],
26	other	JJ	O	other	amod	28	SENT_30	[p2l1422t2942r1598b3003],
27	ErbB	NN	O	erbb	nn	28	SENT_30	[p2l1623t2942r1799b3002],
28	receptors	NNS	O	receptor	prep_of	23	SENT_30	[p2l1830t2951r2145b3020],
29	were	VBD	O	be	cop	32	SENT_30	[p2l8t3064r173b3105],
30	the	DT	O	the	det	32	SENT_30	[p2l206t3045r309b3105],
31	other	JJ	O	other	amod	32	SENT_30	[p2l343t3045r520b3106],
32	predictors	NNS	O	predictor	ccomp	3	SENT_30	[p2l549t3045r893b3123],
33	of	IN	O	of	_	0	SENT_30	[p2l928t3045r1003b3106],
34	gefitinib	NN	O	gefitinib	nn	35	SENT_30	[p2l1031t3045r1320b3123],
35	sensitivity	NN	O	sensitivity	prep_of	32	SENT_30	[p2l1357t3045r1728b3123],
36	.	.	O	.	_	0	SENT_30	[p2l1357t3045r1728b3123],

1	The	DT	O	the	det	2	SENT_31	[p2l1762t3045r1894b3105],
2	EGFR	NN	ORGANIZATION	egfr	nsubjpass	37	SENT_31	[p2l1927t3046r2147b3106],
3	and	CC	O	and	_	0	SENT_31	[p2l9t3148r131b3208],
4	chromosome	NN	O	chromosome	nsubjpass	37	SENT_31	[p2l164t3148r608b3209],
5	7	CD	NUMBER	7	num	7	SENT_31	[p2l643t3150r680b3208],
6	copy	NN	O	copy	nn	7	SENT_31	[p2l717t3167r882b3226],
7	numbers	NNS	O	number	nsubjpass	11	SENT_31	[p2l917t3148r1211b3208],
8	in	IN	O	in	_	0	SENT_31	[p2l1247t3148r1312b3208],
9	NSCLC	NNP	O	NSCLC	prep_in	7	SENT_31	[p2l1344t3149r1620b3209],
10	were	VBD	O	be	auxpass	11	SENT_31	[p2l1656t3167r1821b3208],
11	assessed	VBN	O	assess	rcmod	2	SENT_31	[p2l1857t3148r2147b3208],
12	using	VBG	O	use	xcomp	11	SENT_31	[p2l7t3251r197b3329],
13	ﬂuorescence	NN	O	ﬂuorescence	dobj	12	SENT_31	[p2l234t3251r683b3312],
14	in	IN	O	in	_	0	SENT_31	[p2l723t3253r786b3311],
15	sitn	NN	O	sitn	nn	16	SENT_31	[p2l822t3253r948b3312],
16	hybridization	NN	O	hybridization	prep_in	12	SENT_31	[p2l985t3251r1461b3329],
17	(	CD	NUMBER	(	num	19	SENT_31	[p2l1499t3252r1770b3326],
18	FISH	NN	O	fish	nn	19	SENT_31	[p2l1499t3252r1770b3326],
19	)	NN	O	)	dep	16	SENT_31	[p2l1499t3252r1770b3326],
20	,	,	O	,	_	0	SENT_31	[p2l1499t3252r1770b3326],
21	and	CC	O	and	_	0	SENT_31	[p2l1807t3251r1932b3311],
22	more	JJR	O	more	mwe	23	SENT_31	[p2l1967t3270r2146b3312],
23	than	IN	O	than	quantmod	24	SENT_31	[p2l7t3354r159b3414],
24	3	CD	NUMBER	3	num	26	SENT_31	[p2l197t3354r231b3414],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_31	[p2l272t3355r496b3415],
26	copies	NNS	O	copy	conj_and	16	SENT_31	[p2l532t3354r756b3432],
27	per	IN	O	per	_	0	SENT_31	[p2l793t3373r907b3432],
28	cell	NN	O	cell	nn	29	SENT_31	[p2l942t3354r1068b3414],
29	(	NN	O	(	prep_per	26	SENT_31	[p2l1108t3354r1452b3429],
30	balanced	JJ	O	balanced	amod	31	SENT_31	[p2l1108t3354r1452b3429],
31	polysomy	NN	O	polysomy	tmod	12	SENT_31	[p2l1486t3354r1836b3432],
32	or	CC	O	or	_	0	SENT_31	[p2l1874t3373r1946b3415],
33	gene	NN	O	gene	nn	35	SENT_31	[p2l1982t3373r2146b3432],
34	amplification	NN	O	amplification	nn	35	SENT_31	[p2l9t3457r519b3535],
35	)	NN	O	)	conj_or	31	SENT_31	[p2l9t3457r519b3535],
36	were	VBD	O	be	auxpass	37	SENT_31	[p2l558t3476r729b3517],
37	detected	VBN	O	detect	_	0	SENT_31	[p2l767t3457r1067b3517],
38	in	IN	O	in	_	0	SENT_31	[p2l1103t3457r1170b3517],
39	39	CD	PERCENT	39	number	40	SENT_31	[p2l1209t3457r1292b3518],
40	(	CD	PERCENT	(	nn	49	SENT_31	[p2l1333t3457r1550b3532],
41	22	CD	PERCENT	22	number	42	SENT_31	[p2l1333t3457r1550b3532],
42	%	NN	PERCENT	%	amod	40	SENT_31	[p2l1333t3457r1550b3532],
43	)	CD	NUMBER	)	npadvmod	40	SENT_31	[p2l1333t3457r1550b3532],
44	of	IN	O	of	_	0	SENT_31	[p2l1590t3457r1666b3518],
45	183	CD	NUMBER	183	num	46	SENT_31	[p2l1706t3457r1824b3517],
46	patients	NNS	O	patient	prep_of	40	SENT_31	[p2l1865t3457r2145b3535],
47	(	CD	NUMBER	(	number	48	SENT_31	[p2l10t3561r170b3635],
48	11	CD	NUMBER	11	num	46	SENT_31	[p2l10t3561r170b3635],
49	)	NN	O	)	prep_in	37	SENT_31	[p2l10t3561r170b3635],
50	.	.	O	.	_	0	SENT_31	[p2l10t3561r170b3635],

1	A	DT	O	a	det	2	SENT_32	[p2l196t3561r257b3619],
2	correlation	NN	O	correlation	nsubjpass	14	SENT_32	[p2l283t3560r655b3621],
3	between	IN	O	between	_	0	SENT_32	[p2l680t3560r967b3620],
4	an	DT	O	a	det	8	SENT_32	[p2l994t3579r1072b3620],
5	increased	VBN	O	increase	amod	8	SENT_32	[p2l1098t3560r1423b3620],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_32	[p2l1447t3561r1667b3621],
7	copy	NN	O	copy	nn	8	SENT_32	[p2l1693t3579r1858b3638],
8	number	NN	O	number	prep_between	2	SENT_32	[p2l1884t3560r2148b3620],
9	and	CC	O	and	_	0	SENT_32	[p2l9t3663r131b3723],
10	gefitinib	NN	O	gefitinib	nn	11	SENT_32	[p2l166t3663r455b3741],
11	sensitivity	NN	O	sensitivity	prep_between	2	SENT_32	[p2l494t3663r844b3741],
12	was	VBD	O	be	auxpass	14	SENT_32	[p2l880t3682r1010b3723],
13	also	RB	O	also	advmod	14	SENT_32	[p2l1048t3663r1183b3724],
14	proposed	VBN	O	propose	_	0	SENT_32	[p2l1218t3663r1535b3741],
15	in	IN	O	in	_	0	SENT_32	[p2l1569t3663r1634b3722],
16	another	DT	O	another	det	17	SENT_32	[p2l1670t3663r1928b3724],
17	study	NN	O	study	prep_in	14	SENT_32	[p2l1964t3663r2146b3741],
18	from	IN	O	from	_	0	SENT_32	[p3l8t19r175b80],
19	USA	NNP	LOCATION	USA	prep_from	14	SENT_32	[p3l200t20r372b80],
20	(	CD	NUMBER	(	num	19	SENT_32	[p3l401t20r561b94],
21	12	CD	NUMBER	12	num	22	SENT_32	[p3l401t20r561b94],
22	)	NN	O	)	dep	19	SENT_32	[p3l401t20r561b94],
23	.	.	O	.	_	0	SENT_32	[p3l401t20r561b94],

1	Determining	VBG	O	determine	csubj	12	SENT_33	[p3l590t19r1024b97],
2	the	DT	O	the	det	6	SENT_33	[p3l1052t19r1156b79],
3	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_33	[p3l1183t20r1403b80],
4	gene	NN	O	gene	nn	6	SENT_33	[p3l1431t38r1590b97],
5	mutation	NN	O	mutation	nn	6	SENT_33	[p3l1618t19r1924b80],
6	status	NN	O	status	dobj	1	SENT_33	[p3l1954t28r2144b79],
7	and	CC	O	and	_	0	SENT_33	[p3l9t122r144b182],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_33	[p3l192t123r431b183],
9	gene	NN	O	gene	nn	10	SENT_33	[p3l480t141r660b200],
10	amplification	NN	O	amplification	dobj	1	SENT_33	[p3l711t122r1247b200],
11	may	MD	O	may	aux	12	SENT_33	[p3l1296t141r1455b200],
12	bring	VB	O	bring	_	0	SENT_33	[p3l1504t122r1710b200],
13	important	JJ	O	important	amod	14	SENT_33	[p3l1760t122r2148b200],
14	information	NN	O	information	dobj	12	SENT_33	[p3l8t225r441b286],
15	whether	IN	O	whether	complm	20	SENT_33	[p3l478t225r772b285],
16	gefitinib	NN	O	gefitinib	nsubj	20	SENT_33	[p3l809t225r1119b303],
17	is	VBZ	O	be	cop	20	SENT_33	[p3l1158t225r1214b285],
18	a	DT	O	a	det	20	SENT_33	[p3l1255t244r1291b285],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_33	[p3l1327t225r1734b303],
20	option	NN	O	option	ccomp	12	SENT_33	[p3l1774t225r2006b303],
21	for	IN	O	for	_	0	SENT_33	[p3l2043t225r2148b286],
22	Japanese	JJ	MISC	japanese	amod	24	SENT_33	[p3l7t330r320b406],
23	NSCLC	NN	O	nsclc	nn	24	SENT_33	[p3l356t329r636b389],
24	patients	NNS	O	patient	prep_for	20	SENT_33	[p3l673t328r970b406],
25	.	.	O	.	_	0	SENT_33	[p3l673t328r970b406],

1	Therefore	RB	O	therefore	advmod	4	SENT_34	[p3l1007t328r1379b400],
2	,	,	O	,	_	0	SENT_34	[p3l1007t328r1379b400],
3	we	PRP	O	we	nsubj	4	SENT_34	[p3l1414t347r1513b388],
4	evaluated	VBD	O	evaluate	_	0	SENT_34	[p3l1550t328r1889b388],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_34	[p3l1924t329r2147b389],
6	mutation	NN	O	mutation	dobj	4	SENT_34	[p3l7t431r307b492],
7	and	CC	O	and	_	0	SENT_34	[p3l335t431r454b491],
8	copy	NN	O	copy	nn	9	SENT_34	[p3l480t450r641b509],
9	number	NN	O	number	dobj	4	SENT_34	[p3l668t431r926b491],
10	as	IN	O	as	_	0	SENT_34	[p3l952t450r1016b491],
11	predictors	NNS	O	predictor	prep_as	6	SENT_34	[p3l1044t431r1375b509],
12	of	IN	O	of	_	0	SENT_34	[p3l1405t431r1478b492],
13	gefitinib	NN	O	gefitinib	nn	14	SENT_34	[p3l1500t431r1778b509],
14	sensitivity	NN	O	sensitivity	prep_of	11	SENT_34	[p3l1809t431r2146b509],
15	in	IN	O	in	_	0	SENT_34	[p3l8t534r73b594],
16	patients	NNS	O	patient	prep_in	4	SENT_34	[p3l95t534r362b612],
17	with	IN	O	with	_	0	SENT_34	[p3l388t534r540b594],
18	NSCLC	NN	ORGANIZATION	nsclc	prep_with	16	SENT_34	[p3l563t535r839b595],
19	in	IN	O	in	_	0	SENT_34	[p3l865t534r930b593],
20	this	DT	O	this	det	21	SENT_34	[p3l953t534r1074b594],
21	study	NN	O	study	prep_in	4	SENT_34	[p3l1103t534r1306b612],
22	.	.	O	.	_	0	SENT_34	[p3l1103t534r1306b612],

1	Patients	NNS	O	patient	_	0	SENT_35	[p3l7t740r303b801],
2	and	CC	O	and	_	0	SENT_35	[p3l328t742r464b801],
3	methods	NNS	O	method	conj_and	1	SENT_35	[p3l489t741r799b801],

1	Patients	NNS	O	patient	_	0	SENT_36	[p3l6t950r289b1009],
2	and	CC	O	and	_	0	SENT_36	[p3l316t948r448b1008],
3	genomic	JJ	O	genomic	amod	4	SENT_36	[p3l471t950r762b1025],
4	DNA	NN	O	dna	conj_and	1	SENT_36	[p3l787t949r981b1009],
5	.	.	O	.	_	0	SENT_36	[p3l787t949r981b1009],

1	NSCLC	JJ	O	nsclc	amod	2	SENT_37	[p3l1009t949r1285b1009],
2	tissues	NNS	O	tissue	nsubjpass	4	SENT_37	[p3l1313t948r1540b1009],
3	were	VBD	O	be	auxpass	4	SENT_37	[p3l1570t967r1735b1009],
4	obtained	VBN	O	obtain	_	0	SENT_37	[p3l1764t948r2060b1009],
5	at	IN	O	at	_	0	SENT_37	[p3l2088t957r2148b1008],
6	Nagoya	NNP	ORGANIZATION	Nagoya	nn	9	SENT_37	[p3l7t1053r278b1129],
7	City	NNP	ORGANIZATION	City	nn	9	SENT_37	[p3l312t1051r459b1129],
8	University	NNP	ORGANIZATION	University	nn	9	SENT_37	[p3l495t1051r860b1129],
9	Hospital	NNP	ORGANIZATION	Hospital	prep_at	4	SENT_37	[p3l896t1051r1190b1129],
10	by	IN	O	by	_	0	SENT_37	[p3l1224t1051r1309b1129],
11	surgical	JJ	O	surgical	amod	12	SENT_37	[p3l1349t1051r1619b1129],
12	excision	NN	O	excision	prep_by	9	SENT_37	[p3l1656t1051r1944b1112],
13	from	IN	O	from	_	0	SENT_37	[p3l1979t1051r2148b1112],
14	22	CD	NUMBER	22	num	15	SENT_37	[p3l9t1155r93b1213],
15	patients	NNS	O	patient	prep_from	4	SENT_37	[p3l130t1154r411b1232],
16	who	WP	O	who	nsubjpass	19	SENT_37	[p3l451t1154r600b1215],
17	were	VBD	O	be	auxpass	19	SENT_37	[p3l639t1173r810b1214],
18	subsequently	RB	O	subsequently	advmod	19	SENT_37	[p3l851t1154r1321b1232],
19	treated	VBN	O	treat	rcmod	15	SENT_37	[p3l1359t1154r1606b1214],
20	with	IN	O	with	_	0	SENT_37	[p3l1643t1154r1801b1214],
21	gefitinib	NN	O	gefitinib	nn	24	SENT_37	[p3l1839t1154r2145b1232],
22	(	CD	NUMBER	(	num	24	SENT_37	[p3l10t1255r321b1332],
23	Iressa	NNP	O	Iressa	nn	24	SENT_37	[p3l10t1255r321b1332],
24	®	NNP	O	®	prep_with	19	SENT_37	[p3l10t1255r321b1332],
25	,	,	O	,	_	0	SENT_37	[p3l10t1255r321b1332],
26	Astra	NNP	ORGANIZATION	Astra	nn	32	SENT_37	[p3l358t1258r558b1318],
27	Zeneca	NNP	ORGANIZATION	Zeneca	nn	32	SENT_37	[p3l594t1259r883b1329],
28	,	,	O	,	_	0	SENT_37	[p3l594t1259r883b1329],
29	London	NNP	LOCATION	London	appos	32	SENT_37	[p3l920t1257r1229b1329],
30	,	,	O	,	_	0	SENT_37	[p3l920t1257r1229b1329],
31	UK	NNP	LOCATION	UK	appos	32	SENT_37	[p3l1266t1258r1421b1332],
32	)	NNP	O	)	appos	24	SENT_37	[p3l1266t1258r1421b1332],
33	for	IN	O	for	_	0	SENT_37	[p3l1462t1257r1568b1318],
34	their	PRP$	O	they	poss	36	SENT_37	[p3l1604t1257r1775b1318],
35	recurrent	JJ	O	recurrent	amod	36	SENT_37	[p3l1810t1266r2148b1318],
36	disease	NN	O	disease	prep_for	32	SENT_37	[p3l8t1360r276b1421],
37	.	.	O	.	_	0	SENT_37	[p3l8t1360r276b1421],

1	The	DT	O	the	det	3	SENT_38	[p3l311t1360r443b1421],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_38	[p3l478t1361r698b1421],
3	mutation	NN	O	mutation	nsubjpass	9	SENT_38	[p3l732t1360r1038b1421],
4	and	CC	O	and	_	0	SENT_38	[p3l1074t1360r1195b1420],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_38	[p3l1229t1361r1449b1421],
6	copy	NN	O	copy	nn	7	SENT_38	[p3l1483t1379r1648b1439],
7	number	NN	O	number	conj_and	3	SENT_38	[p3l1683t1360r1947b1421],
8	were	VBD	O	be	auxpass	9	SENT_38	[p3l1981t1379r2146b1421],
9	analyzed	VBN	O	analyze	_	0	SENT_38	[p3l9t1463r337b1542],
10	in	IN	O	in	_	0	SENT_38	[p3l375t1463r443b1523],
11	these	DT	O	these	det	14	SENT_38	[p3l481t1463r669b1524],
12	22	CD	NUMBER	22	num	14	SENT_38	[p3l709t1464r795b1523],
13	gefitinib	NN	O	gefitinib	nn	14	SENT_38	[p3l834t1463r1443b1541],
14	—	NN	O	—	prep_in	9	SENT_38	[p3l834t1463r1443b1541],
15	treated	VBN	O	treat	partmod	14	SENT_38	[p3l834t1463r1443b1541],
16	samples	NNS	O	sample	dobj	15	SENT_38	[p3l1484t1463r1801b1542],
17	.	.	O	.	_	0	SENT_38	[p3l1484t1463r1801b1542],

1	We	PRP	O	we	nsubj	3	SENT_39	[p3l1839t1465r1961b1524],
2	also	RB	O	also	advmod	3	SENT_39	[p3l2001t1463r2146b1524],
3	analyzed	VBD	O	analyze	_	0	SENT_39	[p3l9t1566r348b1645],
4	143	CD	NUMBER	143	num	6	SENT_39	[p3l396t1567r521b1626],
5	additional	JJ	O	additional	amod	6	SENT_39	[p3l567t1566r953b1627],
6	gefitinib	NN	O	gefitinib	nsubj	11	SENT_39	[p3l994t1566r1570b1644],
7	—	CD	NUMBER	—	dep	6	SENT_39	[p3l994t1566r1570b1644],
8	na	TO	O	na	infmod	7	SENT_39	[p3l994t1566r1570b1644],
9	'	''	O	'	_	0	SENT_39	[p3l994t1566r1570b1644],
10	1	CD	NUMBER	1	dep	8	SENT_39	[p3l994t1566r1570b1644],
11	've	VBP	O	have	ccomp	3	SENT_39	[p3l994t1566r1570b1644],
12	NSCLC	NN	O	nsclc	nn	13	SENT_39	[p3l1610t1567r1905b1627],
13	cases	NNS	O	case	dobj	11	SENT_39	[p3l1947t1585r2145b1627],
14	operated	VBD	O	operate	rcmod	13	SENT_39	[p3l8t1669r304b1748],
15	between	IN	O	between	_	0	SENT_39	[p3l334t1669r622b1730],
16	1997	CD	DATE	1997	prep_between	14	SENT_39	[p3l661t1670r822b1731],
17	and	CC	DATE	and	_	0	SENT_39	[p3l858t1669r980b1729],
18	2000	CD	DATE	2000	conj_and	16	SENT_39	[p3l1012t1670r1180b1729],
19	at	IN	O	at	_	0	SENT_39	[p3l1215t1678r1275b1729],
20	Nagoya	NNP	ORGANIZATION	Nagoya	nn	23	SENT_39	[p3l1305t1671r1574b1748],
21	City	NNP	ORGANIZATION	City	nn	23	SENT_39	[p3l1605t1669r1751b1748],
22	University	NNP	ORGANIZATION	University	nn	23	SENT_39	[p3l1783t1669r2146b1748],
23	Hospital	NNP	ORGANIZATION	Hospital	prep_at	14	SENT_39	[p3l7t1772r319b1851],
24	.	.	O	.	_	0	SENT_39	[p3l7t1772r319b1851],

1	We	PRP	O	we	nsubj	2	SENT_40	[p3l349t1774r468b1833],
2	evaluated	VBD	O	evaluate	_	0	SENT_40	[p3l499t1772r829b1833],
3	the	DT	O	the	det	6	SENT_40	[p3l858t1772r961b1833],
4	ErbB2	NN	O	erbb2	nn	6	SENT_40	[p3l991t1772r1215b1832],
5	copy	NN	O	copy	nn	6	SENT_40	[p3l1246t1791r1411b1851],
6	number	NN	O	number	nsubj	18	SENT_40	[p3l1441t1772r1706b1833],
7	in	IN	O	in	_	0	SENT_40	[p3l1734t1772r1800b1832],
8	59	CD	NUMBER	59	prep_in	6	SENT_40	[p3l1830t1772r1912b1834],
9	of	IN	O	of	_	0	SENT_40	[p3l1944t1772r2019b1833],
10	the	DT	O	the	det	12	SENT_40	[p3l2043t1772r2146b1833],
11	additional	JJ	O	additional	quantmod	12	SENT_40	[p3l9t1875r361b1936],
12	143	CD	NUMBER	143	prep_of	8	SENT_40	[p3l405t1876r523b1935],
13	gefitinib	NN	O	gefitinib	dep	12	SENT_40	[p3l564t1875r1085b1953],
14	—	CD	NUMBER	—	num	13	SENT_40	[p3l564t1875r1085b1953],
15	na	TO	O	na	infmod	13	SENT_40	[p3l564t1875r1085b1953],
16	'	''	O	'	_	0	SENT_40	[p3l564t1875r1085b1953],
17	1	CD	NUMBER	1	dep	15	SENT_40	[p3l564t1875r1085b1953],
18	've	VBP	O	have	ccomp	2	SENT_40	[p3l564t1875r1085b1953],
19	NSCLC	NN	O	nsclc	nn	20	SENT_40	[p3l1121t1876r1401b1936],
20	cases	NNS	O	case	dobj	18	SENT_40	[p3l1439t1894r1645b1936],
21	.	.	O	.	_	0	SENT_40	[p3l1439t1894r1645b1936],

1	The	DT	O	the	det	2	SENT_41	[p3l1682t1875r1816b1936],
2	research	NN	O	research	_	0	SENT_41	[p3l1851t1875r2147b1936],

1	534	CD	NUMBER	534	num	2	SENT_42	[p3l178t2034r245b2065],
2	ENDO	NN	O	endo	_	0	SENT_42	[p3l613t2029r704b2053],
3	et	FW	O	et	nn	4	SENT_42	[p3l714t2034r738b2053],
4	al	FW	O	al	dep	2	SENT_42	[p3l746t2029r778b2053],
5	:	:	O	:	_	0	SENT_42	[p3l746t2029r778b2053],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_42	[p3l798t2029r882b2053],
7	MUTATION	NN	O	mutation	dep	2	SENT_42	[p3l891t2029r1068b2053],
8	AND	CC	O	and	_	0	SENT_42	[p3l1078t2030r1148b2053],
9	COPY	NN	O	copy	nn	10	SENT_42	[p3l1158t2029r1246b2053],
10	NUMBER	NN	O	number	dep	2	SENT_42	[p3l1255t2030r1397b2053],
11	IN	IN	O	in	_	0	SENT_42	[p3l1406t2030r1441b2053],
12	NON-SMALL	NNP	O	NON-SMALL	nn	15	SENT_42	[p3l1449t2029r1645b2053],
13	CELL	NNP	O	CELL	nn	15	SENT_42	[p3l1654t2029r1737b2053],
14	LUNG	NN	O	lung	nn	15	SENT_42	[p3l1746t2029r1837b2053],
15	CANCER	NNP	O	CANCER	prep_in	7	SENT_42	[p3l1847t2029r1981b2053],

1	was	VBD	O	be	auxpass	2	SENT_43	[p3l13t2240r150b2281],
2	approved	VBN	O	approve	_	0	SENT_43	[p3l193t2221r536b2299],
3	by	IN	O	by	_	0	SENT_43	[p3l573t2221r660b2299],
4	the	DT	O	the	det	7	SENT_43	[p3l699t2221r810b2281],
5	Institutional	JJ	ORGANIZATION	institutional	amod	7	SENT_43	[p3l849t2221r1307b2282],
6	Review	NNP	ORGANIZATION	Review	nn	7	SENT_43	[p3l1345t2221r1625b2281],
7	Board	NNP	ORGANIZATION	Board	agent	2	SENT_43	[p3l1664t2221r1888b2282],
8	of	IN	O	of	_	0	SENT_43	[p3l1927t2221r2005b2282],
9	the	DT	O	the	det	10	SENT_43	[p3l2037t2221r2147b2281],
10	hospital	NN	O	hospital	prep_of	7	SENT_43	[p3l12t2324r305b2402],
11	.	.	O	.	_	0	SENT_43	[p3l12t2324r305b2402],

1	All	PDT	O	all	predet	3	SENT_44	[p3l334t2324r442b2384],
2	the	DT	O	the	det	3	SENT_44	[p3l471t2324r574b2384],
3	patients	NNS	O	patient	nsubj	4	SENT_44	[p3l602t2324r868b2402],
4	consented	VBD	O	consent	_	0	SENT_44	[p3l899t2324r1243b2385],
5	to	TO	O	to	_	0	SENT_44	[p3l1270t2333r1334b2385],
6	the	DT	O	the	det	7	SENT_44	[p3l1363t2324r1467b2384],
7	use	NN	O	use	prep_to	4	SENT_44	[p3l1495t2343r1608b2384],
8	of	IN	O	of	_	0	SENT_44	[p3l1638t2324r1713b2385],
9	their	PRP$	O	they	poss	10	SENT_44	[p3l1735t2324r1893b2384],
10	tissues	NNS	O	tissue	prep_of	7	SENT_44	[p3l1919t2324r2146b2384],
11	for	IN	O	for	_	0	SENT_44	[p3l13t2427r116b2488],
12	the	DT	O	the	det	14	SENT_44	[p3l150t2427r255b2487],
13	present	JJ	DATE	present	amod	14	SENT_44	[p3l291t2436r549b2505],
14	analysis	NN	O	analysis	prep_for	4	SENT_44	[p3l585t2427r891b2505],
15	.	.	O	.	_	0	SENT_44	[p3l585t2427r891b2505],

1	The	DT	O	the	det	2	SENT_45	[p3l928t2427r1062b2487],
2	tissues	NNS	O	tissue	nsubjpass	4	SENT_45	[p3l1099t2427r1333b2487],
3	were	VBD	O	be	auxpass	4	SENT_45	[p3l1371t2446r1540b2487],
4	placed	VBN	O	place	_	0	SENT_45	[p3l1576t2427r1807b2505],
5	in	IN	O	in	_	0	SENT_45	[p3l1843t2427r1909b2487],
6	liquid	JJ	O	liquid	amod	7	SENT_45	[p3l1945t2427r2148b2505],
7	nitrogen	NN	O	nitrogen	prep_in	4	SENT_45	[p3l13t2530r300b2608],
8	immediately	RB	O	immediately	advmod	4	SENT_45	[p3l334t2530r765b2608],
9	after	IN	O	after	_	0	SENT_45	[p3l802t2530r959b2590],
10	resection	NN	O	resection	prep_after	4	SENT_45	[p3l990t2530r1303b2591],
11	or	CC	O	or	_	0	SENT_45	[p3l1337t2549r1408b2591],
12	were	VBD	O	be	cop	14	SENT_45	[p3l1440t2549r1606b2590],
13	formalin	NN	O	formalin	nn	14	SENT_45	[p3l1640t2530r2149b2591],
14	—	NN	O	—	conj_or	4	SENT_45	[p3l1640t2530r2149b2591],
15	fixed	VBN	O	fix	dep	14	SENT_45	[p3l1640t2530r2149b2591],
16	and	CC	O	and	_	0	SENT_45	[p3l15t2633r136b2693],
17	paraffin	NN	O	paraffin	npadvmod	19	SENT_45	[p3l168t2633r845b2711],
18	—	CD	NUMBER	—	num	17	SENT_45	[p3l168t2633r845b2711],
19	embedded	JJ	O	embedded	dep	14	SENT_45	[p3l168t2633r845b2711],
20	.	.	O	.	_	0	SENT_45	[p3l168t2633r845b2711],

1	Genomic	JJ	O	genomic	amod	2	SENT_46	[p3l881t2633r1194b2694],
2	DNA	NN	O	dna	nsubjpass	4	SENT_46	[p3l1229t2634r1414b2694],
3	was	VBD	O	be	auxpass	4	SENT_46	[p3l1449t2652r1578b2693],
4	extracted	VBN	O	extract	_	0	SENT_46	[p3l1614t2633r1930b2693],
5	using	VBG	O	use	xcomp	4	SENT_46	[p3l1962t2633r2147b2711],
6	the	DT	O	the	det	12	SENT_46	[p3l13t2736r115b2796],
7	Wizard	NNP	O	Wizard	nn	12	SENT_46	[p3l139t2736r393b2797],
8	SV	NNP	O	SV	nn	12	SENT_46	[p3l419t2737r524b2797],
9	Genomic	JJ	O	genomic	amod	12	SENT_46	[p3l550t2736r862b2797],
10	DNA	NN	O	dna	nn	12	SENT_46	[p3l888t2737r1073b2796],
11	purification	NN	O	purification	nn	12	SENT_46	[p3l1096t2736r1499b2814],
12	system	NN	O	system	nsubj	14	SENT_46	[p3l1526t2745r1762b2814],
13	(	CD	NUMBER	(	num	14	SENT_46	[p3l1787t2737r2145b2814],
14	Promega	NNP	O	Promega	xcomp	5	SENT_46	[p3l1787t2737r2145b2814],
15	)	CD	NUMBER	)	num	14	SENT_46	[p3l1787t2737r2145b2814],
16	according	VBG	O	accord	_	0	SENT_46	[p3l15t2839r351b2917],
17	to	TO	O	to	prepc_according_to	14	SENT_46	[p3l375t2848r439b2900],
18	the	DT	O	the	det	19	SENT_46	[p3l464t2839r567b2899],
19	manufacturer	NN	O	manufacturer	poss	21	SENT_46	[p3l592t2839r1097b2899],
20	's	POS	O	's	_	0	SENT_46	[p3l592t2839r1097b2899],
21	instructions	NNS	O	instruction	pobj	14	SENT_46	[p3l1124t2839r1546b2900],
22	.	.	O	.	_	0	SENT_46	[p3l1124t2839r1546b2900],

1	Analysis	NN	O	analysis	_	0	SENT_47	[p3l9t3046r315b3123],
2	of	IN	O	of	_	0	SENT_47	[p3l353t3046r433b3123],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_47	[p3l454t3047r679b3107],
4	mutation	NN	O	mutation	prep_of	1	SENT_47	[p3l716t3048r1055b3106],
5	.	.	O	.	_	0	SENT_47	[p3l716t3048r1055b3106],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_48	[p3l1093t3048r1528b3124],
2	—	CD	NUMBER	—	nsubjpass	21	SENT_48	[p3l1093t3048r1528b3124],
3	two	CD	NUMBER	two	num	5	SENT_48	[p3l1093t3048r1528b3124],
4	gefitinib	NN	O	gefitinib	nn	5	SENT_48	[p3l1566t3046r2149b3124],
5	—	NN	O	—	nsubj	17	SENT_48	[p3l1566t3046r2149b3124],
6	treated	VBN	O	treat	partmod	5	SENT_48	[p3l1566t3046r2149b3124],
7	samples	NNS	O	sample	dobj	6	SENT_48	[p3l16t3149r310b3227],
8	and	CC	O	and	_	0	SENT_48	[p3l352t3149r481b3209],
9	the	DT	O	the	det	11	SENT_48	[p3l519t3149r629b3209],
10	additional	JJ	O	additional	quantmod	11	SENT_48	[p3l670t3149r1046b3210],
11	143	CD	NUMBER	143	conj_and	7	SENT_48	[p3l1093t3149r1215b3209],
12	gefitinib	NN	O	gefitinib	dep	11	SENT_48	[p3l1259t3149r1817b3227],
13	—	CD	NUMBER	—	num	12	SENT_48	[p3l1259t3149r1817b3227],
14	na	TO	O	na	xcomp	6	SENT_48	[p3l1259t3149r1817b3227],
15	'	''	O	'	_	0	SENT_48	[p3l1259t3149r1817b3227],
16	1	CD	NUMBER	1	dep	14	SENT_48	[p3l1259t3149r1817b3227],
17	've	VBP	O	have	rcmod	2	SENT_48	[p3l1259t3149r1817b3227],
18	NSCLC	NN	O	nsclc	nn	19	SENT_48	[p3l1856t3149r2146b3210],
19	samples	NNS	O	sample	dobj	17	SENT_48	[p3l16t3252r287b3330],
20	were	VBD	O	be	auxpass	21	SENT_48	[p3l323t3271r488b3312],
21	analyzed	VBN	O	analyze	_	0	SENT_48	[p3l523t3252r827b3330],
22	by	IN	O	by	_	0	SENT_48	[p3l858t3252r943b3330],
23	the	DT	O	the	det	26	SENT_48	[p3l977t3252r1080b3312],
24	TaqMan	NNP	O	TaqMan	nn	26	SENT_48	[p3l1114t3254r1405b3330],
25	PCR	NN	O	pcr	nn	26	SENT_48	[p3l1437t3253r1599b3313],
26	assay	NN	O	assay	agent	21	SENT_48	[p3l1634t3271r1816b3330],
27	(	CD	NUMBER	(	number	28	SENT_48	[p3l1853t3253r1989b3327],
28	14	CD	NUMBER	14	num	29	SENT_48	[p3l1853t3253r1989b3327],
29	)	NN	O	)	dep	26	SENT_48	[p3l1853t3253r1989b3327],
30	and	CC	O	and	_	0	SENT_48	[p3l2027t3252r2148b3312],
31	direct	JJ	O	direct	amod	32	SENT_48	[p3l14t3355r221b3416],
32	sequencing	NN	O	sequencing	agent	21	SENT_48	[p3l260t3355r665b3434],
33	(	CD	NUMBER	(	number	34	SENT_48	[p3l706t3356r875b3430],
34	13	CD	NUMBER	13	num	35	SENT_48	[p3l706t3356r875b3430],
35	)	NN	O	)	dep	32	SENT_48	[p3l706t3356r875b3430],
36	.	.	O	.	_	0	SENT_48	[p3l706t3356r875b3430],

1	The	DT	O	the	det	2	SENT_49	[p3l914t3355r1050b3416],
2	primers	NNS	O	primer	nsubjpass	9	SENT_49	[p3l1087t3355r1363b3434],
3	and	CC	O	and	_	0	SENT_49	[p3l1404t3355r1530b3415],
4	TaqMan	NNP	O	TaqMan	nn	7	SENT_49	[p3l1567t3353r1911b3434],
5	®	NNP	O	®	nn	7	SENT_49	[p3l1567t3353r1911b3434],
6	MGB	NNP	O	MGB	nn	7	SENT_49	[p3l1948t3356r2143b3416],
7	probes	NNS	O	probe	conj_and	2	SENT_49	[p3l12t3458r254b3537],
8	were	VBD	O	be	auxpass	9	SENT_49	[p3l294t3478r468b3519],
9	designed	VBN	O	design	_	0	SENT_49	[p3l507t3458r833b3536],
10	with	IN	O	with	_	0	SENT_49	[p3l871t3458r1031b3518],
11	Primer	NN	O	primer	nn	12	SENT_49	[p3l1069t3458r1318b3519],
12	Express	NN	O	express	prep_with	9	SENT_49	[p3l1354t3460r1642b3537],
13	2.0	CD	NUMBER	2.0	num	14	SENT_49	[p3l1683t3459r1792b3519],
14	software	NN	O	software	tmod	9	SENT_49	[p3l1834t3458r2147b3519],
15	(	CD	NUMBER	(	num	18	SENT_49	[p3l15t3561r345b3640],
16	Applied	NNP	O	Applied	nn	18	SENT_49	[p3l15t3561r345b3640],
17	Biosystems	NNP	O	Biosystems	nn	18	SENT_49	[p3l383t3561r870b3640],
18	)	NN	O	)	dep	14	SENT_49	[p3l383t3561r870b3640],
19	.	.	O	.	_	0	SENT_49	[p3l383t3561r870b3640],

1	We	PRP	O	we	nsubj	2	SENT_50	[p3l908t3563r1030b3622],
2	designed	VBD	O	design	_	0	SENT_50	[p3l1070t3561r1401b3639],
3	13	CD	NUMBER	13	num	4	SENT_50	[p3l1448t3562r1523b3621],
4	sets	NNS	O	set	nsubj	9	SENT_50	[p3l1569t3570r1703b3622],
5	of	IN	O	of	_	0	SENT_50	[p3l1744t3561r1822b3622],
6	specific	JJ	O	specific	amod	8	SENT_50	[p3l1858t3561r2146b3640],
7	TaqMan	NNP	O	TaqMan	nn	8	SENT_50	[p3l13t3666r304b3743],
8	probes	NNS	O	probe	prep_of	4	SENT_50	[p3l333t3664r560b3743],
9	(	VBP	O	(	ccomp	2	SENT_50	[p3l596t3665r755b3739],
10	14	CD	NUMBER	14	num	11	SENT_50	[p3l596t3665r755b3739],
11	)	CD	NUMBER	)	dobj	9	SENT_50	[p3l596t3665r755b3739],
12	.	.	O	.	_	0	SENT_50	[p3l596t3665r755b3739],

1	TaqMan	NNP	O	TaqMan	nn	2	SENT_51	[p3l787t3666r1078b3743],
2	PCR	NN	O	pcr	nsubjpass	7	SENT_51	[p3l1109t3665r1270b3725],
3	and	CC	O	and	_	0	SENT_51	[p3l1302t3664r1424b3724],
4	genotyping	NN	O	genotyping	nn	5	SENT_51	[p3l1455t3664r1840b3743],
5	analysis	NN	O	analysis	conj_and	2	SENT_51	[p3l1873t3664r2146b3743],
6	were	VBD	O	be	auxpass	7	SENT_51	[p4l13t39r181b80],
7	performed	VBN	O	perform	_	0	SENT_51	[p4l216t19r582b98],
8	on	IN	O	on	_	0	SENT_51	[p4l618t38r703b80],
9	7500	CD	DATE	7500	num	13	SENT_51	[p4l739t19r909b80],
10	Real	JJ	O	real	amod	13	SENT_51	[p4l946t19r1106b80],
11	Time	NNP	O	Time	nn	13	SENT_51	[p4l1141t19r1324b80],
12	PCR	NN	O	pcr	nn	13	SENT_51	[p4l1360t20r1523b80],
13	system	NN	O	system	prep_on	7	SENT_51	[p4l1562t28r1802b98],
14	(	CD	NUMBER	(	num	16	SENT_51	[p4l1839t19r2149b98],
15	Applied	NNP	O	Applied	nn	16	SENT_51	[p4l1839t19r2149b98],
16	Biosystems	NNP	O	Biosystems	dobj	7	SENT_51	[p4l13t122r436b201],
17	)	CD	NUMBER	)	num	16	SENT_51	[p4l13t122r436b201],
18	according	VBG	O	accord	_	0	SENT_51	[p4l464t122r800b200],
19	to	TO	O	to	prepc_according_to	16	SENT_51	[p4l825t131r889b183],
20	the	DT	O	the	det	21	SENT_51	[p4l914t122r1016b183],
21	manufacturer	NN	O	manufacturer	poss	23	SENT_51	[p4l1041t122r1547b183],
22	's	POS	O	's	_	0	SENT_51	[p4l1041t122r1547b183],
23	instructions	NNS	O	instruction	pobj	16	SENT_51	[p4l1573t122r1995b183],
24	.	.	O	.	_	0	SENT_51	[p4l1573t122r1995b183],

1	Analysis	NN	O	analysis	_	0	SENT_52	[p4l9t329r321b407],
2	of	IN	O	of	_	0	SENT_52	[p4l360t330r440b407],
3	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_52	[p4l462t331r689b390],
4	and	CC	O	and	_	0	SENT_52	[p4l727t329r864b390],
5	ErbB2	NN	O	erbb2	nn	7	SENT_52	[p4l896t329r1128b390],
6	copy	NN	O	copy	nn	7	SENT_52	[p4l1170t350r1337b407],
7	number	NN	O	number	prep_of	1	SENT_52	[p4l1374t329r1672b390],
8	.	.	O	.	_	0	SENT_52	[p4l1374t329r1672b390],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_53	[p4l1710t330r1937b390],
2	copy	NN	O	copy	nn	3	SENT_53	[p4l1975t348r2147b408],
3	number	NN	O	number	nsubj	33	SENT_53	[p4l13t432r277b493],
4	was	VBD	O	be	auxpass	5	SENT_53	[p4l301t451r431b492],
5	analyzed	VBN	O	analyze	rcmod	3	SENT_53	[p4l460t432r764b511],
6	for	IN	O	for	_	0	SENT_53	[p4l790t432r890b493],
7	the	DT	O	the	det	10	SENT_53	[p4l913t432r1016b493],
8	22	CD	NUMBER	22	num	10	SENT_53	[p4l1044t433r1126b492],
9	gefitinib	NN	O	gefitinib	nn	10	SENT_53	[p4l1153t432r1708b510],
10	—	NN	O	—	prep_for	5	SENT_53	[p4l1153t432r1708b510],
11	treated	VBN	O	treat	partmod	10	SENT_53	[p4l1153t432r1708b510],
12	patients	NNS	O	patient	dobj	11	SENT_53	[p4l1732t432r1998b511],
13	and	CC	O	and	_	0	SENT_53	[p4l2027t432r2149b492],
14	for	IN	O	for	_	0	SENT_53	[p4l13t535r117b596],
15	the	DT	O	the	det	17	SENT_53	[p4l151t535r257b596],
16	additional	JJ	O	additional	quantmod	17	SENT_53	[p4l297t535r654b596],
17	143	CD	NUMBER	143	conj_and	10	SENT_53	[p4l699t536r817b595],
18	gefitinib	NN	O	gefitinib	dep	17	SENT_53	[p4l859t535r1389b613],
19	—	CD	NUMBER	—	num	18	SENT_53	[p4l859t535r1389b613],
20	na	TO	O	na	infmod	18	SENT_53	[p4l859t535r1389b613],
21	'	''	O	'	_	0	SENT_53	[p4l859t535r1389b613],
22	1	CD	NUMBER	1	dep	20	SENT_53	[p4l859t535r1389b613],
23	've	VBP	O	have	aux	33	SENT_53	[p4l859t535r1389b613],
24	NSCLC	NN	O	nsclc	nn	25	SENT_53	[p4l1426t536r1708b596],
25	patients	NNS	O	patient	dobj	33	SENT_53	[p4l1745t535r2023b614],
26	by	IN	O	by	_	0	SENT_53	[p4l2061t535r2147b614],
27	quantitative	JJ	O	quantitative	amod	31	SENT_53	[p4l14t638r429b717],
28	real	JJ	O	real	amod	31	SENT_53	[p4l464t638r782b699],
29	—	NN	O	—	nn	31	SENT_53	[p4l464t638r782b699],
30	time	NN	O	time	nn	31	SENT_53	[p4l464t638r782b699],
31	PCR	NN	O	pcr	prep_by	33	SENT_53	[p4l818t639r1004b710],
32	,	,	O	,	_	0	SENT_53	[p4l818t639r1004b710],
33	performed	VBN	O	perform	_	0	SENT_53	[p4l1038t638r1405b717],
34	on	IN	O	on	_	0	SENT_53	[p4l1441t658r1525b699],
35	7500	CD	DATE	7500	num	39	SENT_53	[p4l1561t638r1733b699],
36	Real	JJ	MISC	real	amod	39	SENT_53	[p4l1770t638r1929b699],
37	Time	NNP	MISC	Time	nn	39	SENT_53	[p4l1965t638r2147b699],
38	PCR	NN	MISC	pcr	nn	39	SENT_53	[p4l13t742r175b802],
39	System	NN	MISC	system	prep_on	33	SENT_53	[p4l212t742r466b820],
40	using	VBG	O	use	xcomp	33	SENT_53	[p4l499t741r686b819],
41	a	DT	O	a	det	43	SENT_53	[p4l723t760r759b801],
42	QuantiTect	JJ	O	quantitect	amod	43	SENT_53	[p4l795t741r1185b816],
43	SYBR	NN	O	sybr	dobj	40	SENT_53	[p4l1222t742r1687b802],
44	.	.	O	.	_	0	SENT_53	[p4l1222t742r1687b802],

1	—	NN	O	—	_	0	SENT_54	[p4l1222t742r1687b802],
2	.	.	O	.	_	0	SENT_54	[p4l1222t742r1687b802],

1	Green	NNP	O	Green	nn	2	SENT_55	[p4l1222t742r1687b802],
2	kit	NN	O	kit	nsubj	14	SENT_55	[p4l1721t741r1813b801],
3	(	CD	NUMBER	(	num	2	SENT_55	[p4l1850t741r2149b819],
4	Qiagen	NNP	ORGANIZATION	Qiagen	nn	11	SENT_55	[p4l1850t741r2149b819],
5	,	,	ORGANIZATION	,	_	0	SENT_55	[p4l1850t741r2149b819],
6	Inc.	NNP	ORGANIZATION	Inc.	appos	11	SENT_55	[p4l13t846r165b916],
7	,	,	O	,	_	0	SENT_55	[p4l13t846r165b916],
8	Valencia	NNP	LOCATION	Valencia	appos	11	SENT_55	[p4l193t844r521b916],
9	,	,	O	,	_	0	SENT_55	[p4l193t844r521b916],
10	CA	NNP	LOCATION	CA	appos	11	SENT_55	[p4l549t845r692b919],
11	)	NNP	O	)	dep	2	SENT_55	[p4l549t845r692b919],
12	as	IN	O	as	advmod	14	SENT_55	[p4l725t863r791b904],
13	previously	RB	DATE	previously	advmod	12	SENT_55	[p4l821t844r1184b923],
14	described	VBN	O	describe	_	0	SENT_55	[p4l1214t844r1543b905],
15	(	NN	O	(	nn	17	SENT_55	[p4l1574t845r1733b919],
16	14	CD	NUMBER	14	num	17	SENT_55	[p4l1574t845r1733b919],
17	)	NN	O	)	dobj	14	SENT_55	[p4l1574t845r1733b919],
18	.	.	O	.	_	0	SENT_55	[p4l1574t845r1733b919],

1	The	DT	O	the	det	4	SENT_56	[p4l1763t844r1895b905],
2	ErbB2	NN	O	erbb2	nn	4	SENT_56	[p4l1923t844r2147b904],
3	copy	NN	O	copy	nn	4	SENT_56	[p4l13t966r182b1026],
4	number	NN	O	number	nsubj	16	SENT_56	[p4l219t947r489b1008],
5	was	VBD	O	be	auxpass	7	SENT_56	[p4l524t966r656b1007],
6	also	RB	O	also	advmod	7	SENT_56	[p4l696t947r834b1008],
7	analyzed	VBN	O	analyze	rcmod	4	SENT_56	[p4l873t947r1186b1026],
8	for	IN	O	for	_	0	SENT_56	[p4l1222t947r1325b1008],
9	the	DT	O	the	det	11	SENT_56	[p4l1359t947r1464b1008],
10	59	CD	NUMBER	59	num	11	SENT_56	[p4l1502t947r1584b1009],
11	gefitinib	NN	O	gefitinib	prep_for	7	SENT_56	[p4l1623t947r2147b1025],
12	—	CD	NUMBER	—	num	11	SENT_56	[p4l1623t947r2147b1025],
13	na	TO	O	na	xcomp	7	SENT_56	[p4l1623t947r2147b1025],
14	'	''	O	'	_	0	SENT_56	[p4l1623t947r2147b1025],
15	1	CD	NUMBER	1	dep	13	SENT_56	[p4l1623t947r2147b1025],
16	've	VBP	O	have	_	0	SENT_56	[p4l1623t947r2147b1025],
17	NSCLC	NN	O	nsclc	nn	18	SENT_56	[p4l12t1051r287b1111],
18	patients	NNS	O	patient	dobj	16	SENT_56	[p4l314t1050r580b1129],
19	by	IN	O	by	_	0	SENT_56	[p4l607t1050r691b1129],
20	quantitative	JJ	O	quantitative	amod	24	SENT_56	[p4l719t1050r1123b1129],
21	real	JJ	O	real	amod	24	SENT_56	[p4l1149t1050r1459b1111],
22	—	NN	O	—	nn	24	SENT_56	[p4l1149t1050r1459b1111],
23	time	NN	O	time	nn	24	SENT_56	[p4l1149t1050r1459b1111],
24	PCR	NN	O	pcr	prep_by	16	SENT_56	[p4l1485t1051r1667b1111],
25	.	.	O	.	_	0	SENT_56	[p4l1485t1051r1667b1111],

1	An	DT	O	a	det	3	SENT_57	[p4l1694t1051r1798b1110],
2	increased	VBN	O	increase	amod	3	SENT_57	[p4l1824t1050r2148b1111],
3	EGFR	NN	ORGANIZATION	egfr	nsubjpass	10	SENT_57	[p4l12t1154r232b1214],
4	and	CC	O	and	_	0	SENT_57	[p4l261t1153r383b1213],
5	an	DT	O	a	det	8	SENT_57	[p4l412t1172r490b1213],
6	ErbB2	NN	O	erbb2	nn	8	SENT_57	[p4l518t1154r740b1213],
7	copy	NN	O	copy	nn	8	SENT_57	[p4l770t1172r935b1232],
8	number	NN	O	number	conj_and	3	SENT_57	[p4l964t1153r1227b1214],
9	was	VBD	O	be	auxpass	10	SENT_57	[p4l1254t1172r1384b1213],
10	defined	VBN	O	define	_	0	SENT_57	[p4l1415t1153r1672b1214],
11	as	IN	O	as	_	0	SENT_57	[p4l1701t1172r1767b1213],
12	more	JJR	O	more	mwe	13	SENT_57	[p4l1798t1173r1972b1214],
13	than	IN	O	than	quantmod	14	SENT_57	[p4l2001t1153r2148b1213],
14	three	CD	NUMBER	three	num	15	SENT_57	[p4l13t1256r183b1317],
15	copies	NNS	O	copy	prep_as	10	SENT_57	[p4l208t1256r446b1335],
16	.	.	O	.	_	0	SENT_57	[p4l208t1256r446b1335],

1	Clinical	JJ	O	clinical	amod	2	SENT_58	[p4l16t1463r292b1524],
2	evaluation	NN	O	evaluation	_	0	SENT_58	[p4l326t1463r688b1524],
3	of	IN	O	of	_	0	SENT_58	[p4l725t1464r803b1541],
4	the	DT	O	the	det	5	SENT_58	[p4l826t1463r926b1524],
5	response	NN	O	response	prep_of	2	SENT_58	[p4l963t1484r1267b1541],
6	to	TO	O	to	_	0	SENT_58	[p4l1305t1475r1367b1524],
7	gefitinib	NN	O	gefitinib	prep_to	2	SENT_58	[p4l1403t1463r1711b1541],
8	.	.	O	.	_	0	SENT_58	[p4l1403t1463r1711b1541],

1	Tumor	NN	O	tumor	nn	2	SENT_59	[p4l1747t1465r1982b1524],
2	size	NN	O	size	nsubjpass	4	SENT_59	[p4l2018t1463r2147b1524],
3	was	VBD	O	be	auxpass	4	SENT_59	[p4l13t1585r143b1626],
4	determined	VBN	O	determine	_	0	SENT_59	[p4l179t1566r566b1627],
5	by	IN	O	by	_	0	SENT_59	[p4l598t1567r682b1645],
6	computed	JJ	O	computed	amod	8	SENT_59	[p4l717t1566r1056b1645],
7	tomographic	JJ	O	tomographic	amod	8	SENT_59	[p4l1089t1566r1522b1645],
8	(	NN	O	(	agent	4	SENT_59	[p4l1560t1567r1720b1641],
9	CT	NN	O	ct	nsubj	11	SENT_59	[p4l1560t1567r1720b1641],
10	)	CD	NUMBER	)	num	9	SENT_59	[p4l1560t1567r1720b1641],
11	scan	VB	O	scan	rcmod	8	SENT_59	[p4l1759t1585r1908b1626],
12	of	IN	O	of	_	0	SENT_59	[p4l1942t1566r2017b1627],
13	the	DT	O	the	det	14	SENT_59	[p4l2044t1566r2147b1627],
14	chest	NN	O	chest	prep_of	11	SENT_59	[p4l13t1669r193b1730],
15	before	IN	O	before	_	0	SENT_59	[p4l226t1669r449b1730],
16	treatment	NN	O	treatment	prep_before	11	SENT_59	[p4l485t1678r838b1730],
17	.	.	O	.	_	0	SENT_59	[p4l485t1678r838b1730],

1	Tumor	NN	O	tumor	nn	2	SENT_60	[p4l875t1671r1113b1730],
2	response	NN	O	response	nsubjpass	4	SENT_60	[p4l1146t1688r1453b1748],
3	was	VBD	O	be	auxpass	4	SENT_60	[p4l1490t1688r1621b1729],
4	assessed	VBN	O	assess	_	0	SENT_60	[p4l1661t1669r1956b1730],
5	by	IN	O	by	_	0	SENT_60	[p4l1990t1669r2075b1748],
6	a	DT	O	a	det	7	SENT_60	[p4l2113t1688r2149b1729],
7	CT	NN	O	ct	agent	4	SENT_60	[p4l14t1773r121b1833],
8	scan	VB	O	scan	ccomp	4	SENT_60	[p4l154t1791r303b1832],
9	4	CD	DURATION	4	num	10	SENT_60	[p4l333t1773r373b1832],
10	weeks	NNS	NUMBER	week	tmod	8	SENT_60	[p4l405t1772r616b1833],
11	after	IN	O	after	_	0	SENT_60	[p4l650t1772r806b1833],
12	treatment	NN	O	treatment	prep_after	8	SENT_60	[p4l834t1781r1179b1833],
13	.	.	O	.	_	0	SENT_60	[p4l834t1781r1179b1833],

1	A	DT	O	a	det	6	SENT_61	[p4l1211t1773r1271b1832],
2	complete	JJ	O	complete	amod	6	SENT_61	[p4l1302t1772r1615b1851],
3	response	NN	O	response	nn	6	SENT_61	[p4l1645t1791r1946b1851],
4	(	CD	NUMBER	(	num	6	SENT_61	[p4l1980t1773r2145b1847],
5	CR	JJ	O	cr	amod	6	SENT_61	[p4l1980t1773r2145b1847],
6	)	NN	O	)	nsubjpass	8	SENT_61	[p4l1980t1773r2145b1847],
7	was	VBD	O	be	auxpass	8	SENT_61	[p4l13t1894r147b1935],
8	defined	VBN	O	define	_	0	SENT_61	[p4l186t1875r450b1936],
9	as	IN	O	as	_	0	SENT_61	[p4l486t1894r552b1935],
10	the	DT	O	the	det	11	SENT_61	[p4l589t1875r693b1936],
11	disappearance	NN	O	disappearance	prep_as	8	SENT_61	[p4l729t1875r1226b1954],
12	of	IN	O	of	_	0	SENT_61	[p4l1262t1875r1338b1936],
13	all	DT	O	all	det	17	SENT_61	[p4l1369t1875r1452b1935],
14	clinical	JJ	O	clinical	amod	17	SENT_61	[p4l1488t1875r1745b1935],
15	and	CC	O	and	_	0	SENT_61	[p4l1782t1875r1905b1935],
16	radiological	JJ	O	radiological	conj_and	14	SENT_61	[p4l1938t1875r2145b1936, p4l13t1978r242b2056],
17	evidence	NN	O	evidence	prep_of	11	SENT_61	[p4l276t1978r576b2039],
18	of	IN	O	of	_	0	SENT_61	[p4l613t1978r688b2039],
19	tumor	NN	O	tumor	prep_of	17	SENT_61	[p4l718t1987r926b2039],
20	for	IN	O	for	_	0	SENT_61	[p4l959t1978r1060b2039],
21	>	JJR	O	>	prep_for	8	SENT_61	[p4l1093t1979r1183b2038],
22	4	CD	DURATION	4	num	23	SENT_61	[p4l1093t1979r1183b2038],
23	weeks	NNS	NUMBER	week	tmod	21	SENT_61	[p4l1220t1979r1455b2039],
24	.	.	O	.	_	0	SENT_61	[p4l1220t1979r1455b2039],

1	A	DT	O	a	det	6	SENT_62	[p4l1492t1979r1552b2038],
2	partial	JJ	O	partial	amod	6	SENT_62	[p4l1586t1978r1808b2057],
3	response	NN	O	response	nn	6	SENT_62	[p4l1843t1997r2147b2057],
4	(	CD	NUMBER	(	num	6	SENT_62	[p4l15t2082r171b2156],
5	PR	NN	O	pr	nn	6	SENT_62	[p4l15t2082r171b2156],
6	)	NN	O	)	nsubj	7	SENT_62	[p4l15t2082r171b2156],
7	required	VBD	O	require	_	0	SENT_62	[p4l202t2081r489b2160],
8	a	DT	O	a	det	12	SENT_62	[p4l520t2100r555b2141],
9	>	JJR	O	>	amod	12	SENT_62	[p4l582t2081r783b2142],
10	50	CD	PERCENT	50	number	11	SENT_62	[p4l582t2081r783b2142],
11	%	NN	PERCENT	%	amod	12	SENT_62	[p4l582t2081r783b2142],
12	reduction	NN	O	reduction	dobj	7	SENT_62	[p4l812t2081r1129b2142],
13	in	IN	O	in	_	0	SENT_62	[p4l1156t2081r1220b2141],
14	the	DT	O	the	det	15	SENT_62	[p4l1246t2081r1347b2142],
15	sum	NN	O	sum	prep_in	12	SENT_62	[p4l1377t2100r1516b2141],
16	of	IN	O	of	_	0	SENT_62	[p4l1542t2081r1615b2142],
17	the	DT	O	the	det	18	SENT_62	[p4l1636t2081r1737b2142],
18	products	NNS	O	product	prep_of	15	SENT_62	[p4l1763t2081r2050b2160],
19	of	IN	O	of	_	0	SENT_62	[p4l2080t2081r2153b2142],
20	the	DT	O	the	det	22	SENT_62	[p4l13t2184r114b2245],
21	perpendicular	JJ	O	perpendicular	amod	22	SENT_62	[p4l147t2184r616b2263],
22	diameters	NNS	O	diameter	prep_of	18	SENT_62	[p4l650t2184r984b2245],
23	of	IN	O	of	_	0	SENT_62	[p4l1022t2184r1097b2245],
24	all	DT	O	all	det	26	SENT_62	[p4l1129t2184r1211b2244],
25	measurable	JJ	O	measurable	amod	26	SENT_62	[p4l1247t2184r1641b2245],
26	lesions	NNS	O	lesion	prep_of	22	SENT_62	[p4l1677t2184r1916b2245],
27	for	IN	O	for	_	0	SENT_62	[p4l1953t2184r2054b2245],
28	at	IN	DURATION	at	quantmod	30	SENT_62	[p4l2089t2193r2149b2244],
29	least	JJS	DURATION	least	mwe	28	SENT_62	[p4l13t2287r171b2348],
30	4	CD	DURATION	4	num	31	SENT_62	[p4l205t2288r245b2347],
31	weeks	NNS	NUMBER	week	prep_for	7	SENT_62	[p4l281t2287r517b2348],
32	.	.	O	.	_	0	SENT_62	[p4l281t2287r517b2348],

1	Progressive	JJ	O	progressive	amod	3	SENT_63	[p4l553t2287r956b2365],
2	disease	NN	O	disease	nn	3	SENT_63	[p4l992t2287r1240b2348],
3	(	NN	O	(	nsubjpass	7	SENT_63	[p4l1279t2288r1440b2362],
4	PD	NN	O	pd	nn	5	SENT_63	[p4l1279t2288r1440b2362],
5	)	NN	O	)	dep	3	SENT_63	[p4l1279t2288r1440b2362],
6	was	VBD	O	be	auxpass	7	SENT_63	[p4l1478t2306r1608b2347],
7	defined	VBN	O	define	_	0	SENT_63	[p4l1646t2287r1904b2348],
8	as	IN	O	as	_	0	SENT_63	[p4l1941t2306r2007b2347],
9	the	DT	O	the	det	10	SENT_63	[p4l2044t2287r2147b2348],
10	appearance	NN	O	appearance	prep_as	7	SENT_63	[p4l15t2410r405b2470],
11	of	IN	O	of	_	0	SENT_63	[p4l441t2391r516b2452],
12	an	DT	O	a	det	15	SENT_63	[p4l547t2410r625b2451],
13	unequivocal	JJ	O	unequivocal	amod	15	SENT_63	[p4l659t2391r1085b2470],
14	new	JJ	O	new	amod	15	SENT_63	[p4l1120t2410r1261b2452],
15	lesion	NN	O	lesion	prep_of	10	SENT_63	[p4l1297t2391r1505b2452],
16	or	CC	O	or	_	0	SENT_63	[p4l1540t2411r1611b2452],
17	an	DT	O	a	det	18	SENT_63	[p4l1645t2410r1724b2451],
18	increase	NN	O	increase	prep_as	7	SENT_63	[p4l1758t2391r2042b2452],
19	of	IN	O	of	_	0	SENT_63	[p4l2078t2391r2153b2452],
20	>	JJR	O	>	prep_of	18	SENT_63	[p4l12t2494r225b2555],
21	25	CD	PERCENT	25	number	22	SENT_63	[p4l12t2494r225b2555],
22	%	NN	PERCENT	%	amod	20	SENT_63	[p4l12t2494r225b2555],
23	in	IN	O	in	_	0	SENT_63	[p4l269t2494r338b2554],
24	the	DT	O	the	det	25	SENT_63	[p4l377t2494r490b2555],
25	sum	NN	O	sum	prep_in	7	SENT_63	[p4l532t2513r682b2554],
26	of	IN	O	of	_	0	SENT_63	[p4l721t2494r800b2555],
27	the	DT	O	the	det	28	SENT_63	[p4l833t2494r946b2555],
28	products	NNS	O	product	prep_of	25	SENT_63	[p4l985t2494r1312b2573],
29	of	IN	O	of	_	0	SENT_63	[p4l1354t2494r1433b2555],
30	the	DT	O	the	det	32	SENT_63	[p4l1467t2494r1579b2555],
31	perpendicular	JJ	O	perpendicular	amod	32	SENT_63	[p4l1618t2494r2150b2573],
32	diameters	NNS	O	diameter	prep_of	28	SENT_63	[p4l14t2597r345b2658],
33	of	IN	O	of	_	0	SENT_63	[p4l373t2597r448b2658],
34	any	DT	O	any	prep_of	32	SENT_63	[p4l469t2616r589b2676],
35	measured	VBN	O	measure	partmod	34	SENT_63	[p4l615t2597r945b2658],
36	lesions	NNS	O	lesion	dobj	35	SENT_63	[p4l970t2597r1228b2658],
37	.	.	O	.	_	0	SENT_63	[p4l970t2597r1228b2658],

1	No	DT	O	no	det	4	SENT_64	[p4l1255t2599r1358b2658],
2	change	NN	O	change	nn	4	SENT_64	[p4l1385t2597r1626b2675],
3	(	NN	O	(	nn	4	SENT_64	[p4l1655t2598r1825b2672],
4	NC	NN	O	nc	nsubj	11	SENT_64	[p4l1655t2598r1825b2672],
5	)	CD	NUMBER	)	dep	4	SENT_64	[p4l1655t2598r1825b2672],
6	or	CC	O	or	_	0	SENT_64	[p4l1854t2616r1925b2658],
7	stable	JJ	O	stable	amod	8	SENT_64	[p4l1951t2597r2147b2658],
8	disease	NN	O	disease	conj_or	4	SENT_64	[p4l14t2700r260b2761],
9	was	VBD	O	be	cop	11	SENT_64	[p4l290t2719r419b2760],
10	a	DT	O	a	det	11	SENT_64	[p4l452t2719r488b2760],
11	change	NN	O	change	_	0	SENT_64	[p4l517t2700r758b2778],
12	insufficient	JJ	O	insufficient	amod	11	SENT_64	[p4l788t2700r1180b2761],
13	for	IN	O	for	_	0	SENT_64	[p4l1209t2700r1309b2761],
14	PR	NN	O	pr	prep_for	12	SENT_64	[p4l1336t2702r1440b2760],
15	or	CC	O	or	_	0	SENT_64	[p4l1469t2720r1540b2761],
16	PD	NN	O	pd	amod	11	SENT_64	[p4l1567t2702r1674b2760],
17	for	IN	O	for	_	0	SENT_64	[p4l1705t2700r1805b2761],
18	at	IN	DURATION	at	quantmod	20	SENT_64	[p4l1834t2709r1894b2760],
19	least	JJS	DURATION	least	mwe	18	SENT_64	[p4l1922t2700r2079b2761],
20	4	CD	DURATION	4	num	21	SENT_64	[p4l2106t2701r2147b2760],
21	Weeks	NNS	DURATION	week	prep_for	16	SENT_64	[p4l13t2804r241b2864],
22	after	IN	O	after	_	0	SENT_64	[p4l283t2803r455b2864],
23	the	DT	O	the	det	24	SENT_64	[p4l492t2803r603b2864],
24	start	NN	O	start	prep_after	21	SENT_64	[p4l645t2812r806b2863],
25	of	IN	O	of	_	0	SENT_64	[p4l845t2803r923b2864],
26	therapy	NN	O	therapy	prep_of	24	SENT_64	[p4l956t2803r1237b2882],
27	(	CD	NUMBER	(	number	28	SENT_64	[p4l1279t2803r1454b2878],
28	15	CD	NUMBER	15	num	29	SENT_64	[p4l1279t2803r1454b2878],
29	)	NN	O	)	dep	12	SENT_64	[p4l1279t2803r1454b2878],
30	.	.	O	.	_	0	SENT_64	[p4l1279t2803r1454b2878],

1	Responders	NNS	O	responder	nsubjpass	3	SENT_65	[p4l1494t2803r1929b2882],
2	were	VBD	O	be	auxpass	3	SENT_65	[p4l1971t2823r2147b2864],
3	defined	VBN	O	define	_	0	SENT_65	[p4l14t2906r271b2967],
4	as	IN	O	as	_	0	SENT_65	[p4l301t2925r367b2966],
5	patients	NNS	O	patient	prep_as	3	SENT_65	[p4l397t2906r662b2985],
6	with	IN	O	with	_	0	SENT_65	[p4l694t2906r846b2966],
7	CR	NN	O	cr	prep_with	5	SENT_65	[p4l876t2907r988b2967],
8	or	CC	O	or	_	0	SENT_65	[p4l1018t2926r1088b2967],
9	PR	NN	O	pr	prep_with	5	SENT_65	[p4l1116t2908r1242b2978],
10	,	,	O	,	_	0	SENT_65	[p4l1116t2908r1242b2978],
11	and	CC	O	and	_	0	SENT_65	[p4l1272t2906r1393b2966],
12	non	JJ	O	non	amod	14	SENT_65	[p4l1422t2906r1951b2985],
13	—	NN	O	—	nn	14	SENT_65	[p4l1422t2906r1951b2985],
14	responders	NNS	O	responder	nsubjpass	16	SENT_65	[p4l1422t2906r1951b2985],
15	were	VBD	O	be	auxpass	16	SENT_65	[p4l1983t2926r2147b2967],
16	defined	VBN	O	define	conj_and	3	SENT_65	[p4l14t3009r271b3070],
17	as	IN	O	as	_	0	SENT_65	[p4l306t3028r371b3069],
18	those	DT	O	those	prep_as	16	SENT_65	[p4l407t3009r587b3070],
19	with	IN	O	with	_	0	SENT_65	[p4l622t3009r773b3069],
20	NC	NN	O	nc	prep_with	18	SENT_65	[p4l805t3010r922b3070],
21	or	CC	O	or	_	0	SENT_65	[p4l959t3029r1029b3070],
22	PD	NN	O	pd	conj_or	20	SENT_65	[p4l1061t3011r1190b3070],
23	.	.	O	.	_	0	SENT_65	[p4l1061t3011r1190b3070],

1	As	IN	O	as	mark	10	SENT_66	[p4l1225t3010r1316b3069],
2	patients	NNS	O	patient	nsubj	10	SENT_66	[p4l1351t3009r1617b3088],
3	with	IN	O	with	_	0	SENT_66	[p4l1653t3009r1804b3069],
4	recurrent	JJ	O	recurrent	amod	6	SENT_66	[p4l1837t3018r2149b3070],
5	lung	NN	O	lung	nn	6	SENT_66	[p4l13t3112r165b3190],
6	cancer	NN	O	cancer	prep_with	2	SENT_66	[p4l202t3131r428b3173],
7	often	RB	O	often	advmod	10	SENT_66	[p4l463t3112r639b3173],
8	do	VBP	O	do	aux	10	SENT_66	[p4l675t3112r758b3173],
9	not	RB	O	not	neg	10	SENT_66	[p4l795t3121r905b3173],
10	have	VB	O	have	advcl	16	SENT_66	[p4l938t3112r1100b3173],
11	measurable	JJ	O	measurable	amod	12	SENT_66	[p4l1136t3112r1532b3173],
12	disease	NN	O	disease	dobj	10	SENT_66	[p4l1568t3112r1841b3184],
13	,	,	O	,	_	0	SENT_66	[p4l1568t3112r1841b3184],
14	we	PRP	O	we	nsubj	16	SENT_66	[p4l1876t3132r1974b3173],
15	also	RB	O	also	advmod	16	SENT_66	[p4l2011t3112r2147b3173],
16	included	VBD	O	include	_	0	SENT_66	[p4l13t3215r319b3276],
17	a	DT	O	a	det	28	SENT_66	[p4l356t3234r392b3275],
18	change	NN	O	change	dep	28	SENT_66	[p4l427t3215r675b3293],
19	in	IN	O	in	_	0	SENT_66	[p4l713t3215r779b3275],
20	the	DT	O	the	det	23	SENT_66	[p4l815t3215r920b3276],
21	serum	NN	O	serum	nn	23	SENT_66	[p4l960t3234r1173b3276],
22	carcinoembryonic	JJ	O	carcinoembryonic	amod	23	SENT_66	[p4l1208t3215r1849b3294],
23	antigen	NN	O	antigen	prep_in	18	SENT_66	[p4l1889t3215r2148b3293],
24	(	CD	NUMBER	(	num	25	SENT_66	[p4l15t3319r239b3393],
25	CEA	NNP	ORGANIZATION	CEA	dep	23	SENT_66	[p4l15t3319r239b3393],
26	)	CD	NUMBER	)	num	25	SENT_66	[p4l15t3319r239b3393],
27	level	NN	O	level	nn	28	SENT_66	[p4l277t3318r443b3379],
28	(	NN	O	(	nsubj	29	SENT_66	[p4l482t3318r765b3393],
29	cut	VBD	O	cut	ccomp	16	SENT_66	[p4l482t3318r765b3393],
30	—	CD	NUMBER	—	dobj	29	SENT_66	[p4l482t3318r765b3393],
31	off	RP	O	off	prt	29	SENT_66	[p4l482t3318r765b3393],
32	,	,	O	,	_	0	SENT_66	[p4l482t3318r765b3393],
33	5	CD	NUMBER	5	num	35	SENT_66	[p4l801t3318r836b3378],
34	ng/ml	NN	O	ng/ml	nn	35	SENT_66	[p4l875t3318r1102b3396],
35	)	NN	O	)	nsubj	41	SENT_66	[p4l875t3318r1102b3396],
36	as	IN	O	as	_	0	SENT_66	[p4l1142t3337r1208b3378],
37	an	DT	O	a	det	39	SENT_66	[p4l1247t3337r1325b3378],
38	evaluation	NN	O	evaluation	nn	39	SENT_66	[p4l1360t3318r1720b3379],
39	criterion	NN	O	criterion	prep_as	35	SENT_66	[p4l1755t3318r2048b3379],
40	to	TO	O	to	aux	41	SENT_66	[p4l2082t3327r2147b3379],
41	avoid	VB	O	avoid	xcomp	29	SENT_66	[p4l15t3421r207b3482],
42	underestimating	VBG	O	underestimate	xcomp	41	SENT_66	[p4l241t3421r807b3499],
43	the	DT	O	the	det	44	SENT_66	[p4l844t3421r949b3482],
44	effectiveness	NN	O	effectiveness	dobj	42	SENT_66	[p4l985t3421r1442b3482],
45	of	IN	O	of	_	0	SENT_66	[p4l1480t3421r1556b3482],
46	gefitinib	NN	O	gefitinib	prep_of	44	SENT_66	[p4l1587t3421r1904b3499],
47	.	.	O	.	_	0	SENT_66	[p4l1587t3421r1904b3499],

1	When	WRB	O	when	advmod	5	SENT_67	[p4l1940t3421r2148b3482],
2	the	DT	O	the	det	4	SENT_67	[p4l13t3523r116b3583],
3	elevated	JJ	O	elevated	amod	4	SENT_67	[p4l152t3523r439b3583],
4	CEA	NNP	ORGANIZATION	CEA	nsubj	5	SENT_67	[p4l474t3524r645b3584],
5	decreased	VBD	O	decrease	conj_or	5	SENT_67	[p4l680t3523r1020b3583],
6	to	TO	O	to	_	0	SENT_67	[p4l1054t3532r1118b3584],
7	a	DT	O	a	det	8	SENT_67	[p4l1156t3542r1192b3583],
8	level	NN	O	level	prep_to	5	SENT_67	[p4l1226t3523r1392b3583],
9	less	JJR	O	less	quantmod	11	SENT_67	[p4l1427t3523r1553b3583],
10	than	IN	O	than	quantmod	11	SENT_67	[p4l1590t3523r1737b3583],
11	half	NN	O	half	num	8	SENT_67	[p4l1771t3523r1910b3583],
12	of	IN	O	of	_	0	SENT_67	[p4l1940t3523r2015b3584],
13	the	DT	O	the	det	15	SENT_67	[p4l2044t3523r2147b3583],
14	baseline	NN	O	baseline	nn	15	SENT_67	[p4l12t3626r293b3687],
15	level	NN	O	level	prep_of	8	SENT_67	[p4l328t3626r493b3687],
16	or	CC	O	or	_	0	SENT_67	[p4l528t3646r599b3687],
17	within	IN	O	within	_	0	SENT_67	[p4l631t3626r845b3686],
18	normal	JJ	O	normal	amod	19	SENT_67	[p4l876t3626r1114b3687],
19	limit	NN	O	limit	prep_within	5	SENT_67	[p4l1146t3626r1324b3698],
20	,	,	O	,	_	0	SENT_67	[p4l1146t3626r1324b3698],
21	gefitinib	NN	O	gefitinib	nn	22	SENT_67	[p4l1356t3626r1636b3704],
22	treatment	NN	O	treatment	nsubjpass	24	SENT_67	[p4l1669t3635r1987b3687],
23	was	VBD	O	be	auxpass	24	SENT_67	[p4l2018t3645r2146b3686],
24	judged	VBN	O	judge	_	0	SENT_67	[p4l7t3729r242b3808],
25	as	IN	O	as	_	0	SENT_67	[p4l275t3748r340b3789],
26	effective	JJ	O	effective	prep_as	24	SENT_67	[p4l375t3729r667b3790],
27	or	CC	O	or	_	0	SENT_67	[p4l703t3749r773b3790],
28	as	IN	O	as	_	0	SENT_67	[p4l808t3748r874b3789],
29	partial	JJ	O	partial	amod	30	SENT_67	[p4l909t3729r1128b3808],
30	response	NN	O	response	prep_as	24	SENT_67	[p4l1162t3748r1463b3808],
31	(	CD	NUMBER	(	num	32	SENT_67	[p4l1500t3730r1656b3804],
32	PR	NN	O	pr	dep	30	SENT_67	[p4l1500t3730r1656b3804],
33	)	CD	NUMBER	)	number	34	SENT_67	[p4l1500t3730r1656b3804],
34	(	CD	NUMBER	(	dep	32	SENT_67	[p4l1696t3729r1855b3804],
35	16	CD	NUMBER	16	num	36	SENT_67	[p4l1696t3729r1855b3804],
36	)	NN	O	)	dep	24	SENT_67	[p4l1696t3729r1855b3804],
37	.	.	O	.	_	0	SENT_67	[p4l1696t3729r1855b3804],

1	Overall	JJ	O	overall	amod	5	SENT_68	[p4l1892t3729r2148b3790],
2	survival	NN	O	survival	nn	5	SENT_68	[p5l16t19r297b80],
3	(	CD	NUMBER	(	num	5	SENT_68	[p5l336t20r500b94],
4	OS	NN	O	os	nn	5	SENT_68	[p5l336t20r500b94],
5	)	NN	O	)	nsubjpass	7	SENT_68	[p5l336t20r500b94],
6	was	VBD	O	be	auxpass	7	SENT_68	[p5l539t38r671b80],
7	calculated	VBN	O	calculate	_	0	SENT_68	[p5l710t19r1068b80],
8	as	IN	O	as	_	0	SENT_68	[p5l1105t38r1172b80],
9	the	DT	O	the	det	10	SENT_68	[p5l1210t19r1315b80],
10	time	NN	O	time	prep_as	7	SENT_68	[p5l1352t19r1506b80],
11	from	IN	O	from	_	0	SENT_68	[p5l1543t19r1713b80],
12	the	DT	O	the	det	13	SENT_68	[p5l1748t19r1853b80],
13	start	NN	O	start	prep_from	10	SENT_68	[p5l1893t28r2042b80],
14	of	IN	O	of	_	0	SENT_68	[p5l2078t19r2153b80],
15	gefitinib	NN	O	gefitinib	nn	16	SENT_68	[p5l14t122r328b200],
16	administration	NN	O	administration	prep_of	13	SENT_68	[p5l369t122r908b183],
17	to	TO	O	to	_	0	SENT_68	[p5l945t131r1012b183],
18	death	NN	O	death	prep_to	7	SENT_68	[p5l1052t122r1250b183],
19	from	IN	O	from	_	0	SENT_68	[p5l1288t122r1465b183],
20	any	DT	O	any	det	21	SENT_68	[p5l1503t141r1630b201],
21	cause	NN	O	cause	prep_from	7	SENT_68	[p5l1669t141r1871b183],
22	or	CC	O	or	_	0	SENT_68	[p5l1910t142r1984b183],
23	last	JJ	O	last	amod	24	SENT_68	[p5l2020t122r2149b182],
24	contact	NN	O	contact	conj_or	21	SENT_68	[p5l13t234r280b286],
25	.	.	O	.	_	0	SENT_68	[p5l13t234r280b286],

1	Statistical	JJ	O	statistical	amod	2	SENT_69	[p5l13t442r392b503],
2	analysis	NN	O	analysis	_	0	SENT_69	[p5l429t442r759b520],
3	.	.	O	.	_	0	SENT_69	[p5l429t442r759b520],

1	For	IN	O	for	_	0	SENT_70	[p5l798t444r925b503],
2	comparison	NN	O	comparison	prep_for	12	SENT_70	[p5l962t442r1394b521],
3	of	IN	O	of	_	0	SENT_70	[p5l1432t442r1511b503],
4	proportions	NNS	O	proportion	prep_of	2	SENT_70	[p5l1542t442r2000b521],
5	,	,	O	,	_	0	SENT_70	[p5l1542t442r2000b521],
6	the	DT	O	the	det	7	SENT_70	[p5l2037t442r2147b503],
7	Fisher	NNP	PERSON	Fisher	poss	10	SENT_70	[p5l12t544r304b604],
8	's	POS	O	's	_	0	SENT_70	[p5l12t544r304b604],
9	Exact	JJ	O	exact	amod	10	SENT_70	[p5l344t546r558b604],
10	test	NN	O	test	nsubjpass	12	SENT_70	[p5l596t553r728b604],
11	was	VBD	O	be	auxpass	12	SENT_70	[p5l766t563r904b604],
12	used	VBN	O	use	_	0	SENT_70	[p5l945t544r1139b604],
13	.	.	O	.	_	0	SENT_70	[p5l945t544r1139b604],

1	The	DT	O	the	det	3	SENT_71	[p5l1179t544r1319b604],
2	overall	JJ	O	overall	amod	3	SENT_71	[p5l1360t544r1623b605],
3	survival	NN	O	survival	nsubjpass	5	SENT_71	[p5l1665t544r1968b604],
4	was	VBD	O	be	auxpass	5	SENT_71	[p5l2008t563r2146b604],
5	examined	VBN	O	examine	_	0	SENT_71	[p5l13t647r348b708],
6	by	IN	O	by	_	0	SENT_71	[p5l371t647r456b726],
7	the	DT	O	the	det	8	SENT_71	[p5l482t647r585b708],
8	Kaplan	NNP	PERSON	Kaplan	agent	5	SENT_71	[p5l612t647r1097b726],
9	.	.	O	.	_	0	SENT_71	[p5l612t647r1097b726],

1	—	NN	O	—	_	0	SENT_72	[p5l612t647r1097b726],
2	.	.	O	.	_	0	SENT_72	[p5l612t647r1097b726],

1	Meier	JJR	PERSON	meier	amod	2	SENT_73	[p5l612t647r1097b726],
2	method	NN	O	method	nsubjpass	7	SENT_73	[p5l1121t647r1401b719],
3	,	,	O	,	_	0	SENT_73	[p5l1121t647r1401b719],
4	and	CC	O	and	_	0	SENT_73	[p5l1427t647r1549b707],
5	differences	NNS	O	difference	conj_and	2	SENT_73	[p5l1575t647r1954b708],
6	were	VBD	O	be	auxpass	7	SENT_73	[p5l1983t667r2147b708],
7	examined	VBN	O	examine	_	0	SENT_73	[p5l13t750r348b811],
8	by	IN	O	by	_	0	SENT_73	[p5l372t750r457b829],
9	the	DT	O	the	det	10	SENT_73	[p5l484t750r587b811],
10	log	NN	O	log	agent	7	SENT_73	[p5l614t750r906b828],
11	—	CD	NUMBER	—	num	13	SENT_73	[p5l614t750r906b828],
12	rank	NN	O	rank	nn	13	SENT_73	[p5l614t750r906b828],
13	test	NN	O	test	dep	10	SENT_73	[p5l931t759r1069b811],
14	.	.	O	.	_	0	SENT_73	[p5l931t759r1069b811],

1	The	DT	O	the	det	2	SENT_74	[p5l1097t750r1229b811],
2	association	NN	O	association	nsubj	7	SENT_74	[p5l1258t750r1638b811],
3	of	IN	O	of	_	0	SENT_74	[p5l1665t750r1740b811],
4	risk	NN	O	risk	nn	5	SENT_74	[p5l1760t750r1889b810],
5	factors	NNS	O	factor	prep_of	2	SENT_74	[p5l1915t750r2146b811],
6	Table	NNP	O	Table	dep	7	SENT_74	[p5l17t852r212b913],
7	1	CD	NUMBER	1	_	0	SENT_74	[p5l248t854r295b913],
8	.	.	O	.	_	0	SENT_74	[p5l248t854r295b913],

1	Relationship	NN	O	relationship	nsubj	14	SENT_75	[p5l331t852r770b931],
2	between	IN	O	between	_	0	SENT_75	[p5l805t853r1094b913],
3	the	DT	O	the	det	6	SENT_75	[p5l1129t853r1232b913],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_75	[p5l1268t853r1488b913],
5	copy	NN	O	copy	nn	6	SENT_75	[p5l1524t872r1689b931],
6	number	NN	O	number	prep_between	1	SENT_75	[p5l1725t853r1991b913],
7	and	CC	O	and	_	0	SENT_75	[p5l2026t853r2148b913],
8	clinicopathological	JJ	O	clinicopathological	amod	9	SENT_75	[p5l18t955r679b1034],
9	factors	NNS	O	factor	nsubj	14	SENT_75	[p5l704t955r935b1016],
10	in	IN	O	in	_	0	SENT_75	[p5l961t956r1026b1015],
11	22	CD	NUMBER	22	num	13	SENT_75	[p5l1051t956r1133b1015],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_75	[p5l1159t955r1715b1034],
13	—	NN	O	—	prep_in	9	SENT_75	[p5l1159t955r1715b1034],
14	treated	VBN	O	treat	_	0	SENT_75	[p5l1159t955r1715b1034],
15	patients	NNS	O	patient	dobj	14	SENT_75	[p5l1738t956r2026b1034],
16	.	.	O	.	_	0	SENT_75	[p5l1738t956r2026b1034],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_76	[p5l1176t1161r1397b1221],
2	gene	NN	O	gene	_	0	SENT_76	[p5l1421t1180r1581b1239],

1	Factors	NNS	O	factor	nsubj	2	SENT_77	[p5l16t1367r268b1426],
2	Copy	VBP	O	copy	dep	3	SENT_77	[p5l1067t1366r1250b1444],
3	Copy	VBP	O	copy	_	0	SENT_77	[p5l1484t1366r1668b1444],
4	P-value	JJ	O	p-value	amod	5	SENT_77	[p5l1872t1365r2134b1426],
5	number	NN	O	number	nsubj	8	SENT_77	[p5l971t1468r1235b1527],
6	23	CD	NUMBER	23	num	7	SENT_77	[p5l1258t1468r1342b1527],
7	number	NN	O	number	npadvmod	8	SENT_77	[p5l1388t1468r1652b1527],
8	<	JJR	O	<	xcomp	3	SENT_77	[p5l1676t1468r1760b1527],
9	3	CD	NUMBER	3	nsubj	3	SENT_77	[p5l1676t1468r1760b1527],

1	Gender	NN	O	gender	_	0	SENT_78	[p5l18t1673r271b1733],

1	Male	JJ	O	male	amod	2	SENT_79	[p5l149t1772r324b1833],
2	4	CD	PERCENT	4	dep	8	SENT_79	[p5l991t1773r1031b1832],
3	(	CD	PERCENT	(	num	5	SENT_79	[p5l1059t1773r1333b1847],
4	30.8	CD	PERCENT	30.8	num	5	SENT_79	[p5l1059t1773r1333b1847],
5	%	NN	PERCENT	%	dep	2	SENT_79	[p5l1059t1773r1333b1847],
6	)	CD	NUMBER	)	dep	8	SENT_79	[p5l1059t1773r1333b1847],
7	9	CD	NUMBER	9	num	8	SENT_79	[p5l1589t1773r1627b1834],
8	0.1150	CD	NUMBER	0.1150	dep	15	SENT_79	[p5l1884t1772r2119b1833],
9	Female	JJ	O	female	amod	13	SENT_79	[p5l149t1871r401b1932],
10	o	NN	O	o	nn	13	SENT_79	[p5l991t1872r1031b1931],
11	(	NN	O	(	nn	13	SENT_79	[p5l1059t1871r1224b1946],
12	o	NN	O	o	nn	13	SENT_79	[p5l1059t1871r1224b1946],
13	%	NN	O	%	dep	8	SENT_79	[p5l1059t1871r1224b1946],
14	)	CD	NUMBER	)	num	15	SENT_79	[p5l1059t1871r1224b1946],
15	9	CD	NUMBER	9	_	0	SENT_79	[p5l1589t1872r1627b1933],

1	Age	NN	O	age	_	0	SENT_80	[p5l17t2026r158b2103],

1	Smoking	NN	O	smoking	nn	2	SENT_81	[p5l19t2377r327b2455],
2	status	NN	O	status	_	0	SENT_81	[p5l355t2386r545b2437],

1	Never	RB	O	never	advmod	7	SENT_82	[p5l149t2476r674b2537],
2	—	CD	NUMBER	—	num	3	SENT_82	[p5l149t2476r674b2537],
3	smokers	NNS	O	smoker	pobj	1	SENT_82	[p5l149t2476r674b2537],
4	o	NN	O	o	nn	7	SENT_82	[p5l991t2477r1031b2536],
5	(	CD	PERCENT	(	num	7	SENT_82	[p5l1059t2476r1224b2551],
6	o	NN	PERCENT	o	nn	7	SENT_82	[p5l1059t2476r1224b2551],
7	%	NN	PERCENT	%	_	0	SENT_82	[p5l1059t2476r1224b2551],
8	)	CD	NUMBER	)	number	9	SENT_82	[p5l1059t2476r1224b2551],
9	4	CD	NUMBER	4	amod	7	SENT_82	[p5l1587t2477r1628b2536],
10	0.5055	CD	NUMBER	0.5055	npadvmod	11	SENT_82	[p5l1884t2476r2117b2536],
11	Ever	RB	O	ever	advmod	13	SENT_82	[p5l149t2575r626b2636],
12	—	JJ	O	—	amod	13	SENT_82	[p5l149t2575r626b2636],
13	smokers	NNS	O	smoker	dep	7	SENT_82	[p5l149t2575r626b2636],
14	3	CD	NUMBER	3	number	15	SENT_82	[p5l994t2575r1028b2635],
15	(	NN	O	(	amod	13	SENT_82	[p5l1059t2575r1268b2649],
16	30	CD	PERCENT	30	num	17	SENT_82	[p5l1059t2575r1268b2649],
17	%	NN	PERCENT	%	dep	13	SENT_82	[p5l1059t2575r1268b2649],
18	)	CD	NUMBER	)	number	19	SENT_82	[p5l1059t2575r1268b2649],
19	7	CD	NUMBER	7	num	17	SENT_82	[p5l1588t2576r1626b2635],

1	Differentiation	NN	O	differentiation	_	0	SENT_83	[p5l17t2729r530b2789],

1	Well	RB	O	well	advmod	2	SENT_84	[p5l148t2827r315b2888],
2	2	CD	PERCENT	2	_	0	SENT_84	[p5l993t2828r1031b2887],
3	(	CD	PERCENT	(	number	4	SENT_84	[p5l1059t2828r1333b2902],
4	13.3	CD	PERCENT	13.3	num	5	SENT_84	[p5l1059t2828r1333b2902],
5	%	NN	PERCENT	%	npadvmod	8	SENT_84	[p5l1059t2828r1333b2902],
6	)	CD	NUMBER	)	number	7	SENT_84	[p5l1059t2828r1333b2902],
7	13	CD	NUMBER	13	num	5	SENT_84	[p5l1553t2828r1624b2888],
8	>	JJR	O	>	amod	2	SENT_84	[p5l1835t2828r2119b2889],
9	0.9999	CD	NUMBER	0.9999	dep	2	SENT_84	[p5l1835t2828r2119b2889],
10	Moderately	RB	O	moderately	advmod	9	SENT_84	[p5l149t2926r546b3005],
11	or	CC	O	or	_	0	SENT_84	[p5l571t2946r642b2987],
12	1	CD	PERCENT	1	number	13	SENT_84	[p5l999t2927r1024b2986],
13	(	CD	PERCENT	(	dep	2	SENT_84	[p5l1059t2926r1333b3001],
14	16.7	CD	PERCENT	16.7	num	15	SENT_84	[p5l1059t2926r1333b3001],
15	%	NN	PERCENT	%	dep	13	SENT_84	[p5l1059t2926r1333b3001],
16	)	CD	NUMBER	)	num	17	SENT_84	[p5l1059t2926r1333b3001],
17	5	CD	NUMBER	5	npadvmod	18	SENT_84	[p5l1589t2926r1625b2987],
18	poorly	RB	O	poorly	advmod	13	SENT_84	[p5l148t3025r372b3104],

1	Pathological	JJ	O	pathological	amod	2	SENT_85	[p5l17t3132r448b3210],
2	subtypes	NNS	O	subtype	_	0	SENT_85	[p5l475t3132r771b3211],

1	Adeno	NNP	O	Adeno	_	0	SENT_86	[p5l149t3231r377b3292],
2	4	CD	PERCENT	4	num	1	SENT_86	[p5l991t3232r1031b3291],
3	(	CD	PERCENT	(	number	4	SENT_86	[p5l1059t3231r1332b3306],
4	22.2	CD	PERCENT	22.2	num	5	SENT_86	[p5l1059t3231r1332b3306],
5	%	NN	PERCENT	%	dep	1	SENT_86	[p5l1059t3231r1332b3306],
6	)	CD	NUMBER	)	dep	1	SENT_86	[p5l1059t3231r1332b3306],
7	14	CD	NUMBER	14	number	8	SENT_86	[p5l1553t3232r1628b3291],
8	0.5538	CD	NUMBER	0.5538	num	12	SENT_86	[p5l1884t3231r2117b3292],
9	Non	NNP	O	Non	nn	12	SENT_86	[p5l149t3330r530b3391],
10	—	CD	NUMBER	—	num	12	SENT_86	[p5l149t3330r530b3391],
11	adeno	NN	O	adeno	nn	12	SENT_86	[p5l149t3330r530b3391],
12	o	NN	O	o	dep	6	SENT_86	[p5l991t3331r1030b3390],
13	(	CD	PERCENT	(	number	14	SENT_86	[p5l1059t3331r1224b3405],
14	o	NN	PERCENT	o	num	15	SENT_86	[p5l1059t3331r1224b3405],
15	%	NN	PERCENT	%	dep	6	SENT_86	[p5l1059t3331r1224b3405],
16	)	CD	NUMBER	)	number	17	SENT_86	[p5l1059t3331r1224b3405],
17	4	CD	NUMBER	4	num	15	SENT_86	[p5l1587t3331r1628b3390],

1	Adeno	NNP	O	Adeno	_	0	SENT_87	[p5l17t3510r243b3574],
2	,	,	O	,	_	0	SENT_87	[p5l17t3510r243b3574],
3	adenocarcinoma	NN	O	adenocarcinoma	appos	1	SENT_87	[p5l266t3510r791b3564],
4	.	.	O	.	_	0	SENT_87	[p5l266t3510r791b3564],

1	associated	VBN	O	associate	csubjpass	5	SENT_88	[p6l10t85r408b145],
2	with	IN	O	with	_	0	SENT_88	[p6l447t85r614b145],
3	survival	NN	O	survival	prep_with	1	SENT_88	[p6l657t85r965b145],
4	was	VBD	O	be	auxpass	5	SENT_88	[p6l1005t104r1145b145],
5	evaluated	VBN	O	evaluate	_	0	SENT_88	[p6l1188t85r1558b145],
6	using	VBG	O	use	xcomp	5	SENT_88	[p6l1596t85r1801b163],
7	the	DT	O	the	det	12	SENT_88	[p6l1842t85r1955b145],
8	Cox	NN	ORGANIZATION	cox	nn	12	SENT_88	[p6l1996t85r2147b146],
9	proportional	JJ	O	proportional	amod	12	SENT_88	[p6l7t188r434b266],
10	hazards	NNS	O	hazard	nn	12	SENT_88	[p6l467t188r728b248],
11	regression	NN	O	regression	nn	12	SENT_88	[p6l762t188r1117b266],
12	model	NN	O	model	dobj	6	SENT_88	[p6l1150t188r1385b249],
13	.	.	O	.	_	0	SENT_88	[p6l1150t188r1385b249],

1	Only	RB	O	only	advmod	3	SENT_89	[p6l1420t188r1589b266],
2	those	DT	O	those	det	3	SENT_89	[p6l1623t188r1803b249],
3	variables	NNS	O	variable	nsubjpass	11	SENT_89	[p6l1837t188r2145b248],
4	with	IN	O	with	_	0	SENT_89	[p6l9t291r161b351],
5	significant	JJ	O	significant	amod	6	SENT_89	[p6l198t291r562b369],
6	results	NNS	O	result	prep_with	3	SENT_89	[p6l595t291r818b351],
7	in	IN	O	in	_	0	SENT_89	[p6l856t291r921b350],
8	univariate	JJ	O	univariate	amod	9	SENT_89	[p6l955t291r1300b351],
9	analysis	NN	O	analysis	prep_in	6	SENT_89	[p6l1338t291r1612b369],
10	were	VBD	O	be	auxpass	11	SENT_89	[p6l1649t310r1815b351],
11	included	VBN	O	include	_	0	SENT_89	[p6l1851t291r2148b351],
12	in	IN	O	in	_	0	SENT_89	[p6l9t394r74b453],
13	the	DT	O	the	det	15	SENT_89	[p6l104t394r207b454],
14	multivariate	JJ	O	multivariate	amod	15	SENT_89	[p6l239t394r655b454],
15	analysis	NN	O	analysis	prep_in	11	SENT_89	[p6l688t394r984b472],
16	.	.	O	.	_	0	SENT_89	[p6l688t394r984b472],

1	The	DT	O	the	det	2	SENT_90	[p6l1016t394r1147b454],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_90	[p6l1181t394r1468b472],
3	were	VBD	O	be	auxpass	4	SENT_90	[p6l1502t413r1666b454],
4	done	VBN	O	do	_	0	SENT_90	[p6l1699t394r1864b455],
5	using	VBG	O	use	xcomp	4	SENT_90	[p6l1895t394r2080b472],
6	a	DT	O	a	det	7	SENT_90	[p6l2113t413r2149b454],
7	Stat	NN	O	stat	dobj	5	SENT_90	[p6l11t497r142b557],
8	View	NNP	O	View	dep	7	SENT_90	[p6l169t497r354b557],
9	(	CD	NUMBER	(	num	8	SENT_90	[p6l386t497r665b571],
10	version	NN	O	version	dep	5	SENT_90	[p6l386t497r665b571],
11	5	CD	NUMBER	5	num	10	SENT_90	[p6l695t497r757b568],
12	,	,	O	,	_	0	SENT_90	[p6l695t497r757b568],
13	SAS	NNP	ORGANIZATION	SAS	nn	15	SENT_90	[p6l787t497r937b557],
14	Institute	NNP	ORGANIZATION	Institute	nn	15	SENT_90	[p6l969t497r1250b557],
15	Inc.	NNP	ORGANIZATION	Inc.	appos	10	SENT_90	[p6l1280t498r1432b568],
16	,	,	O	,	_	0	SENT_90	[p6l1280t498r1432b568],
17	Cary	NNP	PERSON	Cary	appos	10	SENT_90	[p6l1460t497r1649b575],
18	,	,	O	,	_	0	SENT_90	[p6l1460t497r1649b575],
19	NC	NNP	O	NC	nn	21	SENT_90	[p6l1675t497r1820b571],
20	)	CD	NUMBER	)	num	21	SENT_90	[p6l1675t497r1820b571],
21	software	NN	O	software	appos	10	SENT_90	[p6l1854t497r2147b557],
22	and	CC	O	and	_	0	SENT_90	[p6l10t600r132b660],
23	considered	VBN	O	consider	conj_and	4	SENT_90	[p6l156t600r529b661],
24	significant	JJ	O	significant	acomp	23	SENT_90	[p6l555t600r917b678],
25	at	IN	O	at	_	0	SENT_90	[p6l942t609r1002b660],
26	p-value	NN	O	p-value	prep_at	24	SENT_90	[p6l1023t600r1281b678],
27	<	JJR	O	<	amod	28	SENT_90	[p6l1307t601r1394b660],
28	o	NN	O	o	dep	24	SENT_90	[p6l1307t601r1394b660],
29	.05	CD	NUMBER	.05	dep	28	SENT_90	[p6l1406t600r1525b660],
30	.	.	O	.	_	0	SENT_90	[p6l1406t600r1525b660],

1	Results	NNS	O	result	_	0	SENT_91	[p6l8t808r275b868],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_92	[p6l7t1016r227b1076],
2	mutation	NN	O	mutation	nn	3	SENT_92	[p6l257t1017r562b1075],
3	status	NN	O	status	nsubj	8	SENT_92	[p6l592t1026r791b1076],
4	in	IN	O	in	_	0	SENT_92	[p6l824t1017r886b1075],
5	22	CD	NUMBER	22	num	7	SENT_92	[p6l915t1015r997b1074],
6	gefitinib	NN	O	gefitinib	nn	7	SENT_92	[p6l1029t1015r1594b1092],
7	—	NN	O	—	prep_in	3	SENT_92	[p6l1029t1015r1594b1092],
8	treated	VBN	O	treat	_	0	SENT_92	[p6l1029t1015r1594b1092],
9	patients	NNS	O	patient	dobj	8	SENT_92	[p6l1612t1017r1912b1092],
10	.	.	O	.	_	0	SENT_92	[p6l1612t1017r1912b1092],

1	Using	VBG	O	use	partmod	13	SENT_93	[p6l1943t1015r2146b1093],
2	direct	JJ	O	direct	amod	3	SENT_93	[p6l9t1118r205b1178],
3	sequencing	NN	O	sequencing	dobj	1	SENT_93	[p6l234t1118r617b1196],
4	or	CC	O	or	_	0	SENT_93	[p6l646t1137r717b1179],
5	the	DT	O	the	det	9	SENT_93	[p6l742t1118r845b1178],
6	T	NN	O	t	nn	9	SENT_93	[p6l872t1119r923b1177],
7	aqMan	NN	O	aqman	nn	9	SENT_93	[p6l928t1119r1165b1196],
8	PCR	NN	O	pcr	nn	9	SENT_93	[p6l1191t1119r1353b1179],
9	assay	NN	O	assay	dobj	1	SENT_93	[p6l1382t1137r1588b1196],
10	,	,	O	,	_	0	SENT_93	[p6l1382t1137r1588b1196],
11	11	CD	NUMBER	11	num	12	SENT_93	[p6l1622t1119r1690b1177],
12	cases	NNS	O	case	nsubj	13	SENT_93	[p6l1726t1137r1904b1178],
13	(	VBP	O	(	_	0	SENT_93	[p6l1936t1118r2145b1192],
14	50	CD	PERCENT	50	num	15	SENT_93	[p6l1936t1118r2145b1192],
15	%	NN	PERCENT	%	dobj	13	SENT_93	[p6l1936t1118r2145b1192],
16	)	CD	NUMBER	)	nsubjpass	18	SENT_93	[p6l1936t1118r2145b1192],
17	were	VBD	O	be	auxpass	18	SENT_93	[p6l9t1240r179b1281],
18	detected	VBN	O	detect	rcmod	15	SENT_93	[p6l217t1221r516b1281],
19	with	IN	O	with	_	0	SENT_93	[p6l552t1221r709b1281],
20	an	DT	O	a	det	22	SENT_93	[p6l747t1240r827b1281],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_93	[p6l863t1222r1088b1281],
22	mutation	NN	O	mutation	prep_with	18	SENT_93	[p6l1124t1221r1464b1282],
23	.	.	O	.	_	0	SENT_93	[p6l1124t1221r1464b1282],

1	Four	CD	NUMBER	four	num	2	SENT_94	[p6l1502t1222r1670b1282],
2	patients	NNS	O	patient	nsubj	3	SENT_94	[p6l1704t1221r1983b1299],
3	had	VBD	O	have	_	0	SENT_94	[p6l2021t1221r2148b1281],
4	deletion	NN	O	deletion	dobj	3	SENT_94	[p6l9t1324r300b1385],
5	in	IN	O	in	_	0	SENT_94	[p6l337t1324r404b1383],
6	exon	NN	O	exon	prep_in	4	SENT_94	[p6l441t1343r613b1385],
7	19	CD	NUMBER	19	num	6	SENT_94	[p6l658t1325r760b1395],
8	,	,	O	,	_	0	SENT_94	[p6l658t1325r760b1395],
9	5	CD	NUMBER	5	num	10	SENT_94	[p6l798t1324r833b1384],
10	patients	NNS	O	patient	nsubj	11	SENT_94	[p6l873t1324r1154b1402],
11	had	VBD	O	have	ccomp	3	SENT_94	[p6l1192t1324r1320b1384],
12	L858R	NN	O	l858r	nn	13	SENT_94	[p6l1356t1324r1604b1384],
13	mutation	NN	O	mutation	dobj	11	SENT_94	[p6l1640t1324r1985b1395],
14	,	,	O	,	_	0	SENT_94	[p6l1640t1324r1985b1395],
15	one	CD	NUMBER	one	num	16	SENT_94	[p6l2022t1343r2147b1385],
16	patient	NN	O	patient	nsubj	17	SENT_94	[p6l7t1427r253b1505],
17	had	VBD	O	have	ccomp	3	SENT_94	[p6l288t1427r415b1487],
18	G719S	NN	O	g719	nn	19	SENT_94	[p6l452t1427r692b1488],
19	mutation	NN	O	mutation	dobj	17	SENT_94	[p6l733t1427r1074b1498],
20	,	,	O	,	_	0	SENT_94	[p6l733t1427r1074b1498],
21	and	CC	O	and	_	0	SENT_94	[p6l1112t1427r1237b1487],
22	one	CD	NUMBER	one	num	23	SENT_94	[p6l1274t1446r1398b1488],
23	patient	NN	O	patient	nsubj	24	SENT_94	[p6l1434t1427r1680b1505],
24	had	VBD	O	have	ccomp	3	SENT_94	[p6l1715t1427r1842b1487],
25	a	DT	O	a	det	27	SENT_94	[p6l1880t1446r1916b1487],
26	novel	JJ	O	novel	amod	27	SENT_94	[p6l1951t1427r2147b1488],
27	insertion	NN	O	insertion	dobj	24	SENT_94	[p6l9t1530r310b1591],
28	in	IN	O	in	_	0	SENT_94	[p6l340t1530r405b1590],
29	exon	NN	O	exon	prep_in	27	SENT_94	[p6l435t1549r601b1591],
30	20	CD	NUMBER	20	number	31	SENT_94	[p6l632t1531r713b1590],
31	(	CD	NUMBER	(	dep	29	SENT_94	[p6l748t1530r1144b1604],
32	2316-2317	CD	DATE	2316-2317	num	34	SENT_94	[p6l748t1530r1144b1604],
33	insertion	NN	O	insertion	nn	34	SENT_94	[p6l1177t1530r1478b1591],
34	GGT	NNP	ORGANIZATION	GGT	dep	31	SENT_94	[p6l1509t1530r1707b1602],
35	,	,	O	,	_	0	SENT_94	[p6l1509t1530r1707b1602],
36	P772_H773	NNP	O	P772_H773	nsubj	37	SENT_94	[p6l1736t1530r2143b1600],
37	ins	VBZ	O	in	ccomp	3	SENT_94	[p6l9t1633r105b1693],
38	V	NN	O	v	nn	39	SENT_94	[p6l131t1634r241b1707],
39	)	NN	O	)	dobj	37	SENT_94	[p6l131t1634r241b1707],
40	.	.	O	.	_	0	SENT_94	[p6l131t1634r241b1707],

1	The	DT	O	the	det	2	SENT_95	[p6l266t1633r398b1693],
2	relationship	NN	O	relationship	nsubjpass	16	SENT_95	[p6l422t1633r829b1711],
3	between	IN	O	between	_	0	SENT_95	[p6l853t1633r1141b1693],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_95	[p6l1165t1634r1384b1693],
5	mutation	NN	O	mutation	prep_between	2	SENT_95	[p6l1408t1633r1714b1694],
6	and	CC	O	and	_	0	SENT_95	[p6l1740t1633r1862b1693],
7	clinicopathological	JJ	O	clinicopathological	amod	8	SENT_95	[p6l1886t1633r2145b1694, p6l7t1736r471b1814],
8	factors	NNS	O	factor	prep_between	2	SENT_95	[p6l509t1736r760b1796],
9	in	IN	O	in	_	0	SENT_95	[p6l801t1736r869b1795],
10	22	CD	NUMBER	22	num	12	SENT_95	[p6l908t1737r994b1795],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_95	[p6l1034t1736r1643b1814],
12	—	NN	O	—	prep_in	8	SENT_95	[p6l1034t1736r1643b1814],
13	treated	VBN	O	treat	partmod	12	SENT_95	[p6l1034t1736r1643b1814],
14	patients	NNS	O	patient	dobj	13	SENT_95	[p6l1679t1736r1968b1814],
15	was	VBD	O	be	auxpass	16	SENT_95	[p6l2009t1755r2146b1796],
16	evaluated	VBN	O	evaluate	_	0	SENT_95	[p6l9t1839r376b1899],
17	.	.	O	.	_	0	SENT_95	[p6l9t1839r376b1899],

1	EGFR	NN	ORGANIZATION	egfr	dep	99	SENT_96	[p6l414t1839r640b1900],
2	mutation	NN	O	mutation	dep	99	SENT_96	[p6l676t1839r996b1900],
3	was	VBD	O	be	dep	99	SENT_96	[p6l1033t1858r1167b1899],
4	found	VBN	O	find	dep	99	SENT_96	[p6l1206t1839r1414b1900],
5	in	IN	O	in	dep	99	SENT_96	[p6l1450t1839r1517b1899],
6	5/13	CD	PERCENT	5/13	dep	99	SENT_96	[p6l1555t1839r1707b1900],
7	(	CD	PERCENT	(	dep	99	SENT_96	[p6l1751t1839r2036b1914],
8	38.5	CD	PERCENT	38.5	dep	99	SENT_96	[p6l1751t1839r2036b1914],
9	%	NN	PERCENT	%	dep	99	SENT_96	[p6l1751t1839r2036b1914],
10	)	CD	NUMBER	)	dep	99	SENT_96	[p6l1751t1839r2036b1914],
11	of	IN	O	of	dep	99	SENT_96	[p6l2077t1839r2153b1900],
12	males	NNS	O	male	dep	99	SENT_96	[p6l8t1942r211b2002],
13	and	CC	O	and	dep	99	SENT_96	[p6l250t1942r374b2002],
14	6/9	CD	PERCENT	6/9	dep	99	SENT_96	[p6l411t1942r518b2003],
15	(	CD	PERCENT	(	dep	99	SENT_96	[p6l559t1942r839b2016],
16	66.7	CD	PERCENT	66.7	dep	99	SENT_96	[p6l559t1942r839b2016],
17	%	NN	PERCENT	%	dep	99	SENT_96	[p6l559t1942r839b2016],
18	)	CD	NUMBER	)	dep	99	SENT_96	[p6l559t1942r839b2016],
19	of	IN	O	of	dep	99	SENT_96	[p6l879t1942r955b2003],
20	females	NNS	O	female	dep	99	SENT_96	[p6l985t1942r1281b2013],
21	;	:	O	;	_	0	SENT_96	[p6l985t1942r1281b2013],
22	6/10	CD	PERCENT	6/10	dep	99	SENT_96	[p6l1322t1942r1473b2003],
23	(	CD	PERCENT	(	dep	99	SENT_96	[p6l1514t1942r1727b2016],
24	60	CD	PERCENT	60	dep	99	SENT_96	[p6l1514t1942r1727b2016],
25	%	NN	PERCENT	%	dep	99	SENT_96	[p6l1514t1942r1727b2016],
26	)	CD	NUMBER	)	dep	99	SENT_96	[p6l1514t1942r1727b2016],
27	of	IN	O	of	dep	99	SENT_96	[p6l1766t1942r1842b2003],
28	patients	NNS	O	patient	dep	99	SENT_96	[p6l1871t1942r2146b2020],
29	who	WP	O	who	dep	99	SENT_96	[p6l9t2045r155b2106],
30	were	VBD	O	be	dep	99	SENT_96	[p6l192t2064r358b2105],
31	564	CD	DURATION	564	dep	99	SENT_96	[p6l395t2045r526b2105],
32	years	NNS	NUMBER	year	dep	99	SENT_96	[p6l562t2064r742b2123],
33	old	JJ	DURATION	old	dep	99	SENT_96	[p6l781t2045r890b2105],
34	and	CC	O	and	dep	99	SENT_96	[p6l926t2045r1049b2105],
35	5/12	CD	PERCENT	5/12	dep	99	SENT_96	[p6l1085t2045r1235b2106],
36	(	CD	PERCENT	(	dep	99	SENT_96	[p6l1274t2045r1551b2120],
37	41.7	CD	PERCENT	41.7	dep	99	SENT_96	[p6l1274t2045r1551b2120],
38	%	NN	PERCENT	%	dep	99	SENT_96	[p6l1274t2045r1551b2120],
39	)	CD	NUMBER	)	dep	99	SENT_96	[p6l1274t2045r1551b2120],
40	of	IN	O	of	dep	99	SENT_96	[p6l1589t2045r1664b2106],
41	patients	NNS	O	patient	dep	99	SENT_96	[p6l1693t2045r1962b2123],
42	who	WP	O	who	dep	99	SENT_96	[p6l2000t2045r2146b2106],
43	were	VBD	O	be	dep	99	SENT_96	[p6l9t2167r175b2208],
44	>	JJR	O	>	dep	99	SENT_96	[p6l210t2148r344b2208],
45	64	CD	DURATION	64	dep	99	SENT_96	[p6l210t2148r344b2208],
46	years	NNS	NUMBER	year	dep	99	SENT_96	[p6l379t2167r559b2226],
47	old	JJ	DURATION	old	dep	99	SENT_96	[p6l598t2148r727b2219],
48	;	:	O	;	_	0	SENT_96	[p6l598t2148r727b2219],
49	11/18	CD	PERCENT	11/18	dep	99	SENT_96	[p6l774t2148r958b2209],
50	(	CD	PERCENT	(	dep	99	SENT_96	[p6l999t2148r1275b2223],
51	61.1	CD	PERCENT	61.1	dep	99	SENT_96	[p6l999t2148r1275b2223],
52	%	NN	PERCENT	%	dep	99	SENT_96	[p6l999t2148r1275b2223],
53	)	CD	NUMBER	)	dep	99	SENT_96	[p6l999t2148r1275b2223],
54	of	IN	O	of	dep	99	SENT_96	[p6l1314t2148r1389b2209],
55	adenocarcinoma	NN	O	adenocarcinoma	dep	99	SENT_96	[p6l1421t2148r1990b2209],
56	and	CC	O	and	dep	99	SENT_96	[p6l2026t2148r2148b2208],
57	0/4	CD	PERCENT	0/4	dep	99	SENT_96	[p6l8t2251r125b2312],
58	(	NN	PERCENT	(	dep	99	SENT_96	[p6l168t2251r348b2326],
59	o	NN	PERCENT	o	dep	99	SENT_96	[p6l168t2251r348b2326],
60	%	NN	PERCENT	%	dep	99	SENT_96	[p6l168t2251r348b2326],
61	)	CD	NUMBER	)	dep	99	SENT_96	[p6l168t2251r348b2326],
62	of	IN	O	of	dep	99	SENT_96	[p6l391t2251r470b2312],
63	non-adenocarcinoma	NN	O	non-adenocarcinoma	dep	99	SENT_96	[p6l504t2251r1332b2322],
64	;	:	O	;	_	0	SENT_96	[p6l504t2251r1332b2322],
65	3/4	CD	PERCENT	3/4	dep	99	SENT_96	[p6l1378t2251r1492b2312],
66	(	CD	PERCENT	(	dep	99	SENT_96	[p6l1535t2251r1760b2326],
67	75	CD	PERCENT	75	dep	99	SENT_96	[p6l1535t2251r1760b2326],
68	%	NN	PERCENT	%	dep	99	SENT_96	[p6l1535t2251r1760b2326],
69	)	CD	NUMBER	)	dep	99	SENT_96	[p6l1535t2251r1760b2326],
70	of	IN	O	of	dep	99	SENT_96	[p6l1801t2251r1880b2312],
71	neversmokers	NNS	O	neversmoker	dep	99	SENT_96	[p6l1911t2270r2145b2311, p6l11t2354r286b2415],
72	and	CC	O	and	dep	99	SENT_96	[p6l315t2354r434b2414],
73	2/10	CD	PERCENT	2/10	dep	99	SENT_96	[p6l459t2354r605b2415],
74	(	CD	PERCENT	(	dep	99	SENT_96	[p6l634t2354r838b2429],
75	20	CD	PERCENT	20	dep	99	SENT_96	[p6l634t2354r838b2429],
76	%	NN	PERCENT	%	dep	99	SENT_96	[p6l634t2354r838b2429],
77	)	CD	NUMBER	)	dep	99	SENT_96	[p6l634t2354r838b2429],
78	of	IN	O	of	dep	99	SENT_96	[p6l867t2354r940b2415],
79	ever-smokers	NNS	O	ever-smoker	dep	99	SENT_96	[p6l960t2354r1431b2425],
80	;	:	O	;	_	0	SENT_96	[p6l960t2354r1431b2425],
81	9/15	CD	PERCENT	9/15	dep	99	SENT_96	[p6l1460t2354r1604b2415],
82	(	CD	PERCENT	(	dep	99	SENT_96	[p6l1636t2354r1845b2429],
83	60	CD	PERCENT	60	dep	99	SENT_96	[p6l1636t2354r1845b2429],
84	%	NN	PERCENT	%	dep	99	SENT_96	[p6l1636t2354r1845b2429],
85	)	CD	NUMBER	)	dep	99	SENT_96	[p6l1636t2354r1845b2429],
86	of	IN	O	of	dep	99	SENT_96	[p6l1876t2354r1950b2415],
87	welldifferentiated	JJ	O	welldifferentiated	dep	99	SENT_96	[p6l1972t2354r2145b2414, p6l9t2457r521b2517],
88	and	CC	O	and	dep	99	SENT_96	[p6l561t2457r690b2517],
89	2/6	CD	PERCENT	2/6	dep	99	SENT_96	[p6l729t2457r842b2518],
90	(	CD	PERCENT	(	dep	99	SENT_96	[p6l885t2457r1181b2532],
91	33.3	CD	PERCENT	33.3	dep	99	SENT_96	[p6l885t2457r1181b2532],
92	%	NN	PERCENT	%	dep	99	SENT_96	[p6l885t2457r1181b2532],
93	)	CD	NUMBER	)	dep	99	SENT_96	[p6l885t2457r1181b2532],
94	of	IN	O	of	dep	99	SENT_96	[p6l1223t2457r1301b2518],
95	moderately	RB	O	moderately	dep	99	SENT_96	[p6l1334t2457r1754b2535],
96	or	CC	O	or	dep	99	SENT_96	[p6l1794t2476r1868b2518],
97	poorly	RB	O	poorly	dep	99	SENT_96	[p6l1904t2457r2147b2535],
98	differentiated	VBN	O	differentiate	dep	99	SENT_96	[p6l9t2559r514b2619],
99	NSCLC	NN	O	nsclc	_	0	SENT_96	[p6l550t2559r863b2619],
100	.	.	O	.	_	0	SENT_96	[p6l550t2559r863b2619],

1	None	NN	O	none	nsubj	7	SENT_97	[p6l902t2560r1096b2619],
2	of	IN	O	of	_	0	SENT_97	[p6l1136t2559r1214b2619],
3	the	DT	O	the	det	4	SENT_97	[p6l1246t2559r1355b2619],
4	trends	NNS	O	trend	prep_of	1	SENT_97	[p6l1393t2559r1616b2619],
5	shown	VBN	O	show	partmod	4	SENT_97	[p6l1660t2559r1893b2619],
6	above	IN	O	above	prep	5	SENT_97	[p6l1932t2559r2147b2619],
7	reached	VBN	O	reach	_	0	SENT_97	[p6l7t2662r276b2722],
8	statistical	JJ	O	statistical	amod	9	SENT_97	[p6l308t2662r630b2722],
9	significance	NN	O	significance	nsubj	11	SENT_97	[p6l663t2662r1076b2740],
10	probably	RB	O	probably	advmod	11	SENT_97	[p6l1105t2662r1411b2740],
11	due	JJ	O	due	xcomp	7	SENT_97	[p6l1443t2662r1564b2722],
12	to	TO	O	to	_	0	SENT_97	[p6l1594t2671r1658b2723],
13	small	JJ	O	small	amod	15	SENT_97	[p6l1692t2662r1874b2722],
14	sample	NN	O	sample	nn	15	SENT_97	[p6l1908t2662r2147b2740],
15	size	NN	O	size	prep_to	11	SENT_97	[p6l11t2783r161b2824],
16	.	.	O	.	_	0	SENT_97	[p6l11t2783r161b2824],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_98	[p6l7t2962r234b3022],
2	copy	NN	O	copy	nn	3	SENT_98	[p6l273t2982r441b3038],
3	number	NN	O	number	nsubj	8	SENT_98	[p6l479t2961r755b3021],
4	in	IN	O	in	_	0	SENT_98	[p6l794t2963r858b3021],
5	22	CD	NUMBER	22	num	7	SENT_98	[p6l896t2961r980b3020],
6	gefitinib	NN	O	gefitinib	nn	7	SENT_98	[p6l1020t2961r1625b3038],
7	—	NN	O	—	prep_in	3	SENT_98	[p6l1020t2961r1625b3038],
8	treated	VBN	O	treat	_	0	SENT_98	[p6l1020t2961r1625b3038],
9	patients	NNS	O	patient	dobj	8	SENT_98	[p6l1651t2963r1971b3038],
10	.	.	O	.	_	0	SENT_98	[p6l1651t2963r1971b3038],

1	The	DT	O	the	det	4	SENT_99	[p6l2010t2961r2147b3021],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_99	[p6l8t3065r228b3124],
3	copy	NN	O	copy	nn	4	SENT_99	[p6l263t3083r428b3142],
4	number	NN	O	number	_	0	SENT_99	[p6l464t3064r728b3124],
5	of	IN	O	of	_	0	SENT_99	[p6l762t3064r836b3125],
6	22	CD	NUMBER	22	num	7	SENT_99	[p6l867t3064r949b3123],
7	samples	NNS	O	sample	prep_of	4	SENT_99	[p6l988t3064r1260b3142],
8	from	IN	O	from	dep	4	SENT_99	[p6l1297t3064r1464b3125],
9	patients	NNS	O	patient	pobj	8	SENT_99	[p6l1496t3064r1763b3142],
10	who	WP	O	who	nsubj	11	SENT_99	[p6l1800t3064r1945b3125],
11	were	VBD	O	be	rcmod	9	SENT_99	[p6l1982t3083r2147b3124],

1	ONCOLOGY	NNP	O	ONCOLOGY	nn	2	SENT_100	[p6l714t3217r899b3241],
2	REPORTS	NNS	O	report	_	0	SENT_100	[p6l908t3217r1052b3241],
3	16	CD	NUMBER	16	num	5	SENT_100	[p6l1075t3217r1111b3241],
4	:	:	O	:	_	0	SENT_100	[p6l1075t3217r1111b3241],
5	533-541	CD	NUMBER	533-541	dep	2	SENT_100	[p6l1131t3217r1250b3245],
6	,	,	O	,	_	0	SENT_100	[p6l1131t3217r1250b3245],
7	2006	CD	DATE	2006	num	8	SENT_100	[p6l1267t3217r1332b3241],
8	535	CD	NUMBER	535	appos	5	SENT_100	[p6l2039t3222r2105b3253],

1	Table	NNP	O	Table	nn	2	SENT_101	[p6l22t3328r115b3357],
2	II	NNP	O	II	_	0	SENT_101	[p6l127t3329r164b3357],
3	.	.	O	.	_	0	SENT_101	[p6l127t3329r164b3357],

1	Relationships	NNPS	O	Relationships	_	0	SENT_102	[p6l175t3328r401b3366],
2	among	IN	O	among	_	0	SENT_102	[p6l414t3337r525b3366],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_102	[p6l537t3328r643b3357],
4	mutation	NN	O	mutation	prep_among	1	SENT_102	[p6l654t3328r812b3362],
5	,	,	O	,	_	0	SENT_102	[p6l654t3328r812b3362],
6	the	DT	O	the	det	9	SENT_102	[p6l823t3328r872b3357],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_102	[p6l884t3328r990b3357],
8	copy	NN	O	copy	nn	9	SENT_102	[p6l1001t3337r1081b3366],
9	number	NN	O	number	prep_among	1	SENT_102	[p6l1092t3328r1220b3357],
10	and	CC	O	and	_	0	SENT_102	[p6l1231t3328r1290b3357],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_102	[p6l1301t3328r1440b3366],
12	sensitivity	NN	O	sensitivity	prep_among	1	SENT_102	[p6l1454t3328r1633b3366],
13	.	.	O	.	_	0	SENT_102	[p6l1454t3328r1633b3366],

1	Responders	NNS	O	responder	nsubj	2	SENT_103	[p6l621t3421r813b3459],
2	Non	VBP	O	non	_	0	SENT_103	[p6l1163t3421r1427b3459],
3	—	CD	NUMBER	—	num	4	SENT_103	[p6l1163t3421r1427b3459],
4	responders	NNS	O	responder	dobj	2	SENT_103	[p6l1163t3421r1427b3459],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_104	[p6l22t3521r127b3550],
2	gene	NN	O	gene	nn	3	SENT_104	[p6l139t3530r216b3559],
3	CR	NN	O	cr	_	0	SENT_104	[p6l544t3521r598b3550],
4	PR	NN	O	pr	nn	7	SENT_104	[p6l831t3522r881b3550],
5	NC	NN	O	nc	nn	7	SENT_104	[p6l1126t3521r1182b3550],
6	PD	NN	O	pd	nn	7	SENT_104	[p6l1413t3522r1464b3550],
7	Responders	NNS	O	responder	dep	3	SENT_104	[p6l1627t3521r1833b3559],
8	/	:	O	/	punct	9	SENT_104	[p6l1627t3521r1833b3559],
9	Response	NN	O	response	dep	7	SENT_104	[p6l1978t3522r2136b3559],
10	total	JJ	O	total	amod	12	SENT_104	[p6l1623t3570r1696b3599],
11	patients	NNS	O	patient	nn	12	SENT_104	[p6l1707t3570r1836b3608],
12	rates	NNS	O	rate	dep	9	SENT_104	[p6l1982t3574r2059b3599],
13	(	CD	PERCENT	(	num	14	SENT_104	[p6l2073t3570r2131b3606],
14	%	NN	PERCENT	%	dep	7	SENT_104	[p6l2073t3570r2131b3606],
15	)	CD	NUMBER	)	dep	3	SENT_104	[p6l2073t3570r2131b3606],

1	Mutant	JJ	O	mutant	amod	2	SENT_105	[p7l22t18r142b47],
2	o	NN	O	o	_	0	SENT_105	[p7l559t18r578b47],
3	9	CD	NUMBER	9	number	4	SENT_105	[p7l858t18r877b47],
4	1	CD	NUMBER	1	num	6	SENT_105	[p7l1141t18r1153b46],
5	1 9/1	CD	NUMBER	1 9/1	number	6	SENT_105	[p7l1710t18r1758b47],[p7l1432t18r1443b46],
6	1	CD	NUMBER	1	nsubj	22	SENT_105	[p7l1767t18r1779b46],
7	81	CD	NUMBER	81	number	8	SENT_105	[p7l2036t18r2071b47],
8	.83	CD	NUMBER	.83	num	12	SENT_105	[p7l2080t18r2118b47],
9	Wild	NNP	O	Wild	nn	12	SENT_105	[p7l21t66r189b104],
10	—	CD	NUMBER	—	num	12	SENT_105	[p7l21t66r189b104],
11	type	NN	O	type	nn	12	SENT_105	[p7l21t66r189b104],
12	o	NN	O	o	dep	6	SENT_105	[p7l559t66r578b95],
13	2	CD	NUMBER	2	number	14	SENT_105	[p7l858t66r877b95],
14	4	CD	NUMBER	4	num	12	SENT_105	[p7l1137t66r1157b95],
15	5	CD	NUMBER	5	number	16	SENT_105	[p7l1428t66r1446b95],
16	2	CD	NUMBER	2	num	12	SENT_105	[p7l1710t66r1741b96],
17	/	:	O	/	punct	19	SENT_105	[p7l1710t66r1741b96],
18	1	CD	NUMBER	1	num	19	SENT_105	[p7l1746t66r1758b95],
19	1	CD	NUMBER	1	dep	6	SENT_105	[p7l1767t66r1779b95],
20	18	CD	NUMBER	18	num	21	SENT_105	[p7l2038t66r2073b96],
21	.23	CD	NUMBER	.23	dep	19	SENT_105	[p7l2080t66r2118b96],
22	Copy	VBP	O	copy	rcmod	2	SENT_105	[p7l22t117r111b155],
23	number	NN	O	number	nsubj	31	SENT_105	[p7l123t117r250b146],
24	23	CD	NUMBER	23	num	25	SENT_105	[p7l260t117r301b146],
25	o	NN	O	o	dep	23	SENT_105	[p7l559t117r578b146],
26	1	CD	NUMBER	1	num	27	SENT_105	[p7l862t117r874b146],
27	o	NN	O	o	dep	23	SENT_105	[p7l1137t117r1156b146],
28	3 1/4	CD	NUMBER	3 1/4	number	29	SENT_105	[p7l1714t117r1761b147],[p7l1429t117r1445b146],
29	25	CD	NUMBER	25	num	30	SENT_105	[p7l2035t116r2087b146],
30	”	NN	O	”	dep	27	SENT_105	[p7l2035t116r2087b146],
31	Copy	VBP	O	copy	ccomp	22	SENT_105	[p7l22t165r111b203],
32	number	NN	O	number	nsubj	52	SENT_105	[p7l122t165r250b194],
33	<	JJR	O	<	dep	32	SENT_105	[p7l261t165r301b194],
34	3	CD	NUMBER	3	num	35	SENT_105	[p7l261t165r301b194],
35	o	NN	O	o	dep	32	SENT_105	[p7l559t165r578b194],
36	10	CD	NUMBER	10	number	37	SENT_105	[p7l841t165r877b194],
37	5	CD	NUMBER	5	num	39	SENT_105	[p7l1138t165r1155b194],
38	3 10/18	CD	NUMBER	3 10/18	number	39	SENT_105	[p7l1693t165r1781b195],[p7l1429t165r1445b194],
39	55	CD	NUMBER	55	dep	35	SENT_105	[p7l2035t165r2073b194],
40	.6	CD	NUMBER	.6	number	41	SENT_105	[p7l2080t164r2118b194],
41	”	CD	NUMBER	”	num	39	SENT_105	[p7l2080t164r2118b194],
42	Total	JJ	O	total	amod	52	SENT_105	[p7l22t216r108b246],
43	o	NN	O	o	nn	52	SENT_105	[p7l559t216r578b246],
44	1	CD	NUMBER	1	num	52	SENT_105	[p7l841t217r853b245],
45	1	CD	NUMBER	1	num	52	SENT_105	[p7l862t216r874b245],
46	5	CD	NUMBER	5	num	52	SENT_105	[p7l1138t216r1155b246],
47	6	CD	NUMBER	6	num	52	SENT_105	[p7l1428t216r1447b246],
48	1 1/22	CD	NUMBER	1 1/22	num	52	SENT_105	[p7l1714t216r1782b246],[p7l1693t217r1705b245],
49	50	CD	NUMBER	50	num	52	SENT_105	[p7l2035t216r2074b246],
50	"	``	O	"	punct	52	SENT_105	[p7l22t308r90b342],
51	‘	NN	O	‘	nn	52	SENT_105	[p7l22t308r90b342],
52	p	NN	O	p	xcomp	31	SENT_105	[p7l22t308r90b342],
53	=	JJ	O	=	amod	54	SENT_105	[p7l22t308r90b342],
54	o	NN	O	o	dep	2	SENT_105	[p7l22t308r90b342],
55	.0089	CD	NUMBER	.0089	dep	54	SENT_105	[p7l95t308r184b339],
56	;	:	O	;	_	0	SENT_105	[p7l95t308r184b339],
57	‘	CD	NUMBER	‘	number	58	SENT_105	[p7l195t304r265b342],
58	°	CD	NUMBER	°	num	59	SENT_105	[p7l195t304r265b342],
59	p	NN	O	p	npadvmod	60	SENT_105	[p7l195t304r265b342],
60	=	JJ	O	=	amod	61	SENT_105	[p7l195t304r265b342],
61	o	NN	O	o	dep	2	SENT_105	[p7l195t304r265b342],
62	.5865	CD	NUMBER	.5865	number	63	SENT_105	[p7l270t308r348b334],
63	(	CD	NUMBER	(	num	61	SENT_105	[p7l362t308r486b340],
64	Fisher	NNP	PERSON	Fisher	poss	68	SENT_105	[p7l362t308r486b340],
65	's	POS	O	's	_	0	SENT_105	[p7l362t308r486b340],
66	exact	JJ	O	exact	amod	68	SENT_105	[p7l498t312r576b334],
67	test	NN	O	test	nn	68	SENT_105	[p7l586t308r659b340],
68	)	NN	O	)	dep	61	SENT_105	[p7l586t308r659b340],
69	;	:	O	;	_	0	SENT_105	[p7l586t308r659b340],
70	CR	NN	O	cr	dep	2	SENT_105	[p7l671t308r729b339],
71	,	,	O	,	_	0	SENT_105	[p7l671t308r729b339],
72	complete	JJ	O	complete	amod	73	SENT_105	[p7l739t308r875b342],
73	response	NN	O	response	appos	70	SENT_105	[p7l886t316r1025b342],
74	;	:	O	;	_	0	SENT_105	[p7l886t316r1025b342],
75	PR	NN	O	pr	dep	2	SENT_105	[p7l1037t309r1092b339],
76	,	,	O	,	_	0	SENT_105	[p7l1037t309r1092b339],
77	partial	JJ	O	partial	amod	78	SENT_105	[p7l1101t308r1196b342],
78	response	NN	O	response	appos	75	SENT_105	[p7l1206t316r1346b342],
79	;	:	O	;	_	0	SENT_105	[p7l1206t316r1346b342],
80	NC	NNP	O	NC	dep	2	SENT_105	[p7l1358t308r1419b339],
81	,	,	O	,	_	0	SENT_105	[p7l1358t308r1419b339],
82	no	DT	O	no	det	83	SENT_105	[p7l1429t316r1465b334],
83	change	NN	O	change	appos	80	SENT_105	[p7l1476t308r1590b342],
84	;	:	O	;	_	0	SENT_105	[p7l1476t308r1590b342],
85	PD	NN	O	pd	dep	2	SENT_105	[p7l1602t309r1658b339],
86	,	,	O	,	_	0	SENT_105	[p7l1602t309r1658b339],
87	progressive	JJ	O	progressive	amod	88	SENT_105	[p7l1668t308r1840b342],
88	disease	NN	O	disease	appos	85	SENT_105	[p7l1851t308r1967b334],
89	.	.	O	.	_	0	SENT_105	[p7l1851t308r1967b334],

1	Mutant	JJ	O	mutant	amod	2	SENT_106	[p7l1529t516r1636b541],
2	.....	NN	O	.....	_	0	SENT_106	[p7l1419t597r1475b604],
3	.	.	O	.	_	0	SENT_106	[p7l1480t597r1487b604],

1	.	.	O	.	_	0	SENT_107	[p7l1492t597r1500b604],

1	Wild	NNP	O	Wild	_	0	SENT_108	[p7l1528t582r1678b617],
2	—	CD	NUMBER	—	num	3	SENT_108	[p7l1528t582r1678b617],
3	type	NN	O	type	dep	1	SENT_108	[p7l1528t582r1678b617],

1	One	CD	NUMBER	one	num	3	SENT_109	[p7l1423t679r1560b713],
2	—	CD	NUMBER	—	num	3	SENT_109	[p7l1423t679r1560b713],
3	year	NN	NUMBER	year	_	0	SENT_109	[p7l1423t679r1560b713],
4	survival	NN	O	survival	nn	5	SENT_109	[p7l1571t679r1688b706],
5	rate	NN	O	rate	dep	3	SENT_109	[p7l1698t684r1749b706],
6	Mutant	JJ	O	mutant	amod	3	SENT_109	[p7l1422t747r1536b772],
7	:	:	O	:	_	0	SENT_109	[p7l1422t747r1536b772],
8	66.7	CD	PERCENT	66.7	num	9	SENT_109	[p7l1577t746r1668b774],
9	%	NN	PERCENT	%	dep	3	SENT_109	[p7l1577t746r1668b774],

1	Survival	NN	O	survival	nn	2	SENT_110	[p7l417t727r444b849],
2	rate	NN	O	rate	_	0	SENT_110	[p7l422t660r444b716],
3	.9	CD	NUMBER	.9	dep	2	SENT_110	[p7l465t804r491b830],
4	.	.	O	.	_	0	SENT_110	[p7l465t695r491b722],

1	o	NN	O	o	_	0	SENT_111	[p7l465t695r491b722],
2	-	:	O	-	_	0	SENT_111	[p7l493t804r510b830],
3	J	NN	O	j	amod	5	SENT_111	[p7l493t804r510b830],
4	>	JJR	O	>	dep	3	SENT_111	[p7l493t804r510b830],
5	ox	NN	O	ox	dep	1	SENT_111	[p7l494t695r511b722],

1	+	CC	O	+	cc	4	SENT_112	[p7l721t791r788b848],
2	Wild	NNP	O	Wild	nn	4	SENT_112	[p7l1421t813r1673b847],
3	—	CD	NUMBER	—	num	4	SENT_112	[p7l1421t813r1673b847],
4	type	NN	O	type	dep	12	SENT_112	[p7l1421t813r1673b847],
5	:18.2	CD	PERCENT	:18.2	num	6	SENT_112	[p7l1421t813r1673b847],
6	%	NN	PERCENT	%	dep	4	SENT_112	[p7l1421t813r1673b847],
7	log	NN	O	log	nn	9	SENT_112	[p7l1421t880r1554b913],
8	—	CD	NUMBER	—	num	9	SENT_112	[p7l1421t880r1554b913],
9	rank	NN	O	rank	dep	4	SENT_112	[p7l1421t880r1554b913],
10	:	:	O	:	_	0	SENT_112	[p7l1421t880r1554b913],
11	p	NN	O	p	dep	4	SENT_112	[p7l1566t881r1704b914],
12	=	JJ	O	=	_	0	SENT_112	[p7l1566t881r1704b914],
13	0.0123	CD	NUMBER	0.0123	tmod	12	SENT_112	[p7l1566t881r1704b914],

1	E3	NN	O	e3	nn	2	SENT_113	[p7l464t916r490b942],
2	N	NN	O	n	_	0	SENT_113	[p7l493t915r510b941],

1	O	NN	O	o	_	0	SENT_114	[p7l497t1024r514b1050],

1	Days	NNS	DURATION	day	_	0	SENT_115	[p7l650t1176r724b1210],
2	from	IN	O	from	_	0	SENT_115	[p7l736t1175r807b1202],
3	the	DT	O	the	det	4	SENT_115	[p7l817t1176r861b1202],
4	start	NN	O	start	prep_from	1	SENT_115	[p7l873t1179r935b1202],
5	of	IN	O	of	_	0	SENT_115	[p7l945t1176r978b1202],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_115	[p7l985t1176r1108b1210],
7	administration	NN	O	administration	prep_of	1	SENT_115	[p7l1118t1176r1332b1203],

1	Figure	NNP	O	Figure	_	0	SENT_116	[p7l22t1222r108b1253],
2	1	CD	NUMBER	1	dep	1	SENT_116	[p7l124t1222r144b1246],
3	.	.	O	.	_	0	SENT_116	[p7l124t1222r144b1246],

1	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	2	SENT_117	[p7l157t1222r344b1253],
2	curves	NNS	O	curve	_	0	SENT_117	[p7l356t1229r441b1246],
3	of	IN	O	of	_	0	SENT_117	[p7l454t1222r483b1246],
4	overall	JJ	O	overall	amod	5	SENT_117	[p7l494t1222r585b1246],
5	survival	NN	O	survival	prep_of	2	SENT_117	[p7l599t1222r704b1246],
6	according	VBG	O	accord	_	0	SENT_117	[p7l718t1222r847b1253],
7	to	TO	O	to	prepc_according_to	5	SENT_117	[p7l860t1226r885b1246],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_117	[p7l897t1222r982b1246],
9	mutation	NN	O	mutation	pobj	5	SENT_117	[p7l994t1222r1112b1246],
10	in	IN	O	in	_	0	SENT_117	[p7l1125t1222r1149b1246],
11	22	CD	NUMBER	22	num	13	SENT_117	[p7l1163t1222r1194b1246],
12	gefitinib-treated	JJ	O	gefitinib-treated	amod	13	SENT_117	[p7l1207t1222r1421b1253],
13	patients	NNS	O	patient	prep_in	9	SENT_117	[p7l1433t1222r1544b1253],
14	.	.	O	.	_	0	SENT_117	[p7l1433t1222r1544b1253],

1	One-year	JJ	DURATION	one-year	amod	3	SENT_118	[p7l1558t1222r1681b1253],
2	survival	NN	O	survival	nn	3	SENT_118	[p7l1694t1222r1799b1246],
3	rate	NN	O	rate	nsubj	12	SENT_118	[p7l1812t1226r1861b1246],
4	of	IN	O	of	_	0	SENT_118	[p7l1874t1222r1903b1246],
5	the	DT	O	the	det	6	SENT_118	[p7l1913t1222r1952b1246],
6	patients	NNS	O	patient	prep_of	3	SENT_118	[p7l1965t1222r2067b1253],
7	with	IN	O	with	_	0	SENT_118	[p7l2081t1222r2139b1246],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_118	[p7l22t1262r106b1286],
9	mutation	NN	O	mutation	prep_with	6	SENT_118	[p7l116t1262r233b1286],
10	was	VBD	O	be	cop	12	SENT_118	[p7l244t1269r294b1286],
11	66.7	CD	PERCENT	66.7	num	12	SENT_118	[p7l305t1262r388b1286],
12	%	NN	PERCENT	%	_	0	SENT_118	[p7l305t1262r388b1286],
13	vs	CC	O	vs	_	0	SENT_118	[p7l400t1269r427b1286],
14	18.2	CD	PERCENT	18.2	num	15	SENT_118	[p7l441t1262r522b1286],
15	%	NN	PERCENT	%	conj_vs	12	SENT_118	[p7l441t1262r522b1286],
16	of	IN	O	of	_	0	SENT_118	[p7l534t1262r562b1286],
17	the	DT	O	the	det	18	SENT_118	[p7l570t1262r610b1286],
18	patients	NNS	O	patient	prep_of	15	SENT_118	[p7l619t1262r722b1293],
19	with	IN	O	with	_	0	SENT_118	[p7l733t1262r791b1286],
20	wild-type	JJ	O	wild-type	amod	21	SENT_118	[p7l801t1262r927b1293],
21	EGFR	NN	ORGANIZATION	egfr	prep_with	18	SENT_118	[p7l938t1262r1030b1286],
22	.	.	O	.	_	0	SENT_118	[p7l938t1262r1030b1286],

1	Patients	NNS	O	patient	nsubj	5	SENT_119	[p7l1040t1262r1144b1286],
2	with	IN	O	with	_	0	SENT_119	[p7l1155t1262r1213b1286],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_119	[p7l1223t1262r1307b1286],
4	mutation	NN	O	mutation	prep_with	1	SENT_119	[p7l1318t1262r1435b1286],
5	had	VBD	O	have	_	0	SENT_119	[p7l1445t1262r1493b1286],
6	a	DT	O	a	det	10	SENT_119	[p7l1503t1269r1517b1286],
7	statistically	RB	O	statistically	advmod	9	SENT_119	[p7l1527t1262r1677b1293],
8	significantly	RB	O	significantly	advmod	9	SENT_119	[p7l1688t1262r1852b1293],
9	longer	JJR	O	longer	amod	10	SENT_119	[p7l1863t1262r1948b1293],
10	OS	NN	O	os	dobj	5	SENT_119	[p7l1957t1262r1997b1286],
11	compared	VBN	O	compare	_	0	SENT_119	[p7l2009t1262r2139b1293],
12	with	IN	O	with	prepc_compared_with	5	SENT_119	[p7l7t1312r128b1361],
13	those	DT	O	those	dep	19	SENT_119	[p7l147t1312r292b1361],
14	with	IN	O	with	_	0	SENT_119	[p7l312t1312r434b1361],
15	wild-type	JJ	O	wild-type	amod	16	SENT_119	[p7l453t1312r717b1376],
16	EGFR	NN	ORGANIZATION	egfr	prep_with	13	SENT_119	[p7l736t1313r913b1361],
17	(	CD	NUMBER	(	num	18	SENT_119	[p7l934t1312r1190b1375],
18	log-rank	NN	O	log-rank	dep	19	SENT_119	[p7l934t1312r1190b1375],
19	p	NN	O	p	dep	23	SENT_119	[p7l1207t1313r1313b1376],
20	=	JJ	O	=	amod	21	SENT_119	[p7l1207t1313r1313b1376],
21	o	NN	O	o	dep	19	SENT_119	[p7l1207t1313r1313b1376],
22	.0123	CD	NUMBER	.0123	num	23	SENT_119	[p7l1323t1313r1511b1372],
23	)	NN	O	)	dep	5	SENT_119	[p7l1323t1313r1511b1372],
24	.	.	O	.	_	0	SENT_119	[p7l1323t1313r1511b1372],

1	treated	VBN	O	treat	csubjpass	5	SENT_120	[p7l6t1533r242b1593],
2	with	IN	O	with	_	0	SENT_120	[p7l273t1533r425b1593],
3	gefitinib	NN	O	gefitinib	prep_with	1	SENT_120	[p7l458t1533r748b1611],
4	was	VBD	O	be	auxpass	5	SENT_120	[p7l781t1552r912b1593],
5	analyzed	VBN	O	analyze	_	0	SENT_120	[p7l948t1533r1253b1611],
6	by	IN	O	by	_	0	SENT_120	[p7l1283t1533r1368b1611],
7	quantitative	JJ	O	quantitative	amod	11	SENT_120	[p7l1402t1533r1808b1611],
8	real	JJ	O	real	amod	11	SENT_120	[p7l1840t1533r2152b1593],
9	—	NN	O	—	nn	11	SENT_120	[p7l1840t1533r2152b1593],
10	time	NN	O	time	nn	11	SENT_120	[p7l1840t1533r2152b1593],
11	PCR	NN	O	pcr	agent	5	SENT_120	[p7l7t1637r197b1697],
12	.	.	O	.	_	0	SENT_120	[p7l7t1637r197b1697],

1	Four	CD	TIME	four	nsubjpass	6	SENT_121	[p7l236t1638r408b1697],
2	of	IN	TIME	of	_	0	SENT_121	[p7l445t1636r523b1697],
3	22	CD	TIME	22	num	4	SENT_121	[p7l556t1637r640b1696],
4	cases	NNS	O	case	prep_of	1	SENT_121	[p7l680t1655r869b1697],
5	were	VBD	O	be	auxpass	6	SENT_121	[p7l909t1655r1083b1697],
6	found	VBN	O	find	_	0	SENT_121	[p7l1122t1636r1333b1697],
7	to	TO	O	to	aux	8	SENT_121	[p7l1370t1645r1437b1697],
8	have	VB	O	have	xcomp	6	SENT_121	[p7l1476t1636r1645b1697],
9	an	DT	O	a	det	13	SENT_121	[p7l1686t1655r1766b1697],
10	increased	VBN	O	increase	amod	13	SENT_121	[p7l1804t1636r2152b1697],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_121	[p7l6t1741r238b1800],
12	copy	NN	O	copy	nn	13	SENT_121	[p7l277t1759r453b1818],
13	number	NN	O	number	dobj	8	SENT_121	[p7l493t1740r799b1800],
14	.	.	O	.	_	0	SENT_121	[p7l493t1740r799b1800],

1	Relationship	NN	O	relationship	dep	124	SENT_122	[p7l838t1740r1316b1818],
2	between	IN	O	between	dep	124	SENT_122	[p7l1355t1740r1666b1800],
3	EGFR	NN	ORGANIZATION	egfr	dep	124	SENT_122	[p7l1704t1740r1936b1800],
4	copy	NN	O	copy	dep	124	SENT_122	[p7l1975t1759r2151b1818],
5	number	NN	O	number	dep	124	SENT_122	[p7l7t1843r272b1903],
6	and	CC	O	and	dep	124	SENT_122	[p7l297t1843r419b1903],
7	clinicopathological	JJ	O	clinicopathological	dep	124	SENT_122	[p7l445t1843r1108b1921],
8	factors	NNS	O	factor	dep	124	SENT_122	[p7l1134t1843r1366b1904],
9	in	IN	O	in	dep	124	SENT_122	[p7l1394t1843r1459b1902],
10	22	CD	NUMBER	22	dep	124	SENT_122	[p7l1486t1843r1568b1902],
11	gefitinib	NN	O	gefitinib	dep	124	SENT_122	[p7l1596t1843r2153b1921],
12	—	NN	O	—	dep	124	SENT_122	[p7l1596t1843r2153b1921],
13	treated	VBN	O	treat	dep	124	SENT_122	[p7l1596t1843r2153b1921],
14	patients	NNS	O	patient	dep	124	SENT_122	[p7l6t1946r299b2024],
15	is	VBZ	O	be	dep	124	SENT_122	[p7l340t1946r397b2006],
16	shown	VBN	O	show	dep	124	SENT_122	[p7l441t1946r678b2007],
17	in	IN	O	in	dep	124	SENT_122	[p7l716t1946r785b2005],
18	Table	NNP	O	Table	dep	124	SENT_122	[p7l824t1946r1034b2006],
19	I.	NNP	O	I.	dep	124	SENT_122	[p7l1073t1947r1124b2006],
20	An	NNP	O	An	dep	124	SENT_122	[p7l1164t1946r1272b2005],
21	increased	VBD	O	increase	dep	124	SENT_122	[p7l1310t1946r1666b2006],
22	EGFR	NN	ORGANIZATION	egfr	dep	124	SENT_122	[p7l1704t1946r1936b2006],
23	copy	NN	O	copy	dep	124	SENT_122	[p7l1975t1965r2151b2024],
24	number	NN	O	number	dep	124	SENT_122	[p7l7t2049r272b2109],
25	was	VBD	O	be	dep	124	SENT_122	[p7l301t2068r432b2109],
26	found	VBN	O	find	dep	124	SENT_122	[p7l465t2049r666b2110],
27	in	IN	O	in	dep	124	SENT_122	[p7l697t2049r762b2108],
28	4/13	CD	PERCENT	4/13	dep	124	SENT_122	[p7l793t2049r941b2110],
29	(	CD	PERCENT	(	dep	124	SENT_122	[p7l979t2049r1254b2124],
30	30.8	CD	PERCENT	30.8	dep	124	SENT_122	[p7l979t2049r1254b2124],
31	%	NN	PERCENT	%	dep	124	SENT_122	[p7l979t2049r1254b2124],
32	)	CD	NUMBER	)	dep	124	SENT_122	[p7l979t2049r1254b2124],
33	of	IN	O	of	dep	124	SENT_122	[p7l1289t2049r1364b2110],
34	males	NNS	O	male	dep	124	SENT_122	[p7l1389t2049r1588b2109],
35	and	CC	O	and	dep	124	SENT_122	[p7l1623t2049r1745b2109],
36	0/9	CD	NUMBER	0/9	dep	124	SENT_122	[p7l1775t2049r1882b2110],
37	(	CD	NUMBER	(	dep	124	SENT_122	[p7l1918t2049r2149b2124],
38	o.	NN	O	o.	dep	124	SENT_122	[p7l1918t2049r2149b2124],
39	o	NN	PERCENT	o	dep	124	SENT_122	[p7l1918t2049r2149b2124],
40	%	NN	PERCENT	%	dep	124	SENT_122	[p7l1918t2049r2149b2124],
41	)	CD	NUMBER	)	dep	124	SENT_122	[p7l1918t2049r2149b2124],
42	of	IN	O	of	dep	124	SENT_122	[p7l8t2152r82b2213],
43	females	NNS	O	female	dep	124	SENT_122	[p7l111t2152r400b2223],
44	;	:	O	;	_	0	SENT_122	[p7l111t2152r400b2223],
45	2/10	CD	PERCENT	2/10	dep	124	SENT_122	[p7l439t2152r587b2213],
46	(	CD	PERCENT	(	dep	124	SENT_122	[p7l626t2152r836b2226],
47	20	CD	PERCENT	20	dep	124	SENT_122	[p7l626t2152r836b2226],
48	%	NN	PERCENT	%	dep	124	SENT_122	[p7l626t2152r836b2226],
49	)	CD	NUMBER	)	dep	124	SENT_122	[p7l626t2152r836b2226],
50	of	IN	O	of	dep	124	SENT_122	[p7l874t2152r948b2213],
51	patients	NNS	O	patient	dep	124	SENT_122	[p7l976t2152r1243b2230],
52	who	WP	O	who	dep	124	SENT_122	[p7l1279t2152r1425b2213],
53	were	VBD	O	be	dep	124	SENT_122	[p7l1461t2171r1626b2212],
54	:64	CD	NUMBER	:64	dep	124	SENT_122	[p7l1662t2152r1793b2212],
55	years	NNS	NUMBER	year	dep	124	SENT_122	[p7l1828t2171r2007b2230],
56	old	JJ	O	old	dep	124	SENT_122	[p7l2044t2152r2153b2213],
57	and	CC	O	and	dep	124	SENT_122	[p7l9t2255r134b2315],
58	2/12	CD	PERCENT	2/12	dep	124	SENT_122	[p7l171t2255r326b2316],
59	(	CD	PERCENT	(	dep	124	SENT_122	[p7l367t2255r652b2330],
60	16.7	CD	PERCENT	16.7	dep	124	SENT_122	[p7l367t2255r652b2330],
61	%	NN	PERCENT	%	dep	124	SENT_122	[p7l367t2255r652b2330],
62	)	CD	NUMBER	)	dep	124	SENT_122	[p7l367t2255r652b2330],
63	of	IN	O	of	dep	124	SENT_122	[p7l692t2255r769b2316],
64	those	DT	O	those	dep	124	SENT_122	[p7l800t2255r987b2315],
65	who	WP	O	who	dep	124	SENT_122	[p7l1025t2255r1174b2315],
66	were	VBD	O	be	dep	124	SENT_122	[p7l1213t2274r1383b2315],
67	>	JJR	O	>	dep	124	SENT_122	[p7l1420t2255r1557b2315],
68	64	CD	DURATION	64	dep	124	SENT_122	[p7l1420t2255r1557b2315],
69	years	NNS	NUMBER	year	dep	124	SENT_122	[p7l1595t2274r1781b2333],
70	old	JJ	DURATION	old	dep	124	SENT_122	[p7l1820t2255r1954b2326],
71	;	:	O	;	_	0	SENT_122	[p7l1820t2255r1954b2326],
72	4/18	CD	PERCENT	4/18	dep	124	SENT_122	[p7l1994t2255r2148b2316],
73	(	CD	PERCENT	(	dep	124	SENT_122	[p7l9t2358r323b2433],
74	22.2	CD	PERCENT	22.2	dep	124	SENT_122	[p7l9t2358r323b2433],
75	%	NN	PERCENT	%	dep	124	SENT_122	[p7l9t2358r323b2433],
76	)	CD	NUMBER	)	dep	124	SENT_122	[p7l9t2358r323b2433],
77	of	IN	O	of	dep	124	SENT_122	[p7l383t2358r465b2419],
78	adenocarcinoma	NN	O	adenocarcinoma	dep	124	SENT_122	[p7l517t2358r1169b2419],
79	and	CC	O	and	dep	124	SENT_122	[p7l1225t2358r1361b2418],
80	0/4	CD	PERCENT	0/4	dep	124	SENT_122	[p7l1416t2358r1538b2419],
81	(	NN	PERCENT	(	dep	124	SENT_122	[p7l1597t2358r1783b2433],
82	o	NN	PERCENT	o	dep	124	SENT_122	[p7l1597t2358r1783b2433],
83	%	NN	PERCENT	%	dep	124	SENT_122	[p7l1597t2358r1783b2433],
84	)	CD	NUMBER	)	dep	124	SENT_122	[p7l1597t2358r1783b2433],
85	of	IN	O	of	dep	124	SENT_122	[p7l1843t2358r1925b2419],
86	nonadenocarcinoma	NN	O	nonadenocarcinoma	dep	124	SENT_122	[p7l1975t2377r2149b2419, p7l9t2461r595b2533],
87	;	:	O	;	_	0	SENT_122	[p7l1975t2377r2149b2419, p7l9t2461r595b2533],
88	0/4	CD	PERCENT	0/4	dep	124	SENT_122	[p7l627t2461r735b2522],
89	(	CD	PERCENT	(	dep	124	SENT_122	[p7l768t2461r934b2535],
90	o	NN	PERCENT	o	dep	124	SENT_122	[p7l768t2461r934b2535],
91	%	NN	PERCENT	%	dep	124	SENT_122	[p7l768t2461r934b2535],
92	)	CD	NUMBER	)	dep	124	SENT_122	[p7l768t2461r934b2535],
93	of	IN	O	of	dep	124	SENT_122	[p7l967t2461r1041b2522],
94	never-smokers	NNS	O	never-smoker	dep	124	SENT_122	[p7l1065t2461r1572b2522],
95	and	CC	O	and	dep	124	SENT_122	[p7l1605t2461r1727b2521],
96	3/10	CD	PERCENT	3/10	dep	124	SENT_122	[p7l1758t2461r1906b2522],
97	(	CD	PERCENT	(	dep	124	SENT_122	[p7l1940t2461r2149b2536],
98	30	CD	PERCENT	30	dep	124	SENT_122	[p7l1940t2461r2149b2536],
99	%	NN	PERCENT	%	dep	124	SENT_122	[p7l1940t2461r2149b2536],
100	)	CD	NUMBER	)	dep	124	SENT_122	[p7l1940t2461r2149b2536],
101	of	IN	O	of	dep	124	SENT_122	[p7l8t2564r82b2625],
102	ever-smokers	NNS	O	ever-smoker	dep	124	SENT_122	[p7l107t2564r593b2636],
103	;	:	O	;	_	0	SENT_122	[p7l107t2564r593b2636],
104	2/15	CD	PERCENT	2/15	dep	124	SENT_122	[p7l627t2564r774b2625],
105	(	CD	PERCENT	(	dep	124	SENT_122	[p7l810t2564r1085b2639],
106	13.3	CD	PERCENT	13.3	dep	124	SENT_122	[p7l810t2564r1085b2639],
107	%	NN	PERCENT	%	dep	124	SENT_122	[p7l810t2564r1085b2639],
108	)	CD	NUMBER	)	dep	124	SENT_122	[p7l810t2564r1085b2639],
109	of	IN	O	of	dep	124	SENT_122	[p7l1118t2564r1193b2625],
110	well	RB	O	well	dep	124	SENT_122	[p7l1217t2564r1862b2624],
111	—	CD	NUMBER	—	dep	124	SENT_122	[p7l1217t2564r1862b2624],
112	differentiated	VBN	O	differentiate	dep	124	SENT_122	[p7l1217t2564r1862b2624],
113	and	CC	O	and	dep	124	SENT_122	[p7l1892t2564r2014b2624],
114	1/6	CD	PERCENT	1/6	dep	124	SENT_122	[p7l2052t2564r2150b2625],
115	(	CD	PERCENT	(	dep	124	SENT_122	[p7l9t2667r284b2742],
116	16.7	CD	PERCENT	16.7	dep	124	SENT_122	[p7l9t2667r284b2742],
117	%	NN	PERCENT	%	dep	124	SENT_122	[p7l9t2667r284b2742],
118	)	CD	NUMBER	)	dep	124	SENT_122	[p7l9t2667r284b2742],
119	of	IN	O	of	dep	124	SENT_122	[p7l318t2667r393b2728],
120	moderately	RB	O	moderately	dep	124	SENT_122	[p7l418t2667r806b2745],
121	or	CC	O	or	dep	124	SENT_122	[p7l838t2686r909b2728],
122	poorly	RB	O	poorly	dep	124	SENT_122	[p7l936t2667r1161b2745],
123	differentiated	VBN	O	differentiate	dep	124	SENT_122	[p7l1193t2667r1660b2727],
124	NSCLC	NN	O	nsclc	_	0	SENT_122	[p7l1689t2667r1987b2728],
125	.	.	O	.	_	0	SENT_122	[p7l1689t2667r1987b2728],

1	The	DT	O	the	det	4	SENT_123	[p7l2019t2667r2151b2727],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_123	[p7l6t2771r227b2830],
3	copy	NN	O	copy	nn	4	SENT_123	[p7l252t2789r417b2848],
4	number	NN	O	number	nsubjpass	8	SENT_123	[p7l443t2770r708b2830],
5	was	VBD	O	be	auxpass	8	SENT_123	[p7l732t2789r863b2830],
6	not	RB	O	not	neg	8	SENT_123	[p7l890t2779r1000b2831],
7	significantly	RB	O	significantly	advmod	8	SENT_123	[p7l1027t2770r1455b2848],
8	correlated	VBD	O	correlate	_	0	SENT_123	[p7l1482t2770r1827b2831],
9	with	IN	O	with	_	0	SENT_123	[p7l1852t2770r2004b2830],
10	any	DT	O	any	prep_with	8	SENT_123	[p7l2031t2789r2151b2848],
11	of	IN	O	of	_	0	SENT_123	[p7l8t2873r84b2934],
12	clinicopathological	JJ	O	clinicopathological	amod	13	SENT_123	[p7l115t2873r802b2951],
13	factors	NNS	O	factor	prep_of	10	SENT_123	[p7l839t2873r1103b2934],
14	.	.	O	.	_	0	SENT_123	[p7l839t2873r1103b2934],

1	In	IN	O	in	_	0	SENT_124	[p7l1140t2874r1212b2932],
2	the	DT	O	the	det	4	SENT_124	[p7l1247t2873r1353b2933],
3	11	CD	NUMBER	11	num	4	SENT_124	[p7l1399t2874r1469b2932],
4	cases	NNS	O	case	prep_in	15	SENT_124	[p7l1513t2892r1697b2933],
5	with	IN	O	with	_	0	SENT_124	[p7l1736t2873r1892b2933],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_124	[p7l1927t2873r2152b2933],
7	mutation	NN	O	mutation	prep_with	4	SENT_124	[p7l7t2976r336b3036],
8	in	IN	O	in	_	0	SENT_124	[p7l374t2976r442b3035],
9	this	DT	O	this	det	10	SENT_124	[p7l480t2976r611b3036],
10	cohort	NN	O	cohort	prep_in	7	SENT_124	[p7l652t2976r913b3048],
11	,	,	O	,	_	0	SENT_124	[p7l652t2976r913b3048],
12	only	RB	O	only	advmod	14	SENT_124	[p7l951t2976r1111b3054],
13	one	CD	NUMBER	one	num	14	SENT_124	[p7l1150t2995r1278b3037],
14	case	NN	O	case	nsubj	15	SENT_124	[p7l1318t2995r1473b3036],
15	had	VBD	O	have	_	0	SENT_124	[p7l1511t2976r1642b3036],
16	an	DT	O	a	det	20	SENT_124	[p7l1681t2995r1763b3036],
17	increased	VBN	O	increase	amod	20	SENT_124	[p7l1801t2976r2153b3036],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_124	[p7l6t3079r243b3139],
19	copy	NN	O	copy	nn	20	SENT_124	[p7l283t3098r464b3157],
20	number	NN	O	number	dobj	15	SENT_124	[p7l505t3079r820b3139],
21	.	.	O	.	_	0	SENT_124	[p7l505t3079r820b3139],

1	The	DT	O	the	det	4	SENT_125	[p7l861t3079r1004b3139],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_125	[p7l1045t3080r1281b3139],
3	copy	NN	O	copy	nn	4	SENT_125	[p7l1322t3098r1503b3157],
4	number	NN	O	number	nsubj	7	SENT_125	[p7l1544t3079r1835b3139],
5	did	VBD	O	do	aux	7	SENT_125	[p7l1874t3079r1994b3139],
6	not	RB	O	not	neg	7	SENT_125	[p7l2033t3088r2153b3140],
7	correlate	VB	O	correlate	_	0	SENT_125	[p7l7t3182r308b3243],
8	with	IN	O	with	_	0	SENT_125	[p7l333t3182r485b3242],
9	the	DT	O	the	det	12	SENT_125	[p7l509t3182r612b3242],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_125	[p7l636t3183r857b3242],
11	mutation	NN	O	mutation	nn	12	SENT_125	[p7l881t3182r1187b3243],
12	status	NN	O	status	prep_with	7	SENT_125	[p7l1214t3191r1405b3242],
13	(	CD	NUMBER	(	num	14	SENT_125	[p7l1434t3182r1838b3260],
14	p	NN	O	p	dobj	7	SENT_125	[p7l1434t3182r1838b3260],
15	=	JJ	O	=	amod	14	SENT_125	[p7l1434t3182r1838b3260],
16	0.5865	CD	NUMBER	0.5865	num	17	SENT_125	[p7l1434t3182r1838b3260],
17	)	NN	O	)	dep	15	SENT_125	[p7l1434t3182r1838b3260],
18	.	.	O	.	_	0	SENT_125	[p7l1434t3182r1838b3260],

1	Gefitinib	JJ	O	gefitinib	amod	2	SENT_126	[p7l10t3390r364b3467],
2	sensitivity	NN	O	sensitivity	_	0	SENT_126	[p7l406t3392r815b3467],
3	in	IN	O	in	_	0	SENT_126	[p7l859t3392r927b3450],
4	22	CD	NUMBER	22	num	6	SENT_126	[p7l969t3390r1057b3449],
5	gefitinib-treated	JJ	O	gefitinib-treated	amod	6	SENT_126	[p7l1100t3390r1769b3467],
6	patients	NNS	O	patient	prep_in	2	SENT_126	[p7l1798t3392r2150b3467],
7	.	.	O	.	_	0	SENT_126	[p7l1798t3392r2150b3467],

1	Relationship	NN	O	relationship	nsubjpass	13	SENT_127	[p7l6t3493r490b3571],
2	between	IN	O	between	_	0	SENT_127	[p7l530t3493r845b3553],
3	gefitinib	NN	O	gefitinib	nn	4	SENT_127	[p7l884t3493r1209b3571],
4	sensitivity	NN	O	sensitivity	prep_between	1	SENT_127	[p7l1253t3493r1647b3571],
5	and	CC	O	and	_	0	SENT_127	[p7l1690t3493r1820b3553],
6	clinicopathological	JJ	O	clinicopathological	amod	7	SENT_127	[p7l1859t3493r2150b3554, p7l6t3596r470b3674],
7	factors	NNS	O	factor	nsubjpass	13	SENT_127	[p7l509t3596r761b3657],
8	in	IN	O	in	_	0	SENT_127	[p7l801t3596r870b3655],
9	22	CD	NUMBER	22	num	11	SENT_127	[p7l909t3596r995b3655],
10	gefitinib-treated	JJ	O	gefitinib-treated	amod	11	SENT_127	[p7l1035t3596r1646b3674],
11	patients	NNS	O	patient	prep_in	7	SENT_127	[p7l1682t3596r1972b3674],
12	was	VBD	O	be	auxpass	13	SENT_127	[p7l2013t3615r2150b3656],
13	evaluated	VBN	O	evaluate	_	0	SENT_127	[p7l13t3699r379b3759],
14	.	.	O	.	_	0	SENT_127	[p7l13t3699r379b3759],

1	Responders	NNS	O	responder	nsubj	2	SENT_128	[p7l417t3699r834b3777],
2	(	VBP	O	(	_	0	SENT_128	[p7l875t3699r1018b3774],
3	CR	JJ	O	cr	nsubj	10	SENT_128	[p7l875t3699r1018b3774],
4	or	CC	O	or	_	0	SENT_128	[p7l1055t3718r1128b3760],
5	PR	NN	O	pr	nsubj	10	SENT_128	[p7l1163t3700r1297b3773],
6	)	CD	NUMBER	)	num	5	SENT_128	[p7l1163t3700r1297b3773],
7	to	TO	O	to	_	0	SENT_128	[p7l1336t3708r1401b3760],
8	gefitinib	NN	O	gefitinib	prep_to	5	SENT_128	[p7l1441t3699r1744b3777],
9	were	VBD	O	be	cop	10	SENT_128	[p7l1782t3718r1953b3759],
10	5/13	CD	NUMBER	5/13	ccomp	2	SENT_128	[p7l1992t3699r2143b3760],

1	(	NN	O	(	nsubj	96	SENT_129	[p8l15t19r289b94],
2	38.5	CD	PERCENT	38.5	num	3	SENT_129	[p8l15t19r289b94],
3	%	NN	PERCENT	%	dep	1	SENT_129	[p8l15t19r289b94],
4	)	CD	NUMBER	)	dep	1	SENT_129	[p8l15t19r289b94],
5	of	IN	O	of	_	0	SENT_129	[p8l320t19r395b80],
6	males	NNS	O	male	prep_of	4	SENT_129	[p8l417t19r615b79],
7	and	CC	O	and	_	0	SENT_129	[p8l647t19r768b79],
8	6/9	CD	PERCENT	6/9	number	9	SENT_129	[p8l797t19r902b80],
9	(	CD	PERCENT	(	conj_and	1	SENT_129	[p8l935t19r1208b94],
10	66.7	CD	PERCENT	66.7	num	11	SENT_129	[p8l935t19r1208b94],
11	%	NN	PERCENT	%	dep	9	SENT_129	[p8l935t19r1208b94],
12	)	CD	NUMBER	)	dep	9	SENT_129	[p8l935t19r1208b94],
13	of	IN	O	of	_	0	SENT_129	[p8l1240t19r1314b80],
14	females	NNS	O	female	prep_of	12	SENT_129	[p8l1338t19r1625b91],
15	;	:	O	;	_	0	SENT_129	[p8l1338t19r1625b91],
16	5/10	CD	PERCENT	5/10	number	17	SENT_129	[p8l1658t19r1805b80],
17	(	CD	PERCENT	(	conj_and	1	SENT_129	[p8l1838t19r2046b94],
18	50	CD	PERCENT	50	num	19	SENT_129	[p8l1838t19r2046b94],
19	%	NN	PERCENT	%	dep	17	SENT_129	[p8l1838t19r2046b94],
20	)	CD	NUMBER	)	dep	17	SENT_129	[p8l1838t19r2046b94],
21	of	IN	O	of	_	0	SENT_129	[p8l2078t19r2153b80],
22	patients	NNS	O	patient	prep_of	17	SENT_129	[p8l11t122r285b200],
23	who	WP	O	who	nsubj	27	SENT_129	[p8l323t122r471b183],
24	were	VBD	O	be	cop	27	SENT_129	[p8l508t141r676b182],
25	564	CD	DURATION	564	num	26	SENT_129	[p8l714t122r846b182],
26	years	NNS	NUMBER	year	npadvmod	27	SENT_129	[p8l883t141r1066b200],
27	old	JJ	DURATION	old	rcmod	22	SENT_129	[p8l1104t122r1215b183],
28	and	CC	O	and	_	0	SENT_129	[p8l1252t122r1376b182],
29	6/12	CD	PERCENT	6/12	number	30	SENT_129	[p8l1413t122r1565b183],
30	(	CD	PERCENT	(	conj_and	9	SENT_129	[p8l1604t122r1817b197],
31	50	CD	PERCENT	50	num	32	SENT_129	[p8l1604t122r1817b197],
32	%	NN	PERCENT	%	dep	30	SENT_129	[p8l1604t122r1817b197],
33	)	CD	NUMBER	)	dep	9	SENT_129	[p8l1604t122r1817b197],
34	of	IN	O	of	_	0	SENT_129	[p8l1857t122r1932b182],
35	those	DT	O	those	prep_of	33	SENT_129	[p8l1962t122r2147b182],
36	who	WP	O	who	nsubj	38	SENT_129	[p8l13t225r158b286],
37	were	VBD	O	be	cop	38	SENT_129	[p8l193t244r358b285],
38	>	JJR	O	>	rcmod	35	SENT_129	[p8l392t225r524b285],
39	64	CD	DURATION	64	num	40	SENT_129	[p8l392t225r524b285],
40	years	NNS	NUMBER	year	npadvmod	41	SENT_129	[p8l559t244r737b303],
41	old	JJ	DURATION	old	amod	35	SENT_129	[p8l773t225r902b296],
42	;	:	O	;	_	0	SENT_129	[p8l773t225r902b296],
43	10/18	CD	PERCENT	10/18	number	44	SENT_129	[p8l947t225r1130b286],
44	(	CD	PERCENT	(	dep	33	SENT_129	[p8l1170t225r1443b300],
45	55.6	CD	PERCENT	55.6	number	46	SENT_129	[p8l1170t225r1443b300],
46	%	NN	PERCENT	%	amod	44	SENT_129	[p8l1170t225r1443b300],
47	)	CD	NUMBER	)	npadvmod	44	SENT_129	[p8l1170t225r1443b300],
48	of	IN	O	of	_	0	SENT_129	[p8l1480t225r1555b286],
49	adenocarcinoma	NN	O	adenocarcinoma	prep_of	44	SENT_129	[p8l1585t225r2149b286],
50	and	CC	O	and	_	0	SENT_129	[p8l14t328r136b388],
51	1/4	CD	PERCENT	1/4	number	52	SENT_129	[p8l176t328r275b389],
52	(	CD	PERCENT	(	prep_of	44	SENT_129	[p8l312t328r520b403],
53	25	CD	PERCENT	25	num	54	SENT_129	[p8l312t328r520b403],
54	%	NN	PERCENT	%	dep	52	SENT_129	[p8l312t328r520b403],
55	)	CD	NUMBER	)	dep	49	SENT_129	[p8l312t328r520b403],
56	of	IN	O	of	_	0	SENT_129	[p8l557t328r631b389],
57	non	JJ	O	non	amod	59	SENT_129	[p8l659t328r1402b400],
58	—	NN	O	—	nn	59	SENT_129	[p8l659t328r1402b400],
59	adenocarcinoma	NN	O	adenocarcinoma	prep_of	55	SENT_129	[p8l659t328r1402b400],
60	;	:	O	;	_	0	SENT_129	[p8l659t328r1402b400],
61	3/4	CD	PERCENT	3/4	number	62	SENT_129	[p8l1441t328r1546b389],
62	(	CD	PERCENT	(	dep	59	SENT_129	[p8l1582t328r1791b403],
63	75	CD	PERCENT	75	num	64	SENT_129	[p8l1582t328r1791b403],
64	%	NN	PERCENT	%	dep	73	SENT_129	[p8l1582t328r1791b403],
65	)	CD	NUMBER	)	dep	64	SENT_129	[p8l1582t328r1791b403],
66	of	IN	O	of	_	0	SENT_129	[p8l1827t328r1902b389],
67	neversmokers	NNS	O	neversmoker	prep_of	65	SENT_129	[p8l1929t347r2145b388, p8l15t431r307b492],
68	and	CC	O	and	_	0	SENT_129	[p8l349t431r474b491],
69	3/10	CD	PERCENT	3/10	num	70	SENT_129	[p8l513t431r666b492],
70	(	CD	PERCENT	(	conj_and	67	SENT_129	[p8l708t431r924b506],
71	30	CD	PERCENT	30	num	72	SENT_129	[p8l708t431r924b506],
72	%	NN	PERCENT	%	dep	73	SENT_129	[p8l708t431r924b506],
73	)	CD	NUMBER	)	dep	83	SENT_129	[p8l708t431r924b506],
74	of	IN	O	of	_	0	SENT_129	[p8l965t431r1042b492],
75	ever	RB	O	ever	advmod	76	SENT_129	[p8l1074t431r1581b502],
76	—	JJ	O	—	amod	77	SENT_129	[p8l1074t431r1581b502],
77	smokers	NNS	O	smoker	prep_of	73	SENT_129	[p8l1074t431r1581b502],
78	;	:	O	;	_	0	SENT_129	[p8l1074t431r1581b502],
79	9/15	CD	PERCENT	9/15	number	80	SENT_129	[p8l1623t431r1775b492],
80	(	CD	PERCENT	(	dep	77	SENT_129	[p8l1819t431r2036b506],
81	60	CD	PERCENT	60	num	82	SENT_129	[p8l1819t431r2036b506],
82	%	NN	PERCENT	%	dep	80	SENT_129	[p8l1819t431r2036b506],
83	)	CD	NUMBER	)	dep	59	SENT_129	[p8l1819t431r2036b506],
84	of	IN	O	of	_	0	SENT_129	[p8l2077t431r2153b492],
85	well-differentiated	JJ	O	well-differentiated	prep_of	59	SENT_129	[p8l13t534r659b594],
86	and	CC	O	and	_	0	SENT_129	[p8l693t534r814b594],
87	2/6	CD	PERCENT	2/6	number	88	SENT_129	[p8l848t534r953b595],
88	(	CD	PERCENT	(	prep_of	44	SENT_129	[p8l990t534r1263b609],
89	33.3	CD	PERCENT	33.3	num	90	SENT_129	[p8l990t534r1263b609],
90	%	NN	PERCENT	%	dep	88	SENT_129	[p8l990t534r1263b609],
91	)	CD	NUMBER	)	npadvmod	92	SENT_129	[p8l990t534r1263b609],
92	of	IN	O	of	advmod	96	SENT_129	[p8l1300t534r1375b595],
93	moderately	RB	O	moderately	advmod	96	SENT_129	[p8l1402t534r1788b612],
94	or	CC	O	or	_	0	SENT_129	[p8l1822t553r1893b595],
95	poorly	RB	O	poorly	conj_or	93	SENT_129	[p8l1923t534r2147b612],
96	differentiated	VBN	O	differentiate	_	0	SENT_129	[p8l13t637r481b697],
97	NSCLC	NN	O	nsclc	dobj	96	SENT_129	[p8l514t637r813b698],
98	.	.	O	.	_	0	SENT_129	[p8l514t637r813b698],

1	There	EX	O	there	expl	2	SENT_130	[p8l849t637r1049b697],
2	was	VBD	O	be	_	0	SENT_130	[p8l1085t656r1215b697],
3	no	DT	O	no	det	5	SENT_130	[p8l1253t656r1336b698],
4	significant	JJ	O	significant	amod	5	SENT_130	[p8l1375t637r1739b715],
5	correlation	NN	O	correlation	nsubj	2	SENT_130	[p8l1773t637r2148b698],
6	between	IN	O	between	_	0	SENT_130	[p8l11t740r338b800],
7	the	DT	O	the	det	8	SENT_130	[p8l379t740r494b800],
8	response	NN	O	response	prep_between	5	SENT_130	[p8l535t759r881b818],
9	to	TO	O	to	_	0	SENT_130	[p8l923t749r994b800],
10	gefitinib	NN	O	gefitinib	prep_to	2	SENT_130	[p8l1038t740r1378b818],
11	and	CC	O	and	_	0	SENT_130	[p8l1423t740r1557b800],
12	these	DT	O	these	det	14	SENT_130	[p8l1597t740r1798b800],
13	clinicopathological	JJ	O	clinicopathological	amod	14	SENT_130	[p8l1841t740r2145b801, p8l11t843r437b921],
14	factors	NNS	O	factor	prep_to	2	SENT_130	[p8l462t843r715b904],
15	.	.	O	.	_	0	SENT_130	[p8l462t843r715b904],

1	Relationships	NNPS	O	Relationships	_	0	SENT_131	[p8l10t1050r538b1127],
2	among	IN	O	among	_	0	SENT_131	[p8l578t1071r830b1127],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_131	[p8l869t1051r1102b1111],
4	mutation	NN	O	mutation	prep_among	1	SENT_131	[p8l1142t1052r1505b1120],
5	,	,	O	,	_	0	SENT_131	[p8l1142t1052r1505b1120],
6	the	DT	O	the	det	9	SENT_131	[p8l1549t1050r1659b1110],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_131	[p8l1698t1051r1932b1111],
8	copy	NN	O	copy	nn	9	SENT_131	[p8l1973t1071r2148b1127],
9	number	NN	O	number	prep_among	1	SENT_131	[p8l13t1153r293b1223],
10	,	,	O	,	_	0	SENT_131	[p8l13t1153r293b1223],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_131	[p8l330t1153r616b1230],
12	sensitivity	NN	O	sensitivity	prep_among	1	SENT_131	[p8l651t1155r994b1230],
13	and	CC	O	and	_	0	SENT_131	[p8l1028t1153r1160b1213],
14	clinical	JJ	O	clinical	amod	15	SENT_131	[p8l1191t1153r1449b1213],
15	outcome	NN	O	outcome	prep_among	1	SENT_131	[p8l1482t1164r1792b1213],
16	.	.	O	.	_	0	SENT_131	[p8l1482t1164r1792b1213],

1	Relationships	NNPS	O	Relationships	nsubjpass	14	SENT_132	[p8l1828t1153r2145b1214, p8l15t1256r189b1334],
2	among	IN	O	among	_	0	SENT_132	[p8l228t1275r461b1334],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_132	[p8l498t1256r719b1316],
4	mutation	NN	O	mutation	prep_among	1	SENT_132	[p8l754t1256r1088b1327],
5	,	,	O	,	_	0	SENT_132	[p8l754t1256r1088b1327],
6	the	DT	O	the	det	9	SENT_132	[p8l1122t1256r1226b1316],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_132	[p8l1262t1256r1484b1316],
8	copy	NN	O	copy	nn	9	SENT_132	[p8l1520t1275r1686b1334],
9	number	NN	O	number	prep_among	1	SENT_132	[p8l1723t1256r1990b1316],
10	and	CC	O	and	_	0	SENT_132	[p8l2025t1256r2148b1316],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_132	[p8l13t1359r321b1437],
12	sensitivity	NN	O	sensitivity	prep_among	1	SENT_132	[p8l363t1359r736b1437],
13	are	VBP	O	be	auxpass	14	SENT_132	[p8l776t1378r881b1419],
14	shown	VBN	O	show	_	0	SENT_132	[p8l923t1359r1153b1419],
15	in	IN	O	in	_	0	SENT_132	[p8l1191t1359r1258b1418],
16	Table	NNP	O	Table	nn	17	SENT_132	[p8l1295t1359r1499b1419],
17	II	NNP	O	II	prep_in	14	SENT_132	[p8l1537t1360r1617b1419],
18	.	.	O	.	_	0	SENT_132	[p8l1537t1360r1617b1419],

1	The	DT	O	the	det	3	SENT_133	[p8l1656t1359r1792b1419],
2	response	NN	O	response	nn	3	SENT_133	[p8l1830t1378r2147b1437],
3	rates	NNS	O	rate	nsubj	23	SENT_133	[p8l11t1471r184b1522],
4	of	IN	O	of	_	0	SENT_133	[p8l224t1462r302b1523],
5	patients	NNS	O	patient	prep_of	3	SENT_133	[p8l333t1462r620b1540],
6	with	IN	O	with	_	0	SENT_133	[p8l660t1462r820b1522],
7	mutant	JJ	O	mutant	amod	10	SENT_133	[p8l858t1471r1113b1522],
8	and	CC	O	and	_	0	SENT_133	[p8l1151t1462r1279b1522],
9	wild-type	JJ	O	wild-type	amod	10	SENT_133	[p8l1316t1462r1668b1540],
10	EGFR	NN	ORGANIZATION	egfr	prep_with	5	SENT_133	[p8l1706t1463r1935b1522],
11	were	VBD	O	be	cop	23	SENT_133	[p8l1973t1481r2147b1522],
12	81.8	CD	PERCENT	81.8	num	13	SENT_133	[p8l16t1565r238b1626],
13	%	NN	PERCENT	%	nn	23	SENT_133	[p8l16t1565r238b1626],
14	and	CC	O	and	_	0	SENT_133	[p8l281t1565r406b1625],
15	18.2	CD	PERCENT	18.2	num	16	SENT_133	[p8l451t1565r696b1636],
16	%	NN	PERCENT	%	nn	23	SENT_133	[p8l451t1565r696b1636],
17	,	,	O	,	_	0	SENT_133	[p8l451t1565r696b1636],
18	respectively	RB	O	respectively	advmod	20	SENT_133	[p8l731t1565r1168b1643],
19	(	CD	NUMBER	(	num	20	SENT_133	[p8l1209t1565r1631b1643],
20	p	NN	O	p	rcmod	13	SENT_133	[p8l1209t1565r1631b1643],
21	=	JJ	O	=	amod	23	SENT_133	[p8l1209t1565r1631b1643],
22	0.0089	CD	NUMBER	0.0089	tmod	21	SENT_133	[p8l1209t1565r1631b1643],
23	)	NN	O	)	_	0	SENT_133	[p8l1209t1565r1631b1643],
24	.	.	O	.	_	0	SENT_133	[p8l1209t1565r1631b1643],

1	Two	CD	NUMBER	two	num	2	SENT_134	[p8l1669t1566r1828b1625],
2	patients	NNS	O	patient	nsubj	9	SENT_134	[p8l1866t1565r2145b1643],
3	with	IN	O	with	_	0	SENT_134	[p8l13t1668r166b1728],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_134	[p8l198t1668r419b1728],
5	mutation	NN	O	mutation	prep_with	2	SENT_134	[p8l452t1668r761b1729],
6	were	VBD	O	be	cop	9	SENT_134	[p8l794t1687r960b1728],
7	non	JJ	O	non	amod	9	SENT_134	[p8l994t1668r1552b1746],
8	—	NN	O	—	nn	9	SENT_134	[p8l994t1668r1552b1746],
9	responders	NNS	O	responder	_	0	SENT_134	[p8l994t1668r1552b1746],
10	;	:	O	;	_	0	SENT_134	[p8l994t1668r1552b1746],
11	one	CD	NUMBER	one	num	12	SENT_134	[p8l1589t1687r1711b1729],
12	patient	NN	O	patient	nsubjpass	14	SENT_134	[p8l1744t1668r1982b1746],
13	was	VBD	O	be	auxpass	14	SENT_134	[p8l2015t1687r2145b1728],
14	judged	VBN	O	judge	parataxis	9	SENT_134	[p8l6t1771r247b1849],
15	as	IN	O	as	_	0	SENT_134	[p8l281t1790r347b1831],
16	NC	NN	O	nc	prep_as	14	SENT_134	[p8l381t1771r498b1832],
17	and	CC	O	and	_	0	SENT_134	[p8l534t1771r656b1831],
18	one	CD	NUMBER	one	num	19	SENT_134	[p8l688t1790r810b1831],
19	patient	NN	O	patient	nsubj	20	SENT_134	[p8l842t1771r1079b1849],
20	had	VBD	O	have	parataxis	9	SENT_134	[p8l1109t1771r1233b1831],
21	PD	NN	O	pd	dobj	20	SENT_134	[p8l1264t1772r1393b1831],
22	.	.	O	.	_	0	SENT_134	[p8l1264t1772r1393b1831],

1	The	DT	O	the	det	2	SENT_135	[p8l1426t1771r1558b1831],
2	patient	NN	O	patient	nsubj	5	SENT_135	[p8l1589t1771r1825b1849],
3	with	IN	O	with	_	0	SENT_135	[p8l1856t1771r2008b1831],
4	PD	NN	O	pd	prep_with	2	SENT_135	[p8l2039t1772r2146b1830],
5	had	VBD	O	have	_	0	SENT_135	[p8l12t1874r144b1934],
6	a	DT	O	a	det	14	SENT_135	[p8l184t1893r220b1934],
7	novel	JJ	O	novel	amod	14	SENT_135	[p8l257t1874r463b1935],
8	exon	NN	O	exon	nn	14	SENT_135	[p8l503t1893r681b1935],
9	20	CD	NUMBER	20	num	14	SENT_135	[p8l721t1874r806b1934],
10	insertion	NN	O	insertion	nn	14	SENT_135	[p8l848t1874r1181b1935],
11	(	CD	NUMBER	(	num	14	SENT_135	[p8l1222t1874r1692b1948],
12	P772_H773	NN	O	p772_h773	nn	14	SENT_135	[p8l1222t1874r1692b1948],
13	insV	NN	O	insv	nn	14	SENT_135	[p8l1736t1874r1967b1949],
14	)	NN	O	)	dobj	5	SENT_135	[p8l1736t1874r1967b1949],
15	.	.	O	.	_	0	SENT_135	[p8l1736t1874r1967b1949],

1	The	DT	O	the	det	3	SENT_136	[p8l2007t1874r2147b1934],
2	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	3	SENT_136	[p8l13t1977r497b2055],
3	curves	NNS	O	curve	_	0	SENT_136	[p8l528t1996r749b2037],
4	of	IN	O	of	_	0	SENT_136	[p8l784t1977r859b2038],
5	OS	NNP	O	OS	prep_of	3	SENT_136	[p8l886t1977r989b2037],
6	according	VBG	O	accord	_	0	SENT_136	[p8l1028t1977r1363b2055],
7	to	TO	O	to	prepc_according_to	3	SENT_136	[p8l1396t1986r1461b2038],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_136	[p8l1494t1978r1713b2037],
9	mutation	NN	O	mutation	pobj	3	SENT_136	[p8l1745t1977r2050b2038],
10	in	IN	O	in	prep	9	SENT_136	[p8l2083t1977r2148b2036],

1	536	CD	NUMBER	536	num	2	SENT_137	[p8l21t2135r88b2166],
2	ENDO	NN	O	endo	_	0	SENT_137	[p8l458t2130r549b2154],
3	et	FW	O	et	nn	4	SENT_137	[p8l560t2135r583b2154],
4	al	FW	O	al	dep	2	SENT_137	[p8l591t2130r623b2154],
5	:	:	O	:	_	0	SENT_137	[p8l591t2130r623b2154],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_137	[p8l643t2130r727b2154],
7	MUTATION	NN	O	mutation	dep	2	SENT_137	[p8l737t2130r914b2154],
8	AND	CC	O	and	_	0	SENT_137	[p8l923t2130r994b2154],
9	COPY	NN	O	copy	nn	10	SENT_137	[p8l1004t2130r1091b2154],
10	NUMBER	NN	O	number	dep	2	SENT_137	[p8l1100t2131r1242b2154],
11	IN	IN	O	in	_	0	SENT_137	[p8l1251t2131r1286b2154],
12	NON-SMALL	NNP	O	NON-SMALL	nn	15	SENT_137	[p8l1295t2130r1490b2154],
13	CELL	NNP	O	CELL	nn	15	SENT_137	[p8l1500t2130r1582b2154],
14	LUNG	NN	O	lung	nn	15	SENT_137	[p8l1591t2130r1683b2154],
15	CANCER	NNP	O	CANCER	prep_in	7	SENT_137	[p8l1692t2130r1826b2154],

1	—	NN	O	—	_	0	SENT_138	[p8l1338t2325r1422b2333],
2	--	:	O	--	_	0	SENT_138	[p8l1338t2325r1422b2333],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_138	[p8l1449t2314r1543b2340],
4	copy	NN	O	copy	nn	5	SENT_138	[p8l1554t2322r1624b2349],
5	number	NN	O	number	dep	1	SENT_138	[p8l1635t2316r1747b2342],
6	2	CD	NUMBER	2	number	7	SENT_138	[p8l1758t2321r1776b2342],
7	3	CD	NUMBER	3	num	8	SENT_138	[p8l1788t2316r1803b2342],
8	-----	CD	NUMBER	-----	dep	5	SENT_138	[p8l1338t2396r1395b2403],
9	--	:	O	--	_	0	SENT_138	[p8l1401t2396r1420b2403],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_138	[p8l1448t2382r1543b2407],
11	copy	NN	O	copy	nn	12	SENT_138	[p8l1553t2390r1623b2416],
12	number	NN	O	number	dep	5	SENT_138	[p8l1635t2383r1746b2409],
13	<	JJR	O	<	dep	12	SENT_138	[p8l1758t2388r1774b2405],
14	3	CD	NUMBER	3	dep	13	SENT_138	[p8l1787t2383r1802b2409],

1	One-year	JJ	DURATION	one-year	amod	3	SENT_139	[p8l1347t2479r1486b2512],
2	survival	NN	O	survival	nn	3	SENT_139	[p8l1496t2479r1614b2505],
3	rate	NN	O	rate	_	0	SENT_139	[p8l1623t2484r1679b2506],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_139	[p8l1346t2546r1442b2572],
5	copy	NN	O	copy	nn	6	SENT_139	[p8l1452t2553r1522b2580],
6	number	NN	O	number	dep	3	SENT_139	[p8l1533t2546r1646b2572],
7	2	CD	NUMBER	2	number	8	SENT_139	[p8l1657t2552r1675b2572],
8	3	CD	NUMBER	3	dep	6	SENT_139	[p8l1686t2547r1701b2573],
9	:	:	O	:	_	0	SENT_139	[p8l1715t2555r1720b2573],
10	25	CD	PERCENT	25	num	11	SENT_139	[p8l1733t2546r1796b2574],
11	%	NN	PERCENT	%	dep	6	SENT_139	[p8l1733t2546r1796b2574],
12	EGFR	NN	O	egfr	nn	14	SENT_139	[p8l1346t2613r1441b2638],
13	copy	NN	O	copy	nn	14	SENT_139	[p8l1451t2620r1522b2646],
14	number	NN	O	number	dep	11	SENT_139	[p8l1533t2613r1646b2639],
15	<	JJR	O	<	amod	14	SENT_139	[p8l1657t2619r1673b2635],
16	3	CD	NUMBER	3	dep	15	SENT_139	[p8l1686t2614r1701b2639],
17	:	:	O	:	_	0	SENT_139	[p8l1714t2621r1719b2639],
18	49.8	CD	PERCENT	49.8	num	19	SENT_139	[p8l1732t2613r1823b2641],
19	%	NN	PERCENT	%	dep	6	SENT_139	[p8l1732t2613r1823b2641],
20	log-rank	NN	O	log-rank	dep	19	SENT_139	[p8l1346t2679r1479b2713],
21	:	:	O	:	_	0	SENT_139	[p8l1346t2679r1479b2713],
22	p	NN	O	p	dep	6	SENT_139	[p8l1492t2680r1613b2713],
23	=	JJ	O	=	amod	24	SENT_139	[p8l1492t2680r1613b2713],
24	O.	NNP	O	O.	dep	22	SENT_139	[p8l1492t2680r1613b2713],
25	285	CD	NUMBER	285	num	26	SENT_139	[p8l1492t2680r1613b2713],
26	l	NN	O	l	dep	3	SENT_139	[p8l1619t2680r1629b2706],

1	0.6	CD	NUMBER	0.6	_	0	SENT_140	[p8l401t2483r445b2510],
2	0.4	CD	NUMBER	0.4	number	3	SENT_140	[p8l400t2589r445b2615],
3	5	CD	NUMBER	5	amod	1	SENT_140	[p8l820t2561r975b2604],
4	...	:	O	...	_	0	SENT_140	[p8l820t2561r975b2604],
5	Q.	NNP	O	Q.	dep	1	SENT_140	[p8l820t2561r975b2604],
6	.	.	O	.	_	0	SENT_140	[p8l820t2561r975b2604],

1	¢	NN	O	¢	_	0	SENT_141	[p8l820t2561r975b2604],
2	Q	NNP	O	Q	nn	6	SENT_141	[p8l820t2561r975b2604],
3	.....	NNP	O	.....	nn	6	SENT_141	[p8l980t2586r1220b2594],
4	.....	NNP	O	.....	nn	6	SENT_141	[p8l980t2586r1220b2594],
5	.....	NNP	O	.....	nn	6	SENT_141	[p8l980t2586r1220b2594],
6	.....	NNP	O	.....	dep	1	SENT_141	[p8l980t2586r1220b2594],
7	...	:	O	...	_	0	SENT_141	[p8l1226t2576r1284b2605],
8	Q	NNP	O	Q	dep	6	SENT_141	[p8l1226t2576r1284b2605],

1	Survival	NN	O	survival	nn	2	SENT_142	[p8l329t2505r355b2628],
2	rate	NN	O	rate	_	0	SENT_142	[p8l334t2439r356b2494],

1	Days	NNS	DURATION	day	_	0	SENT_143	[p8l581t2954r656b2987],
2	from	IN	O	from	_	0	SENT_143	[p8l668t2953r738b2980],
3	the	DT	O	the	det	4	SENT_143	[p8l748t2953r792b2980],
4	start	NN	O	start	prep_from	1	SENT_143	[p8l803t2957r865b2980],
5	of	IN	O	of	_	0	SENT_143	[p8l876t2953r909b2980],
6	gefitinib	NN	O	gefitinib	nn	7	SENT_143	[p8l916t2953r1040b2987],
7	administration	NN	O	administration	prep_of	1	SENT_143	[p8l1051t2953r1263b2980],

1	Figure	NN	O	figure	_	0	SENT_144	[p8l20t3045r106b3076],
2	2	CD	NUMBER	2	dep	1	SENT_144	[p8l117t3045r141b3069],
3	.	.	O	.	_	0	SENT_144	[p8l117t3045r141b3069],

1	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	2	SENT_145	[p8l152t3045r339b3076],
2	curves	NNS	O	curve	_	0	SENT_145	[p8l349t3052r434b3069],
3	of	IN	O	of	_	0	SENT_145	[p8l445t3045r474b3069],
4	overall	JJ	O	overall	amod	5	SENT_145	[p8l483t3045r574b3069],
5	survival	NN	O	survival	prep_of	2	SENT_145	[p8l586t3045r691b3069],
6	according	VBG	O	accord	_	0	SENT_145	[p8l703t3045r832b3076],
7	to	TO	O	to	prepc_according_to	5	SENT_145	[p8l844t3049r868b3069],
8	the	DT	O	the	det	11	SENT_145	[p8l879t3045r919b3069],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_145	[p8l929t3045r1014b3069],
10	copy	NN	O	copy	nn	11	SENT_145	[p8l1025t3053r1088b3076],
11	number	NN	O	number	pobj	5	SENT_145	[p8l1099t3045r1201b3069],
12	in	IN	O	in	_	0	SENT_145	[p8l1211t3045r1236b3069],
13	22	CD	NUMBER	22	num	15	SENT_145	[p8l1247t3045r1279b3069],
14	geﬁtinib-treated	JJ	O	geﬁtinib-treated	amod	15	SENT_145	[p8l1290t3045r1504b3076],
15	patients	NNS	O	patient	prep_in	11	SENT_145	[p8l1514t3045r1625b3076],
16	.	.	O	.	_	0	SENT_145	[p8l1514t3045r1625b3076],

1	One-year	JJ	DURATION	one-year	amod	3	SENT_146	[p8l1636t3045r1760b3076],
2	survival	NN	O	survival	nn	3	SENT_146	[p8l1771t3045r1876b3069],
3	rate	NN	O	rate	nsubj	15	SENT_146	[p8l1887t3049r1936b3069],
4	of	IN	O	of	_	0	SENT_146	[p8l1947t3045r1976b3069],
5	the	DT	O	the	det	6	SENT_146	[p8l1984t3045r2024b3069],
6	patients	NNS	O	patient	prep_of	3	SENT_146	[p8l2034t3045r2137b3076],
7	with	IN	O	with	_	0	SENT_146	[p8l21t3085r78b3109],
8	an	DT	O	a	det	12	SENT_146	[p8l91t3092r121b3109],
9	increased	VBN	O	increase	amod	12	SENT_146	[p8l133t3085r258b3109],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_146	[p8l269t3085r353b3109],
11	copy	NN	O	copy	nn	12	SENT_146	[p8l365t3092r429b3116],
12	number	NN	O	number	prep_with	6	SENT_146	[p8l441t3085r542b3109],
13	was	VBD	O	be	cop	15	SENT_146	[p8l554t3092r604b3109],
14	25	CD	PERCENT	25	num	15	SENT_146	[p8l617t3085r675b3109],
15	%	NN	PERCENT	%	_	0	SENT_146	[p8l617t3085r675b3109],
16	vs	CC	O	vs	_	0	SENT_146	[p8l688t3092r716b3109],
17	49.8	CD	PERCENT	49.8	num	18	SENT_146	[p8l728t3085r812b3109],
18	%	NN	PERCENT	%	conj_vs	15	SENT_146	[p8l728t3085r812b3109],
19	of	IN	O	of	_	0	SENT_146	[p8l826t3085r854b3109],
20	the	DT	O	the	det	21	SENT_146	[p8l864t3085r903b3109],
21	patients	NNS	O	patient	prep_of	18	SENT_146	[p8l915t3085r1017b3116],
22	without	IN	O	without	_	0	SENT_146	[p8l1030t3085r1131b3109],
23	an	DT	O	a	det	27	SENT_146	[p8l1143t3092r1173b3109],
24	increased	VBN	O	increase	amod	27	SENT_146	[p8l1185t3085r1310b3109],
25	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_146	[p8l1321t3085r1406b3109],
26	copy	NN	O	copy	nn	27	SENT_146	[p8l1418t3092r1481b3116],
27	number	NN	O	number	prep_without	15	SENT_146	[p8l1493t3085r1602b3109],
28	.	.	O	.	_	0	SENT_146	[p8l1493t3085r1602b3109],

1	The	DT	O	the	det	2	SENT_147	[p8l1614t3085r1665b3109],
2	difference	NN	O	difference	nsubj	5	SENT_147	[p8l1677t3085r1811b3109],
3	did	VBD	O	do	aux	5	SENT_147	[p8l1823t3085r1865b3109],
4	not	RB	O	not	neg	5	SENT_147	[p8l1876t3089r1918b3109],
5	reach	VB	O	reach	_	0	SENT_147	[p8l1929t3085r2000b3109],
6	statistical	JJ	O	statistical	amod	10	SENT_147	[p8l2013t3085r2137b3109],
7	significance	NN	O	significance	nn	10	SENT_147	[p8l21t3125r180b3156],
8	(	CD	NUMBER	(	num	10	SENT_147	[p8l190t3125r313b3156],
9	log-rank	NN	O	log-rank	nn	10	SENT_147	[p8l190t3125r313b3156],
10	p	NN	O	p	nsubj	13	SENT_147	[p8l322t3125r467b3156],
11	=	JJ	O	=	amod	13	SENT_147	[p8l322t3125r467b3156],
12	0.2851	CD	NUMBER	0.2851	num	13	SENT_147	[p8l322t3125r467b3156],
13	)	NN	O	)	xcomp	5	SENT_147	[p8l322t3125r467b3156],
14	.	.	O	.	_	0	SENT_147	[p8l322t3125r467b3156],

1	Table	NNP	O	Table	nn	2	SENT_148	[p8l21t3231r116b3261],
2	III	NNP	O	III	_	0	SENT_148	[p8l134t3232r185b3260],
3	.	.	O	.	_	0	SENT_148	[p8l134t3232r185b3260],

1	Univariate	NNP	O	Univariate	_	0	SENT_149	[p8l203t3231r381b3261],
2	and	CC	O	and	_	0	SENT_149	[p8l399t3231r458b3260],
3	multivariate	JJ	O	multivariate	amod	4	SENT_149	[p8l475t3231r679b3261],
4	analyses	NNS	O	analysis	conj_and	1	SENT_149	[p8l698t3231r838b3269],
5	of	IN	O	of	_	0	SENT_149	[p8l857t3231r893b3261],
6	association	NN	O	association	prep_of	4	SENT_149	[p8l908t3231r1095b3261],
7	between	IN	O	between	_	0	SENT_149	[p8l1112t3231r1253b3261],
8	clinicopathological	JJ	O	clinicopathological	amod	9	SENT_149	[p8l1270t3231r1594b3269],
9	factors	NNS	O	factor	prep_between	6	SENT_149	[p8l1612t3231r1725b3261],
10	and	CC	O	and	_	0	SENT_149	[p8l1744t3231r1803b3260],
11	overall	JJ	O	overall	amod	12	SENT_149	[p8l1821t3231r1937b3261],
12	survival	NN	O	survival	conj_and	1	SENT_149	[p8l1956t3231r2090b3260],
13	in	IN	O	in	_	0	SENT_149	[p8l2107t3231r2139b3260],
14	patients	NNS	O	patient	prep_in	12	SENT_149	[p8l21t3281r149b3319],
15	with	IN	O	with	_	0	SENT_149	[p8l162t3281r235b3310],
16	gefitinib	NN	O	gefitinib	nn	17	SENT_149	[p8l247t3281r385b3319],
17	therapy	NN	O	therapy	prep_with	14	SENT_149	[p8l398t3281r531b3319],
18	.	.	O	.	_	0	SENT_149	[p8l398t3281r531b3319],

1	Univariate	NNP	O	Univariate	nn	2	SENT_150	[p8l1317t3382r1492b3411],
2	Multivariate	NNP	O	Multivariate	_	0	SENT_150	[p8l1931t3382r2135b3411],

1	Risk	NN	O	risk	nn	2	SENT_151	[p8l21t3482r97b3511],
2	factors	NNS	O	factor	_	0	SENT_151	[p8l108t3482r220b3511],
3	P	NN	O	p	nn	6	SENT_151	[p8l1343t3482r1469b3511],
4	—	CD	NUMBER	—	num	6	SENT_151	[p8l1343t3482r1469b3511],
5	value	NN	O	value	nn	6	SENT_151	[p8l1343t3482r1469b3511],
6	P-value	NN	O	p-value	dep	2	SENT_151	[p8l1990t3482r2116b3511],

1	Gender	NN	O	gender	nn	2	SENT_152	[p9l22t22r144b51],
2	(	NN	O	(	dep	3	SENT_152	[p9l156t22r248b58],
3	male	JJ	O	male	_	0	SENT_152	[p9l156t22r248b58],
4	vs	CC	O	vs	_	0	SENT_152	[p9l260t31r295b51],
5	female	JJ	O	female	amod	6	SENT_152	[p9l307t22r432b58],
6	)	JJ	O	)	amod	12	SENT_152	[p9l307t22r432b58],
7	0.0084	CD	NUMBER	0.0084	num	12	SENT_152	[p9l1347t22r1461b51],
8	0.5949	CD	NUMBER	0.5949	num	12	SENT_152	[p9l1988t22r2101b52],
9	Age	NNP	O	Age	nn	12	SENT_152	[p9l21t74r89b111],
10	(	CD	NUMBER	(	num	12	SENT_152	[p9l102t73r178b109],
11	564	CD	DURATION	564	num	12	SENT_152	[p9l102t73r178b109],
12	years	NNS	NUMBER	year	nsubj	17	SENT_152	[p9l190t82r276b111],
13	vs	CC	O	vs	_	0	SENT_152	[p9l289t82r323b102],
14	>	JJR	O	>	conj_vs	12	SENT_152	[p9l335t73r400b102],
15	64	CD	DURATION	64	num	16	SENT_152	[p9l335t73r400b102],
16	years	NNS	NUMBER	year	dep	14	SENT_152	[p9l411t74r511b111],
17	)	VBP	O	)	ccomp	3	SENT_152	[p9l411t74r511b111],
18	0.9135	CD	NUMBER	0.9135	number	19	SENT_152	[p9l1347t73r1459b103],
19	—	CD	NUMBER	—	num	21	SENT_152	[p9l2040t91r2050b94],
20	Pathological	JJ	O	pathological	amod	21	SENT_152	[p9l21t125r228b163],
21	sybtypes	NNS	O	sybtype	dobj	17	SENT_152	[p9l242t125r384b163],
22	(	VBP	O	(	rcmod	21	SENT_152	[p9l398t125r508b161],
23	adeno	NN	O	adeno	dobj	22	SENT_152	[p9l398t125r508b161],
24	vs	CC	O	vs	_	0	SENT_152	[p9l521t134r555b154],
25	non	JJ	O	non	amod	27	SENT_152	[p9l568t125r755b161],
26	—	NN	O	—	nn	27	SENT_152	[p9l568t125r755b161],
27	adeno	NN	O	adeno	dobj	22	SENT_152	[p9l568t125r755b161],
28	)	CD	NUMBER	)	number	29	SENT_152	[p9l568t125r755b161],
29	0.0124	CD	NUMBER	0.0124	dep	27	SENT_152	[p9l1347t125r1460b155],
30	0.3525	CD	NUMBER	0.3525	num	32	SENT_152	[p9l1988t125r2100b155],
31	Smoking	NN	O	smoking	nn	32	SENT_152	[p9l23t176r170b214],
32	status	NN	O	status	dep	27	SENT_152	[p9l184t181r275b205],
33	(	CD	NUMBER	(	tmod	32	SENT_152	[p9l289t176r545b212],
34	never	RB	O	never	advmod	33	SENT_152	[p9l289t176r545b212],
35	—	CD	NUMBER	—	num	36	SENT_152	[p9l289t176r545b212],
36	smokers	NNS	O	smoker	pobj	34	SENT_152	[p9l289t176r545b212],
37	vs	CC	O	vs	cc	21	SENT_152	[p9l557t185r592b205],
38	ever	RB	O	ever	advmod	21	SENT_152	[p9l605t176r841b212],
39	—	JJ	O	—	amod	40	SENT_152	[p9l605t176r841b212],
40	smokers	NNS	O	smoker	dep	21	SENT_152	[p9l605t176r841b212],
41	)	VBP	O	)	rcmod	40	SENT_152	[p9l605t176r841b212],
42	0.0094	CD	NUMBER	0.0094	num	44	SENT_152	[p9l1347t177r1461b206],
43	0.6570	CD	NUMBER	0.6570	num	44	SENT_152	[p9l1988t176r2101b205],
44	Differentiation	NN	O	differentiation	dobj	41	SENT_152	[p9l21t228r268b258],
45	(	RB	O	(	advmod	41	SENT_152	[p9l281t228r364b264],
46	well	RB	O	well	advmod	41	SENT_152	[p9l281t228r364b264],
47	vs	CC	O	vs	_	0	SENT_152	[p9l376t237r410b257],
48	moderately	RB	O	moderately	advmod	56	SENT_152	[p9l423t228r609b266],
49	or	CC	O	or	_	0	SENT_152	[p9l621t237r655b258],
50	poorly	RB	O	poorly	conj_or	48	SENT_152	[p9l665t228r786b266],
51	)	CD	NUMBER	)	num	52	SENT_152	[p9l665t228r786b266],
52	0.0250	CD	NUMBER	0.0250	pobj	48	SENT_152	[p9l1347t228r1460b258],
53	0.9748	CD	NUMBER	0.9748	num	56	SENT_152	[p9l1988t228r2100b258],
54	EGFR	NN	ORGANIZATION	egfr	nn	56	SENT_152	[p9l21t280r127b309],
55	mutation	NN	O	mutation	nn	56	SENT_152	[p9l138t279r286b309],
56	(	NN	O	(	conj_vs	40	SENT_152	[p9l298t280r426b315],
57	mutant	JJ	O	mutant	dep	56	SENT_152	[p9l298t280r426b315],
58	vs	CC	O	vs	_	0	SENT_152	[p9l437t288r472b308],
59	wild-type	JJ	O	wild-type	amod	60	SENT_152	[p9l485t279r656b317],
60	)	NN	O	)	conj_vs	56	SENT_152	[p9l485t279r656b317],
61	0.0123	CD	NUMBER	0.0123	number	62	SENT_152	[p9l1347t279r1459b308],
62	0.3680	CD	NUMBER	0.3680	num	64	SENT_152	[p9l1988t279r2101b308],
63	EGFR	NN	ORGANIZATION	egfr	nn	64	SENT_152	[p9l21t331r127b361],
64	copy	NN	O	copy	dep	60	SENT_152	[p9l139t340r218b369],
65	number	NN	O	number	npadvmod	67	SENT_152	[p9l230t331r357b361],
66	(	CD	NUMBER	(	num	65	SENT_152	[p9l369t331r423b367],
67	<	JJR	O	<	amod	64	SENT_152	[p9l369t331r423b367],
68	3	CD	NUMBER	3	dep	67	SENT_152	[p9l369t331r423b367],
69	vs	CC	O	vs	_	0	SENT_152	[p9l436t340r471b360],
70	23	CD	NUMBER	23	number	71	SENT_152	[p9l484t331r539b367],
71	)	CD	NUMBER	)	conj_vs	56	SENT_152	[p9l484t331r539b367],
72	0.2851	CD	NUMBER	0.2851	num	76	SENT_152	[p9l1347t331r1457b361],
73	Gefitinib	NN	O	gefitinib	nn	76	SENT_152	[p9l2040t349r2050b352, p9l22t382r170b412],
74	response	NN	O	response	nn	76	SENT_152	[p9l182t391r327b420],
75	(	CD	NUMBER	(	num	76	SENT_152	[p9l340t382r531b420],
76	responders	NNS	O	responder	dep	71	SENT_152	[p9l340t382r531b420],
77	vs	CC	O	vs	_	0	SENT_152	[p9l543t391r578b411],
78	non	JJ	O	non	amod	80	SENT_152	[p9l591t382r859b420],
79	—	NN	O	—	nn	80	SENT_152	[p9l591t382r859b420],
80	responders	NNS	O	responder	conj_vs	56	SENT_152	[p9l591t382r859b420],
81	)	VBP	O	)	rcmod	80	SENT_152	[p9l591t382r859b420],
82	0.0453	CD	NUMBER	0.0453	number	83	SENT_152	[p9l1347t382r1459b411],
83	0.1758	CD	NUMBER	0.1758	dobj	81	SENT_152	[p9l1988t382r2100b411],

1	Adeno	NNP	O	Adeno	_	0	SENT_153	[p9l21t470r130b501],
2	,	,	O	,	_	0	SENT_153	[p9l21t470r130b501],
3	adenocarcinoma	NN	O	adenocarcinoma	appos	1	SENT_153	[p9l141t470r394b497],
4	.	.	O	.	_	0	SENT_153	[p9l141t470r394b497],

1	22	CD	NUMBER	22	num	3	SENT_154	[p9l9t692r92b751],
2	gefitinib-treated	JJ	O	gefitinib-treated	amod	3	SENT_154	[p9l130t692r700b770],
3	patients	NNS	O	patient	nsubjpass	5	SENT_154	[p9l734t692r1007b770],
4	are	VBP	O	be	auxpass	5	SENT_154	[p9l1046t711r1149b752],
5	shown	VBN	O	show	_	0	SENT_154	[p9l1188t692r1414b753],
6	in	IN	O	in	_	0	SENT_154	[p9l1450t692r1515b751],
7	Fig	NN	O	fig	prep_in	5	SENT_154	[p9l1550t692r1687b770],
8	.	.	O	.	_	0	SENT_154	[p9l1550t692r1687b770],

1	1	LS	NUMBER	1	_	0	SENT_155	[p9l1733t693r1786b752],
2	.	.	O	.	_	0	SENT_155	[p9l1733t693r1786b752],

1	One-year	JJ	DURATION	one-year	amod	3	SENT_156	[p9l1825t692r2152b770],
2	survival	NN	O	survival	nn	3	SENT_156	[p9l11t795r284b855],
3	rate	NN	O	rate	nsubj	12	SENT_156	[p9l313t804r441b855],
4	of	IN	O	of	_	0	SENT_156	[p9l472t795r547b855],
5	the	DT	O	the	det	6	SENT_156	[p9l570t795r673b855],
6	patients	NNS	O	patient	prep_of	3	SENT_156	[p9l702t795r969b873],
7	with	IN	O	with	_	0	SENT_156	[p9l1001t795r1153b855],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_156	[p9l1181t796r1402b855],
9	mutation	NN	O	mutation	prep_with	6	SENT_156	[p9l1431t795r1737b856],
10	was	VBD	O	be	cop	12	SENT_156	[p9l1766t814r1897b855],
11	66.7	CD	PERCENT	66.7	num	12	SENT_156	[p9l1930t795r2146b856],
12	%	NN	PERCENT	%	_	0	SENT_156	[p9l1930t795r2146b856],
13	vs	CC	O	vs	_	0	SENT_156	[p9l8t917r80b958],
14	18.2	CD	PERCENT	18.2	num	15	SENT_156	[p9l119t898r329b959],
15	%	NN	PERCENT	%	conj_vs	12	SENT_156	[p9l119t898r329b959],
16	of	IN	O	of	_	0	SENT_156	[p9l362t898r437b959],
17	the	DT	O	the	det	18	SENT_156	[p9l459t898r562b958],
18	patients	NNS	O	patient	prep_of	15	SENT_156	[p9l590t898r857b976],
19	with	IN	O	with	_	0	SENT_156	[p9l888t898r1040b958],
20	wild-type	JJ	O	wild-type	amod	21	SENT_156	[p9l1069t898r1398b976],
21	EGFR	NN	ORGANIZATION	egfr	prep_with	18	SENT_156	[p9l1427t898r1667b958],
22	.	.	O	.	_	0	SENT_156	[p9l1427t898r1667b958],

1	Patients	NNS	O	patient	nsubj	5	SENT_157	[p9l1697t898r1967b958],
2	with	IN	O	with	_	0	SENT_157	[p9l1998t898r2150b958],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_157	[p9l7t1001r231b1061],
4	mutation	NN	O	mutation	prep_with	1	SENT_157	[p9l267t1001r582b1061],
5	had	VBD	O	have	_	0	SENT_157	[p9l617t1001r744b1061],
6	a	DT	O	a	det	10	SENT_157	[p9l782t1020r817b1061],
7	statistically	RB	O	statistically	advmod	9	SENT_157	[p9l855t1001r1259b1079],
8	significantly	RB	O	significantly	advmod	9	SENT_157	[p9l1299t1001r1742b1079],
9	longer	JJR	O	longer	amod	10	SENT_157	[p9l1779t1001r2006b1079],
10	OS	NN	O	os	dobj	5	SENT_157	[p9l2041t1001r2146b1061],
11	compared	VBN	O	compare	_	0	SENT_157	[p9l8t1104r388b1182],
12	with	IN	O	with	prepc_compared_with	5	SENT_157	[p9l428t1104r597b1164],
13	those	DT	O	those	pobj	5	SENT_157	[p9l637t1104r840b1164],
14	with	IN	O	with	_	0	SENT_157	[p9l882t1104r1051b1164],
15	wild-type	JJ	O	wild-type	amod	16	SENT_157	[p9l1091t1104r1466b1182],
16	EGFR	NN	ORGANIZATION	egfr	prep_with	13	SENT_157	[p9l1507t1105r1744b1164],
17	(	CD	NUMBER	(	num	19	SENT_157	[p9l1786t1104r2151b1182],
18	log-rank	NN	O	log-rank	nn	19	SENT_157	[p9l1786t1104r2151b1182],
19	p	NN	O	p	dep	16	SENT_157	[p9l7t1207r385b1285],
20	=	JJ	O	=	amod	22	SENT_157	[p9l7t1207r385b1285],
21	0.0123	CD	NUMBER	0.0123	tmod	20	SENT_157	[p9l7t1207r385b1285],
22	)	NN	O	)	dep	19	SENT_157	[p9l7t1207r385b1285],
23	.	.	O	.	_	0	SENT_157	[p9l7t1207r385b1285],

1	The	DT	O	the	det	3	SENT_158	[p9l421t1207r553b1267],
2	response	NN	O	response	nn	3	SENT_158	[p9l587t1226r888b1285],
3	rates	NNS	O	rate	_	0	SENT_158	[p9l922t1216r1082b1267],
4	of	IN	O	of	_	0	SENT_158	[p9l1120t1207r1195b1267],
5	patients	NNS	O	patient	prep_of	3	SENT_158	[p9l1222t1207r1488b1285],
6	with	IN	O	with	_	0	SENT_158	[p9l1525t1207r1677b1267],
7	an	DT	O	a	det	11	SENT_158	[p9l1712t1226r1791b1267],
8	increased	VBN	O	increase	amod	11	SENT_158	[p9l1825t1207r2151b1267],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_158	[p9l7t1311r228b1370],
10	copy	NN	O	copy	nn	11	SENT_158	[p9l254t1329r419b1388],
11	number	NN	O	number	prep_with	5	SENT_158	[p9l445t1310r710b1370],
12	(	CD	NUMBER	(	num	15	SENT_158	[p9l736t1310r982b1385],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_158	[p9l736t1310r982b1385],
14	copy	NN	O	copy	nn	15	SENT_158	[p9l1009t1329r1174b1388],
15	number	NN	O	number	dep	5	SENT_158	[p9l1201t1310r1465b1370],
16	23	CD	NUMBER	23	num	17	SENT_158	[p9l1489t1310r1604b1384],
17	)	NN	O	)	dep	15	SENT_158	[p9l1489t1310r1604b1384],
18	and	CC	O	and	_	0	SENT_158	[p9l1634t1310r1756b1370],
19	without	IN	O	without	conj_and	17	SENT_158	[p9l1782t1310r2046b1370],
20	an	DT	O	a	det	24	SENT_158	[p9l2072t1329r2150b1370],
21	increased	VBN	O	increase	amod	24	SENT_158	[p9l8t1413r334b1473],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_158	[p9l358t1414r578b1473],
23	copy	NN	O	copy	nn	24	SENT_158	[p9l605t1432r770b1491],
24	number	NN	O	number	pobj	19	SENT_158	[p9l796t1413r1060b1473],
25	(	CD	NUMBER	(	num	28	SENT_158	[p9l1087t1414r1333b1488],
26	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_158	[p9l1087t1414r1333b1488],
27	copy	NN	O	copy	nn	28	SENT_158	[p9l1359t1432r1524b1491],
28	number	NN	O	number	dep	15	SENT_158	[p9l1551t1413r1815b1473],
29	<	JJR	O	<	amod	28	SENT_158	[p9l1840t1413r1955b1487],
30	3	CD	NUMBER	3	num	31	SENT_158	[p9l1840t1413r1955b1487],
31	)	NN	O	)	nsubj	34	SENT_158	[p9l1840t1413r1955b1487],
32	were	VBD	O	be	cop	34	SENT_158	[p9l1984t1432r2149b1473],
33	25	CD	PERCENT	25	num	34	SENT_158	[p9l9t1516r160b1577],
34	%	NN	PERCENT	%	ccomp	29	SENT_158	[p9l9t1516r160b1577],
35	and	CC	O	and	_	0	SENT_158	[p9l191t1516r313b1576],
36	55.6	CD	PERCENT	55.6	number	37	SENT_158	[p9l338t1516r582b1587],
37	%	NN	PERCENT	%	amod	28	SENT_158	[p9l338t1516r582b1587],
38	,	,	O	,	_	0	SENT_158	[p9l338t1516r582b1587],
39	respectively	RB	O	respectively	advmod	5	SENT_158	[p9l605t1516r1022b1594],
40	(	CD	NUMBER	(	num	41	SENT_158	[p9l1050t1516r1454b1594],
41	p	NN	O	p	dep	5	SENT_158	[p9l1050t1516r1454b1594],
42	=	JJ	O	=	amod	44	SENT_158	[p9l1050t1516r1454b1594],
43	0.5865	CD	NUMBER	0.5865	tmod	42	SENT_158	[p9l1050t1516r1454b1594],
44	)	NN	O	)	dep	41	SENT_158	[p9l1050t1516r1454b1594],
45	.	.	O	.	_	0	SENT_158	[p9l1050t1516r1454b1594],

1	Three	CD	NUMBER	three	num	2	SENT_159	[p9l1480t1516r1680b1576],
2	patients	NNS	O	patient	nsubj	10	SENT_159	[p9l1704t1516r1971b1594],
3	with	IN	O	with	_	0	SENT_159	[p9l1998t1516r2150b1576],
4	an	DT	O	a	det	8	SENT_159	[p9l10t1638r88b1679],
5	increased	VBN	O	increase	amod	8	SENT_159	[p9l124t1619r456b1679],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_159	[p9l490t1619r713b1679],
7	copy	NN	O	copy	nn	8	SENT_159	[p9l750t1638r917b1697],
8	number	NN	O	number	prep_with	2	SENT_159	[p9l953t1619r1222b1679],
9	were	VBD	O	be	cop	10	SENT_159	[p9l1256t1638r1424b1679],
10	non-responders	NNS	O	non-responder	_	0	SENT_159	[p9l1460t1619r2025b1697],
11	;	:	O	;	_	0	SENT_159	[p9l1460t1619r2025b1697],
12	all	DT	O	all	det	14	SENT_159	[p9l2066t1619r2150b1679],
13	three	CD	NUMBER	three	num	14	SENT_159	[p9l7t1722r192b1782],
14	patients	NNS	O	patient	nsubj	15	SENT_159	[p9l230t1722r522b1800],
15	had	VBD	O	have	parataxis	10	SENT_159	[p9l561t1722r693b1782],
16	PD	NN	O	pd	dobj	15	SENT_159	[p9l730t1723r867b1782],
17	.	.	O	.	_	0	SENT_159	[p9l730t1723r867b1782],

1	The	DT	O	the	det	3	SENT_160	[p9l906t1722r1045b1782],
2	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	3	SENT_160	[p9l1084t1722r1609b1800],
3	curves	NNS	O	curve	nsubjpass	16	SENT_160	[p9l1647t1741r1885b1782],
4	of	IN	O	of	_	0	SENT_160	[p9l1927t1722r2005b1782],
5	OS	NNP	O	OS	prep_of	3	SENT_160	[p9l2039t1722r2146b1782],
6	according	VBG	O	accord	_	0	SENT_160	[p9l10t1825r371b1903],
7	to	TO	O	to	prepc_according_to	16	SENT_160	[p9l410t1834r477b1886],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_160	[p9l515t1826r745b1885],
9	copy	NN	O	copy	nn	10	SENT_160	[p9l783t1844r957b1903],
10	number	NN	O	number	pobj	16	SENT_160	[p9l996t1825r1276b1885],
11	in	IN	O	in	_	0	SENT_160	[p9l1313t1825r1381b1884],
12	22	CD	NUMBER	22	num	14	SENT_160	[p9l1420t1825r1505b1884],
13	gefitinib-treated	JJ	O	gefitinib-treated	amod	14	SENT_160	[p9l1545t1825r2151b1903],
14	patients	NNS	O	patient	prep_in	10	SENT_160	[p9l7t1928r278b2006],
15	are	VBP	O	be	auxpass	16	SENT_160	[p9l318t1947r421b1988],
16	shown	VBN	O	show	_	0	SENT_160	[p9l460t1928r684b1989],
17	in	IN	O	in	_	0	SENT_160	[p9l720t1928r786b1987],
18	Fig	NN	O	fig	prep_in	16	SENT_160	[p9l821t1928r957b2006],
19	.	.	O	.	_	0	SENT_160	[p9l821t1928r957b2006],

1	2	LS	NUMBER	2	_	0	SENT_161	[p9l996t1928r1056b1988],
2	.	.	O	.	_	0	SENT_161	[p9l996t1928r1056b1988],

1	One-year	JJ	DURATION	one-year	amod	3	SENT_162	[p9l1094t1928r1421b2006],
2	survival	NN	O	survival	nn	3	SENT_162	[p9l1458t1928r1737b1988],
3	rate	NN	O	rate	nsubj	15	SENT_162	[p9l1772t1937r1902b1988],
4	of	IN	O	of	_	0	SENT_162	[p9l1939t1928r2015b1989],
5	the	DT	O	the	det	6	SENT_162	[p9l2044t1928r2149b1988],
6	patients	NNS	O	patient	prep_of	3	SENT_162	[p9l7t2031r273b2109],
7	with	IN	O	with	_	0	SENT_162	[p9l310t2031r461b2091],
8	an	DT	O	a	det	12	SENT_162	[p9l497t2050r575b2091],
9	increased	VBN	O	increase	amod	12	SENT_162	[p9l609t2031r934b2091],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_162	[p9l967t2032r1187b2091],
11	copy	NN	O	copy	nn	12	SENT_162	[p9l1222t2050r1386b2109],
12	number	NN	O	number	prep_with	6	SENT_162	[p9l1421t2031r1686b2091],
13	was	VBD	O	be	cop	15	SENT_162	[p9l1718t2050r1849b2091],
14	25	CD	PERCENT	25	num	15	SENT_162	[p9l1886t2031r2037b2092],
15	%	NN	PERCENT	%	_	0	SENT_162	[p9l1886t2031r2037b2092],
16	vs	CC	O	vs	_	0	SENT_162	[p9l2075t2050r2148b2091],
17	49.8	CD	PERCENT	49.8	num	18	SENT_162	[p9l7t2134r239b2195],
18	%	NN	PERCENT	%	conj_vs	15	SENT_162	[p9l7t2134r239b2195],
19	of	IN	O	of	_	0	SENT_162	[p9l282t2134r360b2195],
20	the	DT	O	the	det	21	SENT_162	[p9l393t2134r503b2194],
21	patients	NNS	O	patient	prep_of	18	SENT_162	[p9l541t2134r831b2212],
22	without	IN	O	without	_	0	SENT_162	[p9l872t2134r1156b2195],
23	an	DT	O	a	det	27	SENT_162	[p9l1195t2153r1276b2194],
24	increased	VBN	O	increase	amod	27	SENT_162	[p9l1315t2134r1668b2194],
25	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_162	[p9l1705t2135r1935b2194],
26	copy	NN	O	copy	nn	27	SENT_162	[p9l1974t2153r2149b2212],
27	number	NN	O	number	prep_without	15	SENT_162	[p9l8t2237r302b2298],
28	.	.	O	.	_	0	SENT_162	[p9l8t2237r302b2298],

1	However	RB	O	however	advmod	7	SENT_163	[p9l340t2238r693b2309],
2	,	,	O	,	_	0	SENT_163	[p9l340t2238r693b2309],
3	the	DT	O	the	det	4	SENT_163	[p9l728t2237r835b2298],
4	difference	NN	O	difference	nsubj	7	SENT_163	[p9l874t2237r1239b2298],
5	did	VBD	O	do	aux	7	SENT_163	[p9l1277t2237r1390b2297],
6	not	RB	O	not	neg	7	SENT_163	[p9l1426t2246r1540b2298],
7	reach	VB	O	reach	_	0	SENT_163	[p9l1574t2237r1769b2298],
8	statistical	JJ	O	statistical	amod	12	SENT_163	[p9l1808t2237r2150b2297],
9	significance	NN	O	significance	nn	12	SENT_163	[p9l11t2340r446b2418],
10	(	CD	NUMBER	(	num	12	SENT_163	[p9l486t2340r821b2418],
11	log-rank	NN	O	log-rank	nn	12	SENT_163	[p9l486t2340r821b2418],
12	p	NN	O	p	nsubj	15	SENT_163	[p9l856t2340r1252b2418],
13	=	JJ	O	=	amod	15	SENT_163	[p9l856t2340r1252b2418],
14	0.2851	CD	NUMBER	0.2851	num	15	SENT_163	[p9l856t2340r1252b2418],
15	)	NN	O	)	xcomp	7	SENT_163	[p9l856t2340r1252b2418],
16	.	.	O	.	_	0	SENT_163	[p9l856t2340r1252b2418],

1	The	DT	O	the	det	2	SENT_164	[p9l1290t2340r1426b2400],
2	presence	NN	O	presence	nsubjpass	8	SENT_164	[p9l1462t2359r1778b2418],
3	of	IN	O	of	_	0	SENT_164	[p9l1816t2340r1893b2401],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_164	[p9l1924t2341r2150b2400],
5	mutation	NN	O	mutation	prep_of	2	SENT_164	[p9l8t2443r315b2504],
6	was	VBD	O	be	auxpass	8	SENT_164	[p9l345t2462r475b2503],
7	significantly	RB	O	significantly	advmod	8	SENT_164	[p9l510t2443r937b2521],
8	associated	VBN	O	associate	_	0	SENT_164	[p9l970t2443r1323b2504],
9	with	IN	O	with	_	0	SENT_164	[p9l1353t2443r1505b2503],
10	a	DT	O	a	det	13	SENT_164	[p9l1536t2462r1572b2503],
11	higher	JJR	O	higher	amod	13	SENT_164	[p9l1600t2443r1821b2521],
12	response	NN	O	response	nn	13	SENT_164	[p9l1848t2462r2150b2521],
13	rate	NN	O	rate	prep_with	8	SENT_164	[p9l7t2555r151b2606],
14	and	CC	O	and	_	0	SENT_164	[p9l193t2546r326b2606],
15	a	DT	O	a	det	17	SENT_164	[p9l367t2565r403b2606],
16	longer	JJR	O	longer	amod	17	SENT_164	[p9l441t2546r688b2624],
17	OS	NN	O	os	conj_and	13	SENT_164	[p9l728t2546r866b2606],
18	.	.	O	.	_	0	SENT_164	[p9l728t2546r866b2606],

1	However	RB	O	however	advmod	25	SENT_165	[p9l908t2547r1282b2617],
2	,	,	O	,	_	0	SENT_165	[p9l908t2547r1282b2617],
3	the	DT	O	the	det	4	SENT_165	[p9l1321t2546r1435b2606],
4	association	NN	O	association	nsubj	25	SENT_165	[p9l1477t2546r1911b2607],
5	of	IN	O	of	_	0	SENT_165	[p9l1952t2546r2032b2607],
6	an	DT	O	a	det	10	SENT_165	[p9l2068t2565r2151b2606],
7	increased	VBN	O	increase	amod	10	SENT_165	[p9l9t2649r335b2709],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_165	[p9l368t2650r589b2709],
9	copy	NN	O	copy	nn	10	SENT_165	[p9l624t2668r789b2727],
10	number	NN	O	number	prep_of	4	SENT_165	[p9l825t2649r1089b2709],
11	and	CC	O	and	_	0	SENT_165	[p9l1124t2649r1246b2709],
12	lower	JJR	O	lower	amod	14	SENT_165	[p9l1281t2649r1477b2709],
13	response	NN	O	response	nn	14	SENT_165	[p9l1509t2668r1811b2727],
14	rate	NN	O	rate	conj_and	10	SENT_165	[p9l1846t2658r1974b2709],
15	or	CC	O	or	_	0	SENT_165	[p9l2011t2668r2081b2710],
16	a	DT	O	a	det	18	SENT_165	[p9l2116t2668r2152b2709],
17	shorter	JJR	O	shorter	amod	18	SENT_165	[p9l11t2752r251b2813],
18	OS	NN	O	os	conj_and	10	SENT_165	[p9l286t2752r389b2812],
19	was	VBD	O	be	cop	25	SENT_165	[p9l429t2771r560b2812],
20	not	RB	O	not	neg	25	SENT_165	[p9l598t2761r708b2813],
21	statistically	RB	O	statistically	advmod	25	SENT_165	[p9l745t2752r1139b2830],
22	significant	JJ	O	significant	amod	25	SENT_165	[p9l1179t2752r1567b2830],
23	,	,	O	,	_	0	SENT_165	[p9l1179t2752r1567b2830],
24	possibly	RB	O	possibly	advmod	25	SENT_165	[p9l1600t2752r1890b2830],
25	due	JJ	O	due	_	0	SENT_165	[p9l1927t2752r2049b2812],
26	to	TO	O	to	_	0	SENT_165	[p9l2085t2761r2150b2812],
27	the	DT	O	the	det	29	SENT_165	[p9l8t2855r111b2915],
28	small	JJ	O	small	amod	29	SENT_165	[p9l150t2855r332b2915],
29	number	NN	O	number	prep_to	25	SENT_165	[p9l366t2855r631b2915],
30	of	IN	O	of	_	0	SENT_165	[p9l665t2855r739b2916],
31	patients	NNS	O	patient	prep_of	29	SENT_165	[p9l767t2855r1033b2933],
32	with	IN	O	with	_	0	SENT_165	[p9l1070t2855r1223b2915],
33	an	DT	O	a	det	37	SENT_165	[p9l1258t2874r1336b2915],
34	increased	VBN	O	increase	amod	37	SENT_165	[p9l1371t2855r1697b2915],
35	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_165	[p9l1730t2856r1950b2915],
36	copy	NN	O	copy	nn	37	SENT_165	[p9l1985t2874r2150b2933],
37	number	NN	O	number	prep_with	25	SENT_165	[p9l8t2958r315b3018],
38	.	.	O	.	_	0	SENT_165	[p9l8t2958r315b3018],

1	To	TO	O	to	aux	2	SENT_166	[p9l355t2959r452b3019],
2	define	VB	O	define	purpcl	21	SENT_166	[p9l492t2958r725b3018],
3	which	WDT	O	which	dobj	6	SENT_166	[p9l764t2958r990b3018],
4	variables	NNS	O	variable	nsubj	6	SENT_166	[p9l1028t2958r1368b3018],
5	were	VBD	O	be	cop	6	SENT_166	[p9l1409t2977r1586b3018],
6	predictive	JJ	O	predictive	ccomp	2	SENT_166	[p9l1625t2958r2004b3036],
7	for	IN	O	for	_	0	SENT_166	[p9l2045t2958r2152b3019],
8	survival	NN	O	survival	prep_for	6	SENT_166	[p9l11t3061r308b3132],
9	,	,	O	,	_	0	SENT_166	[p9l11t3061r308b3132],
10	those	DT	O	those	det	11	SENT_166	[p9l333t3061r513b3121],
11	factors	NNS	O	factor	nsubjpass	21	SENT_166	[p9l540t3061r772b3122],
12	that	WDT	O	that	nsubj	15	SENT_166	[p9l800t3061r929b3121],
13	were	VBD	O	be	cop	15	SENT_166	[p9l954t3080r1120b3121],
14	statistically	RB	O	statistically	advmod	15	SENT_166	[p9l1150t3061r1539b3139],
15	significant	JJ	O	significant	rcmod	11	SENT_166	[p9l1569t3061r1931b3139],
16	in	IN	O	in	_	0	SENT_166	[p9l1956t3061r2021b3120],
17	the	DT	O	the	det	19	SENT_166	[p9l2047t3061r2150b3121],
18	univariate	JJ	O	univariate	amod	19	SENT_166	[p9l8t3164r352b3224],
19	analysis	NN	O	analysis	prep_in	15	SENT_166	[p9l380t3164r653b3242],
20	were	VBD	O	be	auxpass	21	SENT_166	[p9l680t3183r845b3224],
21	included	VBN	O	include	_	0	SENT_166	[p9l871t3164r1168b3224],
22	in	IN	O	in	_	0	SENT_166	[p9l1192t3164r1257b3223],
23	the	DT	O	the	det	25	SENT_166	[p9l1281t3164r1385b3224],
24	multivariate	JJ	O	multivariate	amod	25	SENT_166	[p9l1410t3164r1827b3224],
25	analysis	NN	O	analysis	prep_in	21	SENT_166	[p9l1854t3164r2150b3242],
26	.	.	O	.	_	0	SENT_166	[p9l1854t3164r2150b3242],

1	Univariate	NNP	O	Univariate	nsubjpass	19	SENT_167	[p9l8t3267r372b3327],
2	and	CC	O	and	_	0	SENT_167	[p9l409t3267r531b3327],
3	multivariate	JJ	O	multivariate	amod	4	SENT_167	[p9l564t3267r981b3327],
4	analyses	NNS	O	analysis	conj_and	1	SENT_167	[p9l1017t3267r1305b3345],
5	of	IN	O	of	_	0	SENT_167	[p9l1343t3267r1418b3328],
6	association	NN	O	association	prep_of	4	SENT_167	[p9l1448t3267r1830b3328],
7	between	IN	O	between	_	0	SENT_167	[p9l1863t3267r2151b3327],
8	clinicopathological	JJ	O	clinicopathological	amod	9	SENT_167	[p9l9t3370r693b3448],
9	factors	NNS	O	factor	prep_between	6	SENT_167	[p9l730t3370r968b3430],
10	and	CC	O	and	_	0	SENT_167	[p9l1008t3370r1133b3430],
11	overall	JJ	O	overall	amod	12	SENT_167	[p9l1169t3370r1414b3430],
12	survival	NN	O	survival	prep_of	4	SENT_167	[p9l1453t3370r1735b3430],
13	in	IN	O	in	_	0	SENT_167	[p9l1773t3370r1839b3429],
14	patients	NNS	O	patient	prep_in	12	SENT_167	[p9l1874t3370r2149b3448],
15	with	IN	O	with	_	0	SENT_167	[p9l9t3473r179b3533],
16	gefitinib	NN	O	gefitinib	nn	17	SENT_167	[p9l220t3473r558b3551],
17	therapy	NN	O	therapy	prep_with	14	SENT_167	[p9l600t3473r894b3551],
18	are	VBP	O	be	auxpass	19	SENT_167	[p9l937t3492r1050b3533],
19	shown	VBN	O	show	_	0	SENT_167	[p9l1094t3473r1340b3534],
20	in	IN	O	in	_	0	SENT_167	[p9l1381t3473r1452b3532],
21	Table	NNP	O	Table	nn	22	SENT_167	[p9l1493t3473r1712b3533],
22	III	NNP	O	III	prep_in	19	SENT_167	[p9l1753t3474r1876b3533],
23	.	.	O	.	_	0	SENT_167	[p9l1753t3474r1876b3533],

1	In	IN	O	in	_	0	SENT_168	[p9l1918t3474r1994b3532],
2	the	DT	O	the	det	4	SENT_168	[p9l2035t3473r2150b3533],
3	univariate	JJ	O	univariate	amod	4	SENT_168	[p9l8t3576r370b3636],
4	analyses	NNS	O	analysis	prep_in	9	SENT_168	[p9l409t3576r737b3654],
5	,	,	O	,	_	0	SENT_168	[p9l409t3576r737b3654],
6	OS	NN	O	os	nsubjpass	9	SENT_168	[p9l774t3576r879b3636],
7	was	VBD	O	be	auxpass	9	SENT_168	[p9l920t3595r1054b3636],
8	significantly	RB	O	significantly	advmod	9	SENT_168	[p9l1096t3576r1547b3654],
9	associated	VBN	O	associate	_	0	SENT_168	[p9l1586t3576r1957b3636],
10	with	IN	O	with	_	0	SENT_168	[p9l1993t3576r2151b3636],
11	gender	NN	O	gender	prep_with	9	SENT_168	[p9l9t3679r251b3757],
12	(	CD	NUMBER	(	num	11	SENT_168	[p9l288t3679r485b3753],
13	male	JJ	O	male	dobj	9	SENT_168	[p9l288t3679r485b3753],
14	vs	CC	O	vs	_	0	SENT_168	[p9l522t3698r596b3739],
15	female	JJ	O	female	dobj	9	SENT_168	[p9l635t3679r899b3750],
16	,	,	O	,	_	0	SENT_168	[p9l635t3679r899b3750],
17	p	NN	O	p	appos	15	SENT_168	[p9l933t3679r1327b3757],
18	=	JJ	O	=	amod	20	SENT_168	[p9l933t3679r1327b3757],
19	0.0084	CD	NUMBER	0.0084	tmod	18	SENT_168	[p9l933t3679r1327b3757],
20	)	NN	O	)	dep	17	SENT_168	[p9l933t3679r1327b3757],
21	,	,	O	,	_	0	SENT_168	[p9l933t3679r1327b3757],
22	pathological	JJ	O	pathological	amod	23	SENT_168	[p9l1361t3679r1803b3757],
23	subtypes	NNS	O	subtype	appos	15	SENT_168	[p9l1843t3679r2149b3757],

1	(	NN	O	(	nn	2	SENT_169	[p10l11t19r680b94],
2	adenocarcinoma	NN	O	adenocarcinoma	dep	16	SENT_169	[p10l11t19r680b94],
3	VS	NN	O	v	nn	4	SENT_169	[p10l719t38r797b79],
4	non-adenocarcinoma	NN	O	non-adenocarcinoma	dep	2	SENT_169	[p10l839t19r1684b91],
5	,	,	O	,	_	0	SENT_169	[p10l839t19r1684b91],
6	p	NN	O	p	appos	4	SENT_169	[p10l1722t20r2152b97],
7	=	JJ	O	=	amod	6	SENT_169	[p10l1722t20r2152b97],
8	0.0124	CD	NUMBER	0.0124	num	9	SENT_169	[p10l1722t20r2152b97],
9	)	NN	O	)	tmod	7	SENT_169	[p10l1722t20r2152b97],
10	,	,	O	,	_	0	SENT_169	[p10l1722t20r2152b97],
11	smoking	NN	O	smoking	nn	12	SENT_169	[p10l11t122r304b200],
12	status	NN	O	status	appos	9	SENT_169	[p10l342t131r533b182],
13	(	CD	NUMBER	(	num	14	SENT_169	[p10l572t122r1104b196],
14	never-smokers	NNS	O	never-smoker	dep	16	SENT_169	[p10l572t122r1104b196],
15	VS	NNP	O	VS	nn	16	SENT_169	[p10l1141t141r1214b182],
16	eVer	NNP	O	eVer	dep	24	SENT_169	[p10l1250t122r1738b194],
17	—	CD	NUMBER	—	num	18	SENT_169	[p10l1250t122r1738b194],
18	smokers	NNS	O	smoker	dep	16	SENT_169	[p10l1250t122r1738b194],
19	,	,	O	,	_	0	SENT_169	[p10l1250t122r1738b194],
20	p	NN	O	p	nn	22	SENT_169	[p10l1770t123r1903b200],
21	=	JJ	O	=	amod	22	SENT_169	[p10l1770t123r1903b200],
22	o	NN	O	o	appos	18	SENT_169	[p10l1770t123r1903b200],
23	.0094	CD	NUMBER	.0094	num	24	SENT_169	[p10l1915t123r2152b197],
24	)	NN	O	)	_	0	SENT_169	[p10l1915t123r2152b197],
25	,	,	O	,	_	0	SENT_169	[p10l1915t123r2152b197],
26	differentiation	NN	O	differentiation	npadvmod	28	SENT_169	[p10l9t225r513b286],
27	(	RB	O	(	advmod	26	SENT_169	[p10l552t225r728b299],
28	well	RB	O	well	advmod	29	SENT_169	[p10l552t225r728b299],
29	differentiated	VBN	O	differentiate	partmod	24	SENT_169	[p10l764t225r1240b285],
30	VS	NN	O	v	tmod	29	SENT_169	[p10l1275t244r1348b285],
31	moderately	RB	O	moderately	advmod	34	SENT_169	[p10l1386t225r1780b303],
32	or	CC	O	or	_	0	SENT_169	[p10l1817t244r1889b285],
33	poorly	RB	O	poorly	advmod	34	SENT_169	[p10l1922t225r2150b303],
34	differentiated	VBN	O	differentiate	partmod	30	SENT_169	[p10l9t328r501b399],
35	,	,	O	,	_	0	SENT_169	[p10l9t328r501b399],
36	p	NN	O	p	appos	30	SENT_169	[p10l534t328r919b406],
37	=	JJ	O	=	amod	36	SENT_169	[p10l534t328r919b406],
38	0.0250	CD	NUMBER	0.0250	num	39	SENT_169	[p10l534t328r919b406],
39	)	NN	O	)	tmod	37	SENT_169	[p10l534t328r919b406],
40	,	,	O	,	_	0	SENT_169	[p10l534t328r919b406],
41	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_169	[p10l953t328r1174b388],
42	mutation	NN	O	mutation	nn	43	SENT_169	[p10l1209t328r1518b389],
43	(	NN	O	(	appos	39	SENT_169	[p10l1556t328r1824b403],
44	mutant	JJ	O	mutant	amod	46	SENT_169	[p10l1556t328r1824b403],
45	VS	NN	O	v	nn	46	SENT_169	[p10l1858t347r1931b388],
46	wildONCOLOGY	NN	O	wildoncology	dep	30	SENT_169	[p10l1969t328r2148b388, p10l387t481r572b505],

1	REPORTS	NNS	O	report	_	0	SENT_170	[p10l581t481r726b505],
2	16	CD	NUMBER	16	num	4	SENT_170	[p10l748t481r784b505],
3	:	:	O	:	_	0	SENT_170	[p10l748t481r784b505],
4	533-541	CD	NUMBER	533-541	dep	1	SENT_170	[p10l804t481r923b509],
5	,	,	O	,	_	0	SENT_170	[p10l804t481r923b509],
6	2006	CD	DATE	2006	appos	4	SENT_170	[p10l941t481r1005b505],

1	Table	NNP	O	Table	_	0	SENT_171	[p10l9t673r203b733],
2	IV	CD	NUMBER	iv	dep	1	SENT_171	[p10l231t674r341b733],
3	.	.	O	.	_	0	SENT_171	[p10l231t674r341b733],

1	Relationship	NN	O	relationship	_	0	SENT_172	[p10l369t673r804b751],
2	between	IN	O	between	_	0	SENT_172	[p10l832t673r1119b733],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_172	[p10l1146t673r1366b733],
4	mutation	NN	O	mutation	prep_between	1	SENT_172	[p10l1393t673r1700b734],
5	and	CC	O	and	_	0	SENT_172	[p10l1729t673r1850b733],
6	clinicopathological	JJ	O	clinicopathological	amod	7	SENT_172	[p10l1878t673r2137b734, p10l8t776r460b854],
7	factors	NNS	O	factor	prep_between	1	SENT_172	[p10l497t776r742b836],
8	in	IN	O	in	_	0	SENT_172	[p10l781t776r848b835],
9	the	DT	O	the	det	12	SENT_172	[p10l884t776r991b836],
10	additional	JJ	O	additional	amod	12	SENT_172	[p10l1030t776r1394b837],
11	143	CD	NUMBER	143	num	12	SENT_172	[p10l1438t776r1558b836],
12	gefitinib-na	NN	O	gefitinib-na	prep_in	1	SENT_172	[p10l1599t776r2138b854],
13	'	''	O	'	_	0	SENT_172	[p10l1599t776r2138b854],
14	1	CD	NUMBER	1	num	17	SENT_172	[p10l1599t776r2138b854],
15	'Ve	NN	O	've	nn	17	SENT_172	[p10l1599t776r2138b854],
16	NSCLC	NN	O	nsclc	nn	17	SENT_172	[p10l8t879r280b940],
17	patients	NNS	O	patient	dep	12	SENT_172	[p10l304t879r593b957],
18	.	.	O	.	_	0	SENT_172	[p10l304t879r593b957],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_173	[p10l1168t1084r1388b1144],
2	gene	NN	O	gene	_	0	SENT_173	[p10l1413t1103r1572b1162],

1	Factors	NNS	O	factor	_	0	SENT_174	[p10l8t1290r259b1350],
2	Mutant	JJ	O	mutant	amod	3	SENT_174	[p10l1026t1290r1275b1349],
3	Wild-type	JJ	O	wild-type	amod	1	SENT_174	[p10l1392t1289r1741b1367],

1	Gender	NN	O	gender	_	0	SENT_175	[p10l9t1494r263b1554],

1	Male	JJ	O	male	amod	3	SENT_176	[p10l140t1603r316b1664],
2	12	CD	NUMBER	12	tmod	1	SENT_176	[p10l995t1604r1070b1663],
3	(	NN	O	(	_	0	SENT_176	[p10l1097t1604r1156b1678],
4	1	CD	PERCENT	1	number	5	SENT_176	[p10l1097t1604r1156b1678],
5	1	CD	PERCENT	1	num	6	SENT_176	[p10l1175t1604r1200b1663],
6	%	NN	PERCENT	%	npadvmod	9	SENT_176	[p10l1214t1604r1306b1678],
7	)	CD	NUMBER	)	number	8	SENT_176	[p10l1214t1604r1306b1678],
8	97	CD	NUMBER	97	num	6	SENT_176	[p10l1527t1604r1607b1665],
9	Female	JJ	O	female	amod	3	SENT_176	[p10l140t1714r393b1774],
10	19	CD	PERCENT	19	num	11	SENT_176	[p10l995t1715r1069b1776],
11	(	CD	PERCENT	(	dep	3	SENT_176	[p10l1097t1714r1371b1789],
12	55.9	CD	PERCENT	55.9	num	13	SENT_176	[p10l1097t1714r1371b1789],
13	%	NN	PERCENT	%	dep	11	SENT_176	[p10l1097t1714r1371b1789],
14	)	CD	NUMBER	)	number	15	SENT_176	[p10l1097t1714r1371b1789],
15	15	CD	NUMBER	15	num	13	SENT_176	[p10l1534t1714r1606b1774],

1	Age	NN	O	age	_	0	SENT_177	[p10l9t1824r150b1902],

1	Smoking	NN	O	smoking	nn	2	SENT_178	[p10l11t2154r318b2232],
2	status	NN	O	status	_	0	SENT_178	[p10l346t2162r536b2214],

1	NeVer	JJR	O	never	dep	12	SENT_179	[p10l140t2264r666b2325],
2	—	CD	NUMBER	—	num	3	SENT_179	[p10l140t2264r666b2325],
3	smokers	NNS	O	smoker	dep	1	SENT_179	[p10l140t2264r666b2325],
4	17	CD	PERCENT	17	number	5	SENT_179	[p10l995t2265r1068b2325],
5	(	CD	PERCENT	(	dep	3	SENT_179	[p10l1097t2264r1371b2339],
6	48.6	CD	PERCENT	48.6	num	7	SENT_179	[p10l1097t2264r1371b2339],
7	%	NN	PERCENT	%	dep	12	SENT_179	[p10l1097t2264r1371b2339],
8	)	CD	NUMBER	)	num	12	SENT_179	[p10l1097t2264r1371b2339],
9	18	CD	NUMBER	18	num	12	SENT_179	[p10l1534t2265r1606b2325],
10	EVer	NN	O	ever	nn	12	SENT_179	[p10l140t2375r618b2435],
11	—	CD	NUMBER	—	num	12	SENT_179	[p10l140t2375r618b2435],
12	smokers	NNS	O	smoker	dep	18	SENT_179	[p10l140t2375r618b2435],
13	12	CD	PERCENT	12	number	14	SENT_179	[p10l995t2375r1070b2434],
14	(	CD	PERCENT	(	dep	12	SENT_179	[p10l1097t2375r1371b2449],
15	12.4	CD	PERCENT	12.4	num	16	SENT_179	[p10l1097t2375r1371b2449],
16	%	NN	PERCENT	%	dep	14	SENT_179	[p10l1097t2375r1371b2449],
17	)	CD	NUMBER	)	num	18	SENT_179	[p10l1097t2375r1371b2449],
18	83	CD	NUMBER	83	_	0	SENT_179	[p10l1529t2375r1606b2435],

1	Lymph	NN	O	lymph	_	0	SENT_180	[p10l8t2485r257b2564],
2	node	NN	O	node	nn	3	SENT_180	[p10l280t2485r446b2546],
3	metastasis	NN	O	metastasis	dep	1	SENT_180	[p10l471t2485r823b2546],

1	No	DT	O	no	det	3	SENT_181	[p10l140t2595r242b2655],
2	21	CD	NUMBER	21	num	3	SENT_181	[p10l988t2595r1063b2654],
3	(	NN	O	(	_	0	SENT_181	[p10l1097t2595r1203b2669],
4	23	CD	PERCENT	23	number	5	SENT_181	[p10l1097t2595r1203b2669],
5	.3	NN	PERCENT	.3	num	6	SENT_181	[p10l1218t2595r1268b2655],
6	%	NN	PERCENT	%	dep	3	SENT_181	[p10l1279t2595r1371b2669],
7	)	CD	NUMBER	)	number	8	SENT_181	[p10l1279t2595r1371b2669],
8	69	CD	NUMBER	69	dep	9	SENT_181	[p10l1527t2594r1608b2656],
9	N	NN	O	n	dep	6	SENT_181	[p10l140t2708r249b2767],
10	+	CC	O	+	_	0	SENT_181	[p10l140t2708r249b2767],
11	10	CD	PERCENT	10	dep	3	SENT_181	[p10l995t2707r1069b2767],
12	(	CD	PERCENT	(	number	13	SENT_181	[p10l1097t2707r1371b2781],
13	18.9	CD	PERCENT	18.9	num	14	SENT_181	[p10l1097t2707r1371b2781],
14	%	NN	PERCENT	%	dep	11	SENT_181	[p10l1097t2707r1371b2781],
15	)	CD	NUMBER	)	num	16	SENT_181	[p10l1097t2707r1371b2781],
16	43	CD	NUMBER	43	dep	3	SENT_181	[p10l1525t2707r1605b2766],

1	Differentiation	NN	O	differentiation	_	0	SENT_182	[p10l9t2816r522b2876],

1	Well	RB	O	well	dep	2	SENT_183	[p10l140t2925r307b2986],
2	18	CD	PERCENT	18	dep	3	SENT_183	[p10l995t2926r1067b2986],
3	(	CD	PERCENT	(	dep	5	SENT_183	[p10l1097t2926r1306b3000],
4	29	CD	PERCENT	29	num	5	SENT_183	[p10l1097t2926r1306b3000],
5	%	NN	PERCENT	%	_	0	SENT_183	[p10l1097t2926r1306b3000],
6	)	CD	NUMBER	)	number	7	SENT_183	[p10l1097t2926r1306b3000],
7	44	CD	NUMBER	44	num	5	SENT_183	[p10l1525t2926r1609b2985],
8	Moderately	RB	O	moderately	advmod	5	SENT_183	[p10l140t3036r537b3114],
9	or	CC	O	or	_	0	SENT_183	[p10l563t3055r633b3097],
10	12	CD	PERCENT	12	number	11	SENT_183	[p10l995t3037r1069b3096],
11	(	CD	PERCENT	(	conj_or	5	SENT_183	[p10l1097t3036r1371b3111],
12	16.9	CD	PERCENT	16.9	num	13	SENT_183	[p10l1097t3036r1371b3111],
13	%	NN	PERCENT	%	dep	11	SENT_183	[p10l1097t3036r1371b3111],
14	)	CD	NUMBER	)	num	15	SENT_183	[p10l1097t3036r1371b3111],
15	59	CD	NUMBER	59	npadvmod	16	SENT_183	[p10l1527t3036r1608b3097],
16	poorly	RB	O	poorly	advmod	11	SENT_183	[p10l140t3145r364b3224],

1	Pathological	JJ	O	pathological	amod	2	SENT_184	[p10l9t3256r440b3334],
2	subtypes	NNS	O	subtype	_	0	SENT_184	[p10l467t3256r763b3335],

1	Adeno	NNP	O	Adeno	dep	9	SENT_185	[p10l141t3366r368b3427],
2	27	CD	PERCENT	27	num	1	SENT_185	[p10l988t3366r1068b3426],
3	(	CD	PERCENT	(	number	4	SENT_185	[p10l1097t3366r1160b3440],
4	3	CD	PERCENT	3	dep	1	SENT_185	[p10l1097t3366r1160b3440],
5	1	CD	PERCENT	1	num	6	SENT_185	[p10l1175t3366r1306b3440],
6	%	NN	PERCENT	%	dep	4	SENT_185	[p10l1175t3366r1306b3440],
7	)	CD	NUMBER	)	dep	9	SENT_185	[p10l1175t3366r1306b3440],
8	60	CD	NUMBER	60	num	9	SENT_185	[p10l1527t3365r1608b3426],
9	Non	NNP	O	Non	dep	17	SENT_185	[p10l140t3476r522b3537],
10	—	CD	NUMBER	—	num	9	SENT_185	[p10l140t3476r522b3537],
11	adeno	JJ	O	adeno	amod	13	SENT_185	[p10l140t3476r522b3537],
12	4	CD	PERCENT	4	number	13	SENT_185	[p10l1029t3477r1070b3536],
13	(	CD	PERCENT	(	dep	9	SENT_185	[p10l1097t3477r1328b3551],
14	7.1	CD	PERCENT	7.1	number	15	SENT_185	[p10l1097t3477r1328b3551],
15	%	NN	PERCENT	%	amod	13	SENT_185	[p10l1097t3477r1328b3551],
16	)	CD	NUMBER	)	num	17	SENT_185	[p10l1097t3477r1328b3551],
17	52	CD	NUMBER	52	_	0	SENT_185	[p10l1527t3476r1609b3537],

1	pStage	NN	O	pstage	_	0	SENT_186	[p10l8t3586r241b3663],

1	I	PRP	O	I	_	0	SENT_187	[p10l141t3697r167b3755],
2	17	CD	PERCENT	17	number	3	SENT_187	[p10l995t3696r1068b3756],
3	(	CD	PERCENT	(	dep	1	SENT_187	[p10l1097t3696r1306b3770],
4	27	CD	PERCENT	27	num	5	SENT_187	[p10l1097t3696r1306b3770],
5	%	NN	PERCENT	%	dep	3	SENT_187	[p10l1097t3696r1306b3770],
6	)	CD	NUMBER	)	dep	1	SENT_187	[p10l1097t3696r1306b3770],

1	P	NN	O	p	_	0	SENT_188	[p10l1864t1289r2126b1349],
2	.	.	O	.	_	0	SENT_188	[p10l1864t1289r2126b1349],

1	—	NN	O	—	_	0	SENT_189	[p10l1864t1289r2126b1349],
2	.	.	O	.	_	0	SENT_189	[p10l1864t1289r2126b1349],

1	Value	NN	O	value	_	0	SENT_190	[p10l1864t1289r2126b1349],

1	II	NNP	O	II	_	0	SENT_191	[p11l141t27r316b86],
2	.	.	O	.	_	0	SENT_191	[p11l141t27r316b86],

1	—	NN	O	—	_	0	SENT_192	[p11l141t27r316b86],
2	.	.	O	.	_	0	SENT_192	[p11l141t27r316b86],

1	IV	CD	NUMBER	iv	num	2	SENT_193	[p11l141t27r316b86],
2	14	CD	NUMBER	14	_	0	SENT_193	[p11l995t26r1070b85],
3	(	NN	O	(	dep	2	SENT_193	[p11l1097t25r1371b100],
4	17.5	CD	PERCENT	17.5	num	5	SENT_193	[p11l1097t25r1371b100],
5	%	NN	PERCENT	%	dep	3	SENT_193	[p11l1097t25r1371b100],
6	)	CD	NUMBER	)	number	7	SENT_193	[p11l1097t25r1371b100],
7	66	CD	NUMBER	66	num	5	SENT_193	[p11l1527t25r1608b86],

1	N	NN	O	n	_	0	SENT_194	[p11l8t206r127b270],
2	+	CC	O	+	rcmod	1	SENT_194	[p11l8t206r127b270],
3	,	,	O	,	_	0	SENT_194	[p11l8t206r127b270],
4	lymph	NN	O	lymph	nn	5	SENT_194	[p11l148t205r345b276],
5	node	NN	O	node	appos	1	SENT_194	[p11l367t205r516b260],
6	metastasis-positive	JJ	O	metastasis-positive	dep	5	SENT_194	[p11l538t205r1148b276],
7	;	:	O	;	_	0	SENT_194	[p11l538t205r1148b276],
8	adeno	NN	O	adeno	dep	1	SENT_194	[p11l1175t205r1378b270],
9	,	,	O	,	_	0	SENT_194	[p11l1175t205r1378b270],
10	adenocarcinoma	NN	O	adenocarcinoma	appos	8	SENT_194	[p11l1400t205r1926b260],
11	.	.	O	.	_	0	SENT_194	[p11l1400t205r1926b260],

1	type	NN	O	type	_	0	SENT_195	[p11l9t507r178b576],
2	,	,	O	,	_	0	SENT_195	[p11l9t507r178b576],
3	p	NN	O	p	nn	5	SENT_195	[p11l211t498r343b576],
4	=	JJ	O	=	amod	5	SENT_195	[p11l211t498r343b576],
5	O	NN	O	o	appos	1	SENT_195	[p11l211t498r343b576],
6	.0123	CD	NUMBER	.0123	num	7	SENT_195	[p11l356t498r592b572],
7	)	NN	O	)	dep	5	SENT_195	[p11l356t498r592b572],
8	,	,	O	,	_	0	SENT_195	[p11l356t498r592b572],
9	and	CC	O	and	_	0	SENT_195	[p11l627t498r749b558],
10	gefitinib	NN	O	gefitinib	nn	11	SENT_195	[p11l784t497r1073b576],
11	response	NN	O	response	conj_and	5	SENT_195	[p11l1108t517r1409b576],
12	(	CD	NUMBER	(	num	13	SENT_195	[p11l1448t497r1845b576],
13	responders	NNS	O	responder	npadvmod	14	SENT_195	[p11l1448t497r1845b576],
14	VS	JJ	O	vs	amod	15	SENT_195	[p11l1882t517r1954b558],
15	nonresponders	NNS	O	nonresponder	dep	11	SENT_195	[p11l1991t517r2145b558, p11l8t601r444b679],
16	,	,	O	,	_	0	SENT_195	[p11l1991t517r2145b558, p11l8t601r444b679],
17	p	NN	O	p	appos	1	SENT_195	[p11l480t600r896b679],
18	=	JJ	O	=	amod	17	SENT_195	[p11l480t600r896b679],
19	0.0453	CD	NUMBER	0.0453	tmod	18	SENT_195	[p11l480t600r896b679],
20	)	NN	O	)	dep	1	SENT_195	[p11l480t600r896b679],
21	,	,	O	,	_	0	SENT_195	[p11l480t600r896b679],
22	but	CC	O	but	_	0	SENT_195	[p11l933t601r1052b661],
23	not	RB	O	not	_	0	SENT_195	[p11l1089t609r1207b661],
24	the	DT	O	the	det	27	SENT_195	[p11l1244t601r1354b661],
25	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_195	[p11l1394t601r1624b661],
26	copy	NN	O	copy	nn	27	SENT_195	[p11l1661t620r1834b679],
27	number	NN	O	number	dep	1	SENT_195	[p11l1871t601r2150b661],
28	(	CD	NUMBER	(	num	31	SENT_195	[p11l11t703r415b782],
29	p	NN	O	p	nn	31	SENT_195	[p11l11t703r415b782],
30	=	JJ	O	=	amod	31	SENT_195	[p11l11t703r415b782],
31	O.	NNP	O	O.	dep	1	SENT_195	[p11l11t703r415b782],
32	2851	CD	DATE	2851	number	33	SENT_195	[p11l11t703r415b782],
33	)	CD	NUMBER	)	dep	31	SENT_195	[p11l11t703r415b782],
34	.	.	O	.	_	0	SENT_195	[p11l11t703r415b782],

1	However	RB	O	however	advmod	15	SENT_196	[p11l450t705r789b775],
2	,	,	O	,	_	0	SENT_196	[p11l450t705r789b775],
3	in	IN	O	in	_	0	SENT_196	[p11l822t703r887b763],
4	the	DT	O	the	det	6	SENT_196	[p11l920t704r1023b764],
5	multivariate	JJ	O	multivariate	amod	6	SENT_196	[p11l1058t703r1476b764],
6	analyses	NNS	O	analysis	prep_in	15	SENT_196	[p11l1514t703r1836b782],
7	,	,	O	,	_	0	SENT_196	[p11l1514t703r1836b782],
8	none	NN	O	none	nsubj	15	SENT_196	[p11l1871t723r2040b764],
9	of	IN	O	of	_	0	SENT_196	[p11l2078t703r2153b764],
10	these	DT	O	these	prep_of	8	SENT_196	[p11l9t807r184b867],
11	was	VBD	O	be	cop	15	SENT_196	[p11l210t825r340b867],
12	a	DT	O	a	det	15	SENT_196	[p11l368t825r404b866],
13	significant	JJ	O	significant	amod	15	SENT_196	[p11l430t806r792b885],
14	prognostic	JJ	O	prognostic	amod	15	SENT_196	[p11l815t806r1178b885],
15	factor	NN	O	factor	_	0	SENT_196	[p11l1204t806r1427b878],
16	,	,	O	,	_	0	SENT_196	[p11l1204t806r1427b878],
17	including	VBG	O	include	_	0	SENT_196	[p11l1451t806r1774b885],
18	the	DT	O	the	det	20	SENT_196	[p11l1800t807r1903b867],
19	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_196	[p11l1928t807r2148b867],
20	mutation	NN	O	mutation	prep_including	15	SENT_196	[p11l9t909r315b970],
21	(	CD	NUMBER	(	num	24	SENT_196	[p11l341t909r745b988],
22	p	NN	O	p	nn	24	SENT_196	[p11l341t909r745b988],
23	=	JJ	O	=	amod	24	SENT_196	[p11l341t909r745b988],
24	O.	NNP	O	O.	dep	20	SENT_196	[p11l341t909r745b988],
25	3680	CD	NUMBER	3680	number	26	SENT_196	[p11l341t909r745b988],
26	)	CD	NUMBER	)	dep	24	SENT_196	[p11l341t909r745b988],
27	.	.	O	.	_	0	SENT_196	[p11l341t909r745b988],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_197	[p11l7t1118r228b1178],
2	mutation	NN	O	mutation	nn	3	SENT_197	[p11l264t1119r572b1177],
3	status	NN	O	status	_	0	SENT_197	[p11l607t1128r808b1177],
4	in	IN	O	in	_	0	SENT_197	[p11l847t1119r909b1177],
5	the	DT	O	the	quantmod	7	SENT_197	[p11l947t1117r1047b1177],
6	additional	JJ	O	additional	quantmod	7	SENT_197	[p11l1084t1116r1443b1177],
7	143	CD	NUMBER	143	num	10	SENT_197	[p11l1479t1117r1603b1177],
8	geﬁtinib-naive	JJ	O	geﬁtinib-naive	amod	10	SENT_197	[p11l1639t1116r2147b1194],
9	NCSLC	NN	O	ncslc	nn	10	SENT_197	[p11l6t1221r290b1281],
10	patients	NNS	O	patient	prep_in	3	SENT_197	[p11l319t1222r652b1297],
11	.	.	O	.	_	0	SENT_197	[p11l319t1222r652b1297],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_198	[p11l692t1220r925b1280],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_198	[p11l963t1219r1298b1280],
3	was	VBD	O	be	auxpass	4	SENT_198	[p11l1337t1238r1475b1280],
4	analyzed	VBN	O	analyze	_	0	SENT_198	[p11l1518t1219r1852b1298],
5	for	IN	O	for	_	0	SENT_198	[p11l1890t1219r1999b1280],
6	the	DT	O	the	det	8	SENT_198	[p11l2036t1220r2147b1280],
7	additional	JJ	O	additional	quantmod	8	SENT_198	[p11l11t1322r352b1383],
8	143	CD	NUMBER	143	prep_for	4	SENT_198	[p11l389t1323r504b1382],
9	gefitinib	NN	O	gefitinib	dep	8	SENT_198	[p11l537t1322r1043b1401],
10	—	CD	NUMBER	—	num	9	SENT_198	[p11l537t1322r1043b1401],
11	na	TO	O	na	infmod	9	SENT_198	[p11l537t1322r1043b1401],
12	'	''	O	'	_	0	SENT_198	[p11l537t1322r1043b1401],
13	1	CD	NUMBER	1	num	16	SENT_198	[p11l537t1322r1043b1401],
14	'Ve	NN	O	've	nn	16	SENT_198	[p11l537t1322r1043b1401],
15	NSCLC	NN	O	nsclc	nn	16	SENT_198	[p11l1071t1323r1347b1383],
16	patients	NNS	O	patient	xcomp	4	SENT_198	[p11l1376t1323r1642b1401],
17	who	WP	O	who	nsubjpass	20	SENT_198	[p11l1672t1323r1817b1383],
18	were	VBD	O	be	auxpass	20	SENT_198	[p11l1846t1342r2011b1383],
19	not	RB	O	not	neg	20	SENT_198	[p11l2039t1332r2150b1383],
20	treated	VBN	O	treat	rcmod	16	SENT_198	[p11l9t1425r245b1486],
21	by	IN	O	by	_	0	SENT_198	[p11l278t1426r364b1504],
22	gefitinib	NN	O	gefitinib	agent	20	SENT_198	[p11l401t1425r693b1504],
23	using	VBG	O	use	partmod	22	SENT_198	[p11l729t1426r915b1504],
24	direct	JJ	O	direct	amod	25	SENT_198	[p11l952t1425r1150b1486],
25	sequencing	NN	O	sequencing	dobj	23	SENT_198	[p11l1187t1425r1574b1504],
26	or	CC	O	or	_	0	SENT_198	[p11l1611t1445r1682b1486],
27	the	DT	O	the	det	30	SENT_198	[p11l1715t1426r1819b1486],
28	TaqMan	NNP	O	TaqMan	nn	30	SENT_198	[p11l1854t1427r2148b1504],
29	PCR	NN	O	pcr	nn	30	SENT_198	[p11l9t1529r170b1589],
30	assay	NN	O	assay	dobj	23	SENT_198	[p11l206t1547r409b1607],
31	.	.	O	.	_	0	SENT_198	[p11l206t1547r409b1607],

1	Thirty	CD	NUMBER	thirty	num	2	SENT_199	[p11l444t1528r812b1607],
2	—	CD	NUMBER	—	nsubjpass	6	SENT_199	[p11l444t1528r812b1607],
3	one	CD	NUMBER	one	num	4	SENT_199	[p11l444t1528r812b1607],
4	mutations	NNS	O	mutation	dep	2	SENT_199	[p11l846t1529r1184b1589],
5	were	VBD	O	be	auxpass	6	SENT_199	[p11l1219t1548r1384b1589],
6	detected	VBN	O	detect	_	0	SENT_199	[p11l1419t1528r1726b1600],
7	;	:	O	;	_	0	SENT_199	[p11l1419t1528r1726b1600],
8	18	CD	NUMBER	18	num	9	SENT_199	[p11l1771t1529r1843b1589],
9	patients	NNS	O	patient	nsubj	10	SENT_199	[p11l1879t1528r2146b1607],
10	had	VBD	O	have	conj_and	6	SENT_199	[p11l8t1632r132b1692],
11	the	DT	O	the	det	12	SENT_199	[p11l157t1632r260b1692],
12	deletion	NN	O	deletion	dobj	10	SENT_199	[p11l288t1631r564b1692],
13	in	IN	O	in	_	0	SENT_199	[p11l590t1631r655b1691],
14	exon	NN	DATE	exon	prep_in	12	SENT_199	[p11l681t1651r847b1692],
15	19	CD	DATE	19	num	14	SENT_199	[p11l881t1632r980b1703],
16	,	,	O	,	_	0	SENT_199	[p11l881t1632r980b1703],
17	11	CD	NUMBER	11	num	18	SENT_199	[p11l1013t1632r1081b1691],
18	patients	NNS	O	patient	nsubj	19	SENT_199	[p11l1113t1631r1379b1710],
19	had	VBD	O	have	ccomp	6	SENT_199	[p11l1407t1632r1531b1692],
20	L858R	NN	O	l858r	nn	21	SENT_199	[p11l1556t1631r1795b1692],
21	mutation	NN	O	mutation	dobj	19	SENT_199	[p11l1820t1631r2149b1703],
22	,	,	O	,	_	0	SENT_199	[p11l1820t1631r2149b1703],
23	one	CD	NUMBER	one	num	24	SENT_199	[p11l10t1754r131b1795],
24	patient	NN	O	patient	nsubj	25	SENT_199	[p11l157t1735r393b1813],
25	had	VBD	O	have	ccomp	6	SENT_199	[p11l418t1735r542b1795],
26	G719S	NN	O	g719	nn	27	SENT_199	[p11l568t1735r802b1796],
27	mutation	NN	O	mutation	dobj	25	SENT_199	[p11l833t1734r1161b1806],
28	,	,	O	,	_	0	SENT_199	[p11l833t1734r1161b1806],
29	and	CC	O	and	_	0	SENT_199	[p11l1189t1734r1310b1795],
30	one	CD	NUMBER	one	num	31	SENT_199	[p11l1337t1754r1458b1795],
31	patient	NN	O	patient	nsubj	32	SENT_199	[p11l1484t1735r1721b1813],
32	had	VBD	O	have	conj_and	6	SENT_199	[p11l1745t1735r1869b1795],
33	a	DT	O	a	det	36	SENT_199	[p11l1897t1753r1933b1794],
34	novel	JJ	O	novel	amod	36	SENT_199	[p11l1957t1734r2148b1795],
35	insertion	NN	O	insertion	nn	36	SENT_199	[p11l9t1837r339b1898],
36	mutation	NN	O	mutation	dobj	32	SENT_199	[p11l377t1837r708b1898],
37	in	IN	O	in	_	0	SENT_199	[p11l747t1838r815b1897],
38	eXon	NNP	O	eXon	prep_in	36	SENT_199	[p11l854t1857r1031b1898],
39	20	CD	NUMBER	20	number	40	SENT_199	[p11l1071t1838r1155b1898],
40	(	CD	NUMBER	(	num	42	SENT_199	[p11l1198t1838r1664b1912],
41	P772_H773	NN	O	p772_h773	nn	42	SENT_199	[p11l1198t1838r1664b1912],
42	ins	NNS	O	in	dep	38	SENT_199	[p11l1708t1837r1811b1898],
43	V	NN	O	v	nn	44	SENT_199	[p11l1852t1838r1968b1912],
44	)	NN	O	)	dep	42	SENT_199	[p11l1852t1838r1968b1912],
45	.	.	O	.	_	0	SENT_199	[p11l1852t1838r1968b1912],

1	The	DT	O	the	det	2	SENT_200	[p11l2008t1838r2147b1898],
2	relationship	NN	O	relationship	dep	23	SENT_200	[p11l8t1940r455b2019],
3	between	IN	O	between	_	0	SENT_200	[p11l494t1941r803b2001],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_200	[p11l841t1941r1072b2001],
5	mutation	NN	O	mutation	prep_between	2	SENT_200	[p11l1110t1941r1442b2001],
6	and	CC	O	and	_	0	SENT_200	[p11l1482t1941r1611b2001],
7	clinicopatho	NN	O	clinicopatho	nn	10	SENT_200	[p11l1650t1940r2146b2019],
8	—	CD	NUMBER	—	num	10	SENT_200	[p11l1650t1940r2146b2019],
9	logical	JJ	O	logical	amod	10	SENT_200	[p11l9t2043r242b2122],
10	factors	NNS	O	factor	prep_between	2	SENT_200	[p11l268t2043r499b2104],
11	in	IN	O	in	_	0	SENT_200	[p11l526t2044r591b2103],
12	the	DT	O	the	det	14	SENT_200	[p11l616t2044r719b2104],
13	additional	JJ	O	additional	quantmod	14	SENT_200	[p11l747t2043r1089b2104],
14	143	CD	NUMBER	143	prep_in	2	SENT_200	[p11l1123t2044r1238b2103],
15	gefitinib	NN	O	gefitinib	dep	14	SENT_200	[p11l1268t2043r1775b2122],
16	—	CD	NUMBER	—	num	15	SENT_200	[p11l1268t2043r1775b2122],
17	na	TO	O	na	infmod	15	SENT_200	[p11l1268t2043r1775b2122],
18	'	''	O	'	_	0	SENT_200	[p11l1268t2043r1775b2122],
19	1	CD	NUMBER	1	num	21	SENT_200	[p11l1268t2043r1775b2122],
20	'Ve	NN	O	've	nn	21	SENT_200	[p11l1268t2043r1775b2122],
21	patients	NNS	O	patient	nsubjpass	23	SENT_200	[p11l1799t2043r2066b2122],
22	is	VBZ	O	be	auxpass	23	SENT_200	[p11l2093t2044r2146b2104],
23	shown	VBN	O	show	_	0	SENT_200	[p11l12t2147r233b2207],
24	in	IN	O	in	_	0	SENT_200	[p11l266t2146r331b2206],
25	Table	NNP	O	Table	prep_in	23	SENT_200	[p11l363t2146r557b2207],
26	IV	CD	NUMBER	iv	num	25	SENT_200	[p11l590t2148r700b2207],
27	.	.	O	.	_	0	SENT_200	[p11l590t2148r700b2207],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_201	[p11l733t2147r954b2207],
2	mutation	NN	O	mutation	nn	3	SENT_201	[p11l986t2146r1292b2207],
3	status	NN	O	status	nsubjpass	6	SENT_201	[p11l1327t2155r1517b2207],
4	was	VBD	O	be	auxpass	6	SENT_201	[p11l1552t2165r1682b2207],
5	significantly	RB	O	significantly	advmod	6	SENT_201	[p11l1720t2146r2147b2225],
6	correlated	VBN	O	correlate	ccomp	21	SENT_201	[p11l9t2249r362b2310],
7	with	IN	O	with	_	0	SENT_201	[p11l397t2249r551b2310],
8	gender	NN	O	gender	nn	9	SENT_201	[p11l588t2250r826b2328],
9	(	NN	O	(	prep_with	6	SENT_201	[p11l863t2249r1058b2324],
10	male	JJ	O	male	amod	12	SENT_201	[p11l863t2249r1058b2324],
11	VS	NN	O	v	nn	12	SENT_201	[p11l1095t2269r1168b2310],
12	female	NN	O	female	dep	9	SENT_201	[p11l1206t2249r1467b2321],
13	,	,	O	,	_	0	SENT_201	[p11l1206t2249r1467b2321],
14	p	NN	O	p	dep	15	SENT_201	[p11l1501t2250r1890b2328],
15	<	JJR	O	<	appos	9	SENT_201	[p11l1501t2250r1890b2328],
16	0.0001	CD	NUMBER	0.0001	num	17	SENT_201	[p11l1501t2250r1890b2328],
17	)	NN	O	)	dep	15	SENT_201	[p11l1501t2250r1890b2328],
18	,	,	O	,	_	0	SENT_201	[p11l1501t2250r1890b2328],
19	pathological	JJ	O	pathological	amod	20	SENT_201	[p11l1923t2250r2145b2328, p11l9t2352r248b2431],
20	subtypes	NNS	O	subtype	nsubj	21	SENT_201	[p11l287t2353r590b2431],
21	(	VBP	O	(	_	0	SENT_201	[p11l631t2352r1238b2427],
22	adenocarcinoma	NN	O	adenocarcinoma	nn	23	SENT_201	[p11l631t2352r1238b2427],
23	VS	NN	O	v	dobj	21	SENT_201	[p11l1273t2372r1346b2413],
24	non	JJ	O	non	amod	26	SENT_201	[p11l1384t2352r2149b2424],
25	—	NN	O	—	nn	26	SENT_201	[p11l1384t2352r2149b2424],
26	adenocarcinoma	NN	O	adenocarcinoma	dep	23	SENT_201	[p11l1384t2352r2149b2424],
27	,	,	O	,	_	0	SENT_201	[p11l1384t2352r2149b2424],
28	Table	NNP	O	Table	nn	30	SENT_201	[p11l18t2456r213b2517],
29	V.	NNP	O	V.	nn	30	SENT_201	[p11l245t2458r326b2517],
30	Relationship	NN	O	relationship	dobj	21	SENT_201	[p11l359t2456r795b2535],
31	between	IN	O	between	_	0	SENT_201	[p11l828t2457r1116b2517],
32	the	DT	O	the	det	35	SENT_201	[p11l1148t2456r1251b2517],
33	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_201	[p11l1283t2457r1503b2517],
34	copy	NN	O	copy	nn	35	SENT_201	[p11l1536t2475r1701b2535],
35	number	NN	O	number	prep_between	30	SENT_201	[p11l1734t2456r1998b2517],
36	and	CC	O	and	_	0	SENT_201	[p11l2031t2456r2152b2516],
37	clinicopathological	JJ	O	clinicopathological	amod	38	SENT_201	[p11l19t2559r705b2638],
38	factors	NNS	O	factor	dobj	21	SENT_201	[p11l741t2559r980b2620],
39	in	IN	O	in	_	0	SENT_201	[p11l1018t2559r1084b2619],
40	the	DT	O	the	det	42	SENT_201	[p11l1119t2559r1225b2620],
41	additional	JJ	O	additional	quantmod	42	SENT_201	[p11l1263t2559r1618b2620],
42	143	CD	NUMBER	143	prep_in	38	SENT_201	[p11l1661t2560r1779b2619],
43	gefitinib	NN	O	gefitinib	dep	42	SENT_201	[p11l1821t2559r2149b2637],
44	—	CD	NUMBER	—	num	43	SENT_201	[p11l1821t2559r2149b2637],
45	na	TO	O	na	infmod	43	SENT_201	[p11l18t2667r200b2723],
46	'	''	O	'	_	0	SENT_201	[p11l18t2667r200b2723],
47	1	CD	NUMBER	1	num	50	SENT_201	[p11l18t2667r200b2723],
48	'Ve	NN	O	've	nn	50	SENT_201	[p11l18t2667r200b2723],
49	NSCLC	NN	O	nsclc	nn	50	SENT_201	[p11l223t2663r498b2723],
50	patients	NNS	O	patient	dep	38	SENT_201	[p11l523t2662r812b2741],
51	.	.	O	.	_	0	SENT_201	[p11l523t2662r812b2741],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_202	[p11l1179t2868r1400b2928],
2	gene	NN	O	gene	_	0	SENT_202	[p11l1424t2886r1584b2945],

1	Factors	NNS	O	factor	nsubj	2	SENT_203	[p11l18t3074r269b3133],
2	Copy	VBP	O	copy	_	0	SENT_203	[p11l1069t3073r1253b3151],
3	Copy	VBP	O	copy	ccomp	2	SENT_203	[p11l1487t3073r1672b3151],
4	P	NN	O	p	dobj	3	SENT_203	[p11l1876t3072r2138b3133],
5	.	.	O	.	_	0	SENT_203	[p11l1876t3072r2138b3133],

1	—	NN	O	—	_	0	SENT_204	[p11l1876t3072r2138b3133],
2	.	.	O	.	_	0	SENT_204	[p11l1876t3072r2138b3133],

1	Value	NNP	O	Value	_	0	SENT_205	[p11l1876t3072r2138b3133],
2	number	NN	O	number	dep	1	SENT_205	[p11l974t3174r1238b3234],
3	23	CD	NUMBER	23	num	4	SENT_205	[p11l1261t3175r1345b3234],
4	number	NN	O	number	npadvmod	5	SENT_205	[p11l1391t3174r1656b3234],
5	<	JJR	O	<	amod	2	SENT_205	[p11l1679t3175r1764b3234],
6	3	CD	NUMBER	3	dep	1	SENT_205	[p11l1679t3175r1764b3234],

1	Gender	NN	O	gender	_	0	SENT_206	[p11l19t3379r273b3440],

1	Male	JJ	O	male	dep	10	SENT_207	[p11l150t3489r326b3549],
2	9	CD	PERCENT	9	num	3	SENT_207	[p11l999t3490r1036b3550],
3	(	NN	PERCENT	(	dep	1	SENT_207	[p11l1065t3489r1296b3564],
4	8.2	CD	PERCENT	8.2	num	5	SENT_207	[p11l1065t3489r1296b3564],
5	%	NN	PERCENT	%	dep	3	SENT_207	[p11l1065t3489r1296b3564],
6	)	CD	NUMBER	)	number	7	SENT_207	[p11l1065t3489r1296b3564],
7	100	CD	NUMBER	100	num	5	SENT_207	[p11l1546t3490r1663b3549],
8	0.4519	CD	NUMBER	0.4519	dep	10	SENT_207	[p11l1906t3489r2141b3550],
9	Female	JJ	O	female	amod	10	SENT_207	[p11l150t3599r403b3660],
10	1	CD	PERCENT	1	dep	15	SENT_207	[p11l1005t3600r1030b3659],
11	(	CD	PERCENT	(	num	13	SENT_207	[p11l1065t3600r1296b3674],
12	2.9	CD	PERCENT	2.9	num	13	SENT_207	[p11l1065t3600r1296b3674],
13	%	NN	PERCENT	%	dep	10	SENT_207	[p11l1065t3600r1296b3674],
14	)	CD	NUMBER	)	num	15	SENT_207	[p11l1065t3600r1296b3674],
15	33	CD	NUMBER	33	_	0	SENT_207	[p11l1583t3600r1661b3660],

1	Age	NN	O	age	_	0	SENT_208	[p11l18t3710r160b3787],

1	Smoking	NN	O	smoking	nn	2	SENT_209	[p12l20t243r328b321],
2	status	NN	O	status	_	0	SENT_209	[p12l356t252r547b303],

1	NeVer	JJR	O	never	dep	7	SENT_210	[p12l150t353r676b414],
2	—	CD	NUMBER	—	num	3	SENT_210	[p12l150t353r676b414],
3	smokers	NNS	O	smoker	dep	1	SENT_210	[p12l150t353r676b414],
4	3	CD	NUMBER	3	num	5	SENT_210	[p12l1000t354r1034b413],
5	(	NN	O	(	dep	7	SENT_210	[p12l1065t353r1296b428],
6	8.6	CD	PERCENT	8.6	num	7	SENT_210	[p12l1065t353r1296b428],
7	%	NN	PERCENT	%	dep	13	SENT_210	[p12l1065t353r1296b428],
8	)	CD	NUMBER	)	number	9	SENT_210	[p12l1065t353r1296b428],
9	32	CD	NUMBER	32	dep	7	SENT_210	[p12l1583t354r1664b413],
10	0.7014	CD	NUMBER	0.7014	num	11	SENT_210	[p12l1906t354r2142b414],
11	EVer	NN	O	ever	dep	9	SENT_210	[p12l150t463r628b524],
12	—	CD	NUMBER	—	num	13	SENT_210	[p12l150t463r628b524],
13	smokers	NNS	O	smoker	dep	19	SENT_210	[p12l150t463r628b524],
14	6	CD	PERCENT	6	number	15	SENT_210	[p12l999t463r1037b523],
15	(	CD	PERCENT	(	dep	13	SENT_210	[p12l1065t463r1296b538],
16	6.3	CD	PERCENT	6.3	num	17	SENT_210	[p12l1065t463r1296b538],
17	%	NN	PERCENT	%	dep	15	SENT_210	[p12l1065t463r1296b538],
18	)	CD	NUMBER	)	num	19	SENT_210	[p12l1065t463r1296b538],
19	89	CD	NUMBER	89	_	0	SENT_210	[p12l1584t464r1663b525],

1	Lymph	NN	O	lymph	_	0	SENT_211	[p12l18t573r267b651],
2	node	NN	O	node	nn	3	SENT_211	[p12l290t573r456b633],
3	metastasis	NN	O	metastasis	dep	1	SENT_211	[p12l481t573r833b633],

1	No	DT	O	no	det	3	SENT_212	[p12l150t684r252b744],
2	8	CD	PERCENT	8	num	3	SENT_212	[p12l1001t684r1034b744],
3	(	NN	PERCENT	(	_	0	SENT_212	[p12l1065t683r1296b758],
4	8.9	CD	PERCENT	8.9	num	5	SENT_212	[p12l1065t683r1296b758],
5	%	NN	PERCENT	%	dep	3	SENT_212	[p12l1065t683r1296b758],
6	)	CD	NUMBER	)	number	7	SENT_212	[p12l1065t683r1296b758],
7	82	CD	NUMBER	82	num	5	SENT_212	[p12l1584t684r1664b744],
8	0.3230	CD	NUMBER	0.3230	num	9	SENT_212	[p12l1906t683r2141b744],
9	N	NN	O	n	dep	5	SENT_212	[p12l150t794r259b853],
10	+	CC	O	+	_	0	SENT_212	[p12l150t794r259b853],
11	2	CD	PERCENT	2	number	12	SENT_212	[p12l999t793r1037b852],
12	(	CD	PERCENT	(	conj_+	5	SENT_212	[p12l1065t793r1296b867],
13	3.8	CD	PERCENT	3.8	num	14	SENT_212	[p12l1065t793r1296b867],
14	%	NN	PERCENT	%	dep	12	SENT_212	[p12l1065t793r1296b867],
15	)	CD	NUMBER	)	num	16	SENT_212	[p12l1065t793r1296b867],
16	51	CD	NUMBER	51	dep	3	SENT_212	[p12l1582t793r1657b853],

1	Differentiation	NN	O	differentiation	_	0	SENT_213	[p12l18t903r532b964],

1	Well	RB	O	well	dep	3	SENT_214	[p12l150t1013r316b1074],
2	3	CD	PERCENT	3	num	3	SENT_214	[p12l1000t1013r1034b1073],
3	(	NN	PERCENT	(	dep	5	SENT_214	[p12l1065t1013r1296b1088],
4	4.8	CD	PERCENT	4.8	num	5	SENT_214	[p12l1065t1013r1296b1088],
5	%	NN	PERCENT	%	_	0	SENT_214	[p12l1065t1013r1296b1088],
6	)	CD	NUMBER	)	number	7	SENT_214	[p12l1065t1013r1296b1088],
7	59	CD	NUMBER	59	num	5	SENT_214	[p12l1582t1013r1663b1075],
8	0.3365	CD	NUMBER	0.3365	dep	5	SENT_214	[p12l1906t1013r2139b1073],
9	Moderately	RB	O	moderately	advmod	5	SENT_214	[p12l150t1123r548b1202],
10	or	CC	O	or	_	0	SENT_214	[p12l573t1143r644b1184],
11	7	CD	PERCENT	7	num	12	SENT_214	[p12l998t1125r1035b1183],
12	(	CD	PERCENT	(	conj_or	5	SENT_214	[p12l1065t1124r1296b1198],
13	9.9	CD	PERCENT	9.9	number	14	SENT_214	[p12l1065t1124r1296b1198],
14	%	NN	PERCENT	%	amod	12	SENT_214	[p12l1065t1124r1296b1198],
15	)	CD	NUMBER	)	num	16	SENT_214	[p12l1065t1124r1296b1198],
16	64	CD	NUMBER	64	npadvmod	17	SENT_214	[p12l1582t1123r1664b1183],
17	poorly	RB	O	poorly	advmod	12	SENT_214	[p12l149t1233r374b1311],

1	Pathological	JJ	O	pathological	amod	2	SENT_215	[p12l18t1342r449b1421],
2	subtypes	NNS	O	subtype	_	0	SENT_215	[p12l477t1343r773b1421],

1	Adeno	NNP	O	Adeno	_	0	SENT_216	[p12l150t1453r378b1514],
2	4	CD	PERCENT	4	num	1	SENT_216	[p12l997t1454r1037b1513],
3	(	CD	PERCENT	(	number	4	SENT_216	[p12l1065t1453r1296b1528],
4	4.6	CD	PERCENT	4.6	num	5	SENT_216	[p12l1065t1453r1296b1528],
5	%	NN	PERCENT	%	dep	1	SENT_216	[p12l1065t1453r1296b1528],
6	)	CD	NUMBER	)	dep	1	SENT_216	[p12l1065t1453r1296b1528],
7	83	CD	NUMBER	83	number	8	SENT_216	[p12l1584t1453r1661b1514],
8	0.1899	CD	NUMBER	0.1899	num	11	SENT_216	[p12l1906t1454r2141b1515],
9	Non	NNP	O	Non	nn	11	SENT_216	[p12l150t1563r532b1624],
10	—	CD	NUMBER	—	num	11	SENT_216	[p12l150t1563r532b1624],
11	adeno	NN	O	adeno	dep	6	SENT_216	[p12l150t1563r532b1624],
12	6	CD	NUMBER	6	num	13	SENT_216	[p12l999t1562r1037b1623],
13	(	NN	O	(	dep	6	SENT_216	[p12l1065t1563r1339b1637],
14	10.7	CD	PERCENT	10.7	num	15	SENT_216	[p12l1065t1563r1339b1637],
15	%	NN	PERCENT	%	dep	13	SENT_216	[p12l1065t1563r1339b1637],
16	)	CD	NUMBER	)	number	17	SENT_216	[p12l1065t1563r1339b1637],
17	50	CD	NUMBER	50	num	15	SENT_216	[p12l1582t1563r1663b1623],

1	pStage	NN	O	pstage	_	0	SENT_217	[p12l17t1673r251b1751],

1	I	PRP	O	I	_	0	SENT_218	[p12l151t1784r177b1843],
2	5	CD	PERCENT	5	number	3	SENT_218	[p12l999t1783r1034b1843],
3	(	CD	PERCENT	(	dep	1	SENT_218	[p12l1065t1783r1296b1858],
4	7.9	CD	PERCENT	7.9	num	5	SENT_218	[p12l1065t1783r1296b1858],
5	%	NN	PERCENT	%	dep	3	SENT_218	[p12l1065t1783r1296b1858],
6	)	CD	NUMBER	)	number	7	SENT_218	[p12l1065t1783r1296b1858],
7	58	CD	NUMBER	58	dep	1	SENT_218	[p12l1582t1783r1661b1843],
8	0.7494	CD	NUMBER	0.7494	num	9	SENT_218	[p12l1906t1784r2142b1844],
9	II	CD	NUMBER	ii	dep	7	SENT_218	[p12l151t1894r325b1953],
10	.	.	O	.	_	0	SENT_218	[p12l151t1894r325b1953],

1	—	NN	O	—	_	0	SENT_219	[p12l151t1894r325b1953],
2	.	.	O	.	_	0	SENT_219	[p12l151t1894r325b1953],

1	IV	CD	NUMBER	iv	num	2	SENT_220	[p12l151t1894r325b1953],
2	5	CD	PERCENT	5	_	0	SENT_220	[p12l999t1892r1034b1953],
3	(	NN	PERCENT	(	dep	2	SENT_220	[p12l1065t1892r1296b1967],
4	6.3	CD	PERCENT	6.3	num	5	SENT_220	[p12l1065t1892r1296b1967],
5	%	NN	PERCENT	%	dep	3	SENT_220	[p12l1065t1892r1296b1967],
6	)	CD	NUMBER	)	number	7	SENT_220	[p12l1065t1892r1296b1967],
7	75	CD	NUMBER	75	num	5	SENT_220	[p12l1581t1892r1661b1953],

1	N	NN	O	n	_	0	SENT_221	[p12l17t2074r137b2137],
2	+	CC	O	+	rcmod	1	SENT_221	[p12l17t2074r137b2137],
3	,	,	O	,	_	0	SENT_221	[p12l17t2074r137b2137],
4	lymph	NN	O	lymph	nn	5	SENT_221	[p12l158t2072r355b2143],
5	node	NN	O	node	appos	1	SENT_221	[p12l377t2072r526b2127],
6	metastasis-positive	JJ	O	metastasis-positive	dep	5	SENT_221	[p12l548t2072r1159b2143],
7	;	:	O	;	_	0	SENT_221	[p12l548t2072r1159b2143],
8	adeno	NN	O	adeno	dep	1	SENT_221	[p12l1186t2072r1389b2137],
9	,	,	O	,	_	0	SENT_221	[p12l1186t2072r1389b2137],
10	adenocarcinoma	NN	O	adenocarcinoma	appos	8	SENT_221	[p12l1411t2072r1938b2127],
11	.	.	O	.	_	0	SENT_221	[p12l1411t2072r1938b2127],

1	p	NN	O	p	_	0	SENT_222	[p12l8t2366r419b2444],
2	=	JJ	O	=	amod	4	SENT_222	[p12l8t2366r419b2444],
3	0.0007	CD	NUMBER	0.0007	tmod	2	SENT_222	[p12l8t2366r419b2444],
4	)	NN	O	)	dep	1	SENT_222	[p12l8t2366r419b2444],
5	,	,	O	,	_	0	SENT_222	[p12l8t2366r419b2444],
6	and	CC	O	and	_	0	SENT_222	[p12l458t2365r586b2426],
7	smoking	NN	O	smoking	nn	8	SENT_222	[p12l627t2365r939b2444],
8	status	NN	O	status	conj_and	4	SENT_222	[p12l981t2374r1188b2426],
9	(	CD	NUMBER	(	num	10	SENT_222	[p12l1231t2366r1806b2440],
10	never-smokers	NNS	O	never-smoker	dep	8	SENT_222	[p12l1231t2366r1806b2440],
11	VS	NN	O	v	nn	12	SENT_222	[p12l1846t2385r1922b2426],
12	eversmokers	NNS	O	eversmoker	dep	1	SENT_222	[p12l1963t2385r2149b2426, p12l12t2469r323b2540],
13	,	,	O	,	_	0	SENT_222	[p12l1963t2385r2149b2426, p12l12t2469r323b2540],
14	p	NN	O	p	appos	12	SENT_222	[p12l356t2469r490b2547],
15	<	JJR	O	<	amod	16	SENT_222	[p12l356t2469r490b2547],
16	o	NN	O	o	dep	1	SENT_222	[p12l356t2469r490b2547],
17	.0001	CD	NUMBER	.0001	num	18	SENT_222	[p12l503t2469r740b2543],
18	)	NN	O	)	dep	16	SENT_222	[p12l503t2469r740b2543],
19	.	.	O	.	_	0	SENT_222	[p12l503t2469r740b2543],

1	Patients	NNS	O	patient	nsubj	7	SENT_223	[p12l777t2468r1051b2529],
2	with	IN	O	with	_	0	SENT_223	[p12l1089t2469r1243b2529],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_223	[p12l1277t2469r1502b2529],
4	mutation	NN	O	mutation	prep_with	1	SENT_223	[p12l1538t2468r1855b2529],
5	did	VBD	O	do	aux	7	SENT_223	[p12l1892t2468r2004b2529],
6	not	RB	O	not	neg	7	SENT_223	[p12l2040t2478r2153b2529],
7	have	VB	O	have	_	0	SENT_223	[p12l9t2572r174b2632],
8	a	DT	O	a	det	12	SENT_223	[p12l213t2590r249b2631],
9	statistically	RB	O	statistically	advmod	11	SENT_223	[p12l288t2571r692b2650],
10	significantly	RB	O	significantly	advmod	11	SENT_223	[p12l733t2571r1175b2650],
11	longer	JJR	O	longer	amod	12	SENT_223	[p12l1213t2571r1440b2650],
12	OS	NN	O	os	dobj	7	SENT_223	[p12l1476t2572r1580b2632],
13	compared	VBN	O	compare	_	0	SENT_223	[p12l1622t2572r1964b2650],
14	with	IN	O	with	prepc_compared_with	12	SENT_223	[p12l1999t2572r2152b2632],
15	those	DT	O	those	det	32	SENT_223	[p12l9t2675r198b2735],
16	with	IN	O	with	_	0	SENT_223	[p12l236t2675r394b2735],
17	wild	JJ	O	wild	amod	18	SENT_223	[p12l431t2674r776b2753],
18	—	NN	O	—	prep_with	19	SENT_223	[p12l431t2674r776b2753],
19	type	NN	O	type	amod	32	SENT_223	[p12l431t2674r776b2753],
20	EGFR	NN	O	egfr	amod	32	SENT_223	[p12l813t2675r1040b2735],
21	(	CD	NUMBER	(	num	20	SENT_223	[p12l1079t2674r1415b2753],
22	log	NN	O	log	nn	25	SENT_223	[p12l1079t2674r1415b2753],
23	—	CD	NUMBER	—	num	25	SENT_223	[p12l1079t2674r1415b2753],
24	rank	NN	O	rank	nn	25	SENT_223	[p12l1079t2674r1415b2753],
25	p	NN	O	p	dep	20	SENT_223	[p12l1449t2675r1818b2753],
26	=	JJ	O	=	amod	25	SENT_223	[p12l1449t2675r1818b2753],
27	0.9787	CD	NUMBER	0.9787	tmod	26	SENT_223	[p12l1449t2675r1818b2753],
28	,	,	O	,	_	0	SENT_223	[p12l1449t2675r1818b2753],
29	data	NNS	O	datum	appos	25	SENT_223	[p12l1854t2675r2003b2735],
30	not	RB	O	not	neg	31	SENT_223	[p12l2039t2684r2153b2735],
31	shown	VBN	O	show	partmod	29	SENT_223	[p12l12t2778r283b2852],
32	)	NN	O	)	pobj	12	SENT_223	[p12l12t2778r283b2852],
33	.	.	O	.	_	0	SENT_223	[p12l12t2778r283b2852],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_224	[p12l8t2987r235b3047],
2	copy	NN	O	copy	nn	3	SENT_224	[p12l274t3006r440b3063],
3	number	NN	O	number	_	0	SENT_224	[p12l478t2985r753b3046],
4	in	IN	O	in	_	0	SENT_224	[p12l791t2988r855b3046],
5	the	DT	O	the	quantmod	7	SENT_224	[p12l894t2986r999b3046],
6	additional	JJ	O	additional	quantmod	7	SENT_224	[p12l1037t2985r1413b3046],
7	143	CD	NUMBER	143	num	10	SENT_224	[p12l1451t2986r1579b3046],
8	gefitinib-naive	JJ	O	gefitinib-naive	amod	10	SENT_224	[p12l1617t2985r2150b3063],
9	NCSLC	NN	O	ncslc	nn	10	SENT_224	[p12l6t3090r275b3150],
10	patients	NNS	O	patient	prep_in	3	SENT_224	[p12l298t3091r599b3166],
11	.	.	O	.	_	0	SENT_224	[p12l298t3091r599b3166],

1	The	DT	O	the	det	4	SENT_225	[p12l633t3089r765b3149],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_225	[p12l799t3089r1019b3149],
3	copy	NN	O	copy	nn	4	SENT_225	[p12l1053t3108r1218b3167],
4	number	NN	O	number	nsubjpass	6	SENT_225	[p12l1251t3089r1516b3149],
5	was	VBD	O	be	auxpass	6	SENT_225	[p12l1548t3107r1678b3149],
6	analyzed	VBN	O	analyze	_	0	SENT_225	[p12l1715t3088r2020b3167],
7	for	IN	O	for	_	0	SENT_225	[p12l2053t3088r2153b3149],
8	the	DT	O	the	det	10	SENT_225	[p12l9t3192r124b3252],
9	additional	JJ	O	additional	quantmod	10	SENT_225	[p12l168t3191r557b3252],
10	143	CD	NUMBER	143	prep_for	6	SENT_225	[p12l605t3192r729b3251],
11	gefitinib	NN	O	gefitinib	dep	10	SENT_225	[p12l773t3191r1348b3270],
12	—	CD	NUMBER	—	num	11	SENT_225	[p12l773t3191r1348b3270],
13	na	TO	O	na	infmod	11	SENT_225	[p12l773t3191r1348b3270],
14	'	''	O	'	_	0	SENT_225	[p12l773t3191r1348b3270],
15	1	CD	NUMBER	1	num	18	SENT_225	[p12l773t3191r1348b3270],
16	'Ve	NN	O	've	nn	18	SENT_225	[p12l773t3191r1348b3270],
17	NSCLC	NN	O	nsclc	nn	18	SENT_225	[p12l1386t3192r1682b3252],
18	patients	NNS	O	patient	npadvmod	6	SENT_225	[p12l1721t3191r2022b3270],
19	by	IN	O	by	_	0	SENT_225	[p12l2061t3192r2151b3270],
20	quantitative	JJ	O	quantitative	amod	24	SENT_225	[p12l10t3294r405b3373],
21	real	JJ	O	real	amod	24	SENT_225	[p12l431t3294r742b3355],
22	—	NN	O	—	nn	24	SENT_225	[p12l431t3294r742b3355],
23	time	NN	O	time	nn	24	SENT_225	[p12l431t3294r742b3355],
24	PCR	NN	O	pcr	agent	6	SENT_225	[p12l769t3295r951b3355],
25	.	.	O	.	_	0	SENT_225	[p12l769t3295r951b3355],

1	Ten	CD	NUMBER	ten	nsubj	6	SENT_226	[p12l978t3296r1111b3355],
2	of	IN	O	of	_	0	SENT_226	[p12l1137t3294r1212b3355],
3	the	DT	O	the	det	5	SENT_226	[p12l1232t3295r1336b3355],
4	143	CD	NUMBER	143	num	5	SENT_226	[p12l1371t3295r1486b3354],
5	cases	NNS	O	case	prep_of	1	SENT_226	[p12l1517t3313r1695b3355],
6	(	VBP	O	(	_	0	SENT_226	[p12l1726t3295r1956b3369],
7	7.0	CD	PERCENT	7.0	num	8	SENT_226	[p12l1726t3295r1956b3369],
8	%	NN	PERCENT	%	dobj	6	SENT_226	[p12l1726t3295r1956b3369],
9	)	CD	NUMBER	)	nsubjpass	11	SENT_226	[p12l1726t3295r1956b3369],
10	were	VBD	O	be	auxpass	11	SENT_226	[p12l1986t3314r2151b3355],
11	found	VBN	O	find	rcmod	8	SENT_226	[p12l10t3397r234b3458],
12	to	TO	O	to	aux	13	SENT_226	[p12l274t3406r344b3458],
13	have	VB	O	have	xcomp	11	SENT_226	[p12l385t3398r564b3458],
14	an	DT	O	a	det	18	SENT_226	[p12l607t3416r691b3457],
15	increased	VBN	O	increase	amod	18	SENT_226	[p12l732t3398r1104b3458],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_226	[p12l1144t3398r1382b3458],
17	copy	NN	O	copy	nn	18	SENT_226	[p12l1423t3417r1605b3476],
18	number	NN	O	number	dobj	13	SENT_226	[p12l1647t3398r1965b3458],
19	.	.	O	.	_	0	SENT_226	[p12l1647t3398r1965b3458],

1	The	DT	O	the	det	2	SENT_227	[p12l2007t3398r2151b3458],
2	relationship	NN	O	relationship	dep	12	SENT_227	[p12l8t3500r431b3579],
3	between	IN	O	between	_	0	SENT_227	[p12l468t3501r764b3561],
4	the	DT	O	the	det	7	SENT_227	[p12l800t3501r906b3561],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_227	[p12l943t3501r1168b3561],
6	copy	NN	O	copy	nn	7	SENT_227	[p12l1204t3520r1374b3579],
7	number	NN	O	number	prep_between	2	SENT_227	[p12l1410t3501r1682b3561],
8	and	CC	O	and	_	0	SENT_227	[p12l1719t3501r1843b3561],
9	clinico	NN	O	clinico	conj_and	7	SENT_227	[p12l1880t3500r2149b3561],
10	—	CD	NUMBER	—	dep	12	SENT_227	[p12l1880t3500r2149b3561],
11	pathological	JJ	O	pathological	amod	12	SENT_227	[p12l8t3603r462b3682],
12	factors	NNS	O	factor	dep	24	SENT_227	[p12l500t3603r746b3664],
13	in	IN	O	in	_	0	SENT_227	[p12l786t3604r853b3663],
14	the	DT	O	the	det	16	SENT_227	[p12l890t3604r998b3664],
15	additional	JJ	O	additional	quantmod	16	SENT_227	[p12l1038t3603r1402b3664],
16	143	CD	NUMBER	143	prep_in	12	SENT_227	[p12l1448t3604r1568b3663],
17	gefitinib	NN	O	gefitinib	dep	16	SENT_227	[p12l1610t3603r2151b3682],
18	—	CD	NUMBER	—	num	17	SENT_227	[p12l1610t3603r2151b3682],
19	na	TO	O	na	infmod	17	SENT_227	[p12l1610t3603r2151b3682],
20	'	''	O	'	_	0	SENT_227	[p12l1610t3603r2151b3682],
21	1	CD	NUMBER	1	dep	19	SENT_227	[p12l1610t3603r2151b3682],
22	'Ve	NN	O	've	nn	24	SENT_227	[p12l1610t3603r2151b3682],
23	NSCLC	NN	ORGANIZATION	nsclc	nn	24	SENT_227	[p12l9t3707r286b3767],
24	patients	NNS	O	patient	_	0	SENT_227	[p12l322t3707r591b3785],
25	is	VBZ	O	be	auxpass	26	SENT_227	[p12l629t3707r682b3767],
26	shown	VBN	O	show	rcmod	24	SENT_227	[p12l722t3707r945b3767],
27	in	IN	O	in	_	0	SENT_227	[p12l980t3707r1045b3766],
28	Table	NNP	O	Table	nn	29	SENT_227	[p12l1080t3706r1276b3767],
29	V.	NNP	O	V.	prep_in	26	SENT_227	[p12l1312t3708r1393b3767],
30	An	DT	O	a	det	32	SENT_227	[p12l1429t3707r1533b3766],
31	increased	VBN	O	increase	amod	32	SENT_227	[p12l1569t3706r1897b3767],
32	EGFR	NN	ORGANIZATION	egfr	xcomp	26	SENT_227	[p12l1931t3707r2152b3767],

1	copy	NN	O	copy	nn	2	SENT_228	[p13l10t39r175b98],
2	number	NN	O	number	_	0	SENT_228	[p13l210t20r474b80],
3	was	VBD	O	be	auxpass	4	SENT_228	[p13l507t38r637b80],
4	found	VBN	O	find	rcmod	2	SENT_228	[p13l673t19r874b80],
5	in	IN	O	in	_	0	SENT_228	[p13l907t20r972b79],
6	9/109	CD	PERCENT	9/109	number	7	SENT_228	[p13l1007t20r1199b81],
7	(	CD	PERCENT	(	prep_in	4	SENT_228	[p13l1237t20r1468b94],
8	8.2	CD	PERCENT	8.2	number	9	SENT_228	[p13l1237t20r1468b94],
9	%	NN	PERCENT	%	amod	7	SENT_228	[p13l1237t20r1468b94],
10	)	CD	NUMBER	)	dep	18	SENT_228	[p13l1237t20r1468b94],
11	of	IN	O	of	_	0	SENT_228	[p13l1506t19r1580b80],
12	males	NNS	O	male	prep_of	10	SENT_228	[p13l1609t19r1807b80],
13	and	CC	O	and	_	0	SENT_228	[p13l1845t19r1966b80],
14	1/34	CD	PERCENT	1/34	num	15	SENT_228	[p13l2008t20r2150b80],
15	(	CD	PERCENT	(	prep_of	10	SENT_228	[p13l12t123r255b197],
16	2.9	CD	PERCENT	2.9	num	17	SENT_228	[p13l12t123r255b197],
17	%	NN	PERCENT	%	dep	18	SENT_228	[p13l12t123r255b197],
18	)	CD	NUMBER	)	dep	26	SENT_228	[p13l12t123r255b197],
19	of	IN	O	of	_	0	SENT_228	[p13l296t122r373b183],
20	females	NNS	O	female	prep_of	18	SENT_228	[p13l405t122r709b194],
21	;	:	O	;	_	0	SENT_228	[p13l405t122r709b194],
22	8/65	CD	PERCENT	8/65	number	23	SENT_228	[p13l753t122r905b184],
23	(	CD	PERCENT	(	dep	20	SENT_228	[p13l949t123r1238b197],
24	12.3	CD	PERCENT	12.3	num	25	SENT_228	[p13l949t123r1238b197],
25	%	NN	PERCENT	%	dep	23	SENT_228	[p13l949t123r1238b197],
26	)	CD	NUMBER	)	dep	2	SENT_228	[p13l949t123r1238b197],
27	of	IN	O	of	_	0	SENT_228	[p13l1279t122r1356b183],
28	those	DT	O	those	prep_of	26	SENT_228	[p13l1387t123r1577b183],
29	who	WP	O	who	nsubj	33	SENT_228	[p13l1615t123r1766b183],
30	were	VBD	O	be	cop	33	SENT_228	[p13l1805t142r1977b183],
31	564	CD	DURATION	564	num	32	SENT_228	[p13l2015t122r2151b183],
32	years	NNS	NUMBER	year	npadvmod	33	SENT_228	[p13l9t244r188b304],
33	old	JJ	DURATION	old	rcmod	28	SENT_228	[p13l221t225r329b286],
34	and	CC	O	and	_	0	SENT_228	[p13l361t226r482b286],
35	2/78	CD	PERCENT	2/78	number	36	SENT_228	[p13l513t226r660b286],
36	(	CD	PERCENT	(	dep	2	SENT_228	[p13l697t225r927b300],
37	2.6	CD	PERCENT	2.6	num	38	SENT_228	[p13l697t225r927b300],
38	%	NN	PERCENT	%	dep	36	SENT_228	[p13l697t225r927b300],
39	)	CD	NUMBER	)	dep	36	SENT_228	[p13l697t225r927b300],
40	of	IN	O	of	_	0	SENT_228	[p13l961t225r1036b286],
41	those	DT	O	those	prep_of	36	SENT_228	[p13l1060t226r1240b286],
42	who	WP	O	who	nsubj	44	SENT_228	[p13l1271t226r1417b286],
43	were	VBD	O	be	cop	44	SENT_228	[p13l1449t245r1614b286],
44	>	JJR	O	>	rcmod	41	SENT_228	[p13l1644t225r1777b286],
45	64	CD	DURATION	64	num	46	SENT_228	[p13l1644t225r1777b286],
46	years	NNS	NUMBER	year	npadvmod	47	SENT_228	[p13l1808t244r1986b304],
47	old	JJ	DURATION	old	amod	41	SENT_228	[p13l2020t225r2148b297],
48	;	:	O	;	_	0	SENT_228	[p13l2020t225r2148b297],
49	4/87	CD	PERCENT	4/87	number	50	SENT_228	[p13l9t329r162b390],
50	(	CD	PERCENT	(	conj_and	36	SENT_228	[p13l204t328r441b403],
51	4.6	CD	PERCENT	4.6	number	52	SENT_228	[p13l204t328r441b403],
52	%	NN	PERCENT	%	amod	50	SENT_228	[p13l204t328r441b403],
53	)	CD	NUMBER	)	npadvmod	50	SENT_228	[p13l204t328r441b403],
54	of	IN	O	of	_	0	SENT_228	[p13l481t328r557b389],
55	adenocarcinoma	NN	O	adenocarcinoma	prep_of	50	SENT_228	[p13l589t329r1172b389],
56	and	CC	O	and	_	0	SENT_228	[p13l1208t329r1333b389],
57	6/56	CD	PERCENT	6/56	conj_and	36	SENT_228	[p13l1370t328r1523b390],
58	(	CD	PERCENT	(	number	59	SENT_228	[p13l1563t329r1845b403],
59	10.7	CD	PERCENT	10.7	num	60	SENT_228	[p13l1563t329r1845b403],
60	%	NN	PERCENT	%	dep	57	SENT_228	[p13l1563t329r1845b403],
61	)	CD	NUMBER	)	dep	57	SENT_228	[p13l1563t329r1845b403],
62	of	IN	O	of	_	0	SENT_228	[p13l1884t328r1960b389],
63	non538	JJ	O	non538	prep_of	61	SENT_228	[p13l1991t348r2149b389, p13l22t483r89b513],

1	ENDO	NN	ORGANIZATION	endo	_	0	SENT_229	[p13l461t478r552b501],
2	et	FW	O	et	nn	3	SENT_229	[p13l563t482r586b501],
3	al	FW	O	al	dep	1	SENT_229	[p13l594t478r627b501],
4	:	:	O	:	_	0	SENT_229	[p13l594t478r627b501],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_229	[p13l646t478r731b501],
6	MUTATION	NN	O	mutation	dep	1	SENT_229	[p13l740t478r917b501],
7	AND	CC	O	and	_	0	SENT_229	[p13l926t478r997b501],
8	COPY	NN	O	copy	nn	9	SENT_229	[p13l1007t478r1094b501],
9	NUMBER	NN	O	number	dep	1	SENT_229	[p13l1104t478r1245b501],
10	IN	IN	O	in	_	0	SENT_229	[p13l1255t478r1289b501],
11	NON	NNP	O	NON	prep_in	9	SENT_229	[p13l1298t478r1494b501],
12	.	.	O	.	_	0	SENT_229	[p13l1298t478r1494b501],

1	—	NN	O	—	_	0	SENT_230	[p13l1298t478r1494b501],
2	.	.	O	.	_	0	SENT_230	[p13l1298t478r1494b501],

1	SMALL	NNP	O	SMALL	nn	2	SENT_231	[p13l1298t478r1494b501],
2	CELL	NNP	O	CELL	_	0	SENT_231	[p13l1503t478r1585b501],
3	LUNG	NN	O	lung	dep	2	SENT_231	[p13l1594t478r1686b501],
4	CANCER	NNP	O	CANCER	dep	2	SENT_231	[p13l1695t478r1830b501],

1	o	NN	O	o	_	0	SENT_232	[p13l404t719r422b745],
2	8	CD	NUMBER	8	num	1	SENT_232	[p13l433t719r449b746],
3	—	SYM	O	—	dep	1	SENT_232	[p13l1338t706r1421b714],
4	-	:	O	-	_	0	SENT_232	[p13l1338t706r1421b714],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_232	[p13l1447t696r1542b722],
6	copy	NN	O	copy	nn	7	SENT_232	[p13l1553t704r1623b731],
7	number	NN	O	number	dep	1	SENT_232	[p13l1634t698r1746b724],
8	2	CD	NUMBER	2	number	9	SENT_232	[p13l1757t704r1776b725],
9	3	CD	NUMBER	3	dep	7	SENT_232	[p13l1787t698r1802b724],

1	D	NN	O	d	_	0	SENT_233	[p13l349t802r367b817],
2	-----	CD	NUMBER	-----	num	1	SENT_233	[p13l1337t777r1394b784],
3	--	:	O	--	_	0	SENT_233	[p13l1399t777r1419b784],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_233	[p13l1447t763r1542b789],
5	copy	NN	O	copy	nn	6	SENT_233	[p13l1552t772r1622b798],
6	number	NN	O	number	dep	1	SENT_233	[p13l1633t765r1745b790],
7	<	JJR	O	<	dep	6	SENT_233	[p13l1757t770r1774b786],
8	3	CD	NUMBER	3	num	9	SENT_233	[p13l1786t765r1801b790],
9	E	NN	O	e	dep	21	SENT_233	[p13l341t818r367b892],
10	0	CD	NUMBER	0	dep	9	SENT_233	[p13l403t828r448b854],
11	'	''	O	'	_	0	SENT_233	[p13l403t828r448b854],
12	6	CD	NUMBER	6	dep	10	SENT_233	[p13l403t828r448b854],
13	Five-year	JJ	DURATION	five-year	amod	15	SENT_233	[p13l1335t854r1477b888],
14	survival	NN	O	survival	nn	15	SENT_233	[p13l1488t855r1605b882],
15	rate	NN	O	rate	dep	10	SENT_233	[p13l1615t860r1670b882],
16	>	JJR	O	>	amod	17	SENT_233	[p13l349t894r366b911],
17	E	NN	O	e	dep	21	SENT_233	[p13l349t912r367b972],
18	04	CD	NUMBER	04	num	21	SENT_233	[p13l403t932r447b958],
19	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_233	[p13l1334t921r1428b947],
20	copy	NN	O	copy	nn	21	SENT_233	[p13l1439t929r1509b955],
21	number	NN	O	number	dep	31	SENT_233	[p13l1521t922r1633b948],
22	2	CD	NUMBER	2	number	23	SENT_233	[p13l1644t927r1663b949],
23	3	CD	NUMBER	3	dep	21	SENT_233	[p13l1674t922r1688b948],
24	:	:	O	:	_	0	SENT_233	[p13l1702t930r1707b948],
25	56	CD	PERCENT	56	num	26	SENT_233	[p13l1720t922r1783b950],
26	%	NN	PERCENT	%	dep	23	SENT_233	[p13l1720t922r1783b950],
27	(	CD	NUMBER	(	num	28	SENT_233	[p13l340t974r366b990],
28	o	NN	O	o	dep	26	SENT_233	[p13l340t974r366b990],
29	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_233	[p13l1334t988r1428b1013],
30	copy	NN	O	copy	nn	31	SENT_233	[p13l1438t996r1509b1026],
31	number	NN	O	number	dep	1	SENT_233	[p13l1520t988r1632b1014],
32	<	JJR	O	<	dep	31	SENT_233	[p13l1644t994r1660b1010],
33	3	CD	NUMBER	3	dep	32	SENT_233	[p13l1673t989r1688b1015],
34	:	:	O	:	_	0	SENT_233	[p13l1701t997r1706b1015],
35	55.5	CD	PERCENT	55.5	num	36	SENT_233	[p13l1719t989r1810b1017],
36	%	NN	PERCENT	%	dep	32	SENT_233	[p13l1719t989r1810b1017],

1	0	CD	NUMBER	0	_	0	SENT_234	[p13l402t1039r447b1066],
2	'	''	O	'	_	0	SENT_234	[p13l402t1039r447b1066],
3	2	CD	NUMBER	2	dep	1	SENT_234	[p13l402t1039r447b1066],
4	log	NN	O	log	dep	1	SENT_234	[p13l1334t1055r1466b1088],
5	—	CD	NUMBER	—	num	6	SENT_234	[p13l1334t1055r1466b1088],
6	rank	NN	O	rank	dep	4	SENT_234	[p13l1334t1055r1466b1088],
7	:	:	O	:	_	0	SENT_234	[p13l1334t1055r1466b1088],
8	p	NN	O	p	dep	4	SENT_234	[p13l1478t1055r1618b1089],
9	=	JJ	O	=	advmod	13	SENT_234	[p13l1478t1055r1618b1089],
10	0.9473	CD	NUMBER	0.9473	num	11	SENT_234	[p13l1478t1055r1618b1089],
11	o	NN	O	o	dep	9	SENT_234	[p13l506t1218r523b1244],
12	500 1000 1500 2000	CD	NUMBER	500 1000 1500 2000	number	13	SENT_234	[p13l942t1219r1013b1246],[p13l603t1219r657b1245],
13	2500 3000 3500	CD	NUMBER	2500 3000 3500	rcmod	8	SENT_234	[p13l1288t1220r1360b1246],[p13l1056t1219r1128b1246],

1	Survival	NN	O	survival	nn	2	SENT_235	[p13l756t1292r879b1319],
2	time	NN	O	time	_	0	SENT_235	[p13l889t1292r955b1319],
3	(	CD	NUMBER	(	num	4	SENT_235	[p13l966t1293r1054b1327],
4	days	NNS	NUMBER	day	dep	2	SENT_235	[p13l966t1293r1054b1327],
5	)	IN	O	)	amod	4	SENT_235	[p13l966t1293r1054b1327],

1	Figure	NNP	O	Figure	_	0	SENT_236	[p13l21t1338r107b1369],
2	3	CD	NUMBER	3	dep	1	SENT_236	[p13l119t1338r142b1362],
3	.	.	O	.	_	0	SENT_236	[p13l119t1338r142b1362],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_237	[p13l154t1338r341b1369],
2	.	.	O	.	_	0	SENT_237	[p13l154t1338r341b1369],

1	—	NN	O	—	_	0	SENT_238	[p13l154t1338r341b1369],
2	.	.	O	.	_	0	SENT_238	[p13l154t1338r341b1369],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_239	[p13l154t1338r341b1369],
2	curves	NNS	O	curve	nsubj	21	SENT_239	[p13l351t1346r436b1362],
3	of	IN	O	of	_	0	SENT_239	[p13l449t1338r478b1362],
4	overall	JJ	O	overall	prep_of	2	SENT_239	[p13l487t1338r578b1362],
5	survival	NN	O	survival	nsubj	18	SENT_239	[p13l590t1338r696b1362],
6	according	VBG	O	accord	_	0	SENT_239	[p13l708t1338r837b1369],
7	to	TO	O	to	prepc_according_to	5	SENT_239	[p13l849t1342r873b1362],
8	the	DT	O	the	det	11	SENT_239	[p13l885t1338r925b1362],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_239	[p13l936t1339r1020b1362],
10	copy	NN	O	copy	nn	11	SENT_239	[p13l1032t1346r1095b1369],
11	number	NN	O	number	pobj	5	SENT_239	[p13l1107t1338r1208b1362],
12	in	IN	O	in	_	0	SENT_239	[p13l1219t1338r1244b1362],
13	the	DT	O	the	det	16	SENT_239	[p13l1255t1338r1295b1362],
14	additional	JJ	O	additional	amod	16	SENT_239	[p13l1307t1338r1438b1362],
15	143	CD	NUMBER	143	num	16	SENT_239	[p13l1453t1338r1497b1362],
16	gefitinib	NN	O	gefitinib	prep_in	11	SENT_239	[p13l1510t1338r1705b1369],
17	—	CD	NUMBER	—	num	16	SENT_239	[p13l1510t1338r1705b1369],
18	na	TO	O	na	infmod	4	SENT_239	[p13l1510t1338r1705b1369],
19	'	''	O	'	_	0	SENT_239	[p13l1510t1338r1705b1369],
20	1	CD	NUMBER	1	dep	18	SENT_239	[p13l1510t1338r1705b1369],
21	've	VBP	O	have	_	0	SENT_239	[p13l1510t1338r1705b1369],
22	NSCLC	NN	O	nsclc	nn	23	SENT_239	[p13l1716t1338r1823b1362],
23	patients	NNS	O	patient	dobj	21	SENT_239	[p13l1834t1338r1945b1369],
24	.	.	O	.	_	0	SENT_239	[p13l1834t1338r1945b1369],

1	Survival	NN	O	survival	nn	2	SENT_240	[p13l1958t1338r2069b1362],
2	time	NN	O	time	nsubjpass	4	SENT_240	[p13l2080t1338r2138b1362],
3	was	VBD	O	be	auxpass	4	SENT_240	[p13l21t1386r71b1402],
4	calculated	VBN	O	calculate	_	0	SENT_240	[p13l82t1378r216b1402],
5	as	IN	O	as	_	0	SENT_240	[p13l226t1386r251b1402],
6	the	DT	O	the	det	7	SENT_240	[p13l262t1378r301b1402],
7	time	NN	O	time	prep_as	4	SENT_240	[p13l311t1378r369b1402],
8	from	IN	O	from	_	0	SENT_240	[p13l379t1378r443b1402],
9	operation	NN	O	operation	prep_from	7	SENT_240	[p13l452t1378r577b1409],
10	to	TO	O	to	_	0	SENT_240	[p13l587t1382r611b1402],
11	death	NN	O	death	prep_to	4	SENT_240	[p13l621t1378r693b1402],
12	from	IN	O	from	_	0	SENT_240	[p13l702t1378r766b1402],
13	any	DT	O	any	det	14	SENT_240	[p13l776t1386r822b1409],
14	cause	NN	O	cause	prep_from	4	SENT_240	[p13l832t1386r905b1402],
15	or	CC	O	or	_	0	SENT_240	[p13l915t1386r942b1402],
16	last	JJ	O	last	amod	17	SENT_240	[p13l951t1378r997b1402],
17	contact	NN	O	contact	prep_from	4	SENT_240	[p13l1006t1382r1109b1402],
18	.	.	O	.	_	0	SENT_240	[p13l1006t1382r1109b1402],

1	Five	CD	NUMBER	five	number	2	SENT_241	[p13l1119t1378r1247b1409],
2	—	CD	NUMBER	—	dep	3	SENT_241	[p13l1119t1378r1247b1409],
3	year	NN	NUMBER	year	dep	5	SENT_241	[p13l1119t1378r1247b1409],
4	survival	NN	O	survival	nn	5	SENT_241	[p13l1257t1378r1362b1402],
5	rate	NN	O	rate	nsubj	18	SENT_241	[p13l1371t1382r1420b1402],
6	of	IN	O	of	_	0	SENT_241	[p13l1430t1378r1459b1402],
7	the	DT	O	the	det	8	SENT_241	[p13l1467t1378r1506b1402],
8	patients	NNS	O	patient	prep_of	5	SENT_241	[p13l1515t1378r1618b1409],
9	with	IN	O	with	_	0	SENT_241	[p13l1628t1378r1686b1402],
10	an	DT	O	a	det	14	SENT_241	[p13l1696t1386r1726b1402],
11	increased	VBN	O	increase	amod	14	SENT_241	[p13l1736t1378r1861b1402],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_241	[p13l1870t1378r1955b1402],
13	copy	NN	O	copy	nn	14	SENT_241	[p13l1964t1386r2028b1409],
14	number	NN	O	number	prep_with	8	SENT_241	[p13l2038t1378r2139b1402],
15	was	VBD	O	be	cop	18	SENT_241	[p13l21t1426r71b1442],
16	56	CD	PERCENT	56	number	17	SENT_241	[p13l82t1418r140b1442],
17	%	NN	PERCENT	%	amod	18	SENT_241	[p13l82t1418r140b1442],
18	Vs	NNS	O	v	_	0	SENT_241	[p13l151t1426r179b1442],
19	55	CD	PERCENT	55	number	20	SENT_241	[p13l189t1418r220b1442],
20	.5	CD	PERCENT	.5	dep	21	SENT_241	[p13l225t1418r273b1442],
21	%	NN	PERCENT	%	dep	18	SENT_241	[p13l225t1418r273b1442],
22	of	IN	O	of	_	0	SENT_241	[p13l283t1418r312b1442],
23	the	DT	O	the	det	24	SENT_241	[p13l319t1418r359b1442],
24	patients	NNS	O	patient	prep_of	18	SENT_241	[p13l368t1418r470b1449],
25	without	IN	O	without	_	0	SENT_241	[p13l481t1418r582b1442],
26	an	DT	O	a	det	30	SENT_241	[p13l591t1426r621b1442],
27	increased	VBN	O	increase	amod	30	SENT_241	[p13l631t1418r756b1442],
28	EGFR	NN	ORGANIZATION	egfr	nn	30	SENT_241	[p13l764t1419r849b1442],
29	copy	NN	O	copy	nn	30	SENT_241	[p13l858t1426r922b1449],
30	number	NN	O	number	prep_without	18	SENT_241	[p13l931t1418r1040b1442],
31	.	.	O	.	_	0	SENT_241	[p13l931t1418r1040b1442],

1	The	DT	O	the	det	2	SENT_242	[p13l1050t1418r1101b1442],
2	difference	NN	O	difference	nsubj	5	SENT_242	[p13l1110t1418r1244b1442],
3	did	VBD	O	do	aux	5	SENT_242	[p13l1254t1418r1295b1442],
4	not	RB	O	not	neg	5	SENT_242	[p13l1304t1422r1347b1442],
5	reach	VB	O	reach	_	0	SENT_242	[p13l1355t1418r1427b1442],
6	statistical	JJ	O	statistical	amod	12	SENT_242	[p13l1437t1418r1561b1442],
7	significance	NN	O	significance	nn	12	SENT_242	[p13l1571t1418r1730b1449],
8	(	NN	O	(	nn	12	SENT_242	[p13l1740t1418r1863b1449],
9	log	NN	O	log	nn	12	SENT_242	[p13l1740t1418r1863b1449],
10	—	CD	NUMBER	—	num	12	SENT_242	[p13l1740t1418r1863b1449],
11	rank	NN	O	rank	nn	12	SENT_242	[p13l1740t1418r1863b1449],
12	p	NN	O	p	dobj	5	SENT_242	[p13l1871t1419r1922b1449],
13	=	JJ	O	=	amod	14	SENT_242	[p13l1871t1419r1922b1449],
14	o	NN	O	o	dep	12	SENT_242	[p13l1871t1419r1922b1449],
15	.9473	CD	NUMBER	.9473	num	16	SENT_242	[p13l1927t1418r2017b1447],
16	)	NN	O	)	dep	14	SENT_242	[p13l1927t1418r2017b1447],
17	.	.	O	.	_	0	SENT_242	[p13l1927t1418r2017b1447],

1	Table	NNP	O	Table	nn	2	SENT_243	[p13l8t1606r202b1667],
2	VI	NNP	O	VI	_	0	SENT_243	[p13l231t1608r341b1667],
3	.	.	O	.	_	0	SENT_243	[p13l231t1608r341b1667],

1	Relationship	NN	O	relationship	nsubj	17	SENT_244	[p13l370t1606r806b1685],
2	between	IN	O	between	_	0	SENT_244	[p13l835t1607r1123b1667],
3	the	DT	O	the	det	6	SENT_244	[p13l1151t1607r1254b1667],
4	ErbB2	NN	O	erbb2	nn	6	SENT_244	[p13l1283t1607r1506b1667],
5	copy	NN	O	copy	nn	6	SENT_244	[p13l1536t1626r1701b1685],
6	number	NN	O	number	prep_between	1	SENT_244	[p13l1730t1607r1995b1667],
7	and	CC	O	and	_	0	SENT_244	[p13l2023t1607r2145b1667],
8	clinicopathological	JJ	O	clinicopathological	amod	9	SENT_244	[p13l8t1709r718b1788],
9	factors	NNS	O	factor	nsubj	17	SENT_244	[p13l756t1709r1003b1770],
10	in	IN	O	in	_	0	SENT_244	[p13l1044t1710r1111b1769],
11	59	CD	NUMBER	59	num	12	SENT_244	[p13l1150t1709r1234b1771],
12	gefitinib	NN	O	gefitinib	prep_in	9	SENT_244	[p13l1274t1709r1818b1788],
13	—	CD	NUMBER	—	dep	12	SENT_244	[p13l1274t1709r1818b1788],
14	na	TO	O	na	infmod	13	SENT_244	[p13l1274t1709r1818b1788],
15	'	''	O	'	_	0	SENT_244	[p13l1274t1709r1818b1788],
16	1	CD	NUMBER	1	dep	14	SENT_244	[p13l1274t1709r1818b1788],
17	've	VBP	O	have	_	0	SENT_244	[p13l1274t1709r1818b1788],
18	NSCLC	NN	O	nsclc	nn	19	SENT_244	[p13l1856t1710r2143b1770],
19	patients	NNS	O	patient	dobj	17	SENT_244	[p13l7t1812r296b1891],
20	.	.	O	.	_	0	SENT_244	[p13l7t1812r296b1891],

1	ErbB2	NN	O	erbb2	nn	2	SENT_245	[p13l1170t2018r1395b2078],
2	gene	NN	O	gene	_	0	SENT_245	[p13l1421t2037r1581b2096],

1	Factors	NNS	O	factor	nsubj	2	SENT_246	[p13l7t2224r259b2283],
2	Copy	VBP	O	copy	dep	3	SENT_246	[p13l1060t2223r1245b2301],
3	Copy	VBP	O	copy	_	0	SENT_246	[p13l1479t2223r1664b2301],
4	P	NN	O	p	nn	7	SENT_246	[p13l1868t2222r2130b2283],
5	—	CD	NUMBER	—	num	7	SENT_246	[p13l1868t2222r2130b2283],
6	value	NN	O	value	nn	7	SENT_246	[p13l1868t2222r2130b2283],
7	number	NN	O	number	dobj	3	SENT_246	[p13l964t2326r1229b2386],
8	23	CD	NUMBER	23	num	9	SENT_246	[p13l1252t2326r1336b2386],
9	number	NN	O	number	npadvmod	10	SENT_246	[p13l1383t2326r1647b2386],
10	<	JJR	O	<	amod	7	SENT_246	[p13l1671t2326r1756b2386],
11	3	CD	NUMBER	3	nsubj	3	SENT_246	[p13l1671t2326r1756b2386],

1	Gender	NN	O	gender	_	0	SENT_247	[p13l8t2533r263b2594],

1	Male	JJ	O	male	amod	2	SENT_248	[p13l140t2641r316b2702],
2	7	CD	PERCENT	7	dep	12	SENT_248	[p13l985t2643r1023b2702],
3	(	CD	PERCENT	(	number	4	SENT_248	[p13l1052t2641r1327b2716],
4	16.3	CD	PERCENT	16.3	num	5	SENT_248	[p13l1052t2641r1327b2716],
5	%	NN	PERCENT	%	dep	2	SENT_248	[p13l1052t2641r1327b2716],
6	)	CD	NUMBER	)	number	7	SENT_248	[p13l1052t2641r1327b2716],
7	36	CD	NUMBER	36	npadvmod	8	SENT_248	[p13l1542t2641r1623b2702],
8	>	JJR	O	>	amod	5	SENT_248	[p13l1831t2642r1920b2702],
9	o	NN	O	o	dep	12	SENT_248	[p13l1831t2642r1920b2702],
10	.9999	CD	NUMBER	.9999	num	9	SENT_248	[p13l1933t2642r2116b2703],
11	Female	JJ	O	female	amod	12	SENT_248	[p13l140t2748r393b2809],
12	2	CD	PERCENT	2	dep	17	SENT_248	[p13l986t2749r1025b2808],
13	(	CD	PERCENT	(	num	15	SENT_248	[p13l1052t2748r1327b2823],
14	12.5	CD	PERCENT	12.5	num	15	SENT_248	[p13l1052t2748r1327b2823],
15	%	NN	PERCENT	%	dep	12	SENT_248	[p13l1052t2748r1327b2823],
16	)	CD	NUMBER	)	num	17	SENT_248	[p13l1052t2748r1327b2823],
17	14	CD	NUMBER	14	_	0	SENT_248	[p13l1548t2749r1623b2808],

1	Age	NN	O	age	_	0	SENT_249	[p13l8t2856r149b2933],

1	Smoking	NN	O	smoking	nn	2	SENT_250	[p13l10t3176r318b3254],
2	status	NN	O	status	_	0	SENT_250	[p13l346t3185r537b3236],

1	NeVer	SYM	O	never	dep	15	SENT_251	[p13l140t3284r376b3344],
2	-	:	O	-	_	0	SENT_251	[p13l140t3284r376b3344],
3	smokers	NNS	O	smoker	dep	9	SENT_251	[p13l385t3283r667b3344],
4	2	CD	PERCENT	2	num	5	SENT_251	[p13l986t3284r1025b3343],
5	(	CD	PERCENT	(	dep	3	SENT_251	[p13l1052t3284r1112b3358],
6	1	CD	PERCENT	1	dep	9	SENT_251	[p13l1052t3284r1112b3358],
7	1	CD	PERCENT	1	num	9	SENT_251	[p13l1131t3284r1156b3343],
8	.1	CD	PERCENT	.1	num	9	SENT_251	[p13l1174t3284r1221b3343],
9	%	NN	PERCENT	%	dep	14	SENT_251	[p13l1235t3283r1327b3358],
10	)	CD	NUMBER	)	number	11	SENT_251	[p13l1235t3283r1327b3358],
11	16	CD	NUMBER	16	dep	9	SENT_251	[p13l1548t3283r1622b3343],
12	0.7080	CD	NUMBER	0.7080	num	13	SENT_251	[p13l1880t3284r2116b3343],
13	EVer	NN	O	ever	dep	11	SENT_251	[p13l140t3390r618b3451],
14	—	CD	NUMBER	—	dep	15	SENT_251	[p13l140t3390r618b3451],
15	smokers	NNS	O	smoker	dep	21	SENT_251	[p13l140t3390r618b3451],
16	7	CD	PERCENT	7	number	17	SENT_251	[p13l985t3391r1023b3450],
17	(	CD	PERCENT	(	num	15	SENT_251	[p13l1052t3390r1327b3464],
18	17.1	CD	PERCENT	17.1	num	19	SENT_251	[p13l1052t3390r1327b3464],
19	%	NN	PERCENT	%	dep	15	SENT_251	[p13l1052t3390r1327b3464],
20	)	CD	NUMBER	)	num	21	SENT_251	[p13l1052t3390r1327b3464],
21	34	CD	NUMBER	34	_	0	SENT_251	[p13l1542t3390r1623b3450],

1	Differentiation	NN	O	differentiation	_	0	SENT_252	[p13l8t3497r522b3558],

1	Well	RB	O	well	dep	2	SENT_253	[p13l139t3604r306b3665],
2	4	CD	PERCENT	4	dep	5	SENT_253	[p13l984t3606r1025b3664],
3	(	CD	PERCENT	(	number	4	SENT_253	[p13l1052t3605r1327b3679],
4	13.3	CD	PERCENT	13.3	num	5	SENT_253	[p13l1052t3605r1327b3679],
5	%	NN	PERCENT	%	dep	18	SENT_253	[p13l1052t3605r1327b3679],
6	)	CD	NUMBER	)	number	7	SENT_253	[p13l1052t3605r1327b3679],
7	26	CD	NUMBER	26	num	8	SENT_253	[p13l1541t3604r1622b3665],
8	0.7220	CD	NUMBER	0.7220	dep	5	SENT_253	[p13l1881t3605r2116b3665],
9	Moderately	RB	O	moderately	advmod	8	SENT_253	[p13l140t3711r538b3790],
10	or	CC	O	or	_	0	SENT_253	[p13l563t3731r634b3772],
11	5	CD	PERCENT	5	num	12	SENT_253	[p13l986t3711r1021b3772],
12	(	NN	PERCENT	(	conj_or	5	SENT_253	[p13l1052t3712r1112b3786],
13	1	CD	PERCENT	1	number	14	SENT_253	[p13l1052t3712r1112b3786],
14	8	CD	PERCENT	8	amod	12	SENT_253	[p13l1126t3712r1160b3772],
15	.5	CD	PERCENT	.5	num	16	SENT_253	[p13l1174t3711r1225b3772],
16	%	NN	PERCENT	%	dep	14	SENT_253	[p13l1235t3712r1327b3786],
17	)	CD	NUMBER	)	num	18	SENT_253	[p13l1235t3712r1327b3786],
18	22	CD	NUMBER	22	_	0	SENT_253	[p13l1541t3712r1623b3771],

1	poorly	RB	O	poorly	_	0	SENT_254	[p14l139t21r364b100],

1	Pathological	JJ	O	pathological	amod	2	SENT_255	[p14l8t128r440b206],
2	subtypes	NNS	O	subtype	_	0	SENT_255	[p14l467t128r764b207],

1	Adeno	NNP	O	Adeno	dep	11	SENT_256	[p14l140t235r368b296],
2	8	CD	PERCENT	8	number	3	SENT_256	[p14l988t236r1022b296],
3	(	CD	PERCENT	(	dep	1	SENT_256	[p14l1052t236r1327b310],
4	20.0	CD	PERCENT	20.0	num	5	SENT_256	[p14l1052t236r1327b310],
5	%	NN	PERCENT	%	dep	3	SENT_256	[p14l1052t236r1327b310],
6	)	CD	NUMBER	)	dep	11	SENT_256	[p14l1052t236r1327b310],
7	32	CD	NUMBER	32	number	8	SENT_256	[p14l1542t236r1623b296],
8	0.2473	CD	NUMBER	0.2473	num	11	SENT_256	[p14l1880t236r2113b296],
9	Non	NNP	O	Non	nn	11	SENT_256	[p14l140t342r523b403],
10	—	CD	NUMBER	—	num	11	SENT_256	[p14l140t342r523b403],
11	adeno	NN	O	adeno	dep	17	SENT_256	[p14l140t342r523b403],
12	1	CD	PERCENT	1	number	13	SENT_256	[p14l993t343r1018b402],
13	(	CD	PERCENT	(	num	11	SENT_256	[p14l1052t342r1284b417],
14	5.3	CD	PERCENT	5.3	num	15	SENT_256	[p14l1052t342r1284b417],
15	%	NN	PERCENT	%	dep	11	SENT_256	[p14l1052t342r1284b417],
16	)	CD	NUMBER	)	num	17	SENT_256	[p14l1052t342r1284b417],
17	18	CD	NUMBER	18	_	0	SENT_256	[p14l1548t343r1620b403],

1	Adeno	NNP	O	Adeno	_	0	SENT_257	[p14l8t522r235b587],
2	,	,	O	,	_	0	SENT_257	[p14l8t522r235b587],
3	adenocarcinoma	NN	O	adenocarcinoma	appos	1	SENT_257	[p14l257t522r784b577],
4	.	.	O	.	_	0	SENT_257	[p14l257t522r784b577],

1	adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_258	[p14l10t816r626b887],
2	;	:	O	;	_	0	SENT_258	[p14l10t816r626b887],
3	3/35	CD	PERCENT	3/35	number	4	SENT_258	[p14l669t816r822b877],
4	(	CD	PERCENT	(	dep	1	SENT_258	[p14l865t816r1108b890],
5	8.6	CD	PERCENT	8.6	num	6	SENT_258	[p14l865t816r1108b890],
6	%	NN	PERCENT	%	dep	27	SENT_258	[p14l865t816r1108b890],
7	)	CD	NUMBER	)	dep	6	SENT_258	[p14l865t816r1108b890],
8	of	IN	O	of	_	0	SENT_258	[p14l1148t816r1226b877],
9	neVer	NN	O	never	prep_of	7	SENT_258	[p14l1257t816r1790b877],
10	—	CD	NUMBER	—	num	11	SENT_258	[p14l1257t816r1790b877],
11	smokers	NNS	O	smoker	dep	17	SENT_258	[p14l1257t816r1790b877],
12	and	CC	O	and	_	0	SENT_258	[p14l1832t816r1958b876],
13	6/95	CD	PERCENT	6/95	num	14	SENT_258	[p14l1996t815r2149b877],
14	(	CD	PERCENT	(	conj_and	11	SENT_258	[p14l10t918r242b993],
15	6.3	CD	PERCENT	6.3	num	16	SENT_258	[p14l10t918r242b993],
16	%	NN	PERCENT	%	dep	17	SENT_258	[p14l10t918r242b993],
17	)	CD	NUMBER	)	dep	21	SENT_258	[p14l10t918r242b993],
18	of	IN	O	of	_	0	SENT_258	[p14l273t919r348b979],
19	eVer	NN	O	ever	prep_of	17	SENT_258	[p14l371t919r857b990],
20	—	CD	NUMBER	—	num	21	SENT_258	[p14l371t919r857b990],
21	smokers	NNS	O	smoker	dep	7	SENT_258	[p14l371t919r857b990],
22	;	:	O	;	_	0	SENT_258	[p14l371t919r857b990],
23	8/90	CD	PERCENT	8/90	number	24	SENT_258	[p14l892t919r1039b980],
24	(	CD	PERCENT	(	dep	7	SENT_258	[p14l1071t919r1302b993],
25	8.9	CD	PERCENT	8.9	num	26	SENT_258	[p14l1071t919r1302b993],
26	%	NN	PERCENT	%	dep	27	SENT_258	[p14l1071t919r1302b993],
27	)	CD	NUMBER	)	dep	40	SENT_258	[p14l1071t919r1302b993],
28	of	IN	O	of	_	0	SENT_258	[p14l1334t919r1409b979],
29	those	DT	O	those	prep_of	27	SENT_258	[p14l1431t919r1612b979],
30	with	IN	O	with	_	0	SENT_258	[p14l1641t919r1793b979],
31	no	DT	O	no	det	34	SENT_258	[p14l1820t938r1904b979],
32	lymph	NN	O	lymph	nn	34	SENT_258	[p14l1933t918r2153b997],
33	node	NN	O	node	nn	34	SENT_258	[p14l8t1022r174b1082],
34	metastasis	NN	O	metastasis	prep_with	29	SENT_258	[p14l210t1022r564b1082],
35	and	CC	O	and	_	0	SENT_258	[p14l603t1022r726b1082],
36	2/53	CD	PERCENT	2/53	number	37	SENT_258	[p14l761t1021r908b1083],
37	(	CD	PERCENT	(	dep	40	SENT_258	[p14l951t1022r1183b1096],
38	3.8	CD	PERCENT	3.8	num	39	SENT_258	[p14l951t1022r1183b1096],
39	%	NN	PERCENT	%	dep	37	SENT_258	[p14l951t1022r1183b1096],
40	)	CD	NUMBER	)	dep	1	SENT_258	[p14l951t1022r1183b1096],
41	of	IN	O	of	_	0	SENT_258	[p14l1221t1022r1296b1082],
42	those	DT	O	those	prep_of	40	SENT_258	[p14l1326t1022r1507b1082],
43	with	IN	O	with	_	0	SENT_258	[p14l1543t1022r1695b1082],
44	lymph	NN	O	lymph	nn	46	SENT_258	[p14l1731t1021r1951b1100],
45	node	NN	O	node	nn	46	SENT_258	[p14l1986t1022r2152b1082],
46	metastasis	NN	O	metastasis	prep_with	42	SENT_258	[p14l8t1125r420b1196],
47	;	:	O	;	_	0	SENT_258	[p14l8t1125r420b1196],
48	3/62	CD	PERCENT	3/62	number	49	SENT_258	[p14l465t1125r625b1186],
49	(	CD	PERCENT	(	dep	1	SENT_258	[p14l667t1125r917b1199],
50	4.8	CD	PERCENT	4.8	num	51	SENT_258	[p14l667t1125r917b1199],
51	%	NN	PERCENT	%	dep	49	SENT_258	[p14l667t1125r917b1199],
52	)	CD	NUMBER	)	dep	49	SENT_258	[p14l667t1125r917b1199],
53	of	IN	O	of	_	0	SENT_258	[p14l959t1125r1038b1186],
54	well	RB	O	well	_	0	SENT_258	[p14l1071t1124r1229b1185],
55	differentiated	VBN	O	differentiate	dep	49	SENT_258	[p14l1269t1125r1783b1185],
56	and	CC	O	and	_	0	SENT_258	[p14l1822t1125r1952b1185],
57	7/71	CD	PERCENT	7/71	number	58	SENT_258	[p14l1990t1125r2145b1186],
58	(	CD	PERCENT	(	conj_and	55	SENT_258	[p14l11t1228r242b1303],
59	9.9	CD	PERCENT	9.9	number	60	SENT_258	[p14l11t1228r242b1303],
60	%	NN	PERCENT	%	amod	58	SENT_258	[p14l11t1228r242b1303],
61	)	CD	NUMBER	)	dep	62	SENT_258	[p14l11t1228r242b1303],
62	of	IN	O	of	prep	58	SENT_258	[p14l279t1228r353b1289],
63	moderately	RB	O	moderately	pcomp	62	SENT_258	[p14l381t1228r768b1306],
64	or	CC	O	or	_	0	SENT_258	[p14l803t1247r874b1289],
65	poorly	RB	O	poorly	advmod	66	SENT_258	[p14l905t1228r1129b1306],
66	differentiated	VBN	O	differentiate	conj_or	55	SENT_258	[p14l1164t1228r1628b1288],
67	NSCLC	NN	O	nsclc	dobj	66	SENT_258	[p14l1661t1228r1959b1299],
68	;	:	O	;	_	0	SENT_258	[p14l1661t1228r1959b1299],
69	5/63	CD	PERCENT	5/63	number	70	SENT_258	[p14l1997t1228r2143b1289],
70	(	CD	PERCENT	(	dep	67	SENT_258	[p14l11t1331r242b1406],
71	7.9	CD	PERCENT	7.9	num	72	SENT_258	[p14l11t1331r242b1406],
72	%	NN	PERCENT	%	dep	81	SENT_258	[p14l11t1331r242b1406],
73	)	CD	NUMBER	)	dep	72	SENT_258	[p14l11t1331r242b1406],
74	of	IN	O	of	_	0	SENT_258	[p14l275t1331r349b1392],
75	pStage	NN	O	pstage	prep_of	73	SENT_258	[p14l372t1331r606b1409],
76	I	CD	NUMBER	i	num	75	SENT_258	[p14l636t1332r663b1390],
77	and	CC	O	and	_	0	SENT_258	[p14l694t1331r816b1391],
78	5/80	CD	PERCENT	5/80	prep_of	73	SENT_258	[p14l846t1331r994b1392],
79	(	CD	PERCENT	(	dep	81	SENT_258	[p14l1028t1331r1259b1405],
80	6.3	CD	PERCENT	6.3	num	81	SENT_258	[p14l1028t1331r1259b1405],
81	%	NN	PERCENT	%	dep	67	SENT_258	[p14l1028t1331r1259b1405],
82	)	CD	NUMBER	)	dep	81	SENT_258	[p14l1028t1331r1259b1405],
83	of	IN	O	of	_	0	SENT_258	[p14l1292t1331r1367b1391],
84	pStage	NN	O	pstage	nn	86	SENT_258	[p14l1389t1331r1623b1409],
85	II-IV	NN	O	ii-iv	nn	86	SENT_258	[p14l1653t1332r1829b1391],
86	patients	NNS	O	patient	prep_of	67	SENT_258	[p14l1857t1331r2146b1409],
87	.	.	O	.	_	0	SENT_258	[p14l1857t1331r2146b1409],

1	The	DT	O	the	det	4	SENT_259	[p14l8t1434r142b1494],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_259	[p14l179t1435r402b1494],
3	copy	NN	O	copy	nn	4	SENT_259	[p14l439t1453r607b1512],
4	number	NN	O	number	nsubjpass	7	SENT_259	[p14l644t1434r914b1494],
5	was	VBD	O	be	auxpass	7	SENT_259	[p14l949t1453r1082b1494],
6	significantly	RB	O	significantly	advmod	7	SENT_259	[p14l1123t1434r1564b1512],
7	correlated	VBN	O	correlate	_	0	SENT_259	[p14l1602t1434r1957b1495],
8	with	IN	O	with	prep	7	SENT_259	[p14l1993t1434r2148b1494],
9	age	NN	O	age	nn	10	SENT_259	[p14l10t1556r128b1615],
10	(	NN	O	(	pobj	8	SENT_259	[p14l167t1537r328b1612],
11	564	CD	DURATION	564	num	12	SENT_259	[p14l167t1537r328b1612],
12	years	NNS	NUMBER	year	tmod	13	SENT_259	[p14l365t1556r548b1615],
13	VS	JJ	O	vs	amod	14	SENT_259	[p14l586t1556r659b1597],
14	>	JJR	O	>	dep	10	SENT_259	[p14l697t1537r832b1597],
15	64	CD	DURATION	64	num	16	SENT_259	[p14l697t1537r832b1597],
16	years	NNS	NUMBER	year	tmod	10	SENT_259	[p14l869t1556r1078b1615],
17	,	,	O	,	_	0	SENT_259	[p14l869t1556r1078b1615],
18	p	NN	O	p	nn	20	SENT_259	[p14l1112t1538r1246b1615],
19	=	JJ	O	=	amod	20	SENT_259	[p14l1112t1538r1246b1615],
20	o	NN	O	o	appos	10	SENT_259	[p14l1112t1538r1246b1615],
21	.0433	CD	NUMBER	.0433	num	22	SENT_259	[p14l1260t1537r1503b1612],
22	)	NN	O	)	dep	20	SENT_259	[p14l1260t1537r1503b1612],
23	,	,	O	,	_	0	SENT_259	[p14l1260t1537r1503b1612],
24	but	CC	O	but	_	0	SENT_259	[p14l1537t1537r1650b1597],
25	not	RB	O	not	prep	7	SENT_259	[p14l1685t1546r1796b1597],
26	with	IN	O	with	dep	8	SENT_259	[p14l1831t1537r1987b1597],
27	any	DT	O	any	det	30	SENT_259	[p14l2024t1556r2146b1615],
28	other	JJ	O	other	amod	30	SENT_259	[p14l9t1640r190b1701],
29	clinicopathologic	JJ	O	clinicopathologic	amod	30	SENT_259	[p14l225t1640r841b1718],
30	factor	NN	O	factor	pobj	26	SENT_259	[p14l879t1640r1105b1701],
31	.	.	O	.	_	0	SENT_259	[p14l879t1640r1105b1701],

1	In	IN	O	in	_	0	SENT_260	[p14l1142t1641r1214b1699],
2	the	DT	O	the	det	4	SENT_260	[p14l1249t1640r1354b1700],
3	31	CD	NUMBER	31	num	4	SENT_260	[p14l1394t1640r1469b1700],
4	cases	NNS	O	case	prep_in	15	SENT_260	[p14l1513t1659r1696b1700],
5	with	IN	O	with	_	0	SENT_260	[p14l1734t1640r1889b1700],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_260	[p14l1924t1640r2148b1700],
7	mutation	NN	O	mutation	prep_with	4	SENT_260	[p14l8t1743r330b1804],
8	in	IN	O	in	_	0	SENT_260	[p14l368t1743r435b1802],
9	this	DT	O	this	det	10	SENT_260	[p14l471t1743r599b1803],
10	cohort	NN	O	cohort	prep_in	7	SENT_260	[p14l639t1743r894b1814],
11	,	,	O	,	_	0	SENT_260	[p14l639t1743r894b1814],
12	only	RB	O	only	advmod	14	SENT_260	[p14l931t1743r1088b1821],
13	two	CD	NUMBER	two	num	14	SENT_260	[p14l1125t1752r1256b1803],
14	cases	NNS	O	case	nsubj	15	SENT_260	[p14l1295t1762r1482b1803],
15	had	VBD	O	have	_	0	SENT_260	[p14l1521t1743r1650b1803],
16	an	DT	O	a	det	20	SENT_260	[p14l1688t1762r1768b1803],
17	increased	VBN	O	increase	amod	20	SENT_260	[p14l1805t1743r2148b1803],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_260	[p14l8t1847r244b1906],
19	copy	NN	O	copy	nn	20	SENT_260	[p14l284t1865r464b1924],
20	number	NN	O	number	dobj	15	SENT_260	[p14l505t1846r820b1906],
21	.	.	O	.	_	0	SENT_260	[p14l505t1846r820b1906],

1	The	DT	O	the	det	4	SENT_261	[p14l861t1846r1003b1906],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_261	[p14l1044t1846r1279b1906],
3	copy	NN	O	copy	nn	4	SENT_261	[p14l1320t1865r1500b1924],
4	number	NN	O	number	nsubj	7	SENT_261	[p14l1541t1846r1832b1906],
5	did	VBD	O	do	aux	7	SENT_261	[p14l1870t1846r1989b1906],
6	not	RB	O	not	neg	7	SENT_261	[p14l2029t1855r2149b1907],
7	correlate	VB	O	correlate	_	0	SENT_261	[p14l9t1949r348b2010],
8	with	IN	O	with	_	0	SENT_261	[p14l389t1949r555b2009],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_261	[p14l594t1949r829b2009],
10	mutation	NN	O	mutation	nn	11	SENT_261	[p14l869t1949r1209b2010],
11	status	NN	O	status	prep_with	7	SENT_261	[p14l1252t1958r1467b2009],
12	(	CD	NUMBER	(	num	13	SENT_261	[p14l1511t1949r1964b2027],
13	p	NN	O	p	npadvmod	14	SENT_261	[p14l1511t1949r1964b2027],
14	>	JJR	O	>	amod	11	SENT_261	[p14l1511t1949r1964b2027],
15	0.9999	CD	NUMBER	0.9999	num	16	SENT_261	[p14l1511t1949r1964b2027],
16	)	NN	O	)	dobj	7	SENT_261	[p14l1511t1949r1964b2027],
17	.	.	O	.	_	0	SENT_261	[p14l1511t1949r1964b2027],

1	The	DT	O	the	det	3	SENT_262	[p14l2005t1949r2147b2009],
2	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	3	SENT_262	[p14l8t2052r494b2130],
3	curves	NNS	O	curve	nsubjpass	22	SENT_262	[p14l518t2071r739b2112],
4	of	IN	O	of	_	0	SENT_262	[p14l767t2052r842b2112],
5	OS	NNP	O	OS	prep_of	3	SENT_262	[p14l862t2052r965b2112],
6	according	VBG	O	accord	_	0	SENT_262	[p14l996t2052r1333b2130],
7	to	TO	O	to	prepc_according_to	22	SENT_262	[p14l1359t2061r1423b2113],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_262	[p14l1449t2052r1669b2112],
9	copy	NN	O	copy	nn	10	SENT_262	[p14l1694t2071r1859b2130],
10	number	NN	O	number	pobj	22	SENT_262	[p14l1885t2052r2149b2112],
11	in	IN	O	in	_	0	SENT_262	[p14l9t2155r76b2214],
12	the	DT	O	the	det	15	SENT_262	[p14l112t2155r219b2215],
13	additional	JJ	O	additional	amod	15	SENT_262	[p14l259t2155r620b2215],
14	143	CD	NUMBER	143	num	15	SENT_262	[p14l665t2155r784b2215],
15	gefitinib-na	NN	O	gefitinib-na	prep_in	10	SENT_262	[p14l827t2155r1361b2233],
16	'	''	O	'	_	0	SENT_262	[p14l827t2155r1361b2233],
17	1	CD	NUMBER	1	num	20	SENT_262	[p14l827t2155r1361b2233],
18	'Ve	NN	O	've	nn	20	SENT_262	[p14l827t2155r1361b2233],
19	NSCLC	NN	ORGANIZATION	nsclc	nn	20	SENT_262	[p14l1399t2155r1683b2216],
20	patients	NNS	O	patient	dep	15	SENT_262	[p14l1720t2155r2001b2233],
21	are	VBP	O	be	auxpass	22	SENT_262	[p14l2042t2174r2147b2215],
22	shown	VBN	O	show	_	0	SENT_262	[p14l11t2258r234b2318],
23	in	IN	O	in	_	0	SENT_262	[p14l269t2258r334b2317],
24	Fig	NN	O	fig	prep_in	22	SENT_262	[p14l369t2258r504b2336],
25	.	.	O	.	_	0	SENT_262	[p14l369t2258r504b2336],

1	3	LS	NUMBER	3	_	0	SENT_263	[p14l543t2258r602b2318],
2	.	.	O	.	_	0	SENT_263	[p14l543t2258r602b2318],

1	The	DT	O	the	det	4	SENT_264	[p14l638t2258r771b2318],
2	five-year	JJ	DURATION	five-year	amod	4	SENT_264	[p14l807t2258r1122b2336],
3	survival	NN	O	survival	nn	4	SENT_264	[p14l1158t2258r1434b2318],
4	rate	NN	O	rate	nsubj	16	SENT_264	[p14l1468t2267r1597b2318],
5	of	IN	O	of	_	0	SENT_264	[p14l1634t2258r1709b2319],
6	the	DT	O	the	det	7	SENT_264	[p14l1738t2258r1842b2318],
7	patients	NNS	O	patient	prep_of	4	SENT_264	[p14l1877t2258r2146b2336],
8	with	IN	O	with	_	0	SENT_264	[p14l9t2361r161b2421],
9	an	DT	O	a	det	13	SENT_264	[p14l190t2380r268b2421],
10	increased	VBN	O	increase	amod	13	SENT_264	[p14l296t2361r621b2421],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_264	[p14l648t2361r868b2421],
12	copy	NN	O	copy	nn	13	SENT_264	[p14l896t2380r1061b2439],
13	number	NN	O	number	prep_with	7	SENT_264	[p14l1090t2361r1354b2421],
14	was	VBD	O	be	cop	16	SENT_264	[p14l1381t2380r1510b2421],
15	56	CD	PERCENT	56	num	16	SENT_264	[p14l1542t2361r1693b2422],
16	%	NN	PERCENT	%	_	0	SENT_264	[p14l1542t2361r1693b2422],
17	VS	NN	O	v	dep	16	SENT_264	[p14l1725t2380r1798b2421],
18	55.5	CD	PERCENT	55.5	num	19	SENT_264	[p14l1829t2361r2046b2422],
19	%	NN	PERCENT	%	tmod	17	SENT_264	[p14l1829t2361r2046b2422],
20	of	IN	O	of	_	0	SENT_264	[p14l2078t2361r2153b2422],
21	the	DT	O	the	det	22	SENT_264	[p14l8t2464r112b2524],
22	patients	NNS	O	patient	prep_of	19	SENT_264	[p14l147t2464r416b2542],
23	without	IN	O	without	_	0	SENT_264	[p14l454t2464r721b2524],
24	an	DT	O	a	det	28	SENT_264	[p14l756t2483r834b2524],
25	increased	VBN	O	increase	amod	28	SENT_264	[p14l870t2464r1199b2524],
26	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_264	[p14l1233t2465r1454b2524],
27	copy	NN	O	copy	nn	28	SENT_264	[p14l1490t2483r1656b2542],
28	number	NN	O	number	prep_without	17	SENT_264	[p14l1692t2464r1977b2524],
29	.	.	O	.	_	0	SENT_264	[p14l1692t2464r1977b2524],

1	The	DT	O	the	det	2	SENT_265	[p14l2014t2464r2147b2524],
2	difference	NN	O	difference	nsubj	5	SENT_265	[p14l9t2567r377b2627],
3	did	VBD	O	do	aux	5	SENT_265	[p14l416t2567r528b2627],
4	not	RB	O	not	neg	5	SENT_265	[p14l565t2576r679b2628],
5	reach	VB	O	reach	_	0	SENT_265	[p14l714t2567r909b2627],
6	statistical	JJ	O	statistical	amod	10	SENT_265	[p14l949t2567r1294b2627],
7	significance	NN	O	significance	nn	10	SENT_265	[p14l1334t2567r1771b2645],
8	(	CD	NUMBER	(	num	10	SENT_265	[p14l1812t2567r2149b2645],
9	log-tank	NN	O	log-tank	nn	10	SENT_265	[p14l1812t2567r2149b2645],
10	p	NN	O	p	nsubj	13	SENT_265	[p14l7t2670r386b2748],
11	=	JJ	O	=	amod	13	SENT_265	[p14l7t2670r386b2748],
12	0.9473	CD	NUMBER	0.9473	num	13	SENT_265	[p14l7t2670r386b2748],
13	)	NN	O	)	xcomp	5	SENT_265	[p14l7t2670r386b2748],
14	.	.	O	.	_	0	SENT_265	[p14l7t2670r386b2748],

1	ErbB2	NN	O	erbb2	nn	3	SENT_266	[p14l7t2872r230b2932],
2	copy	NN	O	copy	nn	3	SENT_266	[p14l260t2893r420b2949],
3	number	NN	O	number	_	0	SENT_266	[p14l447t2872r711b2932],
4	in	IN	O	in	_	0	SENT_266	[p14l739t2874r801b2932],
5	59	CD	NUMBER	59	num	8	SENT_266	[p14l827t2872r913b2933],
6	geﬁtinib-naive	JJ	O	geﬁtinib-naive	amod	8	SENT_266	[p14l938t2872r1440b2949],
7	NCSLC	NN	O	ncslc	nn	8	SENT_266	[p14l1465t2873r1733b2933],
8	patients	NNS	O	patient	prep_in	3	SENT_266	[p14l1749t2874r2050b2949],
9	.	.	O	.	_	0	SENT_266	[p14l1749t2874r2050b2949],

1	In	IN	O	in	_	0	SENT_267	[p14l2078t2873r2148b2931],
2	the	DT	O	the	det	4	SENT_267	[p14l8t2975r111b3035],
3	59	CD	NUMBER	59	num	4	SENT_267	[p14l144t2975r225b3036],
4	gefitinib-na	NN	O	gefitinib-na	prep_in	15	SENT_267	[p14l259t2975r765b3053],
5	'	''	O	'	_	0	SENT_267	[p14l259t2975r765b3053],
6	1	CD	NUMBER	1	num	9	SENT_267	[p14l259t2975r765b3053],
7	'Ve	NN	O	've	nn	9	SENT_267	[p14l259t2975r765b3053],
8	NSCLC	NN	O	nsclc	nn	9	SENT_267	[p14l796t2975r1072b3036],
9	samples	NNS	O	sample	dep	4	SENT_267	[p14l1107t2975r1404b3053],
10	,	,	O	,	_	0	SENT_267	[p14l1107t2975r1404b3053],
11	ErbB2	NN	O	erbb2	nn	13	SENT_267	[p14l1433t2975r1657b3035],
12	copy	NN	O	copy	nn	13	SENT_267	[p14l1689t2994r1854b3053],
13	number	NN	O	number	nsubjpass	15	SENT_267	[p14l1885t2975r2150b3035],
14	was	VBD	O	be	auxpass	15	SENT_267	[p14l9t3097r144b3138],
15	analyzed	VBN	O	analyze	_	0	SENT_267	[p14l185t3078r530b3156],
16	.	.	O	.	_	0	SENT_267	[p14l185t3078r530b3156],

1	The	DT	O	the	det	2	SENT_268	[p14l569t3078r706b3138],
2	relationship	NN	O	relationship	dep	22	SENT_268	[p14l743t3078r1178b3156],
3	between	IN	O	between	_	0	SENT_268	[p14l1215t3078r1519b3138],
4	the	DT	O	the	det	7	SENT_268	[p14l1556t3078r1664b3138],
5	ErbB2	NN	O	erbb2	nn	7	SENT_268	[p14l1701t3078r1935b3138],
6	copy	NN	O	copy	nn	7	SENT_268	[p14l1974t3097r2147b3156],
7	number	NN	O	number	prep_between	2	SENT_268	[p14l8t3181r272b3241],
8	and	CC	O	and	_	0	SENT_268	[p14l303t3181r425b3241],
9	the	DT	O	the	det	11	SENT_268	[p14l454t3181r558b3241],
10	clinicopathologic	JJ	O	clinicopathologic	amod	11	SENT_268	[p14l589t3181r1187b3259],
11	factors	NNS	O	factor	conj_and	2	SENT_268	[p14l1219t3181r1451b3242],
12	in	IN	O	in	_	0	SENT_268	[p14l1483t3181r1548b3240],
13	the	DT	O	the	det	15	SENT_268	[p14l1579t3181r1681b3241],
14	59	CD	NUMBER	59	num	15	SENT_268	[p14l1714t3181r1795b3242],
15	gefitinibna	NN	O	gefitinibna	prep_in	11	SENT_268	[p14l1828t3181r2145b3259, p14l8t3289r194b3344],
16	'	''	O	'	_	0	SENT_268	[p14l1828t3181r2145b3259, p14l8t3289r194b3344],
17	1	CD	NUMBER	1	num	20	SENT_268	[p14l1828t3181r2145b3259, p14l8t3289r194b3344],
18	'Ve	NN	O	've	nn	20	SENT_268	[p14l1828t3181r2145b3259, p14l8t3289r194b3344],
19	NSCLC	NN	ORGANIZATION	nsclc	nn	20	SENT_268	[p14l230t3284r507b3345],
20	patients	NNS	O	patient	nsubjpass	22	SENT_268	[p14l543t3284r812b3362],
21	is	VBZ	O	be	auxpass	22	SENT_268	[p14l850t3284r903b3344],
22	shown	VBN	O	show	_	0	SENT_268	[p14l943t3284r1166b3345],
23	in	IN	O	in	_	0	SENT_268	[p14l1202t3284r1267b3343],
24	Table	NNP	O	Table	nn	25	SENT_268	[p14l1302t3284r1498b3344],
25	VI	NNP	O	VI	prep_in	22	SENT_268	[p14l1533t3285r1644b3344],
26	.	.	O	.	_	0	SENT_268	[p14l1533t3285r1644b3344],

1	An	DT	O	a	det	5	SENT_269	[p14l1680t3285r1785b3343],
2	increased	VBN	O	increase	amod	5	SENT_269	[p14l1820t3284r2148b3344],
3	ErbB2	NN	O	erbb2	nn	5	SENT_269	[p14l8t3387r232b3447],
4	copy	NN	O	copy	nn	5	SENT_269	[p14l260t3406r424b3465],
5	number	NN	O	number	nsubjpass	7	SENT_269	[p14l451t3387r716b3447],
6	was	VBD	O	be	auxpass	7	SENT_269	[p14l741t3406r871b3447],
7	found	VBN	O	find	_	0	SENT_269	[p14l900t3387r1100b3448],
8	in	IN	O	in	_	0	SENT_269	[p14l1126t3387r1191b3446],
9	7/43	CD	PERCENT	7/43	number	10	SENT_269	[p14l1218t3387r1365b3448],
10	(	CD	PERCENT	(	num	13	SENT_269	[p14l1399t3387r1672b3461],
11	16.3	CD	PERCENT	16.3	number	12	SENT_269	[p14l1399t3387r1672b3461],
12	%	NN	PERCENT	%	amod	13	SENT_269	[p14l1399t3387r1672b3461],
13	)	CD	NUMBER	)	prep_in	7	SENT_269	[p14l1399t3387r1672b3461],
14	of	IN	O	of	_	0	SENT_269	[p14l1702t3387r1778b3447],
15	males	NNS	O	male	prep_of	13	SENT_269	[p14l1798t3387r1996b3447],
16	and	CC	O	and	_	0	SENT_269	[p14l2026t3387r2148b3447],
17	2/16	CD	PERCENT	2/16	number	18	SENT_269	[p14l10t3490r161b3551],
18	(	CD	PERCENT	(	prep_in	7	SENT_269	[p14l201t3490r480b3564],
19	12.5	CD	PERCENT	12.5	num	20	SENT_269	[p14l201t3490r480b3564],
20	%	NN	PERCENT	%	dep	18	SENT_269	[p14l201t3490r480b3564],
21	)	CD	NUMBER	)	dep	18	SENT_269	[p14l201t3490r480b3564],
22	of	IN	O	of	_	0	SENT_269	[p14l520t3490r595b3551],
23	females	NNS	O	female	prep_of	21	SENT_269	[p14l625t3490r919b3562],
24	;	:	O	;	_	0	SENT_269	[p14l625t3490r919b3562],
25	5/28	CD	PERCENT	5/28	prep_in	7	SENT_269	[p14l960t3490r1109b3551],
26	(	CD	PERCENT	(	number	27	SENT_269	[p14l1151t3490r1430b3565],
27	17.9	CD	PERCENT	17.9	num	28	SENT_269	[p14l1151t3490r1430b3565],
28	%	NN	PERCENT	%	dep	25	SENT_269	[p14l1151t3490r1430b3565],
29	)	CD	NUMBER	)	dobj	7	SENT_269	[p14l1151t3490r1430b3565],
30	of	IN	O	of	_	0	SENT_269	[p14l1469t3490r1545b3551],
31	those	DT	O	those	prep_of	29	SENT_269	[p14l1574t3490r1758b3551],
32	who	WP	O	who	nsubj	36	SENT_269	[p14l1795t3490r1942b3551],
33	were	VBD	O	be	cop	36	SENT_269	[p14l1979t3509r2147b3550],
34	364	CD	DURATION	364	num	35	SENT_269	[p14l9t3593r139b3653],
35	years	NNS	NUMBER	year	npadvmod	36	SENT_269	[p14l166t3612r345b3671],
36	old	JJ	DURATION	old	rcmod	31	SENT_269	[p14l374t3593r482b3654],
37	and	CC	O	and	_	0	SENT_269	[p14l509t3593r631b3653],
38	4/31	CD	PERCENT	4/31	number	39	SENT_269	[p14l656t3593r801b3654],
39	(	CD	PERCENT	(	prep_of	29	SENT_269	[p14l837t3593r1111b3668],
40	12.9	CD	PERCENT	12.9	num	41	SENT_269	[p14l837t3593r1111b3668],
41	%	NN	PERCENT	%	dep	39	SENT_269	[p14l837t3593r1111b3668],
42	)	CD	NUMBER	)	dep	29	SENT_269	[p14l837t3593r1111b3668],
43	of	IN	O	of	_	0	SENT_269	[p14l1141t3593r1215b3653],
44	those	DT	O	those	prep_of	42	SENT_269	[p14l1235t3593r1415b3654],
45	who	WP	O	who	nsubj	47	SENT_269	[p14l1443t3593r1588b3653],
46	were	VBD	O	be	cop	47	SENT_269	[p14l1616t3612r1781b3653],
47	>	JJR	O	>	rcmod	44	SENT_269	[p14l1807t3593r1940b3653],
48	64	CD	DURATION	64	num	49	SENT_269	[p14l1807t3593r1940b3653],
49	years	NNS	NUMBER	year	npadvmod	50	SENT_269	[p14l1967t3612r2145b3671],
50	old	JJ	DURATION	old	amod	44	SENT_269	[p14l9t3696r138b3768],
51	;	:	O	;	_	0	SENT_269	[p14l9t3696r138b3768],
52	8/40	CD	PERCENT	8/40	number	53	SENT_269	[p14l174t3696r320b3757],
53	(	CD	PERCENT	(	conj_and	29	SENT_269	[p14l355t3696r564b3771],
54	20	CD	PERCENT	20	num	55	SENT_269	[p14l355t3696r564b3771],
55	%	NN	PERCENT	%	dep	53	SENT_269	[p14l355t3696r564b3771],
56	)	CD	NUMBER	)	dep	53	SENT_269	[p14l355t3696r564b3771],
57	of	IN	O	of	_	0	SENT_269	[p14l597t3696r672b3757],
58	adenocarcinoma	NN	O	adenocarcinoma	prep_of	56	SENT_269	[p14l698t3696r1263b3757],
59	and	CC	O	and	_	0	SENT_269	[p14l1293t3696r1415b3756],
60	1/19	CD	PERCENT	1/19	number	61	SENT_269	[p14l1452t3696r1594b3758],
61	(	CD	PERCENT	(	conj_and	29	SENT_269	[p14l1628t3696r1859b3771],
62	5.3	CD	PERCENT	5.3	num	63	SENT_269	[p14l1628t3696r1859b3771],
63	%	NN	PERCENT	%	dep	61	SENT_269	[p14l1628t3696r1859b3771],
64	)	CD	NUMBER	)	dep	61	SENT_269	[p14l1628t3696r1859b3771],
65	of	IN	O	of	_	0	SENT_269	[p14l1892t3696r1967b3757],
66	nonadenocarcinoma	NN	O	nonadenocarcinoma	prep_of	64	SENT_269	[p14l1991t3715r2145b3757, p15l10t21r612b92],
67	;	:	O	;	_	0	SENT_269	[p14l1991t3715r2145b3757, p15l10t21r612b92],

1	2/18	CD	PERCENT	2/18	number	2	SENT_270	[p15l653t21r803b82],
2	(	CD	PERCENT	(	nsubj	38	SENT_270	[p15l845t21r1126b96],
3	11.1	CD	PERCENT	11.1	num	4	SENT_270	[p15l845t21r1126b96],
4	%	NN	PERCENT	%	dep	2	SENT_270	[p15l845t21r1126b96],
5	)	CD	NUMBER	)	dep	2	SENT_270	[p15l845t21r1126b96],
6	of	IN	O	of	_	0	SENT_270	[p15l1166t21r1242b82],
7	never-smokers	NNS	O	never-smoker	prep_of	5	SENT_270	[p15l1272t21r1792b82],
8	and	CC	O	and	_	0	SENT_270	[p15l1833t21r1957b81],
9	7/41	CD	PERCENT	7/41	conj_and	2	SENT_270	[p15l1993t21r2140b82],
10	(	CD	PERCENT	(	number	11	SENT_270	[p15l11t124r285b199],
11	17.1	CD	PERCENT	17.1	num	12	SENT_270	[p15l11t124r285b199],
12	%	NN	PERCENT	%	dep	9	SENT_270	[p15l11t124r285b199],
13	)	CD	NUMBER	)	dep	9	SENT_270	[p15l11t124r285b199],
14	of	IN	O	of	_	0	SENT_270	[p15l315t124r390b185],
15	ever	RB	O	ever	advmod	16	SENT_270	[p15l410t124r895b196],
16	—	JJ	O	—	amod	17	SENT_270	[p15l410t124r895b196],
17	smokers	NNS	O	smoker	prep_of	13	SENT_270	[p15l410t124r895b196],
18	;	:	O	;	_	0	SENT_270	[p15l410t124r895b196],
19	4/30	CD	PERCENT	4/30	conj_and	2	SENT_270	[p15l924t124r1075b185],
20	(	CD	PERCENT	(	number	21	SENT_270	[p15l1106t124r1380b199],
21	13.3	CD	PERCENT	13.3	num	22	SENT_270	[p15l1106t124r1380b199],
22	%	NN	PERCENT	%	dep	19	SENT_270	[p15l1106t124r1380b199],
23	)	CD	NUMBER	)	dep	19	SENT_270	[p15l1106t124r1380b199],
24	of	IN	O	of	_	0	SENT_270	[p15l1409t124r1484b185],
25	Well	NNP	O	Well	prep_of	23	SENT_270	[p15l1505t124r2148b184],
26	—	CD	NUMBER	—	num	25	SENT_270	[p15l1505t124r2148b184],
27	differentiated	VBN	O	differentiate	partmod	19	SENT_270	[p15l1505t124r2148b184],
28	and	CC	O	and	_	0	SENT_270	[p15l10t227r137b287],
29	5/27	CD	PERCENT	5/27	number	30	SENT_270	[p15l175t227r331b288],
30	(	CD	PERCENT	(	conj_and	2	SENT_270	[p15l374t227r664b302],
31	18.5	CD	PERCENT	18.5	num	32	SENT_270	[p15l374t227r664b302],
32	%	NN	PERCENT	%	dep	30	SENT_270	[p15l374t227r664b302],
33	)	CD	NUMBER	)	npadvmod	34	SENT_270	[p15l374t227r664b302],
34	of	IN	O	of	advmod	38	SENT_270	[p15l705t227r782b288],
35	moderately	RB	O	moderately	advmod	38	SENT_270	[p15l814t227r1225b305],
36	or	CC	O	or	_	0	SENT_270	[p15l1264t246r1338b287],
37	poorly	RB	O	poorly	conj_or	35	SENT_270	[p15l1373t227r1610b305],
38	differentiated	VBN	O	differentiate	_	0	SENT_270	[p15l1649t227r2148b287],
39	NSCLC	NN	O	nsclc	dobj	38	SENT_270	[p15l8t330r322b391],
40	.	.	O	.	_	0	SENT_270	[p15l8t330r322b391],

1	The	DT	O	the	det	4	SENT_271	[p15l362t330r500b390],
2	ErbB2	NN	O	erbb2	nn	4	SENT_271	[p15l538t330r776b390],
3	copy	NN	O	copy	nn	4	SENT_271	[p15l815t349r990b408],
4	number	NN	O	number	nsubjpass	8	SENT_271	[p15l1029t330r1310b390],
5	was	VBD	O	be	auxpass	8	SENT_271	[p15l1347t349r1483b390],
6	not	RB	O	not	neg	8	SENT_271	[p15l1523t339r1640b390],
7	significantly	RB	O	significantly	advmod	8	SENT_271	[p15l1680t330r2147b408],
8	correlated	VBD	O	correlate	_	0	SENT_271	[p15l9t433r389b494],
9	with	IN	O	with	_	0	SENT_271	[p15l428t433r592b493],
10	any	DT	O	any	prep_with	8	SENT_271	[p15l632t452r760b511],
11	of	IN	O	of	_	0	SENT_271	[p15l801t433r879b493],
12	clinicopathological	JJ	O	clinicopathological	amod	13	SENT_271	[p15l913t433r1646b511],
13	factors	NNS	O	factor	prep_of	10	SENT_271	[p15l1686t433r1967b494],
14	.	.	O	.	_	0	SENT_271	[p15l1686t433r1967b494],

1	The	DT	O	the	det	3	SENT_272	[p15l2007t433r2147b493],
2	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	3	SENT_272	[p15l8t536r494b614],
3	curves	NNS	O	curve	nsubjpass	21	SENT_272	[p15l517t555r738b596],
4	of	IN	O	of	_	0	SENT_272	[p15l766t536r840b597],
5	OS	NNP	O	OS	prep_of	3	SENT_272	[p15l861t536r964b596],
6	according	VBG	O	accord	_	0	SENT_272	[p15l994t536r1330b614],
7	to	TO	O	to	prepc_according_to	21	SENT_272	[p15l1356t545r1420b597],
8	ErbB2	NN	O	erbb2	nn	10	SENT_272	[p15l1445t536r1669b596],
9	copy	NN	O	copy	nn	10	SENT_272	[p15l1695t555r1860b614],
10	number	NN	O	number	pobj	21	SENT_272	[p15l1885t536r2149b596],
11	in	IN	O	in	_	0	SENT_272	[p15l9t639r74b698],
12	the	DT	O	the	det	14	SENT_272	[p15l97t639r201b699],
13	59	CD	NUMBER	59	num	14	SENT_272	[p15l227t639r308b700],
14	gefitinib-na	NN	O	gefitinib-na	prep_in	10	SENT_272	[p15l336t639r842b717],
15	'	''	O	'	_	0	SENT_272	[p15l336t639r842b717],
16	1	CD	NUMBER	1	nsubj	17	SENT_272	[p15l336t639r842b717],
17	've	VBP	O	have	rcmod	14	SENT_272	[p15l336t639r842b717],
18	NSCLC	NN	ORGANIZATION	nsclc	nn	19	SENT_272	[p15l867t639r1143b700],
19	patients	NNS	O	patient	dobj	17	SENT_272	[p15l1168t639r1434b717],
20	are	VBP	O	be	auxpass	21	SENT_272	[p15l1462t658r1563b699],
21	shown	VBN	O	show	_	0	SENT_272	[p15l1592t639r1813b700],
22	in	IN	O	in	_	0	SENT_272	[p15l1838t639r1902b698],
23	Fig	NN	O	fig	prep_in	21	SENT_272	[p15l1926t639r2060b717],
24	.	.	O	.	_	0	SENT_272	[p15l1926t639r2060b717],

1	4	LS	NUMBER	4	_	0	SENT_273	[p15l2085t640r2147b699],
2	.	.	O	.	_	0	SENT_273	[p15l2085t640r2147b699],

1	The	DT	O	the	det	4	SENT_274	[p15l8t742r140b802],
2	five-year	JJ	DURATION	five-year	amod	4	SENT_274	[p15l174t742r486b820],
3	survival	NN	O	survival	nn	4	SENT_274	[p15l520t742r793b802],
4	rate	NN	O	rate	nsubj	16	SENT_274	[p15l825t751r953b802],
5	of	IN	O	of	_	0	SENT_274	[p15l988t742r1062b803],
6	the	DT	O	the	det	7	SENT_274	[p15l1089t742r1192b802],
7	patients	NNS	O	patient	prep_of	4	SENT_274	[p15l1225t742r1491b820],
8	with	IN	O	with	_	0	SENT_274	[p15l1526t742r1678b802],
9	an	DT	O	a	det	13	SENT_274	[p15l1712t761r1790b802],
10	increased	VBN	O	increase	amod	13	SENT_274	[p15l1823t742r2148b802],
11	ErbB2	NN	O	erbb2	nn	13	SENT_274	[p15l8t845r239b905],
12	copy	NN	O	copy	nn	13	SENT_274	[p15l277t864r448b923],
13	number	NN	O	number	prep_with	7	SENT_274	[p15l486t845r760b905],
14	was	VBD	O	be	cop	16	SENT_274	[p15l795t864r929b905],
15	63.5	CD	PERCENT	63.5	num	16	SENT_274	[p15l970t845r1193b906],
16	%	NN	PERCENT	%	_	0	SENT_274	[p15l970t845r1193b906],
17	vs	CC	O	vs	_	0	SENT_274	[p15l1234t864r1309b905],
18	55.1	CD	PERCENT	55.1	num	19	SENT_274	[p15l1349t845r1573b906],
19	%	NN	PERCENT	%	conj_vs	16	SENT_274	[p15l1349t845r1573b906],
20	of	IN	O	of	_	0	SENT_274	[p15l1615t845r1691b906],
21	the	DT	O	the	det	22	SENT_274	[p15l1722t845r1829b905],
22	patients	NNS	O	patient	prep_of	19	SENT_274	[p15l1866t845r2146b923],
23	without	IN	O	without	_	0	SENT_274	[p15l9t948r272b1009],
24	an	DT	O	a	det	28	SENT_274	[p15l299t967r376b1008],
25	increased	VBN	O	increase	amod	28	SENT_274	[p15l403t948r728b1008],
26	ErbB2	NN	O	erbb2	nn	28	SENT_274	[p15l753t948r977b1008],
27	copy	NN	O	copy	nn	28	SENT_274	[p15l1004t967r1169b1026],
28	number	NN	O	number	prep_without	16	SENT_274	[p15l1196t948r1478b1008],
29	.	.	O	.	_	0	SENT_274	[p15l1196t948r1478b1008],

1	The	DT	O	the	det	2	SENT_275	[p15l1506t948r1637b1008],
2	difference	NN	O	difference	nsubj	5	SENT_275	[p15l1665t948r2013b1008],
3	did	VBD	O	do	aux	5	SENT_275	[p15l2040t948r2149b1008],
4	not	RB	O	not	neg	5	SENT_275	[p15l8t1060r118b1112],
5	reach	VB	O	reach	_	0	SENT_275	[p15l140t1051r326b1111],
6	statistical	JJ	O	statistical	amod	10	SENT_275	[p15l353t1051r675b1111],
7	significance	NN	O	significance	nn	10	SENT_275	[p15l702t1051r1115b1129],
8	(	CD	NUMBER	(	num	10	SENT_275	[p15l1142t1051r1461b1129],
9	log-rank	NN	O	log-rank	nn	10	SENT_275	[p15l1142t1051r1461b1129],
10	p	NN	O	p	nsubj	14	SENT_275	[p15l1483t1052r1615b1129],
11	=	JJ	O	=	amod	14	SENT_275	[p15l1483t1052r1615b1129],
12	o	NN	O	o	nn	14	SENT_275	[p15l1483t1052r1615b1129],
13	.4133	CD	NUMBER	.4133	num	14	SENT_275	[p15l1627t1051r1861b1126],
14	)	NN	O	)	xcomp	5	SENT_275	[p15l1627t1051r1861b1126],
15	.	.	O	.	_	0	SENT_275	[p15l1627t1051r1861b1126],

1	Relationships	NNPS	O	Relationships	_	0	SENT_276	[p15l6t1253r488b1330],
2	among	IN	O	among	_	0	SENT_276	[p15l524t1274r760b1330],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_276	[p15l795t1254r1018b1314],
4	copy	NN	O	copy	nn	5	SENT_276	[p15l1056t1274r1218b1330],
5	number	NN	O	number	prep_among	1	SENT_276	[p15l1255t1253r1541b1324],
6	,	,	O	,	_	0	SENT_276	[p15l1255t1253r1541b1324],
7	the	DT	O	the	det	10	SENT_276	[p15l1581t1253r1683b1313],
8	ErbB2	NN	O	erbb2	nn	10	SENT_276	[p15l1719t1253r1945b1313],
9	copy	NN	O	copy	nn	10	SENT_276	[p15l1985t1274r2148b1330],
10	number	NN	O	number	prep_among	1	SENT_276	[p15l9t1356r295b1416],
11	and	CC	O	and	_	0	SENT_276	[p15l332t1356r473b1416],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_276	[p15l507t1357r741b1417],
13	mutation	NN	O	mutation	prep_among	1	SENT_276	[p15l780t1358r1142b1416],
14	.	.	O	.	_	0	SENT_276	[p15l780t1358r1142b1416],

1	In	IN	O	in	_	0	SENT_277	[p15l1183t1357r1258b1415],
2	the	DT	O	the	det	4	SENT_277	[p15l1297t1356r1408b1416],
3	59	CD	NUMBER	59	num	4	SENT_277	[p15l1450t1356r1535b1417],
4	gefitinib-na	NN	O	gefitinib-na	pobj	1	SENT_277	[p15l1578t1356r2147b1434],
5	'	''	O	'	_	0	SENT_277	[p15l1578t1356r2147b1434],
6	1	CD	NUMBER	1	nsubj	7	SENT_277	[p15l1578t1356r2147b1434],
7	've	VBP	O	have	rcmod	4	SENT_277	[p15l1578t1356r2147b1434],

1	ONCOLOGY	NNP	O	ONCOLOGY	nn	2	SENT_278	[p15l708t1509r894b1533],
2	REPORTS	NNS	O	report	_	0	SENT_278	[p15l903t1509r1047b1533],
3	16	CD	NUMBER	16	num	5	SENT_278	[p15l1069t1509r1105b1533],
4	:	:	O	:	_	0	SENT_278	[p15l1069t1509r1105b1533],
5	533-541	CD	NUMBER	533-541	dep	2	SENT_278	[p15l1126t1509r1244b1537],
6	,	,	O	,	_	0	SENT_278	[p15l1126t1509r1244b1537],
7	2006	CD	DATE	2006	num	8	SENT_278	[p15l1262t1509r1327b1533],
8	539	CD	NUMBER	539	appos	5	SENT_278	[p15l2029t1514r2095b1545],

1	08	CD	NUMBER	08	num	4	SENT_279	[p15l408t1753r452b1780],
2	j	NN	O	j	nn	4	SENT_279	[p15l1345t1761r1429b1768],
3	ErbB2	NN	O	erbb2	nn	4	SENT_279	[p15l1455t1750r1552b1776],
4	copy	NN	O	copy	_	0	SENT_279	[p15l1563t1759r1633b1785],
5	number	NN	O	number	dep	4	SENT_279	[p15l1644t1752r1756b1778],
6	2	CD	NUMBER	2	num	5	SENT_279	[p15l1767t1758r1786b1779],
7	3	CD	NUMBER	3	number	8	SENT_279	[p15l1796t1753r1811b1779],
8	-----	CD	NUMBER	-----	dep	5	SENT_279	[p15l1345t1832r1402b1838],
9	--	:	O	--	_	0	SENT_279	[p15l1407t1832r1426b1839],
10	ErbB2	NN	O	erbb2	nn	12	SENT_279	[p15l1455t1817r1551b1843],
11	copy	NN	O	copy	nn	12	SENT_279	[p15l1562t1826r1632b1852],
12	number	NN	O	number	dep	5	SENT_279	[p15l1643t1819r1755b1845],
13	<	JJR	O	<	dep	12	SENT_279	[p15l1766t1824r1783b1840],
14	3	CD	NUMBER	3	dep	4	SENT_279	[p15l1796t1820r1810b1845],

1	...	:	O	...	_	0	SENT_280	[p15l684t1830r844b1887],
2	:	:	O	:	_	0	SENT_280	[p15l684t1830r844b1887],
3	m	NN	O	m	nn	5	SENT_280	[p15l684t1830r844b1887],
4	¢	CD	NUMBER	¢	num	5	SENT_280	[p15l684t1830r844b1887],
5	DO	NN	O	do	dep	1	SENT_280	[p15l684t1830r844b1887],

1	O	NN	O	o	_	0	SENT_281	[p15l845t1870r877b1899],
2	.	.	O	.	_	0	SENT_281	[p15l980t1893r988b1900],

1	o	NN	O	o	nn	3	SENT_282	[p15l878t1883r979b1913],
2	%	NN	O	%	nn	3	SENT_282	[p15l878t1883r979b1913],
3	O	NN	O	o	_	0	SENT_282	[p15l1231t1928r1269b1957],
4	Five-year	JJ	DURATION	five-year	amod	6	SENT_282	[p15l1342t1908r1484b1942],
5	survival	NN	O	survival	nn	6	SENT_282	[p15l1495t1910r1613b1936],
6	rate	NN	O	rate	dep	3	SENT_282	[p15l1623t1914r1678b1936],

1	0.4	CD	NUMBER	0.4	num	3	SENT_283	[p15l406t1971r451b1997],
2	ErbB2	NN	O	erbb2	nn	3	SENT_283	[p15l1341t1975r1438b2001],
3	copy	NN	O	copy	dep	6	SENT_283	[p15l1449t1983r1519b2010],
4	number	NN	O	number	npadvmod	6	SENT_283	[p15l1530t1976r1643b2002],
5	_	CD	NUMBER	_	num	4	SENT_283	[p15l1653t1982r1673b2004],
6	>	JJR	O	>	_	0	SENT_283	[p15l1653t1982r1673b2004],
7	.	.	O	.	_	0	SENT_283	[p15l1653t1982r1673b2004],

1	3	CD	NUMBER	3	_	0	SENT_284	[p15l1683t1977r1698b2003],
2	:	:	O	:	_	0	SENT_284	[p15l1712t1985r1717b2002],
3	63.5	CD	PERCENT	63.5	dep	4	SENT_284	[p15l1730t1976r1819b2004],
4	%	NN	PERCENT	%	advmod	7	SENT_284	[p15l1730t1976r1819b2004],
5	ErbB2	NN	O	erbb2	nn	7	SENT_284	[p15l1341t2042r1437b2068],
6	copy	NN	O	copy	nn	7	SENT_284	[p15l1449t2050r1519b2076],
7	number	NN	O	number	dep	1	SENT_284	[p15l1530t2043r1642b2069],
8	<	JJR	O	<	amod	7	SENT_284	[p15l1653t2049r1670b2064],
9	3	CD	NUMBER	3	dep	8	SENT_284	[p15l1683t2043r1698b2069],
10	:	:	O	:	_	0	SENT_284	[p15l1712t2051r1716b2069],
11	55.1	CD	PERCENT	55.1	number	12	SENT_284	[p15l1729t2043r1819b2071],
12	%	NN	PERCENT	%	amod	13	SENT_284	[p15l1729t2043r1819b2071],
13	log	NN	O	log	dep	7	SENT_284	[p15l1340t2110r1473b2143],
14	—	CD	NUMBER	—	num	15	SENT_284	[p15l1340t2110r1473b2143],
15	rank	NN	O	rank	dep	13	SENT_284	[p15l1340t2110r1473b2143],
16	:	:	O	:	_	0	SENT_284	[p15l1340t2110r1473b2143],
17	p	NN	O	p	dep	7	SENT_284	[p15l1486t2110r1625b2143],
18	=	JJ	O	=	amod	20	SENT_284	[p15l1486t2110r1625b2143],
19	0.4	CD	NUMBER	0.4	tmod	18	SENT_284	[p15l1486t2110r1625b2143],
20	l33	NN	O	l33	dep	17	SENT_284	[p15l1486t2110r1625b2143],

1	Survival	NN	O	survival	nn	2	SENT_285	[p15l336t1898r362b2021],
2	rate	NN	O	rate	_	0	SENT_285	[p15l341t1832r363b1888],

1	Survival	NN	O	survival	nn	2	SENT_286	[p15l782t2335r906b2361],
2	time	NN	O	time	_	0	SENT_286	[p15l916t2335r981b2362],
3	(	CD	NUMBER	(	num	4	SENT_286	[p15l992t2335r1081b2369],
4	days	NNS	NUMBER	day	dep	2	SENT_286	[p15l992t2335r1081b2369],
5	)	IN	O	)	amod	4	SENT_286	[p15l992t2335r1081b2369],

1	Figure	NNP	O	Figure	_	0	SENT_287	[p15l21t2381r107b2412],
2	4	CD	NUMBER	4	dep	1	SENT_287	[p15l117t2381r141b2405],
3	.	.	O	.	_	0	SENT_287	[p15l117t2381r141b2405],

1	Kap1an	NN	O	kap1an	_	0	SENT_288	[p15l151t2381r338b2412],
2	.	.	O	.	_	0	SENT_288	[p15l151t2381r338b2412],

1	—	NN	O	—	_	0	SENT_289	[p15l151t2381r338b2412],
2	.	.	O	.	_	0	SENT_289	[p15l151t2381r338b2412],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_290	[p15l151t2381r338b2412],
2	curves	NNS	O	curve	nsubj	19	SENT_290	[p15l347t2389r432b2405],
3	of	IN	O	of	_	0	SENT_290	[p15l442t2381r471b2405],
4	overall	JJ	O	overall	amod	5	SENT_290	[p15l479t2381r570b2405],
5	survival	NN	O	survival	prep_of	2	SENT_290	[p15l581t2381r686b2405],
6	according	VBG	O	accord	_	0	SENT_290	[p15l696t2381r826b2412],
7	to	TO	O	to	prepc_according_to	19	SENT_290	[p15l836t2385r860b2405],
8	the	DT	O	the	det	11	SENT_290	[p15l870t2381r910b2405],
9	ErbB2	NN	O	erbb2	nn	11	SENT_290	[p15l920t2381r1006b2405],
10	copy	NN	O	copy	nn	11	SENT_290	[p15l1016t2389r1079b2412],
11	number	NN	O	number	pobj	19	SENT_290	[p15l1089t2381r1191b2405],
12	in	IN	O	in	_	0	SENT_290	[p15l1200t2381r1224b2405],
13	59	CD	NUMBER	59	num	14	SENT_290	[p15l1235t2381r1266b2405],
14	gefitir1ib	NN	O	gefitir1ib	prep_in	11	SENT_290	[p15l1276t2381r1471b2412],
15	—	CD	NUMBER	—	dep	14	SENT_290	[p15l1276t2381r1471b2412],
16	na	TO	O	na	infmod	15	SENT_290	[p15l1276t2381r1471b2412],
17	'	''	O	'	_	0	SENT_290	[p15l1276t2381r1471b2412],
18	1	CD	NUMBER	1	dep	16	SENT_290	[p15l1276t2381r1471b2412],
19	've	VBP	O	have	_	0	SENT_290	[p15l1276t2381r1471b2412],
20	NSCLC	NN	O	nsclc	nn	21	SENT_290	[p15l1481t2381r1587b2405],
21	patients	NNS	O	patient	dobj	19	SENT_290	[p15l1597t2381r1708b2412],
22	.	.	O	.	_	0	SENT_290	[p15l1597t2381r1708b2412],

1	Survival	NN	O	survival	nn	2	SENT_291	[p15l1719t2381r1830b2405],
2	time	NN	O	time	nsubjpass	4	SENT_291	[p15l1840t2381r1898b2405],
3	was	VBD	O	be	auxpass	4	SENT_291	[p15l1908t2388r1958b2405],
4	calculated	VBN	O	calculate	_	0	SENT_291	[p15l1968t2381r2102b2405],
5	as	IN	O	as	_	0	SENT_291	[p15l2112t2388r2138b2405],
6	the	DT	O	the	det	7	SENT_291	[p15l21t2421r61b2445],
7	time	NN	O	time	prep_as	4	SENT_291	[p15l73t2421r130b2445],
8	from	IN	O	from	_	0	SENT_291	[p15l142t2421r206b2445],
9	operation	NN	O	operation	prep_from	7	SENT_291	[p15l217t2421r342b2452],
10	to	TO	O	to	_	0	SENT_291	[p15l354t2425r378b2445],
11	death	NN	O	death	prep_to	4	SENT_291	[p15l390t2421r461b2445],
12	from	IN	O	from	_	0	SENT_291	[p15l472t2421r536b2445],
13	any	DT	O	any	det	14	SENT_291	[p15l548t2429r594b2452],
14	cause	NN	O	cause	prep_from	4	SENT_291	[p15l606t2428r679b2445],
15	or	CC	O	or	_	0	SENT_291	[p15l690t2429r718b2445],
16	last	JJ	O	last	amod	17	SENT_291	[p15l728t2421r774b2445],
17	contact	NN	O	contact	prep_from	4	SENT_291	[p15l785t2425r888b2445],
18	.	.	O	.	_	0	SENT_291	[p15l785t2425r888b2445],

1	Five	CD	NUMBER	five	number	2	SENT_292	[p15l900t2421r1027b2452],
2	—	CD	NUMBER	—	dep	3	SENT_292	[p15l900t2421r1027b2452],
3	year	NN	NUMBER	year	dep	5	SENT_292	[p15l900t2421r1027b2452],
4	survival	NN	O	survival	nn	5	SENT_292	[p15l1039t2421r1144b2445],
5	rate	NN	O	rate	nsubj	18	SENT_292	[p15l1155t2425r1204b2445],
6	of	IN	O	of	_	0	SENT_292	[p15l1216t2421r1245b2445],
7	the	DT	O	the	det	8	SENT_292	[p15l1254t2421r1294b2445],
8	patients	NNS	O	patient	prep_of	5	SENT_292	[p15l1305t2421r1407b2452],
9	with	IN	O	with	_	0	SENT_292	[p15l1419t2421r1477b2445],
10	an	DT	O	a	det	14	SENT_292	[p15l1489t2428r1519b2445],
11	increased	VBN	O	increase	amod	14	SENT_292	[p15l1531t2421r1656b2445],
12	ErbB2	NN	O	erbb2	nn	14	SENT_292	[p15l1666t2421r1752b2445],
13	copy	NN	O	copy	nn	14	SENT_292	[p15l1764t2429r1828b2452],
14	number	NN	O	number	prep_with	8	SENT_292	[p15l1839t2421r1941b2445],
15	was	VBD	O	be	cop	18	SENT_292	[p15l1952t2428r2001b2445],
16	63	CD	PERCENT	63	num	18	SENT_292	[p15l2014t2421r2044b2445],
17	.5	CD	PERCENT	.5	num	18	SENT_292	[p15l2050t2421r2097b2445],
18	%	NN	PERCENT	%	_	0	SENT_292	[p15l2050t2421r2097b2445],
19	vs	CC	O	vs	_	0	SENT_292	[p15l2110t2429r2138b2445],
20	55.1	CD	PERCENT	55.1	num	21	SENT_292	[p15l22t2461r105b2485],
21	%	NN	PERCENT	%	conj_vs	18	SENT_292	[p15l22t2461r105b2485],
22	of	IN	O	of	_	0	SENT_292	[p15l116t2461r145b2485],
23	the	DT	O	the	det	24	SENT_292	[p15l152t2461r191b2485],
24	patients	NNS	O	patient	prep_of	21	SENT_292	[p15l201t2461r303b2492],
25	Without	IN	O	without	_	0	SENT_292	[p15l313t2461r414b2485],
26	an	DT	O	a	det	30	SENT_292	[p15l424t2468r454b2485],
27	increased	VBN	O	increase	amod	30	SENT_292	[p15l463t2461r588b2485],
28	ErbB2	NN	O	erbb2	nn	30	SENT_292	[p15l597t2461r683b2485],
29	copy	NN	O	copy	nn	30	SENT_292	[p15l693t2469r756b2492],
30	number	NN	O	number	prep_without	18	SENT_292	[p15l766t2461r874b2485],
31	.	.	O	.	_	0	SENT_292	[p15l766t2461r874b2485],

1	The	DT	O	the	det	2	SENT_293	[p15l884t2461r935b2485],
2	difference	NN	O	difference	nsubj	5	SENT_293	[p15l945t2461r1078b2485],
3	did	VBD	O	do	aux	5	SENT_293	[p15l1088t2461r1130b2485],
4	not	RB	O	not	neg	5	SENT_293	[p15l1139t2465r1181b2485],
5	reach	VB	O	reach	_	0	SENT_293	[p15l1189t2461r1261b2485],
6	statistical	JJ	O	statistical	amod	12	SENT_293	[p15l1271t2461r1395b2485],
7	significance	NN	O	significance	nn	12	SENT_293	[p15l1406t2461r1564b2492],
8	(	NN	O	(	nn	12	SENT_293	[p15l1575t2461r1697b2492],
9	log	NN	O	log	nn	12	SENT_293	[p15l1575t2461r1697b2492],
10	—	CD	NUMBER	—	num	12	SENT_293	[p15l1575t2461r1697b2492],
11	rank	NN	O	rank	nn	12	SENT_293	[p15l1575t2461r1697b2492],
12	p	NN	O	p	dobj	5	SENT_293	[p15l1706t2461r1757b2492],
13	=	JJ	O	=	amod	14	SENT_293	[p15l1706t2461r1757b2492],
14	o	NN	O	o	dep	12	SENT_293	[p15l1706t2461r1757b2492],
15	.4133	CD	NUMBER	.4133	num	16	SENT_293	[p15l1761t2461r1851b2490],
16	)	NN	O	)	dep	14	SENT_293	[p15l1761t2461r1851b2490],
17	.	.	O	.	_	0	SENT_293	[p15l1761t2461r1851b2490],

1	NSCLC	NN	ORGANIZATION	nsclc	nn	2	SENT_294	[p15l6t2649r282b2709],
2	patients	NNS	O	patient	nsubjpass	8	SENT_294	[p15l312t2649r604b2727],
3	,	,	O	,	_	0	SENT_294	[p15l312t2649r604b2727],
4	16	CD	NUMBER	16	num	6	SENT_294	[p15l640t2648r715b2709],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_294	[p15l745t2649r966b2709],
6	mutations	NNS	O	mutation	appos	2	SENT_294	[p15l995t2649r1332b2709],
7	were	VBD	O	be	auxpass	8	SENT_294	[p15l1364t2668r1529b2709],
8	detected	VBN	O	detect	_	0	SENT_294	[p15l1560t2649r1867b2709],
9	.	.	O	.	_	0	SENT_294	[p15l1560t2649r1867b2709],

1	Five	CD	NUMBER	five	nsubjpass	7	SENT_295	[p15l1897t2649r2049b2709],
2	of	IN	O	of	_	0	SENT_295	[p15l2080t2649r2154b2709],
3	the	DT	O	the	det	5	SENT_295	[p15l7t2752r111b2812],
4	59	CD	NUMBER	59	num	5	SENT_295	[p15l149t2752r231b2813],
5	cases	NNS	O	case	prep_of	1	SENT_295	[p15l270t2771r452b2812],
6	were	VBD	O	be	auxpass	7	SENT_295	[p15l490t2771r658b2812],
7	found	VBN	O	find	_	0	SENT_295	[p15l695t2752r899b2812],
8	to	TO	O	to	aux	9	SENT_295	[p15l934t2761r999b2812],
9	have	VB	O	have	xcomp	7	SENT_295	[p15l1036t2752r1200b2812],
10	an	DT	O	a	det	14	SENT_295	[p15l1238t2771r1317b2812],
11	increased	VBN	O	increase	amod	14	SENT_295	[p15l1353t2752r1686b2812],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_295	[p15l1721t2752r1944b2812],
13	copy	NN	O	copy	nn	14	SENT_295	[p15l1980t2771r2148b2830],
14	number	NN	O	number	dobj	9	SENT_295	[p15l7t2855r271b2916],
15	and	CC	O	and	_	0	SENT_295	[p15l296t2855r418b2915],
16	nine	CD	NUMBER	nine	nsubjpass	21	SENT_295	[p15l442t2855r589b2916],
17	of	IN	O	of	_	0	SENT_295	[p15l616t2855r691b2916],
18	59	CD	NUMBER	59	num	19	SENT_295	[p15l711t2854r792b2917],
19	cases	NNS	O	case	prep_of	16	SENT_295	[p15l820t2874r998b2916],
20	were	VBD	O	be	auxpass	21	SENT_295	[p15l1025t2874r1191b2916],
21	found	VBN	O	find	conj_and	7	SENT_295	[p15l1217t2855r1418b2916],
22	to	TO	O	to	aux	23	SENT_295	[p15l1441t2863r1506b2916],
23	have	VB	O	have	xcomp	21	SENT_295	[p15l1531t2855r1693b2916],
24	an	DT	O	a	det	28	SENT_295	[p15l1721t2874r1798b2915],
25	increased	VBN	O	increase	amod	28	SENT_295	[p15l1824t2855r2149b2916],
26	ErbB2	NN	O	erbb2	nn	28	SENT_295	[p15l6t2959r230b3019],
27	copy	NN	O	copy	nn	28	SENT_295	[p15l260t2978r425b3037],
28	number	NN	O	number	dobj	23	SENT_295	[p15l455t2959r738b3019],
29	.	.	O	.	_	0	SENT_295	[p15l455t2959r738b3019],

1	Only	RB	O	only	advmod	3	SENT_296	[p15l769t2959r939b3037],
2	one	CD	NUMBER	one	num	3	SENT_296	[p15l969t2978r1090b3019],
3	patient	NN	O	patient	nsubj	4	SENT_296	[p15l1119t2959r1355b3037],
4	had	VBD	O	have	_	0	SENT_296	[p15l1382t2959r1506b3019],
5	both	CC	O	both	advmod	4	SENT_296	[p15l1533t2959r1687b3019],
6	an	DT	O	a	det	10	SENT_296	[p15l1717t2978r1795b3019],
7	increased	VBN	O	increase	amod	10	SENT_296	[p15l1824t2959r2150b3019],
8	ErbB2	NN	O	erbb2	nn	10	SENT_296	[p15l6t3062r247b3122],
9	copy	NN	O	copy	nn	10	SENT_296	[p15l287t3081r465b3140],
10	number	NN	O	number	dep	4	SENT_296	[p15l505t3062r791b3122],
11	and	CC	O	and	_	0	SENT_296	[p15l830t3062r960b3122],
12	an	DT	O	a	det	14	SENT_296	[p15l1001t3081r1083b3122],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_296	[p15l1121t3062r1354b3122],
14	mutation	NN	O	mutation	dep	4	SENT_296	[p15l1393t3062r1754b3122],
15	.	.	O	.	_	0	SENT_296	[p15l1393t3062r1754b3122],

1	Only	RB	O	only	advmod	3	SENT_297	[p15l1795t3061r1977b3140],
2	one	CD	NUMBER	one	num	3	SENT_297	[p15l2018t3081r2148b3122],
3	patient	NN	O	patient	nsubj	11	SENT_297	[p15l6t3165r242b3243],
4	had	VBD	O	have	_	0	SENT_297	[p15l266t3165r390b3225],
5	both	CC	O	both	preconj	4	SENT_297	[p15l414t3165r567b3225],
6	increased	VBD	O	increase	conj_and	4	SENT_297	[p15l593t3165r919b3225],
7	ErbB2	NN	O	erbb2	nn	9	SENT_297	[p15l943t3165r1168b3225],
8	copy	NN	O	copy	nn	9	SENT_297	[p15l1195t3184r1360b3243],
9	number	NN	O	number	dobj	6	SENT_297	[p15l1386t3165r1651b3225],
10	and	CC	O	and	_	0	SENT_297	[p15l1677t3165r1799b3225],
11	increased	VBD	O	increase	conj_and	4	SENT_297	[p15l1824t3165r2150b3225],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_297	[p15l6t3268r239b3328],
13	copy	NN	O	copy	nn	14	SENT_297	[p15l279t3287r457b3346],
14	number	NN	O	number	dobj	11	SENT_297	[p15l497t3268r806b3328],
15	.	.	O	.	_	0	SENT_297	[p15l497t3268r806b3328],

1	The	DT	O	the	det	4	SENT_298	[p15l847t3268r987b3328],
2	ErbB2	NN	O	erbb2	nn	4	SENT_298	[p15l1027t3268r1268b3328],
3	copy	NN	O	copy	nn	4	SENT_298	[p15l1309t3287r1487b3346],
4	number	NN	O	number	nsubj	5	SENT_298	[p15l1527t3268r1813b3328],
5	was	VBD	O	be	dep	8	SENT_298	[p15l1851t3287r1990b3328],
6	not	RB	O	not	neg	5	SENT_298	[p15l2031t3277r2150b3328],
7	significantly	RB	O	significantly	advmod	5	SENT_298	[p15l10t3370r437b3449],
8	correlated	VBD	O	correlate	_	0	SENT_298	[p15l472t3370r817b3431],
9	with	IN	O	with	_	0	SENT_298	[p15l849t3371r1001b3431],
10	the	DT	O	the	det	12	SENT_298	[p15l1034t3371r1137b3431],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_298	[p15l1170t3371r1390b3431],
12	mutation	NN	O	mutation	prep_with	8	SENT_298	[p15l1423t3371r1729b3431],
13	(	CD	NUMBER	(	num	14	SENT_298	[p15l1765t3371r1923b3449],
14	p	NN	O	p	dep	12	SENT_298	[p15l1765t3371r1923b3449],
15	=	JJ	O	=	amod	16	SENT_298	[p15l1765t3371r1923b3449],
16	o	NN	O	o	dep	12	SENT_298	[p15l1765t3371r1923b3449],
17	.4206	CD	NUMBER	.4206	number	18	SENT_298	[p15l1935t3370r2146b3445],
18	)	CD	NUMBER	)	dep	16	SENT_298	[p15l1935t3370r2146b3445],
19	or	CC	O	or	_	0	SENT_298	[p15l8t3493r78b3534],
20	the	DT	O	the	det	23	SENT_298	[p15l101t3474r204b3534],
21	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_298	[p15l228t3474r448b3534],
22	copy	NN	O	copy	nn	23	SENT_298	[p15l473t3493r637b3552],
23	number	NN	O	number	prep_with	8	SENT_298	[p15l662t3474r927b3534],
24	(	CD	NUMBER	(	num	25	SENT_298	[p15l952t3473r1356b3552],
25	p	NN	O	p	npadvmod	26	SENT_298	[p15l952t3473r1356b3552],
26	=	JJ	O	=	amod	23	SENT_298	[p15l952t3473r1356b3552],
27	0.5768	CD	NUMBER	0.5768	num	28	SENT_298	[p15l952t3473r1356b3552],
28	)	NN	O	)	nsubj	8	SENT_298	[p15l952t3473r1356b3552],
29	.	.	O	.	_	0	SENT_298	[p15l952t3473r1356b3552],

1	Discussion	NN	O	discussion	_	0	SENT_299	[p15l7t3681r395b3742],

1	In	IN	O	in	_	0	SENT_300	[p16l7t109r81b167],
2	our	PRP$	O	we	poss	3	SENT_300	[p16l122t127r245b168],
3	study	NN	O	study	prep_in	15	SENT_300	[p16l286t108r514b186],
4	,	,	O	,	_	0	SENT_300	[p16l286t108r514b186],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_300	[p16l552t108r786b168],
6	mutation	NN	O	mutation	nsubj	15	SENT_300	[p16l825t108r1191b179],
7	,	,	O	,	_	0	SENT_300	[p16l825t108r1191b179],
8	but	CC	O	but	_	0	SENT_300	[p16l1228t108r1348b168],
9	not	RB	O	not	_	0	SENT_300	[p16l1386t117r1505b168],
10	the	DT	O	the	det	13	SENT_300	[p16l1543t108r1656b168],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_300	[p16l1696t108r1929b168],
12	copy	NN	O	copy	nn	13	SENT_300	[p16l1969t127r2148b186],
13	number	NN	O	number	conj_negcc	6	SENT_300	[p16l7t211r306b282],
14	,	,	O	,	_	0	SENT_300	[p16l7t211r306b282],
15	correlated	VBD	O	correlate	_	0	SENT_300	[p16l343t211r709b271],
16	with	IN	O	with	_	0	SENT_300	[p16l746t211r905b271],
17	survival	NN	O	survival	prep_with	15	SENT_300	[p16l945t210r1236b271],
18	of	IN	O	of	_	0	SENT_300	[p16l1275t211r1352b271],
19	patients	NNS	O	patient	prep_of	17	SENT_300	[p16l1382t211r1665b289],
20	treated	VBN	O	treat	partmod	19	SENT_300	[p16l1704t211r1953b271],
21	with	IN	O	with	_	0	SENT_300	[p16l1990t211r2149b271],
22	gefitinib	NN	O	gefitinib	prep_with	20	SENT_300	[p16l8t314r319b392],
23	.	.	O	.	_	0	SENT_300	[p16l8t314r319b392],

1	Gefitinib	NN	O	gefitinib	nsubj	2	SENT_301	[p16l354t314r654b374],
2	showed	VBD	O	show	_	0	SENT_301	[p16l689t314r945b374],
3	a	DT	O	a	det	5	SENT_301	[p16l977t333r1012b374],
4	promising	JJ	O	promising	amod	5	SENT_301	[p16l1041t314r1382b392],
5	effect	NN	O	effect	dobj	2	SENT_301	[p16l1414t314r1605b374],
6	on	IN	O	on	_	0	SENT_301	[p16l1635t333r1718b374],
7	a	DT	O	a	det	9	SENT_301	[p16l1751t333r1786b374],
8	few	JJ	O	few	amod	9	SENT_301	[p16l1816t314r1940b374],
9	types	NNS	O	type	prep_on	5	SENT_301	[p16l1972t323r2147b392],
10	of	IN	O	of	_	0	SENT_301	[p16l8t417r82b477],
11	cancer	NN	O	cancer	prep_of	9	SENT_301	[p16l111t436r337b477],
12	in	IN	O	in	_	0	SENT_301	[p16l371t417r437b476],
13	a	DT	O	a	det	14	SENT_301	[p16l475t436r510b477],
14	phase	NN	O	phase	prep_in	11	SENT_301	[p16l544t417r744b495],
15	I	PRP	O	I	dep	14	SENT_301	[p16l781t418r807b476],
16	trial	NN	O	trial	nn	17	SENT_301	[p16l843t416r985b477],
17	(	NN	O	(	tmod	2	SENT_301	[p16l1025t417r1145b491],
18	1	CD	NUMBER	1	num	19	SENT_301	[p16l1025t417r1145b491],
19	)	NN	O	)	dep	17	SENT_301	[p16l1025t417r1145b491],
20	.	.	O	.	_	0	SENT_301	[p16l1025t417r1145b491],

1	Subsequently	RB	O	subsequently	advmod	25	SENT_302	[p16l1185t416r1685b495],
2	,	,	O	,	_	0	SENT_302	[p16l1185t416r1685b495],
3	however	RB	O	however	advmod	25	SENT_302	[p16l1719t417r2047b488],
4	,	,	O	,	_	0	SENT_302	[p16l1719t417r2047b488],
5	in	IN	O	in	_	0	SENT_302	[p16l2083t417r2149b476],
6	phase	NN	O	phase	prep_in	25	SENT_302	[p16l6t520r208b598],
7	II	CD	NUMBER	ii	num	6	SENT_302	[p16l245t521r302b579],
8	randomized	VBN	O	randomize	partmod	6	SENT_302	[p16l338t520r761b580],
9	trials	NNS	O	trial	dobj	8	SENT_302	[p16l797t519r975b580],
10	in	IN	O	in	_	0	SENT_302	[p16l1014t520r1080b579],
11	which	WDT	O	which	rel	15	SENT_302	[p16l1117t520r1333b580],
12	the	DT	O	the	det	13	SENT_302	[p16l1369t520r1476b580],
13	drug	NN	O	drug	nsubjpass	15	SENT_302	[p16l1514t520r1674b598],
14	was	VBD	O	be	auxpass	15	SENT_302	[p16l1711t539r1845b580],
15	used	VBN	O	use	rcmod	9	SENT_302	[p16l1883t520r2046b580],
16	in	IN	O	in	_	0	SENT_302	[p16l2082t520r2149b579],
17	combination	NN	O	combination	prep_in	15	SENT_302	[p16l7t623r449b683],
18	with	IN	O	with	_	0	SENT_302	[p16l485t623r640b683],
19	traditional	JJ	O	traditional	amod	20	SENT_302	[p16l676t622r1040b683],
20	chemotherapy	NN	O	chemotherapy	prep_with	15	SENT_302	[p16l1077t623r1601b701],
21	,	,	O	,	_	0	SENT_302	[p16l1077t623r1601b701],
22	the	DT	O	the	det	23	SENT_302	[p16l1636t623r1741b683],
23	effect	NN	O	effect	nsubj	25	SENT_302	[p16l1778t623r1979b683],
24	was	VBD	O	be	cop	25	SENT_302	[p16l2014t642r2147b683],
25	marginal	JJ	O	marginal	_	0	SENT_302	[p16l7t725r312b804],
26	in	IN	O	in	_	0	SENT_302	[p16l345t726r410b785],
27	patients	NNS	O	patient	prep_in	25	SENT_302	[p16l441t726r707b804],
28	with	IN	O	with	_	0	SENT_302	[p16l742t726r894b786],
29	NSCLC	NN	O	nsclc	prep_with	25	SENT_302	[p16l925t726r1201b786],
30	(	CD	NUMBER	(	number	31	SENT_302	[p16l1237t726r1354b800],
31	7	CD	NUMBER	7	num	32	SENT_302	[p16l1237t726r1354b800],
32	)	NN	O	)	dep	25	SENT_302	[p16l1237t726r1354b800],
33	.	.	O	.	_	0	SENT_302	[p16l1237t726r1354b800],

1	Our	PRP$	O	we	poss	2	SENT_303	[p16l1388t726r1522b786],
2	group	NN	O	group	nsubj	6	SENT_303	[p16l1553t745r1751b804],
3	and	CC	O	and	_	0	SENT_303	[p16l1786t726r1908b786],
4	others	NNS	O	other	conj_and	2	SENT_303	[p16l1940t726r2147b786],
5	have	VBP	O	have	aux	6	SENT_303	[p16l6t829r170b889],
6	reported	VBN	O	report	_	0	SENT_303	[p16l206t829r500b907],
7	on	IN	O	on	_	0	SENT_303	[p16l536t848r620b889],
8	identification	NN	O	identification	prep_on	6	SENT_303	[p16l657t829r1128b889],
9	of	IN	O	of	_	0	SENT_303	[p16l1164t829r1240b889],
10	genetic	JJ	O	genetic	amod	11	SENT_303	[p16l1271t829r1522b907],
11	mutations	NNS	O	mutation	prep_of	8	SENT_303	[p16l1559t829r1904b889],
12	in	IN	O	in	_	0	SENT_303	[p16l1942t829r2008b888],
13	the	DT	O	the	det	16	SENT_303	[p16l2043t829r2148b889],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_303	[p16l6t932r229b993],
15	kinase	NN	O	kinase	nn	16	SENT_303	[p16l263t932r487b992],
16	domain	NN	O	domain	prep_in	6	SENT_303	[p16l524t932r785b993],
17	(	CD	NUMBER	(	number	18	SENT_303	[p16l824t932r1009b1006],
18	6,7	CD	NUMBER	6,7	num	19	SENT_303	[p16l824t932r1009b1006],
19	)	NN	O	)	dep	6	SENT_303	[p16l824t932r1009b1006],
20	.	.	O	.	_	0	SENT_303	[p16l824t932r1009b1006],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_304	[p16l1046t932r1268b993],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_304	[p16l1304t932r1616b993],
3	was	VBD	O	be	auxpass	4	SENT_304	[p16l1652t951r1783b992],
4	seen	VBN	O	see	_	0	SENT_304	[p16l1824t951r1976b992],
5	in	IN	O	in	_	0	SENT_304	[p16l2011t932r2077b991],
6	a	DT	O	a	det	7	SENT_304	[p16l2114t951r2150b992],
7	subset	NN	O	subset	prep_in	4	SENT_304	[p16l10t1035r225b1095],
8	of	IN	O	of	_	0	SENT_304	[p16l260t1035r335b1095],
9	NSCLC	NN	ORGANIZATION	nsclc	prep_of	7	SENT_304	[p16l364t1035r643b1095],
10	with	IN	O	with	_	0	SENT_304	[p16l680t1035r833b1095],
11	a	DT	O	a	det	13	SENT_304	[p16l870t1054r906b1095],
12	good	JJ	O	good	amod	13	SENT_304	[p16l941t1035r1113b1113],
13	response	NN	O	response	prep_with	4	SENT_304	[p16l1147t1054r1452b1113],
14	to	TO	O	to	_	0	SENT_304	[p16l1487t1044r1552b1095],
15	gefitinib	NN	O	gefitinib	prep_to	4	SENT_304	[p16l1590t1035r1905b1113],
16	.	.	O	.	_	0	SENT_304	[p16l1590t1035r1905b1113],

1	These	DT	O	these	det	2	SENT_305	[p16l1942t1035r2148b1095],
2	reports	NNS	O	report	nsubj	3	SENT_305	[p16l6t1147r244b1216],
3	triggered	VBD	O	trigger	_	0	SENT_305	[p16l281t1138r593b1216],
4	further	JJ	O	further	amod	5	SENT_305	[p16l628t1138r863b1198],
5	studies	NNS	O	study	dobj	3	SENT_305	[p16l900t1138r1133b1198],
6	on	IN	O	on	_	0	SENT_305	[p16l1172t1157r1255b1198],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_305	[p16l1290t1138r1510b1198],
8	mutation	NN	O	mutation	prep_on	3	SENT_305	[p16l1545t1138r1852b1198],
9	and	CC	O	and	_	0	SENT_305	[p16l1888t1138r2011b1198],
10	the	DT	O	the	det	11	SENT_305	[p16l2044t1138r2148b1198],
11	tumor	NN	O	tumor	poss	13	SENT_305	[p16l6t1241r275b1301],
12	's	POS	O	's	_	0	SENT_305	[p16l6t1241r275b1301],
13	response	NN	O	response	prep_on	3	SENT_305	[p16l314t1260r634b1319],
14	to	TO	O	to	_	0	SENT_305	[p16l672t1250r739b1301],
15	gefitinib	NN	O	gefitinib	prep_to	3	SENT_305	[p16l779t1241r1089b1319],
16	and	CC	O	and	_	0	SENT_305	[p16l1130t1241r1257b1301],
17	erlotinib	NN	O	erlotinib	conj_and	15	SENT_305	[p16l1294t1240r1606b1301],
18	(	CD	NUMBER	(	num	17	SENT_305	[p16l1647t1240r1849b1315],
19	6-8	CD	NUMBER	6-8	num	20	SENT_305	[p16l1647t1240r1849b1315],
20	)	NN	O	)	dep	17	SENT_305	[p16l1647t1240r1849b1315],
21	.	.	O	.	_	0	SENT_305	[p16l1647t1240r1849b1315],

1	All	PDT	O	all	predet	3	SENT_306	[p16l1888t1240r2002b1300],
2	the	DT	O	the	det	3	SENT_306	[p16l2039t1241r2148b1301],
3	groups	NNS	O	group	nsubj	4	SENT_306	[p16l8t1363r251b1422],
4	identified	VBD	O	identify	_	0	SENT_306	[p16l291t1344r644b1404],
5	recurrent	JJ	O	recurrent	amod	6	SENT_306	[p16l679t1353r1012b1404],
6	mutations	NNS	O	mutation	dobj	4	SENT_306	[p16l1048t1344r1406b1404],
7	in	IN	O	in	_	0	SENT_306	[p16l1446t1344r1513b1403],
8	the	DT	O	the	det	10	SENT_306	[p16l1550t1344r1658b1404],
9	same	JJ	O	same	amod	10	SENT_306	[p16l1700t1363r1879b1404],
10	region	NN	O	region	prep_in	4	SENT_306	[p16l1916t1344r2149b1422],
11	around	IN	O	around	_	0	SENT_306	[p16l9t1447r246b1507],
12	the	DT	O	the	det	16	SENT_306	[p16l274t1447r377b1507],
13	ATP	NN	O	atp	nn	16	SENT_306	[p16l406t1447r861b1525],
14	—	NN	O	—	nn	16	SENT_306	[p16l406t1447r861b1525],
15	binding	NN	O	binding	nn	16	SENT_306	[p16l406t1447r861b1525],
16	pocket	NN	O	pocket	prep_around	4	SENT_306	[p16l890t1447r1121b1525],
17	in	IN	O	in	_	0	SENT_306	[p16l1149t1447r1214b1506],
18	the	DT	O	the	det	22	SENT_306	[p16l1242t1447r1346b1507],
19	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_306	[p16l1375t1447r1595b1507],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_306	[p16l1623t1447r1900b1525],
21	kinase	NN	O	kinase	nn	22	SENT_306	[p16l1928t1447r2148b1507],
22	domain	NN	O	domain	prep_in	16	SENT_306	[p16l7t1550r285b1610],
23	.	.	O	.	_	0	SENT_306	[p16l7t1550r285b1610],

1	In	FW	O	in	nn	2	SENT_307	[p16l310t1552r382b1610],
2	vitro	FW	O	vitro	amod	3	SENT_307	[p16l409t1552r569b1610],
3	studies	NNS	O	study	nsubj	5	SENT_307	[p16l599t1550r833b1610],
4	have	VBP	O	have	aux	5	SENT_307	[p16l861t1550r1022b1610],
5	reported	VBN	O	report	_	0	SENT_307	[p16l1048t1550r1336b1628],
6	that	IN	O	that	complm	17	SENT_307	[p16l1361t1550r1491b1610],
7	the	DT	O	the	det	9	SENT_307	[p16l1515t1550r1619b1610],
8	kinase	NN	O	kinase	nn	9	SENT_307	[p16l1644t1550r1864b1610],
9	activity	NN	O	activity	nsubj	17	SENT_307	[p16l1893t1550r2148b1628],
10	of	IN	O	of	_	0	SENT_307	[p16l8t1653r85b1713],
11	EGFR	NN	ORGANIZATION	egfr	prep_of	9	SENT_307	[p16l117t1653r347b1713],
12	or	CC	O	or	_	0	SENT_307	[p16l385t1672r459b1713],
13	the	DT	O	the	det	14	SENT_307	[p16l495t1653r605b1713],
14	sensitivity	NN	O	sensitivity	nsubj	17	SENT_307	[p16l646t1653r1028b1731],
15	to	TO	O	to	_	0	SENT_307	[p16l1067t1662r1134b1713],
16	gefitinib	NN	O	gefitinib	prep_to	14	SENT_307	[p16l1175t1653r1488b1731],
17	showed	VBD	O	show	ccomp	5	SENT_307	[p16l1531t1653r1807b1713],
18	a	DT	O	a	det	20	SENT_307	[p16l1846t1672r1882b1713],
19	strong	JJ	O	strong	amod	20	SENT_307	[p16l1922t1662r2148b1731],
20	association	NN	O	association	dobj	17	SENT_307	[p16l9t1756r390b1816],
21	with	IN	O	with	_	0	SENT_307	[p16l422t1756r574b1816],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_307	[p16l605t1756r825b1816],
23	gene	NN	O	gene	nn	24	SENT_307	[p16l857t1775r1017b1834],
24	mutation	NN	O	mutation	prep_with	17	SENT_307	[p16l1049t1756r1355b1816],
25	(	CD	NUMBER	(	number	26	SENT_307	[p16l1389t1756r1571b1830],
26	7,9	CD	NUMBER	7,9	num	27	SENT_307	[p16l1389t1756r1571b1830],
27	)	NN	O	)	dep	17	SENT_307	[p16l1389t1756r1571b1830],
28	.	.	O	.	_	0	SENT_307	[p16l1389t1756r1571b1830],

1	In	IN	O	in	_	0	SENT_308	[p16l1603t1757r1674b1815],
2	our	PRP$	O	we	poss	3	SENT_308	[p16l1706t1775r1820b1816],
3	analysis	NN	O	analysis	prep_in	17	SENT_308	[p16l1852t1755r2150b1834],
4	,	,	O	,	_	0	SENT_308	[p16l1852t1755r2150b1834],
5	the	DT	O	the	det	7	SENT_308	[p16l6t1859r114b1919],
6	response	NN	O	response	nn	7	SENT_308	[p16l152t1878r470b1937],
7	rates	NNS	O	rate	nsubj	17	SENT_308	[p16l507t1868r678b1919],
8	of	IN	O	of	_	0	SENT_308	[p16l718t1859r795b1919],
9	patients	NNS	O	patient	prep_of	7	SENT_308	[p16l826t1859r1109b1937],
10	with	IN	O	with	_	0	SENT_308	[p16l1149t1859r1308b1919],
11	mutant	JJ	O	mutant	amod	14	SENT_308	[p16l1345t1867r1598b1919],
12	and	CC	O	and	_	0	SENT_308	[p16l1636t1859r1763b1919],
13	wild-type	JJ	O	wild-type	conj_and	11	SENT_308	[p16l1800t1858r2148b1937],
14	EGFR	NN	ORGANIZATION	egfr	prep_with	9	SENT_308	[p16l6t1962r227b2022],
15	were	VBD	O	be	cop	17	SENT_308	[p16l257t1981r422b2022],
16	81.8	CD	PERCENT	81.8	num	17	SENT_308	[p16l456t1962r670b2022],
17	%	NN	PERCENT	%	_	0	SENT_308	[p16l456t1962r670b2022],
18	and	CC	O	and	_	0	SENT_308	[p16l706t1962r828b2022],
19	18.2	CD	PERCENT	18.2	num	20	SENT_308	[p16l865t1962r1102b2033],
20	%	NN	PERCENT	%	conj_and	17	SENT_308	[p16l865t1962r1102b2033],
21	,	,	O	,	_	0	SENT_308	[p16l865t1962r1102b2033],
22	respectively	RB	O	respectively	advmod	24	SENT_308	[p16l1130t1961r1547b2040],
23	(	CD	NUMBER	(	num	24	SENT_308	[p16l1580t1962r1738b2040],
24	p	NN	O	p	rcmod	20	SENT_308	[p16l1580t1962r1738b2040],
25	=	JJ	O	=	amod	26	SENT_308	[p16l1580t1962r1738b2040],
26	o	NN	O	o	dep	24	SENT_308	[p16l1580t1962r1738b2040],
27	.0089	CD	NUMBER	.0089	num	28	SENT_308	[p16l1751t1962r1984b2036],
28	)	NN	O	)	dep	26	SENT_308	[p16l1751t1962r1984b2036],
29	.	.	O	.	_	0	SENT_308	[p16l1751t1962r1984b2036],

1	The	DT	O	the	det	2	SENT_309	[p16l2016t1962r2148b2022],
2	presence	NN	O	presence	nsubjpass	8	SENT_309	[p16l6t2084r307b2143],
3	of	IN	O	of	_	0	SENT_309	[p16l334t2065r408b2125],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_309	[p16l427t2065r648b2125],
5	mutation	NN	O	mutation	prep_of	2	SENT_309	[p16l672t2065r979b2125],
6	was	VBD	O	be	auxpass	8	SENT_309	[p16l1004t2084r1134b2125],
7	significantly	RB	O	significantly	advmod	8	SENT_309	[p16l1164t2065r1592b2143],
8	associated	VBN	O	associate	_	0	SENT_309	[p16l1619t2065r1973b2125],
9	with	IN	O	with	_	0	SENT_309	[p16l1997t2065r2149b2125],
10	a	DT	O	a	det	13	SENT_309	[p16l9t2187r44b2228],
11	higher	JJR	O	higher	amod	13	SENT_309	[p16l83t2168r331b2246],
12	response	NN	O	response	nn	13	SENT_309	[p16l368t2187r707b2246],
13	rate	NN	O	rate	prep_with	8	SENT_309	[p16l748t2177r918b2228],
14	.	.	O	.	_	0	SENT_309	[p16l748t2177r918b2228],

1	Nine	CD	TIME	nine	nsubj	28	SENT_310	[p16l959t2168r1141b2228],
2	of	IN	TIME	of	_	0	SENT_310	[p16l1183t2168r1263b2228],
3	11	CD	TIME	11	number	4	SENT_310	[p16l1306t2169r1380b2227],
4	(	CD	PERCENT	(	prep_of	1	SENT_310	[p16l1431t2168r1737b2242],
5	81.8	CD	PERCENT	81.8	num	6	SENT_310	[p16l1431t2168r1737b2242],
6	%	NN	PERCENT	%	dep	4	SENT_310	[p16l1431t2168r1737b2242],
7	)	CD	NUMBER	)	num	8	SENT_310	[p16l1431t2168r1737b2242],
8	gefitinibresponders	NNS	O	gefitinibresponder	nsubj	9	SENT_310	[p16l1781t2168r2146b2246, p16l6t2271r384b2349],
9	had	VBD	O	have	parataxis	28	SENT_310	[p16l422t2271r547b2331],
10	an	DT	O	a	det	12	SENT_310	[p16l584t2290r662b2331],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_310	[p16l698t2271r920b2331],
12	mutation	NN	O	mutation	iobj	9	SENT_310	[p16l955t2271r1266b2331],
13	and	CC	O	and	_	0	SENT_310	[p16l1304t2271r1427b2331],
14	only	RB	O	only	advmod	12	SENT_310	[p16l1463t2271r1615b2349],
15	two	CD	NUMBER	two	pobj	14	SENT_310	[p16l1652t2280r1780b2331],
16	of	IN	O	of	_	0	SENT_310	[p16l1817t2271r1893b2331],
17	the	DT	O	the	det	19	SENT_310	[p16l1923t2271r2027b2331],
18	11	CD	NUMBER	11	num	19	SENT_310	[p16l2072t2272r2141b2330],
19	(	NN	O	(	prep_of	14	SENT_310	[p16l9t2374r310b2448],
20	18.2	CD	PERCENT	18.2	num	21	SENT_310	[p16l9t2374r310b2448],
21	%	NN	PERCENT	%	iobj	9	SENT_310	[p16l9t2374r310b2448],
22	)	CD	NUMBER	)	num	23	SENT_310	[p16l9t2374r310b2448],
23	patients	NNS	O	patient	dobj	9	SENT_310	[p16l351t2374r648b2452],
24	with	IN	O	with	_	0	SENT_310	[p16l689t2374r855b2434],
25	wild-type	JJ	O	wild-type	amod	26	SENT_310	[p16l894t2373r1258b2452],
26	EGFR	NN	ORGANIZATION	egfr	prep_with	9	SENT_310	[p16l1298t2374r1531b2434],
27	were	VBD	O	be	cop	28	SENT_310	[p16l1570t2393r1749b2434],
28	gefitinibresponders	NNS	O	gefitinibresponder	_	0	SENT_310	[p16l1790t2374r2146b2452, p16l6t2477r401b2555],
29	.	.	O	.	_	0	SENT_310	[p16l1790t2374r2146b2452, p16l6t2477r401b2555],

1	The	DT	O	the	det	2	SENT_311	[p16l430t2477r562b2537],
2	presence	NN	O	presence	nsubj	11	SENT_311	[p16l590t2496r892b2555],
3	of	IN	O	of	_	0	SENT_311	[p16l922t2477r997b2537],
4	two	CD	NUMBER	two	num	6	SENT_311	[p16l1019t2485r1146b2537],
5	gefitinib-responding	JJ	O	gefitinib-responding	amod	6	SENT_311	[p16l1176t2477r1880b2555],
6	tumors	NNS	O	tumor	prep_of	2	SENT_311	[p16l1910t2486r2147b2537],
7	with	IN	O	with	_	0	SENT_311	[p16l7t2580r159b2640],
8	wild-type	JJ	O	wild-type	amod	9	SENT_311	[p16l188t2579r517b2658],
9	EGFR	NN	ORGANIZATION	egfr	prep_with	6	SENT_311	[p16l546t2580r767b2640],
10	may	MD	O	may	aux	11	SENT_311	[p16l795t2599r942b2658],
11	be	VB	O	be	_	0	SENT_311	[p16l971t2580r1050b2640],
12	because	IN	O	because	_	0	SENT_311	[p16l1079t2580r1352b2640],
13	i	FW	O	i	nn	14	SENT_311	[p16l1382t2580r1429b2654],
14	)	FW	O	)	prep_because	11	SENT_311	[p16l1382t2580r1429b2654],
15	the	DT	O	the	det	18	SENT_311	[p16l1461t2580r1564b2640],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_311	[p16l1593t2580r1814b2640],
17	mutation	NN	O	mutation	nn	18	SENT_311	[p16l1842t2580r2149b2640],
18	analysis	NN	O	analysis	nsubj	21	SENT_311	[p16l9t2682r292b2761],
19	was	VBD	O	be	cop	21	SENT_311	[p16l330t2702r463b2743],
20	not	RB	O	not	neg	21	SENT_311	[p16l501t2692r614b2743],
21	sensitive	JJ	O	sensitive	dep	11	SENT_311	[p16l652t2683r960b2743],
22	enough	RB	O	enough	advmod	21	SENT_311	[p16l998t2683r1281b2761],
23	,	,	O	,	_	0	SENT_311	[p16l998t2683r1281b2761],
24	ii	LS	O	ii	dep	21	SENT_311	[p16l1317t2683r1392b2757],
25	)	IN	O	)	mark	29	SENT_311	[p16l1317t2683r1392b2757],
26	the	DT	O	the	det	28	SENT_311	[p16l1430t2683r1536b2743],
27	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_311	[p16l1573t2683r1797b2743],
28	mutation	NN	O	mutation	nsubj	29	SENT_311	[p16l1833t2683r2149b2743],
29	occurred	VBD	O	occur	dep	21	SENT_311	[p16l8t2786r326b2846],
30	in	IN	O	in	_	0	SENT_311	[p16l363t2786r431b2845],
31	the	DT	O	the	det	32	SENT_311	[p16l467t2786r576b2846],
32	tumors	NNS	O	tumor	prep_in	29	SENT_311	[p16l614t2795r863b2846],
33	after	IN	O	after	_	0	SENT_311	[p16l905t2786r1071b2846],
34	the	DT	O	the	det	37	SENT_311	[p16l1106t2786r1214b2846],
35	primary	JJ	O	primary	amod	37	SENT_311	[p16l1252t2786r1539b2864],
36	surgery	NN	O	surgery	nn	37	SENT_311	[p16l1581t2805r1850b2864],
37	(	NN	O	(	prep_after	29	SENT_311	[p16l1890t2786r2148b2860],
38	whose	WP$	O	whose	poss	39	SENT_311	[p16l1890t2786r2148b2860],
39	sample	NN	O	sample	rel	41	SENT_311	[p16l11t2889r248b2967],
40	we	PRP	O	we	nsubj	41	SENT_311	[p16l274t2908r371b2949],
41	analyzed	VBD	O	analyze	rcmod	37	SENT_311	[p16l398t2888r718b2967],
42	)	CD	NUMBER	)	number	45	SENT_311	[p16l398t2888r718b2967],
43	or	CC	O	or	_	0	SENT_311	[p16l746t2908r816b2949],
44	iii	LS	O	iii	num	47	SENT_311	[p16l840t2889r932b2963],
45	)	CD	NUMBER	)	num	47	SENT_311	[p16l840t2889r932b2963],
46	other	JJ	O	other	amod	47	SENT_311	[p16l960t2889r1132b2949],
47	factors	NNS	O	factor	nsubj	52	SENT_311	[p16l1155t2889r1378b2949],
48	of	IN	O	of	_	0	SENT_311	[p16l1406t2889r1480b2949],
49	gefitinib	NN	O	gefitinib	nn	50	SENT_311	[p16l1500t2889r1779b2967],
50	sensitivity	NN	O	sensitivity	prep_of	47	SENT_311	[p16l1808t2889r2147b2967],
51	were	VBD	O	be	cop	52	SENT_311	[p16l9t3011r181b3052],
52	present	JJ	DATE	present	ccomp	41	SENT_311	[p16l218t3000r484b3070],
53	(	CD	NUMBER	(	number	54	SENT_311	[p16l522t2992r692b3066],
54	17	CD	NUMBER	17	num	55	SENT_311	[p16l522t2992r692b3066],
55	)	NN	O	)	dep	52	SENT_311	[p16l522t2992r692b3066],
56	.	.	O	.	_	0	SENT_311	[p16l522t2992r692b3066],

1	There	EX	O	there	expl	2	SENT_312	[p16l731t2992r940b3052],
2	was	VBD	O	be	conj_and	2	SENT_312	[p16l978t3011r1113b3052],
3	a	DT	O	a	det	6	SENT_312	[p16l1154t3011r1190b3052],
4	statistically	RB	O	statistically	advmod	5	SENT_312	[p16l1229t2991r1648b3070],
5	significantly	RB	O	significantly	amod	6	SENT_312	[p16l1689t2992r2147b3070],
6	correlation	NN	O	correlation	nsubj	2	SENT_312	[p16l9t3095r382b3155],
7	between	IN	O	between	_	0	SENT_312	[p16l412t3095r699b3155],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_312	[p16l730t3095r950b3155],
9	mutation	NN	O	mutation	prep_between	6	SENT_312	[p16l980t3095r1287b3155],
10	and	CC	O	and	_	0	SENT_312	[p16l1319t3095r1441b3155],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_312	[p16l1472t3095r1761b3173],
12	sensitivity	NN	O	sensitivity	prep_between	6	SENT_312	[p16l1797t3095r2147b3173],
13	or	CC	O	or	_	0	SENT_312	[p16l9t3217r80b3258],
14	overall	JJ	O	overall	amod	15	SENT_312	[p16l114t3197r353b3258],
15	survival	NN	O	survival	prep_between	6	SENT_312	[p16l391t3197r666b3258],
16	in	IN	O	in	_	0	SENT_312	[p16l703t3198r767b3257],
17	our	PRP$	O	we	poss	18	SENT_312	[p16l803t3217r918b3258],
18	analysis	NN	O	analysis	prep_in	2	SENT_312	[p16l953t3197r1227b3276],
19	and	CC	O	and	_	0	SENT_312	[p16l1267t3198r1389b3258],
20	from	IN	O	from	_	0	SENT_312	[p16l1424t3198r1591b3258],
21	the	DT	O	the	det	22	SENT_312	[p16l1624t3198r1728b3258],
22	analysis	NN	O	analysis	prep_from	2	SENT_312	[p16l1766t3197r2041b3276],
23	of	IN	O	of	_	0	SENT_312	[p16l2078t3198r2153b3258],
24	the	DT	O	the	det	26	SENT_312	[p16l8t3301r111b3361],
25	other	JJ	O	other	amod	26	SENT_312	[p16l139t3301r315b3361],
26	groups	NNS	O	group	prep_of	22	SENT_312	[p16l341t3320r571b3379],
27	(	VBP	O	(	_	0	SENT_312	[p16l602t3300r985b3375],
28	16,18	CD	NUMBER	16,18	num	29	SENT_312	[p16l602t3300r985b3375],
29	—	CD	NUMBER	—	dobj	27	SENT_312	[p16l602t3300r985b3375],
30	20	CD	NUMBER	20	num	31	SENT_312	[p16l602t3300r985b3375],
31	)	NN	O	)	nsubj	27	SENT_312	[p16l602t3300r985b3375],
32	.	.	O	.	_	0	SENT_312	[p16l602t3300r985b3375],

1	Thus	RB	O	thus	advmod	5	SENT_313	[p16l1013t3301r1206b3372],
2	,	,	O	,	_	0	SENT_313	[p16l1013t3301r1206b3372],
3	these	DT	O	these	det	4	SENT_313	[p16l1231t3301r1406b3361],
4	results	NNS	O	result	nsubj	5	SENT_313	[p16l1432t3301r1655b3361],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_313	[p16l1684t3301r2148b3361],
6	that	IN	O	that	complm	12	SENT_313	[p16l8t3404r139b3464],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_313	[p16l172t3404r394b3464],
8	mutation	NN	O	mutation	nsubj	12	SENT_313	[p16l429t3404r739b3464],
9	was	VBD	O	be	cop	12	SENT_313	[p16l775t3423r906b3464],
10	a	DT	O	a	det	12	SENT_313	[p16l945t3423r981b3464],
11	critical	JJ	O	critical	amod	12	SENT_313	[p16l1016t3403r1257b3464],
12	determinant	NN	O	determinant	ccomp	5	SENT_313	[p16l1294t3404r1712b3464],
13	of	IN	O	of	_	0	SENT_313	[p16l1746t3404r1822b3464],
14	gefitinib	NN	O	gefitinib	nn	15	SENT_313	[p16l1852t3404r2146b3482],
15	sensitivity	NN	O	sensitivity	prep_of	12	SENT_313	[p16l11t3507r387b3585],
16	,	,	O	,	_	0	SENT_313	[p16l11t3507r387b3585],
17	at	IN	O	at	advmod	12	SENT_313	[p16l423t3516r483b3567],
18	least	JJS	O	least	pobj	17	SENT_313	[p16l517t3506r676b3567],
19	in	IN	O	in	_	0	SENT_313	[p16l710t3507r775b3566],
20	the	DT	O	the	det	22	SENT_313	[p16l809t3507r913b3567],
21	Japanese	JJ	MISC	japanese	amod	22	SENT_313	[p16l948t3508r1255b3585],
22	population	NN	O	population	prep_in	17	SENT_313	[p16l1290t3506r1682b3585],
23	.	.	O	.	_	0	SENT_313	[p16l1290t3506r1682b3585],

1	One	CD	NUMBER	one	num	3	SENT_314	[p16l1719t3507r1860b3567],
2	EGFRmutant	NN	O	egfrmutant	nn	3	SENT_314	[p16l1896t3507r2145b3567, p16l8t3618r270b3670],
3	patient	NN	O	patient	nsubj	5	SENT_314	[p16l308t3610r571b3688],
4	was	VBD	O	be	cop	5	SENT_314	[p16l610t3629r750b3670],
5	resistant	JJ	O	resistant	_	0	SENT_314	[p16l791t3610r1115b3670],
6	to	TO	O	to	_	0	SENT_314	[p16l1154t3618r1223b3670],
7	gefitinib	NN	O	gefitinib	nn	8	SENT_314	[p16l1265t3610r1590b3688],
8	therapy	NN	O	therapy	prep_to	5	SENT_314	[p16l1632t3610r1941b3688],
9	.	.	O	.	_	0	SENT_314	[p16l1632t3610r1941b3688],

1	This	DT	O	this	det	2	SENT_315	[p16l1982t3610r2146b3670],
2	patient	NN	O	patient	nsubj	3	SENT_315	[p16l7t3713r243b3791],
3	had	VBD	O	have	_	0	SENT_315	[p16l271t3713r395b3773],
4	a	DT	O	a	det	6	SENT_315	[p16l425t3732r461b3773],
5	novel	JJ	O	novel	amod	6	SENT_315	[p16l489t3712r679b3773],
6	insertion	NN	O	insertion	dobj	3	SENT_315	[p16l709t3713r1010b3773],
7	at	IN	O	at	_	0	SENT_315	[p16l1041t3722r1101b3773],
8	exon	NN	O	exon	prep_at	6	SENT_315	[p16l1129t3732r1295b3773],
9	20	CD	NUMBER	20	number	10	SENT_315	[p16l1326t3713r1407b3773],
10	(	CD	NUMBER	(	num	12	SENT_315	[p16l1441t3713r1875b3787],
11	P772_H773	NN	O	p772_h773	nn	12	SENT_315	[p16l1441t3713r1875b3787],
12	ins	NNS	O	in	dep	8	SENT_315	[p16l1909t3713r2005b3773],
13	V	NN	O	v	nn	14	SENT_315	[p16l2037t3713r2146b3787],
14	)	NN	O	)	dep	12	SENT_315	[p16l2037t3713r2146b3787],
15	.	.	O	.	_	0	SENT_315	[p16l2037t3713r2146b3787],

1	Several	JJ	O	several	amod	3	SENT_316	[p17l11t19r265b80],
2	recent	JJ	O	recent	amod	3	SENT_316	[p17l297t28r509b80],
3	reports	NNS	O	report	nsubj	4	SENT_316	[p17l538t29r775b98],
4	show	VBP	O	show	_	0	SENT_316	[p17l813t20r989b80],
5	that	IN	O	that	complm	19	SENT_316	[p17l1022t20r1151b80],
6	exon	NN	O	exon	nsubjpass	19	SENT_316	[p17l1182t39r1348b80],
7	20	CD	NUMBER	20	num	8	SENT_316	[p17l1381t20r1462b80],
8	mutations	NNS	O	mutation	dep	6	SENT_316	[p17l1496t20r1858b91],
9	,	,	O	,	_	0	SENT_316	[p17l1496t20r1858b91],
10	such	JJ	O	such	_	0	SENT_316	[p17l1892t20r2046b80],
11	as	IN	O	as	_	0	SENT_316	[p17l2079t39r2145b80],
12	T79OM	NN	O	t79om	nn	15	SENT_316	[p17l8t123r285b184],
13	and	CC	O	and	_	0	SENT_316	[p17l327t123r459b183],
14	D770_N771	NN	O	d770_n771	nn	15	SENT_316	[p17l498t123r956b193],
15	ins	NNS	O	in	prep_such_as	16	SENT_316	[p17l1004t123r1110b183],
16	NPG	NNP	ORGANIZATION	NPG	rcmod	6	SENT_316	[p17l1151t123r1361b194],
17	,	,	O	,	_	0	SENT_316	[p17l1151t123r1361b194],
18	are	VBP	O	be	auxpass	19	SENT_316	[p17l1401t142r1512b183],
19	correlated	VBN	O	correlate	ccomp	4	SENT_316	[p17l1553t122r1942b184],
20	with	IN	O	with	_	0	SENT_316	[p17l1981t123r2148b183],
21	gefitinib	NN	O	gefitinib	nn	22	SENT_316	[p17l9t226r298b304],
22	resistance	NN	O	resistance	prep_with	19	SENT_316	[p17l323t226r662b286],
23	(	CD	NUMBER	(	number	24	SENT_316	[p17l690t226r958b300],
24	21,22	CD	NUMBER	21,22	num	25	SENT_316	[p17l690t226r958b300],
25	)	NN	O	)	dep	19	SENT_316	[p17l690t226r958b300],
26	.	.	O	.	_	0	SENT_316	[p17l690t226r958b300],

1	In	IN	O	in	_	0	SENT_317	[p17l130t330r200b388],
2	this	DT	O	this	det	3	SENT_317	[p17l235t329r358b389],
3	report	NN	O	report	prep_in	30	SENT_317	[p17l394t338r626b407],
4	,	,	O	,	_	0	SENT_317	[p17l394t338r626b407],
5	the	DT	O	the	det	7	SENT_317	[p17l660t329r764b389],
6	response	NN	O	response	nn	7	SENT_317	[p17l799t348r1104b407],
7	rates	NNS	O	rate	conj_and	7	SENT_317	[p17l1139t337r1301b389],
8	to	TO	O	to	_	0	SENT_317	[p17l1338t337r1403b389],
9	gefitinib	NN	O	gefitinib	prep_to	7	SENT_317	[p17l1441t329r1734b407],
10	of	IN	O	of	_	0	SENT_317	[p17l1772t329r1847b389],
11	patients	NNS	O	patient	prep_of	9	SENT_317	[p17l1875t329r2145b407],
12	with	IN	O	with	_	0	SENT_317	[p17l9t432r175b492],
13	an	DT	O	a	det	17	SENT_317	[p17l216t451r298b492],
14	increased	VBN	O	increase	amod	17	SENT_317	[p17l339t432r702b492],
15	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_317	[p17l740t432r975b492],
16	copy	NN	O	copy	nn	17	SENT_317	[p17l1015t451r1194b510],
17	number	NN	O	number	prep_with	11	SENT_317	[p17l1234t432r1523b492],
18	and	CC	O	and	_	0	SENT_317	[p17l1562t432r1693b492],
19	without	IN	O	without	_	0	SENT_317	[p17l1733t432r2025b492],
20	an	DT	O	a	det	24	SENT_317	[p17l2065t451r2148b492],
21	increased	VBN	O	increase	amod	24	SENT_317	[p17l9t535r384b595],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_317	[p17l423t535r661b595],
23	copy	NN	O	copy	nn	24	SENT_317	[p17l703t554r886b613],
24	number	NN	O	number	prep_without	7	SENT_317	[p17l927t535r1223b595],
25	were	VBD	O	be	cop	30	SENT_317	[p17l1262t554r1446b595],
26	25	CD	PERCENT	25	number	30	SENT_317	[p17l1489t534r1653b595],
27	%	NN	PERCENT	%	dep	30	SENT_317	[p17l1489t534r1653b595],
28	and	CC	O	and	_	0	SENT_317	[p17l1699t535r1833b595],
29	49.8	CD	PERCENT	49.8	conj_and	30	SENT_317	[p17l1873t535r2148b606],
30	%	NN	PERCENT	%	_	0	SENT_317	[p17l1873t535r2148b606],
31	,	,	O	,	_	0	SENT_317	[p17l1873t535r2148b606],
32	respectively	RB	O	respectively	advmod	30	SENT_317	[p17l7t638r459b716],
33	(	CD	NUMBER	(	num	36	SENT_317	[p17l500t638r936b716],
34	p	NN	O	p	nn	36	SENT_317	[p17l500t638r936b716],
35	=	JJ	O	=	amod	36	SENT_317	[p17l500t638r936b716],
36	O.	NNP	O	O.	attr	30	SENT_317	[p17l500t638r936b716],
37	285l	NN	O	285l	nn	38	SENT_317	[p17l500t638r936b716],
38	)	NN	O	)	dep	36	SENT_317	[p17l500t638r936b716],
39	.	.	O	.	_	0	SENT_317	[p17l500t638r936b716],

1	One	CD	TIME	one	nsubj	21	SENT_318	[p17l976t638r1122b698],
2	of	IN	TIME	of	_	0	SENT_318	[p17l1162t638r1240b698],
3	11	CD	TIME	11	prep_of	1	SENT_318	[p17l1281t639r1352b697],
4	(	CD	PERCENT	(	number	5	SENT_318	[p17l1401t638r1647b712],
5	9.1	CD	PERCENT	9.1	num	6	SENT_318	[p17l1401t638r1647b712],
6	%	NN	PERCENT	%	dep	3	SENT_318	[p17l1401t638r1647b712],
7	)	CD	NUMBER	)	dep	3	SENT_318	[p17l1401t638r1647b712],
8	of	IN	O	of	_	0	SENT_318	[p17l1689t638r1766b698],
9	gefitinibresponders	NNS	O	gefitinibresponder	prep_of	7	SENT_318	[p17l1800t638r2145b716, p17l7t741r379b819],
10	and	CC	O	and	_	0	SENT_318	[p17l411t741r533b801],
11	3/11	CD	PERCENT	3/11	number	12	SENT_318	[p17l563t741r704b802],
12	(	CD	PERCENT	(	conj_and	3	SENT_318	[p17l742t741r1016b815],
13	27.3	CD	PERCENT	27.3	num	14	SENT_318	[p17l742t741r1016b815],
14	%	NN	PERCENT	%	dep	12	SENT_318	[p17l742t741r1016b815],
15	)	CD	NUMBER	)	dep	12	SENT_318	[p17l742t741r1016b815],
16	of	IN	O	of	_	0	SENT_318	[p17l1048t741r1123b801],
17	gefitinib	NN	O	gefitinib	nn	20	SENT_318	[p17l1146t741r1435b819],
18	non	JJ	O	non	amod	20	SENT_318	[p17l1464t741r1995b819],
19	—	NN	O	—	nn	20	SENT_318	[p17l1464t741r1995b819],
20	responders	NNS	O	responder	prep_of	15	SENT_318	[p17l1464t741r1995b819],
21	had	VBD	O	have	_	0	SENT_318	[p17l2024t741r2148b801],
22	an	DT	O	a	det	26	SENT_318	[p17l10t863r88b904],
23	increased	VBN	O	increase	amod	26	SENT_318	[p17l114t844r439b904],
24	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_318	[p17l464t844r684b904],
25	copy	NN	O	copy	nn	26	SENT_318	[p17l710t863r875b922],
26	number	NN	O	number	dobj	21	SENT_318	[p17l901t844r1184b904],
27	.	.	O	.	_	0	SENT_318	[p17l901t844r1184b904],

1	Ten	CD	TIME	ten	nsubj	16	SENT_319	[p17l1211t845r1344b904],
2	of	IN	TIME	of	_	0	SENT_319	[p17l1370t844r1445b904],
3	18	CD	PERCENT	18	num	4	SENT_319	[p17l1473t844r1546b904],
4	(	CD	PERCENT	(	prep_of	1	SENT_319	[p17l1578t843r1851b918],
5	55.6	CD	PERCENT	55.6	number	6	SENT_319	[p17l1578t843r1851b918],
6	%	NN	PERCENT	%	amod	4	SENT_319	[p17l1578t843r1851b918],
7	)	CD	NUMBER	)	num	8	SENT_319	[p17l1578t843r1851b918],
8	patients	NNS	O	patient	dep	4	SENT_319	[p17l1879t844r2145b922],
9	without	IN	O	without	_	0	SENT_319	[p17l9t947r285b1007],
10	an	DT	O	a	det	14	SENT_319	[p17l322t966r402b1007],
11	increased	VBN	O	increase	amod	14	SENT_319	[p17l440t947r781b1007],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_319	[p17l817t947r1043b1007],
13	copy	NN	O	copy	nn	14	SENT_319	[p17l1080t966r1252b1025],
14	number	NN	O	number	prep_without	8	SENT_319	[p17l1289t947r1564b1007],
15	were	VBD	O	be	cop	16	SENT_319	[p17l1600t966r1771b1007],
16	gefitinibresponders	NNS	O	gefitinibresponder	_	0	SENT_319	[p17l1810t947r2145b1025, p17l7t1050r408b1128],
17	.	.	O	.	_	0	SENT_319	[p17l1810t947r2145b1025, p17l7t1050r408b1128],

1	Some	DT	O	some	det	2	SENT_320	[p17l447t1050r641b1110],
2	studies	NNS	O	study	nsubj	3	SENT_320	[p17l680t1050r917b1110],
3	reported	VBD	O	report	_	0	SENT_320	[p17l954t1050r1246b1128],
4	that	IN	O	that	complm	11	SENT_320	[p17l1281t1050r1412b1110],
5	an	DT	O	a	det	9	SENT_320	[p17l1448t1069r1526b1110],
6	increased	VBN	O	increase	amod	9	SENT_320	[p17l1562t1050r1892b1110],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_320	[p17l1926t1050r2148b1110],
8	copy	NN	O	copy	nn	9	SENT_320	[p17l9t1172r176b1231],
9	number	NN	O	number	nsubjpass	11	SENT_320	[p17l213t1153r481b1213],
10	was	VBD	O	be	auxpass	11	SENT_320	[p17l516t1172r647b1213],
11	associated	VBN	O	associate	ccomp	3	SENT_320	[p17l687t1153r1048b1213],
12	with	IN	O	with	_	0	SENT_320	[p17l1083t1153r1237b1213],
13	gefitinib	NN	O	gefitinib	nn	14	SENT_320	[p17l1274t1153r1570b1231],
14	sensitivity	NN	O	sensitivity	prep_with	11	SENT_320	[p17l1610t1153r1991b1231],
15	.	.	O	.	_	0	SENT_320	[p17l1610t1153r1991b1231],

1	For	IN	O	for	_	0	SENT_321	[p17l2027t1154r2150b1213],
2	example	NN	O	example	prep_for	10	SENT_321	[p17l9t1255r338b1334],
3	,	,	O	,	_	0	SENT_321	[p17l9t1255r338b1334],
4	Hirsch	NNP	PERSON	Hirsch	nn	9	SENT_321	[p17l374t1256r614b1316],
5	er	NNP	O	er	nn	9	SENT_321	[p17l652t1267r716b1316],
6	al	NNP	O	al	nn	9	SENT_321	[p17l750t1256r819b1316],
7	(	NNP	O	(	nn	9	SENT_321	[p17l857t1256r1000b1330],
8	11	CD	NUMBER	11	num	9	SENT_321	[p17l857t1256r1000b1330],
9	)	NN	O	)	nsubj	10	SENT_321	[p17l857t1256r1000b1330],
10	reported	VBD	O	report	_	0	SENT_321	[p17l1039t1256r1343b1334],
11	that	IN	O	that	complm	20	SENT_321	[p17l1379t1256r1515b1316],
12	patients	NNS	O	patient	nsubj	20	SENT_321	[p17l1550t1256r1831b1334],
13	with	IN	O	with	_	0	SENT_321	[p17l1871t1256r2029b1316],
14	an	DT	O	a	det	19	SENT_321	[p17l2068t1275r2148b1316],
15	increased	VBN	O	increase	amod	19	SENT_321	[p17l9t1359r341b1419],
16	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_321	[p17l376t1359r598b1419],
17	gene	NN	O	gene	nn	19	SENT_321	[p17l635t1378r797b1437],
18	copy	NN	O	copy	nn	19	SENT_321	[p17l834t1378r1001b1437],
19	number	NN	O	number	prep_with	12	SENT_321	[p17l1038t1359r1307b1419],
20	had	VBD	O	have	ccomp	10	SENT_321	[p17l1340t1359r1466b1419],
21	a	DT	O	a	det	22	SENT_321	[p17l1503t1378r1538b1419],
22	trend	NN	O	trend	dobj	20	SENT_321	[p17l1572t1359r1753b1419],
23	for	IN	O	for	_	0	SENT_321	[p17l1788t1359r1890b1419],
24	higher	JJR	O	higher	amod	26	SENT_321	[p17l1924t1359r2150b1437],
25	response	NN	O	response	nn	26	SENT_321	[p17l7t1481r342b1540],
26	rates	NNS	O	rate	prep_for	22	SENT_321	[p17l382t1471r562b1522],
27	and	CC	O	and	_	0	SENT_321	[p17l605t1462r736b1522],
28	a	DT	O	a	det	30	SENT_321	[p17l778t1481r813b1522],
29	longer	JJR	O	longer	amod	30	SENT_321	[p17l852t1461r1096b1540],
30	time	NN	O	time	prep_for	22	SENT_321	[p17l1134t1462r1304b1522],
31	to	TO	O	to	_	0	SENT_321	[p17l1347t1471r1417b1522],
32	progression	NN	O	progression	prep_to	20	SENT_321	[p17l1459t1462r1924b1540],
33	after	IN	O	after	_	0	SENT_321	[p17l1968t1462r2149b1522],
34	gefitinib	NN	O	gefitinib	nn	35	SENT_321	[p17l9t1565r313b1643],
35	therapy	NN	O	therapy	prep_after	20	SENT_321	[p17l352t1565r645b1643],
36	,	,	O	,	_	0	SENT_321	[p17l352t1565r645b1643],
37	and	CC	O	and	_	0	SENT_321	[p17l684t1565r809b1625],
38	Cappuzzo	NNP	PERSON	Cappuzzo	nn	41	SENT_321	[p17l847t1565r1202b1643],
39	er	NNP	O	er	nn	41	SENT_321	[p17l1243t1576r1306b1625],
40	al	NNP	O	al	nn	41	SENT_321	[p17l1341t1565r1409b1625],
41	(	NNP	O	(	nsubj	44	SENT_321	[p17l1445t1565r1583b1639],
42	12	CD	NUMBER	12	num	43	SENT_321	[p17l1445t1565r1583b1639],
43	)	CD	NUMBER	)	dep	41	SENT_321	[p17l1445t1565r1583b1639],
44	reported	VBD	O	report	conj_and	10	SENT_321	[p17l1620t1565r1912b1643],
45	that	IN	O	that	complm	53	SENT_321	[p17l1947t1565r2077b1625],
46	a	DT	O	a	det	51	SENT_321	[p17l2113t1584r2149b1625],
47	high	JJ	O	high	amod	51	SENT_321	[p17l8t1668r160b1746],
48	EGFR	NN	ORGANIZATION	egfr	nn	51	SENT_321	[p17l194t1668r414b1728],
49	gene	NN	O	gene	nn	51	SENT_321	[p17l449t1687r608b1746],
50	copy	NN	O	copy	nn	51	SENT_321	[p17l644t1687r809b1746],
51	number	NN	O	number	nsubjpass	53	SENT_321	[p17l844t1668r1108b1728],
52	was	VBD	O	be	auxpass	53	SENT_321	[p17l1141t1687r1271b1728],
53	associated	VBN	O	associate	ccomp	44	SENT_321	[p17l1309t1668r1662b1728],
54	with	IN	O	with	_	0	SENT_321	[p17l1696t1668r1848b1728],
55	a	DT	O	a	det	57	SENT_321	[p17l1884t1687r1919b1728],
56	better	JJR	O	better	amod	57	SENT_321	[p17l1951t1668r2149b1728],
57	response	NN	O	response	prep_with	53	SENT_321	[p17l7t1790r351b1849],
58	and	CC	O	and	_	0	SENT_321	[p17l395t1771r529b1831],
59	better	JJR	O	better	amod	60	SENT_321	[p17l568t1771r797b1831],
60	survival	NN	O	survival	conj_and	57	SENT_321	[p17l839t1770r1182b1831],
61	.	.	O	.	_	0	SENT_321	[p17l839t1770r1182b1831],

1	However	RB	O	however	advmod	4	SENT_322	[p17l1225t1772r1606b1842],
2	,	,	O	,	_	0	SENT_322	[p17l1225t1772r1606b1842],
3	there	EX	O	there	expl	4	SENT_322	[p17l1645t1771r1839b1831],
4	was	VBD	O	be	_	0	SENT_322	[p17l1878t1790r2018b1831],
5	no	DT	O	no	det	8	SENT_322	[p17l2058t1790r2146b1831],
6	statistically	RB	O	statistically	advmod	7	SENT_322	[p17l11t1873r385b1952],
7	significant	JJ	O	significant	amod	8	SENT_322	[p17l412t1874r761b1952],
8	correlation	NN	O	correlation	nsubj	4	SENT_322	[p17l784t1873r1144b1934],
9	between	IN	O	between	_	0	SENT_322	[p17l1166t1874r1446b1934],
10	an	DT	O	a	det	14	SENT_322	[p17l1474t1893r1552b1934],
11	increased	VBN	O	increase	amod	14	SENT_322	[p17l1578t1874r1903b1934],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_322	[p17l1928t1874r2148b1934],
13	copy	NN	O	copy	nn	14	SENT_322	[p17l9t1996r175b2055],
14	number	NN	O	number	prep_between	8	SENT_322	[p17l210t1977r476b2037],
15	and	CC	O	and	_	0	SENT_322	[p17l511t1977r633b2037],
16	gefitinib	NN	O	gefitinib	nn	17	SENT_322	[p17l669t1977r960b2055],
17	sensitivity	NN	O	sensitivity	conj_and	14	SENT_322	[p17l999t1977r1352b2055],
18	or	CC	O	or	_	0	SENT_322	[p17l1389t1996r1460b2037],
19	overall	JJ	O	overall	amod	20	SENT_322	[p17l1494t1976r1733b2037],
20	survival	NN	O	survival	conj_or	14	SENT_322	[p17l1771t1976r2047b2037],
21	in	IN	O	in	_	0	SENT_322	[p17l2083t1977r2148b2036],
22	our	PRP$	O	we	poss	23	SENT_322	[p17l9t2099r123b2140],
23	analysis	NN	O	analysis	prep_in	20	SENT_322	[p17l155t2079r428b2158],
24	and	CC	O	and	_	0	SENT_322	[p17l463t2080r586b2140],
25	we	PRP	O	we	nsubj	27	SENT_322	[p17l616t2099r714b2140],
26	were	VBD	O	be	cop	27	SENT_322	[p17l747t2099r912b2140],
27	unable	JJ	O	unable	conj_and	4	SENT_322	[p17l944t2079r1172b2140],
28	to	TO	O	to	aux	29	SENT_322	[p17l1204t2088r1269b2140],
29	show	VB	O	show	xcomp	27	SENT_322	[p17l1304t2080r1481b2140],
30	any	DT	O	any	det	31	SENT_322	[p17l1515t2099r1635b2158],
31	differences	NNS	O	difference	dobj	29	SENT_322	[p17l1669t2080r2049b2140],
32	in	IN	O	in	_	0	SENT_322	[p17l2083t2080r2147b2139],
33	increased	VBN	O	increase	amod	36	SENT_322	[p17l9t2183r336b2243],
34	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_322	[p17l369t2183r590b2243],
35	copy	NN	O	copy	nn	36	SENT_322	[p17l625t2202r790b2261],
36	number	NN	O	number	prep_in	29	SENT_322	[p17l826t2183r1091b2243],
37	between	IN	O	between	_	0	SENT_322	[p17l1123t2183r1412b2243],
38	tumors	NNS	O	tumor	prep_between	36	SENT_322	[p17l1447t2191r1684b2243],
39	carrying	VBG	O	carry	partmod	38	SENT_322	[p17l1722t2183r2008b2261],
40	the	DT	O	the	det	45	SENT_322	[p17l2044t2183r2147b2243],
41	wild	JJ	O	wild	amod	45	SENT_322	[p17l9t2285r345b2364],
42	—	NN	O	—	nn	45	SENT_322	[p17l9t2285r345b2364],
43	type	NN	O	type	nn	45	SENT_322	[p17l9t2285r345b2364],
44	EGFR	NN	ORGANIZATION	egfr	nn	45	SENT_322	[p17l381t2286r603b2346],
45	sequence	NN	O	sequence	dobj	39	SENT_322	[p17l642t2305r960b2364],
46	and	CC	O	and	_	0	SENT_322	[p17l998t2286r1121b2346],
47	tumors	NNS	O	tumor	nsubj	83	SENT_322	[p17l1156t2294r1397b2346],
48	carrying	VBG	O	carry	partmod	47	SENT_322	[p17l1436t2286r1727b2364],
49	the	DT	O	the	det	52	SENT_322	[p17l1763t2286r1868b2346],
50	mutant	JJ	O	mutant	amod	52	SENT_322	[p17l1905t2295r2149b2346],
51	EGFR	NN	ORGANIZATION	egfr	nn	52	SENT_322	[p17l8t2389r239b2449],
52	sequence	NN	O	sequence	dobj	48	SENT_322	[p17l280t2408r645b2467],
53	,	,	O	,	_	0	SENT_322	[p17l280t2408r645b2467],
54	which	WDT	O	which	nsubj	57	SENT_322	[p17l683t2389r908b2449],
55	is	VBZ	O	be	cop	57	SENT_322	[p17l946t2389r1003b2449],
56	not	RB	O	not	neg	57	SENT_322	[p17l1044t2397r1161b2449],
57	surprising	JJ	O	surprising	rcmod	52	SENT_322	[p17l1201t2389r1576b2467],
58	as	IN	O	as	mark	63	SENT_322	[p17l1617t2408r1687b2449],
59	it	PRP	O	it	nsubjpass	63	SENT_322	[p17l1728t2389r1778b2449],
60	has	VBZ	O	have	aux	63	SENT_322	[p17l1815t2389r1934b2449],
61	been	VBN	O	be	auxpass	63	SENT_322	[p17l1974t2389r2147b2449],
62	convincingly	RB	O	convincingly	advmod	63	SENT_322	[p17l9t2491r520b2570],
63	shown	VBN	O	show	advcl	57	SENT_322	[p17l565t2492r809b2552],
64	that	IN	O	that	complm	73	SENT_322	[p17l849t2492r995b2552],
65	EGFR	NN	ORGANIZATION	egfr	nn	66	SENT_322	[p17l1034t2492r1271b2552],
66	mutation	NN	O	mutation	nsubj	73	SENT_322	[p17l1311t2492r1657b2552],
67	and	CC	O	and	_	0	SENT_322	[p17l1699t2492r1833b2552],
68	not	RB	O	not	neg	71	SENT_322	[p17l1872t2501r1993b2552],
69	the	DT	O	the	det	71	SENT_322	[p17l2032t2492r2147b2552],
70	expression	NN	O	expression	nn	71	SENT_322	[p17l9t2595r381b2673],
71	levels	NNS	O	level	nsubj	73	SENT_322	[p17l416t2594r616b2655],
72	is	VBZ	O	be	cop	73	SENT_322	[p17l654t2595r707b2655],
73	responsible	JJ	O	responsible	ccomp	63	SENT_322	[p17l744t2594r1141b2673],
74	for	IN	O	for	_	0	SENT_322	[p17l1177t2595r1278b2655],
75	the	DT	O	the	det	77	SENT_322	[p17l1311t2595r1415b2655],
76	clinical	JJ	O	clinical	amod	77	SENT_322	[p17l1452t2594r1707b2655],
77	response	NN	O	response	prep_for	73	SENT_322	[p17l1742t2614r2046b2673],
78	to	TO	O	to	_	0	SENT_322	[p17l2082t2604r2147b2655],
79	EGFR	NN	ORGANIZATION	egfr	nn	82	SENT_322	[p17l8t2698r235b2758],
80	tyrosine	NN	O	tyrosine	nn	82	SENT_322	[p17l271t2698r563b2776],
81	kinase	NN	O	kinase	nn	82	SENT_322	[p17l600t2698r831b2758],
82	inhibitors	NNS	O	inhibitor	prep_to	77	SENT_322	[p17l869t2698r1217b2758],
83	(	VBP	O	(	conj_and	4	SENT_322	[p17l1258t2697r1566b2772],
84	6,7,23	CD	NUMBER	6,7,23	number	85	SENT_322	[p17l1258t2697r1566b2772],
85	)	CD	NUMBER	)	dobj	83	SENT_322	[p17l1258t2697r1566b2772],
86	.	.	O	.	_	0	SENT_322	[p17l1258t2697r1566b2772],

1	The	DT	O	the	det	2	SENT_323	[p17l1604t2698r1740b2758],
2	difference	NN	O	difference	nsubjpass	12	SENT_323	[p17l1779t2698r2147b2758],
3	between	IN	O	between	_	0	SENT_323	[p17l7t2801r295b2861],
4	the	DT	O	the	det	7	SENT_323	[p17l327t2801r431b2861],
5	previously	RB	DATE	previously	advmod	6	SENT_323	[p17l463t2800r827b2879],
6	published	VBN	O	publish	amod	7	SENT_323	[p17l860t2801r1196b2879],
7	studies	NNS	O	study	prep_between	2	SENT_323	[p17l1231t2801r1465b2861],
8	and	CC	O	and	_	0	SENT_323	[p17l1502t2801r1623b2861],
9	ours	JJ	O	ours	prep_between	2	SENT_323	[p17l1657t2820r1800b2861],
10	might	MD	O	might	aux	12	SENT_323	[p17l1836t2801r2037b2879],
11	be	VB	O	be	auxpass	12	SENT_323	[p17l2067t2801r2147b2861],
12	caused	VBN	O	cause	_	0	SENT_323	[p17l9t2904r243b2964],
13	by	IN	O	by	_	0	SENT_323	[p17l272t2904r357b2982],
14	the	DT	O	the	det	15	SENT_323	[p17l389t2904r492b2964],
15	difference	NN	O	difference	agent	12	SENT_323	[p17l525t2904r872b2964],
16	in	IN	O	in	_	0	SENT_323	[p17l905t2904r970b2963],
17	ethnicity	NN	O	ethnicity	prep_in	15	SENT_323	[p17l1001t2904r1323b2982],
18	;	:	O	;	_	0	SENT_323	[p17l1001t2904r1323b2982],
19	Caucasian	JJ	MISC	caucasian	dep	15	SENT_323	[p17l1358t2904r1712b2964],
20	or	CC	O	or	_	0	SENT_323	[p17l1744t2923r1815b2964],
21	Oriental	JJ	O	oriental	conj_or	19	SENT_323	[p17l1846t2903r2147b2964],
22	.	.	O	.	_	0	SENT_323	[p17l1846t2903r2147b2964],

1	Thus	RB	O	thus	dep	10	SENT_324	[p17l8t3007r228b3078],
2	,	,	O	,	_	0	SENT_324	[p17l8t3007r228b3078],
3	whether	IN	O	whether	dep	10	SENT_324	[p17l268t3007r584b3067],
4	an	DT	O	a	det	8	SENT_324	[p17l625t3026r709b3067],
5	increased	VBN	O	increase	amod	8	SENT_324	[p17l751t3007r1127b3067],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_324	[p17l1167t3007r1406b3067],
7	copy	NN	O	copy	nn	8	SENT_324	[p17l1448t3026r1631b3085],
8	number	NN	O	number	nsubj	10	SENT_324	[p17l1673t3007r1969b3067],
9	is	VBZ	O	be	cop	10	SENT_324	[p17l2009t3007r2068b3067],
10	a	DT	O	a	_	0	SENT_324	[p17l2113t3026r2149b3067],

1	540	CD	NUMBER	540	num	2	SENT_325	[p17l177t3165r244b3196],
2	ENDO	NN	O	endo	_	0	SENT_325	[p17l614t3160r705b3184],
3	et	FW	O	et	nn	4	SENT_325	[p17l715t3165r739b3184],
4	al	FW	O	al	dep	2	SENT_325	[p17l747t3160r779b3184],
5	:	:	O	:	_	0	SENT_325	[p17l747t3160r779b3184],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_325	[p17l799t3160r883b3184],
7	MUTATION	NN	O	mutation	dep	2	SENT_325	[p17l892t3160r1070b3184],
8	AND	CC	O	and	_	0	SENT_325	[p17l1079t3161r1149b3184],
9	COPY	NN	O	copy	nn	10	SENT_325	[p17l1159t3160r1247b3184],
10	NUMBER	NN	O	number	dep	2	SENT_325	[p17l1256t3161r1398b3184],
11	IN	IN	O	in	_	0	SENT_325	[p17l1407t3161r1442b3184],
12	NON-SMALL	NNP	O	NON-SMALL	nn	15	SENT_325	[p17l1451t3160r1646b3184],
13	CELL	NNP	O	CELL	nn	15	SENT_325	[p17l1655t3160r1738b3184],
14	LUNG	NN	O	lung	nn	15	SENT_325	[p17l1747t3160r1839b3184],
15	CANCER	NNP	O	CANCER	prep_in	7	SENT_325	[p17l1848t3160r1982b3184],

1	predictor	NN	O	predictor	nsubj	6	SENT_326	[p17l7t3352r323b3430],
2	of	IN	O	of	_	0	SENT_326	[p17l358t3352r433b3413],
3	gefitinib	NN	O	gefitinib	nn	4	SENT_326	[p17l463t3352r755b3430],
4	sensitivity	NN	O	sensitivity	prep_of	1	SENT_326	[p17l795t3352r1173b3430],
5	,	,	O	,	_	0	SENT_326	[p17l795t3352r1173b3430],
6	remains	VBZ	O	remain	_	0	SENT_326	[p17l1207t3352r1480b3412],
7	to	TO	O	to	aux	9	SENT_326	[p17l1517t3361r1582b3413],
8	be	VB	O	be	auxpass	9	SENT_326	[p17l1617t3352r1698b3412],
9	determined	VBN	O	determine	xcomp	6	SENT_326	[p17l1734t3352r2146b3412],
10	.	.	O	.	_	0	SENT_326	[p17l1734t3352r2146b3412],

1	The	DT	O	the	det	2	SENT_327	[p17l8t3455r142b3515],
2	results	NNS	O	result	nsubj	6	SENT_327	[p17l178t3455r410b3515],
3	of	IN	O	of	_	0	SENT_327	[p17l449t3455r525b3516],
4	multivariate	JJ	O	multivariate	amod	5	SENT_327	[p17l556t3455r976b3515],
5	analyses	NNS	O	analysis	prep_of	2	SENT_327	[p17l1012t3455r1301b3533],
6	suggested	VBD	O	suggest	_	0	SENT_327	[p17l1341t3455r1680b3533],
7	that	IN	O	that	complm	19	SENT_327	[p17l1713t3455r1843b3515],
8	none	NN	O	none	nsubj	19	SENT_327	[p17l1875t3474r2042b3516],
9	of	IN	O	of	_	0	SENT_327	[p17l2077t3455r2152b3516],
10	clinicopathological	JJ	O	clinicopathological	amod	11	SENT_327	[p17l8t3558r651b3636],
11	factors	NNS	O	factor	prep_of	8	SENT_327	[p17l681t3558r937b3630],
12	,	,	O	,	_	0	SENT_327	[p17l681t3558r937b3630],
13	including	VBG	O	include	_	0	SENT_327	[p17l966t3558r1290b3636],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_327	[p17l1320t3559r1540b3619],
15	mutation	NN	O	mutation	prep_including	11	SENT_327	[p17l1569t3558r1876b3619],
16	was	VBD	O	be	cop	19	SENT_327	[p17l1905t3577r2035b3618],
17	an	DT	O	a	det	19	SENT_327	[p17l2069t3577r2147b3618],
18	independent	JJ	O	independent	amod	19	SENT_327	[p17l8t3661r437b3739],
19	predictor	NN	O	predictor	ccomp	6	SENT_327	[p17l470t3661r788b3739],
20	of	IN	O	of	_	0	SENT_327	[p17l823t3661r899b3722],
21	prognosis	NN	O	prognosis	prep_of	19	SENT_327	[p17l927t3661r1290b3739],
22	.	.	O	.	_	0	SENT_327	[p17l927t3661r1290b3739],

1	Further	JJ	O	further	amod	2	SENT_328	[p17l1326t3661r1585b3721],
2	studies	NNS	O	study	nsubjpass	5	SENT_328	[p17l1622t3661r1859b3721],
3	will	MD	O	will	aux	5	SENT_328	[p17l1897t3661r2031b3721],
4	be	VB	O	be	auxpass	5	SENT_328	[p17l2065t3661r2146b3721],
5	needed	VBN	O	need	_	0	SENT_328	[p18l8t19r252b79],
6	to	TO	O	to	aux	7	SENT_328	[p18l278t28r343b80],
7	delineate	VB	O	delineate	xcomp	5	SENT_328	[p18l373t19r681b79],
8	the	DT	O	the	det	9	SENT_328	[p18l710t19r813b79],
9	relationships	NNS	O	relationship	dobj	7	SENT_328	[p18l841t19r1281b97],
10	among	IN	O	among	_	0	SENT_328	[p18l1312t38r1543b97],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_328	[p18l1572t20r1792b80],
12	mutation	NN	O	mutation	prep_among	7	SENT_328	[p18l1820t19r2148b91],
13	,	,	O	,	_	0	SENT_328	[p18l1820t19r2148b91],
14	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_328	[p18l7t123r247b183],
15	gene	NN	O	gene	nn	17	SENT_328	[p18l289t141r468b200],
16	copy	NN	O	copy	nn	17	SENT_328	[p18l511t141r695b200],
17	number	NN	O	number	prep_among	7	SENT_328	[p18l737t122r1062b194],
18	,	,	O	,	_	0	SENT_328	[p18l737t122r1062b194],
19	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_328	[p18l1102t123r1341b183],
20	mRNA	NN	O	mrna	nn	21	SENT_328	[p18l1382t123r1650b183],
21	expression	NN	O	expression	prep_among	7	SENT_328	[p18l1692t122r2148b200],
22	,	,	O	,	_	0	SENT_328	[p18l1692t122r2148b200],
23	gefitinib	NN	O	gefitinib	nn	24	SENT_328	[p18l9t225r297b303],
24	sensitivity	NN	O	sensitivity	prep_among	7	SENT_328	[p18l326t225r700b303],
25	,	,	O	,	_	0	SENT_328	[p18l326t225r700b303],
26	and	CC	O	and	_	0	SENT_328	[p18l725t225r846b285],
27	prognosis	NN	O	prognosis	conj_and	12	SENT_328	[p18l868t225r1224b303],
28	.	.	O	.	_	0	SENT_328	[p18l868t225r1224b303],

1	In	IN	O	in	mark	13	SENT_329	[p18l129t330r199b387],
2	our	PRP$	O	we	poss	3	SENT_329	[p18l225t347r339b389],
3	analysis	NN	O	analysis	nsubj	13	SENT_329	[p18l365t328r637b406],
4	of	IN	O	of	_	0	SENT_329	[p18l666t328r740b389],
5	the	DT	O	the	det	7	SENT_329	[p18l760t328r863b388],
6	additional	JJ	O	additional	quantmod	7	SENT_329	[p18l891t328r1233b389],
7	143	CD	NUMBER	143	prep_of	3	SENT_329	[p18l1267t328r1382b388],
8	gefitinib	NN	O	gefitinib	dep	7	SENT_329	[p18l1412t328r1919b406],
9	—	CD	NUMBER	—	num	8	SENT_329	[p18l1412t328r1919b406],
10	na	TO	O	na	infmod	8	SENT_329	[p18l1412t328r1919b406],
11	'	''	O	'	_	0	SENT_329	[p18l1412t328r1919b406],
12	1	CD	NUMBER	1	dep	10	SENT_329	[p18l1412t328r1919b406],
13	've	VBP	O	have	advcl	21	SENT_329	[p18l1412t328r1919b406],
14	cases	NNS	O	case	dobj	13	SENT_329	[p18l1946t347r2148b400],
15	,	,	O	,	_	0	SENT_329	[p18l1946t347r2148b400],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_329	[p18l7t432r237b492],
17	mutation	NN	O	mutation	nn	18	SENT_329	[p18l274t431r603b492],
18	status	NN	O	status	nsubjpass	21	SENT_329	[p18l644t440r850b491],
19	was	VBD	O	be	auxpass	21	SENT_329	[p18l890t450r1027b491],
20	significantly	RB	O	significantly	advmod	21	SENT_329	[p18l1070t431r1536b509],
21	correlated	VBN	O	correlate	_	0	SENT_329	[p18l1575t431r1948b492],
22	with	IN	O	with	_	0	SENT_329	[p18l1986t431r2147b491],
23	gender	NN	O	gender	prep_with	21	SENT_329	[p18l9t534r281b612],
24	,	,	O	,	_	0	SENT_329	[p18l9t534r281b612],
25	pathological	JJ	O	pathological	amod	26	SENT_329	[p18l317t534r776b612],
26	subtypes	NNS	O	subtype	prep_with	21	SENT_329	[p18l816t534r1160b612],
27	,	,	O	,	_	0	SENT_329	[p18l816t534r1160b612],
28	and	CC	O	and	_	0	SENT_329	[p18l1199t534r1326b594],
29	smoking	NN	O	smoking	nn	30	SENT_329	[p18l1366t534r1676b612],
30	status	NN	O	status	prep_with	21	SENT_329	[p18l1718t543r1947b594],
31	.	.	O	.	_	0	SENT_329	[p18l1718t543r1947b594],

1	This	DT	O	this	det	2	SENT_330	[p18l1986t534r2145b594],
2	result	NN	O	result	nsubj	3	SENT_330	[p18l7t637r199b697],
3	confirmed	VBD	O	confirm	_	0	SENT_330	[p18l227t637r581b698],
4	and	CC	O	and	_	0	SENT_330	[p18l611t637r733b697],
5	extended	VBD	O	extend	conj_and	3	SENT_330	[p18l761t637r1072b697],
6	the	DT	O	the	det	7	SENT_330	[p18l1100t637r1203b697],
7	results	NNS	O	result	nsubj	11	SENT_330	[p18l1231t637r1454b697],
8	of	IN	O	of	_	0	SENT_330	[p18l1486t637r1560b698],
9	previous	JJ	O	previous	amod	10	SENT_330	[p18l1582t637r1878b715],
10	reports	NNS	O	report	prep_of	7	SENT_330	[p18l1907t646r2145b715],
11	(	VBP	O	(	ccomp	5	SENT_330	[p18l10t740r418b815],
12	6,8,9,24	CD	NUMBER	6,8,9,24	number	13	SENT_330	[p18l10t740r418b815],
13	)	CD	NUMBER	)	dobj	11	SENT_330	[p18l10t740r418b815],
14	.	.	O	.	_	0	SENT_330	[p18l10t740r418b815],

1	The	DT	O	the	det	4	SENT_331	[p18l459t740r602b800],
2	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_331	[p18l642t741r878b801],
3	copy	NN	O	copy	nn	4	SENT_331	[p18l918t759r1099b818],
4	number	NN	O	number	nsubjpass	7	SENT_331	[p18l1140t740r1431b800],
5	was	VBD	O	be	auxpass	7	SENT_331	[p18l1469t759r1610b800],
6	significantly	RB	O	significantly	advmod	7	SENT_331	[p18l1655t740r2146b818],
7	correlated	VBN	O	correlate	_	0	SENT_331	[p18l8t843r353b904],
8	with	IN	O	with	_	0	SENT_331	[p18l384t843r536b903],
9	age	NN	O	age	prep_with	7	SENT_331	[p18l568t862r684b921],
10	only	RB	O	only	advmod	9	SENT_331	[p18l717t843r890b921],
11	,	,	O	,	_	0	SENT_331	[p18l717t843r890b921],
12	and	CC	O	and	_	0	SENT_331	[p18l923t843r1044b903],
13	did	VBD	O	do	aux	16	SENT_331	[p18l1076t843r1184b903],
14	not	RB	O	not	neg	16	SENT_331	[p18l1215t852r1325b904],
15	significantly	RB	O	significantly	advmod	16	SENT_331	[p18l1358t843r1785b921],
16	affect	VB	O	affect	csubj	28	SENT_331	[p18l1819t843r2014b903],
17	the	DT	O	the	det	18	SENT_331	[p18l2044t843r2147b903],
18	OS	NNP	O	OS	dobj	16	SENT_331	[p18l9t946r112b1007],
19	in	IN	O	in	_	0	SENT_331	[p18l140t946r206b1005],
20	the	DT	O	the	det	23	SENT_331	[p18l229t946r332b1006],
21	additional	JJ	O	additional	amod	23	SENT_331	[p18l359t946r701b1007],
22	143	CD	NUMBER	143	num	23	SENT_331	[p18l734t946r849b1006],
23	gefitinib	NN	O	gefitinib	prep_in	18	SENT_331	[p18l878t946r1384b1024],
24	—	CD	NUMBER	—	num	23	SENT_331	[p18l878t946r1384b1024],
25	na	TO	O	na	xcomp	16	SENT_331	[p18l878t946r1384b1024],
26	'	''	O	'	_	0	SENT_331	[p18l878t946r1384b1024],
27	1	CD	NUMBER	1	dep	25	SENT_331	[p18l878t946r1384b1024],
28	've	VBP	O	have	conj_and	7	SENT_331	[p18l878t946r1384b1024],
29	cases	NNS	O	case	dobj	28	SENT_331	[p18l1409t965r1610b1006],
30	.	.	O	.	_	0	SENT_331	[p18l1409t965r1610b1006],

1	Overexpression	NN	O	overexpression	nsubjpass	8	SENT_332	[p18l130t1049r684b1127],
2	of	IN	O	of	_	0	SENT_332	[p18l721t1049r797b1110],
3	EGFR/ErbB2	NN	O	egfr/erbb2	nn	6	SENT_332	[p18l826t1049r1305b1110],
4	and	CC	O	and	_	0	SENT_332	[p18l1343t1049r1467b1109],
5	ErbB	NN	O	erbb	conj_and	3	SENT_332	[p18l1502t1049r1681b1109],
6	ligands	NNS	O	ligand	prep_of	1	SENT_332	[p18l1722t1049r1974b1127],
7	was	VBD	O	be	auxpass	8	SENT_332	[p18l2012t1068r2145b1109],
8	correlated	VBN	O	correlate	_	0	SENT_332	[p18l8t1152r353b1213],
9	with	IN	O	with	_	0	SENT_332	[p18l384t1152r536b1212],
10	advanced	JJ	O	advanced	amod	11	SENT_332	[p18l569t1152r893b1212],
11	disease	NN	O	disease	prep_with	8	SENT_332	[p18l925t1152r1171b1212],
12	and	CC	O	and	_	0	SENT_332	[p18l1205t1152r1327b1212],
13	poor	JJ	O	poor	amod	15	SENT_332	[p18l1357t1171r1517b1230],
14	patient	NN	O	patient	nn	15	SENT_332	[p18l1545t1152r1782b1230],
15	prognosis	NN	O	prognosis	conj_and	11	SENT_332	[p18l1811t1152r2145b1230],
16	(	CD	NUMBER	(	number	17	SENT_332	[p18l10t1255r170b1330],
17	25	CD	NUMBER	25	num	18	SENT_332	[p18l10t1255r170b1330],
18	)	NN	O	)	dep	15	SENT_332	[p18l10t1255r170b1330],
19	.	.	O	.	_	0	SENT_332	[p18l10t1255r170b1330],

1	The	DT	O	the	det	2	SENT_333	[p18l201t1255r333b1316],
2	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_333	[p18l364t1255r837b1316],
3	.	.	O	.	_	0	SENT_333	[p18l364t1255r837b1316],

1	—	NN	O	—	_	0	SENT_334	[p18l364t1255r837b1316],
2	.	.	O	.	_	0	SENT_334	[p18l364t1255r837b1316],

1	ErbB2	NN	O	erbb2	nn	2	SENT_335	[p18l364t1255r837b1316],
2	heterodimers	NNS	O	heterodimer	nsubjpass	4	SENT_335	[p18l868t1255r1317b1316],
3	were	VBD	O	be	auxpass	4	SENT_335	[p18l1349t1274r1514b1316],
4	associated	VBN	O	associate	_	0	SENT_335	[p18l1546t1255r1899b1316],
5	with	IN	O	with	_	0	SENT_335	[p18l1929t1255r2081b1315],
6	a	DT	O	a	det	12	SENT_335	[p18l2112t1274r2148b1315],
7	stronger	JJR	O	stronger	amod	12	SENT_335	[p18l11t1367r307b1436],
8	and	CC	O	and	_	0	SENT_335	[p18l345t1358r471b1418],
9	more	RBR	O	more	advmod	10	SENT_335	[p18l507t1377r689b1419],
10	sustained	JJ	O	sustained	amod	12	SENT_335	[p18l730t1358r1067b1418],
11	proliferative	JJ	O	proliferative	amod	12	SENT_335	[p18l1102t1358r1556b1436],
12	signal	NN	O	signal	prep_with	4	SENT_335	[p18l1597t1358r1810b1436],
13	than	IN	O	than	mark	17	SENT_335	[p18l1847t1358r2002b1418],
14	the	DT	O	the	det	16	SENT_335	[p18l2039t1358r2146b1418],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_335	[p18l7t1462r230b1522],
16	homodimers	NNS	O	homodimer	nsubj	17	SENT_335	[p18l265t1461r694b1522],
17	(	VBP	O	(	advcl	4	SENT_335	[p18l732t1461r999b1536],
18	26,27	CD	NUMBER	26,27	number	19	SENT_335	[p18l732t1461r999b1536],
19	)	CD	NUMBER	)	dobj	17	SENT_335	[p18l732t1461r999b1536],
20	.	.	O	.	_	0	SENT_335	[p18l732t1461r999b1536],

1	HER2	NN	O	her2	nn	2	SENT_336	[p18l1034t1462r1247b1521],
2	mutations	NNS	O	mutation	nsubj	15	SENT_336	[p18l1281t1461r1617b1522],
3	were	VBD	O	be	_	0	SENT_336	[p18l1653t1480r1818b1522],
4	in	IN	O	in	_	0	SENT_336	[p18l1852t1461r2146b1522],
5	—	NN	O	—	nn	7	SENT_336	[p18l1852t1461r2146b1522],
6	frame	NN	O	frame	nn	7	SENT_336	[p18l1852t1461r2146b1522],
7	insertions	NNS	O	insertion	prep_in	3	SENT_336	[p18l8t1564r331b1625],
8	in	IN	O	in	_	0	SENT_336	[p18l362t1564r426b1624],
9	exon	NN	O	exon	prep_in	7	SENT_336	[p18l454t1583r621b1625],
10	20	CD	NUMBER	20	num	9	SENT_336	[p18l649t1565r731b1624],
11	and	CC	O	and	_	0	SENT_336	[p18l762t1564r884b1624],
12	were	VBD	O	be	cop	15	SENT_336	[p18l912t1583r1076b1624],
13	significantly	RB	O	significantly	advmod	15	SENT_336	[p18l1108t1564r1535b1642],
14	more	RBR	O	more	advmod	15	SENT_336	[p18l1564t1583r1739b1625],
15	frequent	JJ	O	frequent	conj_and	3	SENT_336	[p18l1768t1564r2055b1642],
16	in	IN	O	in	_	0	SENT_336	[p18l2082t1564r2147b1624],
17	never	RB	O	never	advmod	18	SENT_336	[p18l8t1686r207b1727],
18	smokers	NNS	O	smoker	prep_in	15	SENT_336	[p18l245t1667r538b1728],
19	and	CC	O	and	_	0	SENT_336	[p18l578t1667r704b1727],
20	adenocarcinoma	NN	O	adenocarcinoma	nn	21	SENT_336	[p18l741t1667r1331b1728],
21	histology	NN	O	histology	conj_and	18	SENT_336	[p18l1366t1667r1701b1745],
22	(	CD	NUMBER	(	number	23	SENT_336	[p18l1741t1668r1909b1742],
23	28	CD	NUMBER	28	num	24	SENT_336	[p18l1741t1668r1909b1742],
24	)	NN	O	)	dobj	3	SENT_336	[p18l1741t1668r1909b1742],
25	.	.	O	.	_	0	SENT_336	[p18l1741t1668r1909b1742],

1	Thus	RB	O	thus	advmod	6	SENT_337	[p18l1947t1667r2148b1739],
2	,	,	O	,	_	0	SENT_337	[p18l1947t1667r2148b1739],
3	some	DT	O	some	det	4	SENT_337	[p18l11t1789r189b1831],
4	studies	NNS	O	study	nsubj	6	SENT_337	[p18l229t1770r467b1830],
5	have	VBP	O	have	aux	6	SENT_337	[p18l504t1770r667b1830],
6	reported	VBN	O	report	_	0	SENT_337	[p18l702t1770r995b1848],
7	on	IN	O	on	_	0	SENT_337	[p18l1031t1789r1116b1831],
8	ErbB2	NN	O	erbb2	nn	10	SENT_337	[p18l1150t1770r1377b1830],
9	gene	NN	O	gene	nn	10	SENT_337	[p18l1414t1789r1576b1848],
10	expression	NN	O	expression	prep_on	6	SENT_337	[p18l1613t1770r1988b1848],
11	and	CC	O	and	_	0	SENT_337	[p18l2025t1770r2148b1830],
12	mutation	NN	O	mutation	conj_and	10	SENT_337	[p18l8t1873r330b1945],
13	,	,	O	,	_	0	SENT_337	[p18l8t1873r330b1945],
14	but	CC	O	but	_	0	SENT_337	[p18l351t1873r460b1933],
15	very	RB	O	very	advmod	16	SENT_337	[p18l482t1892r630b1951],
16	few	JJ	O	few	amod	17	SENT_337	[p18l654t1873r778b1933],
17	studies	NNS	O	study	nsubj	19	SENT_337	[p18l806t1873r1033b1933],
18	have	VBP	O	have	aux	19	SENT_337	[p18l1058t1873r1216b1933],
19	reported	VBN	O	report	conj_but	6	SENT_337	[p18l1239t1873r1520b1951],
20	on	IN	O	on	_	0	SENT_337	[p18l1543t1892r1626b1934],
21	the	DT	O	the	det	22	SENT_337	[p18l1649t1873r1750b1933],
22	association	NN	O	association	prep_on	19	SENT_337	[p18l1776t1873r2147b1934],
23	between	IN	O	between	_	0	SENT_337	[p18l7t1976r317b2036],
24	the	DT	O	the	det	28	SENT_337	[p18l353t1976r464b2036],
25	ErbB2	NN	O	erbb2	nn	28	SENT_337	[p18l501t1976r738b2036],
26	gene	NN	O	gene	nn	28	SENT_337	[p18l777t1995r947b2054],
27	copy	NN	O	copy	nn	28	SENT_337	[p18l986t1995r1161b2054],
28	number	NN	O	number	prep_between	22	SENT_337	[p18l1198t1976r1480b2036],
29	and	CC	O	and	_	0	SENT_337	[p18l1517t1976r1646b2036],
30	lung	NN	O	lung	nn	31	SENT_337	[p18l1682t1976r1843b2054],
31	cancer	NN	O	cancer	prep_between	22	SENT_337	[p18l1881t1995r2146b2036],
32	.	.	O	.	_	0	SENT_337	[p18l1881t1995r2146b2036],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nsubj	7	SENT_338	[p18l9t2080r368b2157],
2	et	FW	O	et	dep	1	SENT_338	[p18l409t2091r474b2139],
3	al	FW	O	al	nn	6	SENT_338	[p18l510t2079r580b2139],
4	(	FW	O	(	dep	6	SENT_338	[p18l620t2080r768b2154],
5	29	CD	NUMBER	29	num	6	SENT_338	[p18l620t2080r768b2154],
6	)	NN	O	)	advmod	7	SENT_338	[p18l620t2080r768b2154],
7	reported	VBD	O	report	_	0	SENT_338	[p18l808t2079r1121b2157],
8	that	IN	O	that	complm	14	SENT_338	[p18l1159t2079r1299b2139],
9	HER2	NN	O	her2	nn	11	SENT_338	[p18l1336t2080r1560b2138],
10	gene	NN	O	gene	nn	11	SENT_338	[p18l1601t2098r1771b2157],
11	gain	NN	O	gain	nsubjpass	14	SENT_338	[p18l1812t2079r1969b2157],
12	was	VBD	O	be	auxpass	14	SENT_338	[p18l2007t2098r2145b2139],
13	significantly	RB	O	significantly	advmod	14	SENT_338	[p18l11t2182r480b2260],
14	associated	VBN	O	associate	ccomp	7	SENT_338	[p18l521t2182r905b2243],
15	with	IN	O	with	_	0	SENT_338	[p18l943t2182r1105b2242],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_338	[p18l1142t2183r1373b2243],
17	gene	NN	O	gene	nn	18	SENT_338	[p18l1412t2201r1582b2260],
18	gain	NN	O	gain	prep_with	14	SENT_338	[p18l1622t2182r1779b2260],
19	and	CC	O	and	_	0	SENT_338	[p18l1818t2182r1947b2242],
20	with	IN	O	with	_	0	SENT_338	[p18l1985t2182r2147b2242],
21	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_338	[p18l7t2286r227b2346],
22	gene	NN	O	gene	nn	23	SENT_338	[p18l258t2304r417b2363],
23	mutations	NNS	O	mutation	conj_and	18	SENT_338	[p18l448t2285r810b2357],
24	,	,	O	,	_	0	SENT_338	[p18l448t2285r810b2357],
25	and	CC	O	and	_	0	SENT_338	[p18l841t2285r963b2345],
26	that	IN	O	that	complm	41	SENT_338	[p18l992t2285r1121b2345],
27	EGFR	NN	ORGANIZATION	egfr	npadvmod	29	SENT_338	[p18l1149t2285r1672b2363],
28	—	CD	NUMBER	—	num	27	SENT_338	[p18l1149t2285r1672b2363],
29	positive	JJ	O	positive	amod	30	SENT_338	[p18l1149t2285r1672b2363],
30	patients	NNS	O	patient	nsubj	41	SENT_338	[p18l1701t2285r1968b2363],
31	who	WP	O	who	nsubj	34	SENT_338	[p18l2000t2285r2146b2346],
32	also	RB	O	also	advmod	34	SENT_338	[p18l10t2388r146b2449],
33	had	VBD	O	have	aux	34	SENT_338	[p18l183t2388r308b2448],
34	increased	VBN	O	increase	rcmod	30	SENT_338	[p18l343t2388r675b2448],
35	copy	NN	O	copy	nn	36	SENT_338	[p18l711t2407r878b2466],
36	numbers	NNS	O	number	dobj	34	SENT_338	[p18l915t2388r1214b2448],
37	of	IN	O	of	_	0	SENT_338	[p18l1252t2388r1328b2449],
38	the	DT	O	the	det	40	SENT_338	[p18l1357t2388r1462b2448],
39	HER2	NN	O	her2	nn	40	SENT_338	[p18l1499t2389r1714b2448],
40	gene	NN	O	gene	prep_of	36	SENT_338	[p18l1752t2407r1914b2466],
41	had	VBD	O	have	ccomp	7	SENT_338	[p18l1950t2388r2076b2448],
42	a	DT	O	a	det	45	SENT_338	[p18l2112t2407r2148b2448],
43	better	JJR	O	better	amod	45	SENT_338	[p18l7t2491r208b2551],
44	response	NN	O	response	nn	45	SENT_338	[p18l241t2510r540b2569],
45	rate	NN	O	rate	dobj	41	SENT_338	[p18l573t2500r723b2563],
46	,	,	O	,	_	0	SENT_338	[p18l573t2500r723b2563],
47	disease	NN	O	disease	nn	49	SENT_338	[p18l756t2491r1000b2551],
48	control	NN	O	control	nn	49	SENT_338	[p18l1035t2491r1275b2552],
49	rate	NN	O	rate	dobj	41	SENT_338	[p18l1308t2500r1457b2563],
50	,	,	O	,	_	0	SENT_338	[p18l1308t2500r1457b2563],
51	TTP	NN	O	ttp	dobj	41	SENT_338	[p18l1490t2493r1663b2563],
52	,	,	O	,	_	0	SENT_338	[p18l1490t2493r1663b2563],
53	and	CC	O	and	_	0	SENT_338	[p18l1697t2491r1818b2551],
54	survival	NN	O	survival	dobj	41	SENT_338	[p18l1854t2491r2146b2551],
55	.	.	O	.	_	0	SENT_338	[p18l1854t2491r2146b2551],

1	Because	IN	O	because	mark	10	SENT_339	[p18l8t2596r322b2654],
2	analysis	NN	O	analysis	nsubjpass	10	SENT_339	[p18l366t2594r680b2672],
3	of	IN	O	of	_	0	SENT_339	[p18l724t2594r805b2655],
4	the	DT	O	the	det	7	SENT_339	[p18l839t2594r954b2654],
5	ErbB2	NN	O	erbb2	nn	7	SENT_339	[p18l995t2594r1242b2654],
6	copy	NN	O	copy	nn	7	SENT_339	[p18l1285t2613r1467b2672],
7	number	NN	O	number	prep_of	2	SENT_339	[p18l1509t2594r1803b2654],
8	was	VBD	O	be	auxpass	10	SENT_339	[p18l1842t2613r1984b2654],
9	not	RB	O	not	neg	10	SENT_339	[p18l2026t2603r2148b2655],
10	performed	VBN	O	perform	advcl	20	SENT_339	[p18l7t2697r369b2775],
11	in	IN	O	in	_	0	SENT_339	[p18l403t2697r469b2757],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_339	[p18l504t2697r1064b2775],
13	—	NN	O	—	prep_in	10	SENT_339	[p18l504t2697r1064b2775],
14	treated	VBN	O	treat	partmod	13	SENT_339	[p18l504t2697r1064b2775],
15	patients	NNS	O	patient	dobj	14	SENT_339	[p18l1097t2697r1390b2775],
16	,	,	O	,	_	0	SENT_339	[p18l1097t2697r1390b2775],
17	we	PRP	O	we	nsubj	20	SENT_339	[p18l1425t2716r1522b2757],
18	were	VBD	O	be	cop	20	SENT_339	[p18l1559t2716r1724b2757],
19	not	RB	O	not	neg	20	SENT_339	[p18l1760t2706r1870b2758],
20	able	JJ	O	able	_	0	SENT_339	[p18l1905t2697r2046b2757],
21	to	TO	O	to	aux	22	SENT_339	[p18l2081t2706r2146b2758],
22	show	VB	O	show	xcomp	20	SENT_339	[p18l11t2800r187b2861],
23	the	DT	O	the	det	24	SENT_339	[p18l219t2800r322b2860],
24	relationship	NN	O	relationship	dobj	22	SENT_339	[p18l352t2800r758b2878],
25	between	IN	O	between	_	0	SENT_339	[p18l789t2800r1077b2860],
26	the	DT	O	the	det	30	SENT_339	[p18l1107t2800r1210b2860],
27	ErbB2	NN	O	erbb2	nn	30	SENT_339	[p18l1241t2800r1464b2860],
28	gene	NN	O	gene	nn	30	SENT_339	[p18l1497t2819r1657b2878],
29	copy	NN	O	copy	nn	30	SENT_339	[p18l1689t2819r1853b2878],
30	number	NN	O	number	prep_between	24	SENT_339	[p18l1884t2800r2149b2860],
31	and	CC	O	and	_	0	SENT_339	[p18l10t2903r132b2963],
32	gefitinib	NN	O	gefitinib	nn	33	SENT_339	[p18l167t2903r459b2981],
33	sensitivity	NN	O	sensitivity	prep_between	24	SENT_339	[p18l499t2903r874b2981],
34	.	.	O	.	_	0	SENT_339	[p18l499t2903r874b2981],

1	However	RB	O	however	advmod	5	SENT_340	[p18l911t2905r1251b2975],
2	,	,	O	,	_	0	SENT_340	[p18l911t2905r1251b2975],
3	we	PRP	O	we	nsubj	5	SENT_340	[p18l1286t2922r1384b2963],
4	have	VBP	O	have	aux	5	SENT_340	[p18l1419t2903r1582b2963],
5	shown	VBN	O	show	_	0	SENT_340	[p18l1620t2903r1843b2964],
6	that	IN	O	that	complm	14	SENT_340	[p18l1878t2903r2009b2963],
7	the	DT	O	the	det	10	SENT_340	[p18l2042t2903r2146b2963],
8	ErbB2	NN	O	erbb2	nn	10	SENT_340	[p18l7t3006r231b3066],
9	copy	NN	O	copy	nn	10	SENT_340	[p18l259t3025r424b3084],
10	number	NN	O	number	nsubjpass	14	SENT_340	[p18l451t3006r716b3066],
11	was	VBD	O	be	auxpass	14	SENT_340	[p18l741t3025r871b3066],
12	not	RB	O	not	neg	14	SENT_340	[p18l900t3015r1010b3067],
13	significantly	RB	O	significantly	advmod	14	SENT_340	[p18l1039t3006r1466b3084],
14	correlated	VBD	O	correlate	ccomp	5	SENT_340	[p18l1494t3006r1838b3067],
15	with	IN	O	with	_	0	SENT_340	[p18l1865t3006r2017b3066],
16	the	DT	O	the	det	18	SENT_340	[p18l2043t3006r2146b3066],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_340	[p18l7t3110r227b3170],
18	mutation	NN	O	mutation	prep_with	14	SENT_340	[p18l257t3109r563b3170],
19	and	CC	O	and	_	0	SENT_340	[p18l595t3109r717b3169],
20	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_340	[p18l745t3110r965b3170],
21	copy	NN	O	copy	nn	22	SENT_340	[p18l995t3128r1160b3187],
22	number	NN	O	number	prep_with	14	SENT_340	[p18l1191t3109r1455b3169],
23	in	IN	O	in	_	0	SENT_340	[p18l1484t3109r1549b3169],
24	the	DT	O	the	det	26	SENT_340	[p18l1579t3109r1682b3169],
25	59	CD	NUMBER	59	num	26	SENT_340	[p18l1714t3109r1795b3171],
26	gefitinibna	NN	O	gefitinibna	prep_in	14	SENT_340	[p18l1827t3109r2144b3187, p18l8t3216r192b3271],
27	'	''	O	'	_	0	SENT_340	[p18l1827t3109r2144b3187, p18l8t3216r192b3271],
28	1	CD	NUMBER	1	nsubj	29	SENT_340	[p18l1827t3109r2144b3187, p18l8t3216r192b3271],
29	've	VBP	O	have	rcmod	26	SENT_340	[p18l1827t3109r2144b3187, p18l8t3216r192b3271],
30	NSCLC	NN	O	nsclc	nn	31	SENT_340	[p18l217t3211r492b3272],
31	cases	NNS	O	case	dobj	29	SENT_340	[p18l519t3230r719b3271],
32	.	.	O	.	_	0	SENT_340	[p18l519t3230r719b3271],

1	In	IN	O	in	_	0	SENT_341	[p18l129t3316r199b3373],
2	summary	NN	O	summary	prep_in	8	SENT_341	[p18l229t3333r569b3392],
3	,	,	O	,	_	0	SENT_341	[p18l229t3333r569b3392],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_341	[p18l595t3315r815b3375],
5	mutation	NN	O	mutation	nsubjpass	8	SENT_341	[p18l842t3314r1148b3375],
6	was	VBD	O	be	auxpass	8	SENT_341	[p18l1175t3333r1305b3374],
7	significantly	RB	O	significantly	advmod	8	SENT_341	[p18l1338t3314r1765b3392],
8	associated	VBN	O	associate	_	0	SENT_341	[p18l1795t3314r2147b3375],
9	with	IN	O	with	_	0	SENT_341	[p18l8t3417r163b3477],
10	a	DT	O	a	det	13	SENT_341	[p18l200t3436r236b3477],
11	better	JJR	O	better	amod	13	SENT_341	[p18l269t3417r472b3477],
12	clinical	JJ	O	clinical	amod	13	SENT_341	[p18l507t3417r766b3477],
13	outcome	NN	O	outcome	prep_with	8	SENT_341	[p18l803t3426r1104b3478],
14	in	IN	O	in	_	0	SENT_341	[p18l1140t3417r1206b3477],
15	gefitinib	NN	O	gefitinib	nn	16	SENT_341	[p18l1243t3417r1815b3495],
16	—	NN	O	—	prep_in	13	SENT_341	[p18l1243t3417r1815b3495],
17	treated	VBN	O	treat	partmod	16	SENT_341	[p18l1243t3417r1815b3495],
18	patients	NNS	O	patient	dobj	17	SENT_341	[p18l1849t3417r2148b3495],
19	,	,	O	,	_	0	SENT_341	[p18l1849t3417r2148b3495],
20	but	CC	O	but	_	0	SENT_341	[p18l7t3520r131b3580],
21	an	DT	O	a	det	24	SENT_341	[p18l179t3539r264b3580],
22	increased	VBN	O	increase	amod	24	SENT_341	[p18l312t3520r690b3580],
23	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_341	[p18l737t3521r977b3581],
24	gene	NN	O	gene	nsubj	39	SENT_341	[p18l1025t3539r1205b3598],
25	copy	NN	O	copy	nn	26	SENT_341	[p18l1254t3539r1439b3598],
26	number	NN	O	number	nsubjpass	30	SENT_341	[p18l1488t3520r1785b3580],
27	was	VBD	O	be	auxpass	30	SENT_341	[p18l1832t3539r1974b3580],
28	not	RB	O	not	neg	30	SENT_341	[p18l2025t3529r2148b3581],
29	significantly	RB	O	significantly	advmod	30	SENT_341	[p18l11t3623r465b3701],
30	associated	VBN	O	associate	rcmod	24	SENT_341	[p18l505t3623r878b3684],
31	with	IN	O	with	_	0	SENT_341	[p18l915t3623r1073b3683],
32	a	DT	O	a	det	35	SENT_341	[p18l1112t3642r1147b3683],
33	better	JJR	O	better	amod	35	SENT_341	[p18l1182t3623r1391b3683],
34	clinical	JJ	O	clinical	amod	35	SENT_341	[p18l1428t3623r1695b3683],
35	outcome	NN	O	outcome	prep_with	30	SENT_341	[p18l1734t3632r2042b3684],
36	in	IN	O	in	_	0	SENT_341	[p18l2080t3623r2147b3682],
37	gefitinib	NN	O	gefitinib	nn	38	SENT_341	[p18l9t3726r591b3804],
38	—	NN	O	—	prep_in	35	SENT_341	[p18l9t3726r591b3804],
39	treated	VBN	O	treat	conj_but	8	SENT_341	[p18l9t3726r591b3804],
40	patients	NNS	O	patient	dobj	39	SENT_341	[p18l626t3726r904b3804],
41	and	CC	O	and	_	0	SENT_341	[p18l944t3726r1069b3786],
42	the	DT	O	the	det	45	SENT_341	[p18l1105t3726r1211b3786],
43	additional	JJ	O	additional	amod	45	SENT_341	[p18l1250t3726r1608b3787],
44	143	CD	NUMBER	143	num	45	SENT_341	[p18l1653t3726r1771b3786],
45	gefitinibna	NN	O	gefitinibna	nsubj	48	SENT_341	[p18l1813t3726r2145b3804, p19l8t24r194b79],
46	'	''	O	'	_	0	SENT_341	[p18l1813t3726r2145b3804, p19l8t24r194b79],
47	1	CD	NUMBER	1	dep	45	SENT_341	[p18l1813t3726r2145b3804, p19l8t24r194b79],
48	've	VBP	O	have	conj_and	8	SENT_341	[p18l1813t3726r2145b3804, p19l8t24r194b79],

1	NSCLC	NN	O	nsclc	nn	2	SENT_342	[p19l230t20r508b80],
2	cases	NNS	O	case	_	0	SENT_342	[p19l546t38r749b79],
3	.	.	O	.	_	0	SENT_342	[p19l546t38r749b79],

1	The	DT	O	the	det	2	SENT_343	[p19l786t19r919b79],
2	populations	NNS	O	population	nsubj	8	SENT_343	[p19l954t19r1361b97],
3	with	IN	O	with	_	0	SENT_343	[p19l1399t19r1553b79],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_343	[p19l1587t20r1809b80],
5	mutation	NN	O	mutation	prep_with	2	SENT_343	[p19l1844t19r2147b80],
6	may	MD	O	may	aux	8	SENT_343	[p19l8t141r152b200],
7	be	VB	O	be	cop	8	SENT_343	[p19l174t122r253b182],
8	different	JJ	O	different	_	0	SENT_343	[p19l278t122r567b182],
9	from	IN	O	from	_	0	SENT_343	[p19l588t122r752b183],
10	the	DT	O	the	det	11	SENT_343	[p19l774t122r875b182],
11	populations	NNS	O	population	prep_from	8	SENT_343	[p19l897t122r1289b200],
12	with	IN	O	with	_	0	SENT_343	[p19l1314t122r1463b182],
13	an	DT	O	a	det	17	SENT_343	[p19l1487t141r1564b182],
14	increased	VBN	O	increase	amod	17	SENT_343	[p19l1587t122r1904b182],
15	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_343	[p19l1927t123r2147b183],
16	copy	NN	O	copy	nn	17	SENT_343	[p19l8t244r181b303],
17	number	NN	O	number	prep_with	11	SENT_343	[p19l220t225r498b285],
18	and	CC	O	and	_	0	SENT_343	[p19l535t225r663b285],
19	the	DT	O	the	det	20	SENT_343	[p19l699t225r808b285],
20	effect	NN	O	effect	nsubj	32	SENT_343	[p19l846t225r1056b285],
21	of	IN	O	of	_	0	SENT_343	[p19l1093t225r1171b286],
22	an	DT	O	a	det	26	SENT_343	[p19l1204t244r1285b285],
23	increased	VBN	O	increase	amod	26	SENT_343	[p19l1323t225r1670b285],
24	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_343	[p19l1707t226r1935b286],
25	copy	NN	O	copy	nn	26	SENT_343	[p19l1973t244r2146b303],
26	number	NN	O	number	prep_of	20	SENT_343	[p19l8t328r274b388],
27	to	TO	O	to	_	0	SENT_343	[p19l307t337r372b389],
28	gefitinib	NN	O	gefitinib	nn	29	SENT_343	[p19l409t328r701b406],
29	response	NN	O	response	prep_to	26	SENT_343	[p19l737t347r1041b406],
30	may	MD	O	may	aux	32	SENT_343	[p19l1077t347r1224b406],
31	be	VB	O	be	cop	32	SENT_343	[p19l1259t328r1339b388],
32	different	JJ	O	different	conj_and	8	SENT_343	[p19l1376t328r1676b388],
33	from	IN	O	from	_	0	SENT_343	[p19l1710t328r1879b389],
34	that	DT	O	that	prep_from	32	SENT_343	[p19l1912t328r2043b388],
35	of	IN	O	of	_	0	SENT_343	[p19l2078t328r2153b389],
36	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_343	[p19l7t432r227b492],
37	mutation	NN	O	mutation	prep_of	34	SENT_343	[p19l255t431r581b492],
38	.	.	O	.	_	0	SENT_343	[p19l255t431r581b492],

1	However	RB	O	however	advmod	32	SENT_344	[p19l611t433r949b503],
2	,	,	O	,	_	0	SENT_344	[p19l611t433r949b503],
3	for	IN	O	for	_	0	SENT_344	[p19l977t431r1077b492],
4	another	DT	O	another	det	7	SENT_344	[p19l1105t431r1363b492],
5	TK	NN	O	tk	nn	7	SENT_344	[p19l1389t433r1503b491],
6	inhibitor	NN	O	inhibitor	nn	7	SENT_344	[p19l1531t431r1829b492],
7	erlotinib	NN	O	erlotinib	prep_for	32	SENT_344	[p19l1856t431r2145b492],
8	(	CD	NUMBER	(	num	10	SENT_344	[p19l10t532r375b609],
9	Tarceva	NNP	O	Tarceva	nn	10	SENT_344	[p19l10t532r375b609],
10	®	NNP	O	®	dep	7	SENT_344	[p19l10t532r375b609],
11	,	,	O	,	_	0	SENT_344	[p19l10t532r375b609],
12	Genetech	NNP	ORGANIZATION	Genetech	nn	13	SENT_344	[p19l405t534r781b609],
13	)	NNP	O	)	nsubj	32	SENT_344	[p19l405t534r781b609],
14	,	,	O	,	_	0	SENT_344	[p19l405t534r781b609],
15	because	IN	O	because	mark	20	SENT_344	[p19l808t535r1081b595],
16	the	DT	O	the	det	18	SENT_344	[p19l1111t534r1214b595],
17	dose	NN	O	dose	nn	18	SENT_344	[p19l1245t534r1400b595],
18	setting	NN	O	setting	nsubj	20	SENT_344	[p19l1433t534r1658b612],
19	was	VBD	O	be	cop	20	SENT_344	[p19l1689t553r1819b594],
20	different	JJ	O	different	advcl	32	SENT_344	[p19l1851t534r2148b595],
21	from	IN	O	from	_	0	SENT_344	[p19l8t637r179b698],
22	gefitinib	NN	O	gefitinib	nn	23	SENT_344	[p19l214t637r512b715],
23	therapy	NN	O	therapy	prep_from	20	SENT_344	[p19l550t637r838b716],
24	,	,	O	,	_	0	SENT_344	[p19l550t637r838b716],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_344	[p19l872t638r1096b698],
26	amplification	NN	O	amplification	nsubj	32	SENT_344	[p19l1133t637r1605b716],
27	may	MD	O	may	aux	32	SENT_344	[p19l1641t656r1789b716],
28	still	RB	O	still	advmod	32	SENT_344	[p19l1829t637r1958b697],
29	be	VB	O	be	cop	32	SENT_344	[p19l1993t637r2074b698],
30	a	DT	O	a	det	32	SENT_344	[p19l2112t656r2148b697],
31	better	JJR	O	better	amod	32	SENT_344	[p19l7t740r204b801],
32	predictor	NN	O	predictor	_	0	SENT_344	[p19l232t740r546b819],
33	of	IN	O	of	_	0	SENT_344	[p19l576t740r650b801],
34	erlotinib	NN	O	erlotinib	nn	35	SENT_344	[p19l676t740r965b801],
35	sensitivity	NN	O	sensitivity	prep_of	32	SENT_344	[p19l1001t740r1351b819],
36	for	IN	O	for	mark	39	SENT_344	[p19l1383t740r1483b801],
37	lung	NN	O	lung	nn	38	SENT_344	[p19l1512t740r1663b818],
38	cancers	NNS	O	cancer	nsubj	39	SENT_344	[p19l1695t759r1950b801],
39	(	VBP	O	(	advcl	32	SENT_344	[p19l1986t741r2146b815],
40	30	CD	NUMBER	30	num	41	SENT_344	[p19l1986t741r2146b815],
41	)	CD	NUMBER	)	dobj	39	SENT_344	[p19l1986t741r2146b815],
42	.	.	O	.	_	0	SENT_344	[p19l1986t741r2146b815],

1	In	IN	O	in	_	0	SENT_345	[p19l8t845r80b903],
2	most	JJS	O	most	amod	3	SENT_345	[p19l117t852r291b904],
3	studies	NNS	O	study	prep_in	12	SENT_345	[p19l330t843r604b915],
4	,	,	O	,	_	0	SENT_345	[p19l330t843r604b915],
5	analysis	NN	O	analysis	nsubjpass	12	SENT_345	[p19l642t843r931b922],
6	of	IN	O	of	_	0	SENT_345	[p19l971t843r1048b904],
7	the	DT	O	the	det	10	SENT_345	[p19l1079t843r1188b904],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_345	[p19l1225t844r1452b904],
9	copy	NN	O	copy	nn	10	SENT_345	[p19l1489t862r1661b922],
10	number	NN	O	number	prep_of	5	SENT_345	[p19l1698t843r1974b904],
11	was	VBD	O	be	auxpass	12	SENT_345	[p19l2010t862r2145b903],
12	performed	VBN	O	perform	_	0	SENT_345	[p19l7t946r387b1025],
13	by	IN	O	by	_	0	SENT_345	[p19l422t947r510b1025],
14	FISH	NN	O	fish	agent	12	SENT_345	[p19l547t947r740b1007],
15	or	CC	O	or	_	0	SENT_345	[p19l778t965r852b1007],
16	quantitative	JJ	O	quantitative	conj_or	14	SENT_345	[p19l888t946r1320b1025],
17	real	JJ	O	real	amod	20	SENT_345	[p19l1357t946r1688b1007],
18	—	NN	O	—	nn	20	SENT_345	[p19l1357t946r1688b1007],
19	time	NN	O	time	nn	20	SENT_345	[p19l1357t946r1688b1007],
20	PCR	NN	O	pcr	dep	14	SENT_345	[p19l1726t947r1915b1007],
21	.	.	O	.	_	0	SENT_345	[p19l1726t947r1915b1007],

1	FISH	NN	O	fish	nn	2	SENT_346	[p19l1953t947r2146b1007],
2	analysis	NN	O	analysis	nsubjpass	9	SENT_346	[p19l10t1049r283b1128],
3	was	VBD	O	be	cop	5	SENT_346	[p19l314t1068r443b1109],
4	relatively	RB	O	relatively	advmod	5	SENT_346	[p19l473t1049r798b1128],
5	expensive	JJ	O	expensive	_	0	SENT_346	[p19l827t1049r1170b1128],
6	and	CC	O	and	_	0	SENT_346	[p19l1201t1049r1323b1109],
7	was	VBD	O	be	auxpass	9	SENT_346	[p19l1351t1068r1481b1109],
8	usually	RB	O	usually	advmod	9	SENT_346	[p19l1511t1049r1759b1128],
9	performed	VBN	O	perform	conj_and	5	SENT_346	[p19l1787t1049r2147b1128],
10	on	IN	O	on	_	0	SENT_346	[p19l9t1172r94b1213],
11	one	CD	NUMBER	one	prep_on	9	SENT_346	[p19l133t1172r259b1213],
12	or	CC	O	or	_	0	SENT_346	[p19l298t1172r371b1213],
13	few	JJ	O	few	prep_on	9	SENT_346	[p19l407t1152r538b1213],
14	of	IN	O	of	_	0	SENT_346	[p19l577t1152r654b1213],
15	the	DT	O	the	det	17	SENT_346	[p19l686t1152r794b1213],
16	sliced	JJ	O	sliced	amod	17	SENT_346	[p19l835t1152r1044b1213],
17	sections	NNS	O	section	prep_of	13	SENT_346	[p19l1084t1152r1398b1213],
18	.	.	O	.	_	0	SENT_346	[p19l1084t1152r1398b1213],

1	On	IN	O	on	_	0	SENT_347	[p19l1438t1153r1543b1213],
2	the	DT	O	the	det	4	SENT_347	[p19l1580t1152r1688b1213],
3	other	JJ	O	other	amod	4	SENT_347	[p19l1727t1152r1913b1213],
4	hand	NN	O	hand	prep_on	13	SENT_347	[p19l1949t1152r2148b1224],
5	,	,	O	,	_	0	SENT_347	[p19l1949t1152r2148b1224],
6	quantitative	JJ	O	quantitative	amod	8	SENT_347	[p19l8t1255r414b1334],
7	real	JJ	O	real	amod	8	SENT_347	[p19l445t1255r756b1316],
8	—	NN	O	—	nsubj	16	SENT_347	[p19l445t1255r756b1316],
9	time	NN	O	time	nn	11	SENT_347	[p19l445t1255r756b1316],
10	PCR	NN	O	pcr	nn	11	SENT_347	[p19l788t1256r950b1316],
11	method	NN	O	method	dep	8	SENT_347	[p19l981t1255r1240b1316],
12	is	VBZ	O	be	cop	13	SENT_347	[p19l1271t1255r1324b1315],
13	inexpensive	JJ	O	inexpensive	_	0	SENT_347	[p19l1358t1255r1792b1334],
14	,	,	O	,	_	0	SENT_347	[p19l1358t1255r1792b1334],
15	relatively	RB	O	relatively	advmod	16	SENT_347	[p19l1821t1255r2147b1334],
16	easy	JJ	O	easy	conj_and	13	SENT_347	[p19l8t1377r182b1437],
17	,	,	O	,	_	0	SENT_347	[p19l8t1377r182b1437],
18	and	CC	O	and	_	0	SENT_347	[p19l214t1358r335b1418],
19	efficient	JJ	O	efficient	conj_and	13	SENT_347	[p19l365t1358r672b1419],
20	.	.	O	.	_	0	SENT_347	[p19l365t1358r672b1419],

1	Therefore	RB	O	therefore	advmod	4	SENT_348	[p19l704t1358r1066b1430],
2	,	,	O	,	_	0	SENT_348	[p19l704t1358r1066b1430],
3	we	PRP	O	we	nsubj	4	SENT_348	[p19l1096t1378r1193b1419],
4	adopted	VBD	O	adopt	_	0	SENT_348	[p19l1226t1358r1498b1437],
5	the	DT	O	the	det	7	SENT_348	[p19l1527t1358r1630b1419],
6	latter	JJ	O	latter	amod	7	SENT_348	[p19l1662t1358r1839b1419],
7	method	NN	O	method	dobj	4	SENT_348	[p19l1868t1358r2146b1419],
8	.	.	O	.	_	0	SENT_348	[p19l1868t1358r2146b1419],

1	Although	IN	O	although	mark	16	SENT_349	[p19l8t1461r337b1539],
2	the	DT	O	the	det	3	SENT_349	[p19l372t1461r477b1522],
3	methods	NNS	O	method	nsubjpass	16	SENT_349	[p19l513t1461r806b1522],
4	suited	VBN	O	suit	partmod	3	SENT_349	[p19l847t1461r1052b1522],
5	for	IN	O	for	_	0	SENT_349	[p19l1087t1461r1189b1522],
6	the	DT	O	the	det	7	SENT_349	[p19l1222t1461r1326b1522],
7	analysis	NN	O	analysis	prep_for	4	SENT_349	[p19l1364t1461r1642b1540],
8	of	IN	O	of	_	0	SENT_349	[p19l1680t1461r1756b1522],
9	the	DT	O	the	det	12	SENT_349	[p19l1785t1461r1890b1522],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_349	[p19l1925t1462r2147b1522],
11	copy	NN	O	copy	nn	12	SENT_349	[p19l8t1583r179b1643],
12	number	NN	O	number	prep_of	7	SENT_349	[p19l216t1564r489b1625],
13	can	MD	O	can	aux	16	SENT_349	[p19l524t1573r762b1625],
14	not	RB	O	not	neg	16	SENT_349	[p19l524t1573r762b1625],
15	be	VB	O	be	auxpass	16	SENT_349	[p19l797t1564r879b1625],
16	determined	VBN	O	determine	advcl	26	SENT_349	[p19l914t1564r1331b1636],
17	,	,	O	,	_	0	SENT_349	[p19l914t1564r1331b1636],
18	standardization	NN	O	standardization	nsubjpass	26	SENT_349	[p19l1368t1564r1902b1625],
19	of	IN	O	of	_	0	SENT_349	[p19l1938t1564r2013b1625],
20	the	DT	O	the	det	24	SENT_349	[p19l2042t1564r2146b1625],
21	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_349	[p19l7t1668r224b1728],
22	copy	NN	O	copy	nn	24	SENT_349	[p19l247t1686r409b1746],
23	number	NN	O	number	nn	24	SENT_349	[p19l432t1667r691b1728],
24	analysis	NN	O	analysis	prep_of	18	SENT_349	[p19l713t1667r980b1746],
25	is	VBZ	O	be	auxpass	26	SENT_349	[p19l1008t1667r1060b1727],
26	required	VBN	O	require	_	0	SENT_349	[p19l1086t1667r1374b1746],
27	to	TO	O	to	aux	28	SENT_349	[p19l1398t1676r1462b1728],
28	evaluate	VB	O	evaluate	xcomp	26	SENT_349	[p19l1488t1667r1774b1728],
29	the	DT	O	the	det	32	SENT_349	[p19l1799t1667r1902b1728],
30	EGFR	NN	ORGANIZATION	egfr	nn	32	SENT_349	[p19l1927t1668r2147b1728],
31	copy	NN	O	copy	nn	32	SENT_349	[p19l8t1790r173b1850],
32	number	NN	O	number	dobj	28	SENT_349	[p19l198t1771r462b1832],
33	accurately	RB	O	accurately	advmod	28	SENT_349	[p19l486t1771r858b1850],
34	.	.	O	.	_	0	SENT_349	[p19l486t1771r858b1850],

1	Further	JJ	O	further	amod	2	SENT_350	[p19l128t1874r395b1934],
2	studies	NNS	O	study	nsubjpass	4	SENT_350	[p19l434t1874r680b1934],
3	are	VBP	O	be	auxpass	4	SENT_350	[p19l720t1893r826b1934],
4	required	VBN	O	require	_	0	SENT_350	[p19l862t1874r1165b1952],
5	to	TO	O	to	aux	6	SENT_350	[p19l1201t1883r1268b1935],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_350	[p19l1306t1874r1606b1934],
7	the	DT	O	the	det	9	SENT_350	[p19l1644t1874r1751b1934],
8	predictive	JJ	O	predictive	amod	9	SENT_350	[p19l1788t1874r2151b1952],
9	values	NNS	O	value	dobj	6	SENT_350	[p19l6t1977r227b2038],
10	of	IN	O	of	_	0	SENT_350	[p19l266t1977r342b2038],
11	some	DT	O	some	det	12	SENT_350	[p19l375t1996r555b2038],
12	biomarkers	NNS	O	biomarker	prep_of	9	SENT_350	[p19l590t1977r984b2038],
13	other	JJ	O	other	dep	12	SENT_350	[p19l1023t1977r1203b2038],
14	than	IN	O	than	_	0	SENT_350	[p19l1237t1977r1386b2038],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_350	[p19l1421t1978r1644b2038],
16	mutation	NN	O	mutation	prep_than	12	SENT_350	[p19l1679t1977r1992b2038],
17	and	CC	O	and	_	0	SENT_350	[p19l2029t1977r2152b2038],
18	the	DT	O	the	det	21	SENT_350	[p19l6t2081r109b2141],
19	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_350	[p19l139t2082r360b2142],
20	copy	NN	O	copy	nn	21	SENT_350	[p19l390t2100r554b2159],
21	number	NN	O	number	prep_than	12	SENT_350	[p19l582t2081r861b2153],
22	,	,	O	,	_	0	SENT_350	[p19l582t2081r861b2153],
23	and	CC	O	and	_	0	SENT_350	[p19l889t2081r1009b2141],
24	future	JJ	DATE	future	amod	26	SENT_350	[p19l1036t2081r1235b2141],
25	clinical	JJ	O	clinical	amod	26	SENT_350	[p19l1263t2081r1508b2141],
26	trials	NNS	O	trial	nsubj	28	SENT_350	[p19l1536t2081r1700b2141],
27	may	MD	O	may	aux	28	SENT_350	[p19l1729t2100r1874b2159],
28	need	VB	O	need	conj_and	4	SENT_350	[p19l1902t2081r2061b2141],
29	to	TO	O	to	aux	30	SENT_350	[p19l2087t2090r2151b2142],
30	incorporate	VB	O	incorporate	xcomp	28	SENT_350	[p19l7t2185r430b2263],
31	several	JJ	O	several	amod	33	SENT_350	[p19l473t2185r738b2245],
32	predictive	JJ	O	predictive	amod	33	SENT_350	[p19l776t2185r1160b2263],
33	biomarkers	NNS	O	biomarker	dobj	30	SENT_350	[p19l1198t2185r1623b2246],
34	in	IN	O	in	_	0	SENT_350	[p19l1665t2185r1735b2244],
35	molecular	JJ	O	molecular	prep_in	30	SENT_350	[p19l1773t2185r2153b2246],
36	targeted	VBN	O	target	partmod	35	SENT_350	[p19l6t2289r285b2367],
37	therapy	NN	O	therapy	dobj	36	SENT_350	[p19l308t2289r566b2367],
38	including	VBG	O	include	_	0	SENT_350	[p19l591t2289r916b2367],
39	gefitinib	NN	O	gefitinib	prep_including	37	SENT_350	[p19l942t2289r1232b2367],
40	and	CC	O	and	_	0	SENT_350	[p19l1259t2289r1381b2349],
41	erlotinib	NN	O	erlotinib	prep_including	37	SENT_350	[p19l1405t2289r1717b2350],
42	.	.	O	.	_	0	SENT_350	[p19l1405t2289r1717b2350],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_351	[p19l6t2503r723b2581],

1	The	DT	O	the	det	2	SENT_352	[p19l6t2717r142b2777],
2	authors	NNS	O	author	nsubj	4	SENT_352	[p19l181t2717r440b2778],
3	would	MD	O	would	aux	4	SENT_352	[p19l479t2717r700b2778],
4	like	VB	O	like	_	0	SENT_352	[p19l736t2717r868b2777],
5	to	TO	O	to	aux	6	SENT_352	[p19l905t2726r971b2778],
6	thank	VB	O	thank	xcomp	4	SENT_352	[p19l1008t2717r1207b2777],
7	Dr	NNP	O	Dr	nn	9	SENT_352	[p19l1242t2719r1335b2776],
8	Xiaojun	NNP	PERSON	Xiaojun	nn	9	SENT_352	[p19l1369t2717r1657b2795],
9	Zhao	NNP	PERSON	Zhao	dobj	6	SENT_352	[p19l1693t2717r1873b2778],
10	for	IN	O	for	_	0	SENT_352	[p19l1911t2717r2015b2778],
11	his	PRP$	O	he	poss	14	SENT_352	[p19l2049t2717r2150b2777],
12	excellent	JJ	O	excellent	amod	14	SENT_352	[p19l7t2820r319b2880],
13	technical	JJ	O	technical	amod	14	SENT_352	[p19l346t2820r657b2880],
14	assistance	NN	O	assistance	prep_for	9	SENT_352	[p19l688t2820r1031b2880],
15	with	IN	O	with	_	0	SENT_352	[p19l1060t2820r1212b2880],
16	DNA	NN	O	dna	nn	18	SENT_352	[p19l1240t2821r1426b2881],
17	amplification	NN	O	amplification	nn	18	SENT_352	[p19l1456t2820r1916b2898],
18	assay	NN	O	assay	prep_with	14	SENT_352	[p19l1946t2839r2153b2898],
19	,	,	O	,	_	0	SENT_352	[p19l1946t2839r2153b2898],
20	and	CC	O	and	_	0	SENT_352	[p19l8t2923r128b2983],
21	Dr	NNP	O	Dr	nn	23	SENT_352	[p19l154t2925r245b2982],
22	Naoya	NNP	PERSON	Naoya	nn	23	SENT_352	[p19l269t2925r492b3001],
23	Hosono	NNP	PERSON	Hosono	dobj	6	SENT_352	[p19l517t2925r780b2984],
24	for	IN	O	for	_	0	SENT_352	[p19l808t2923r907b2984],
25	the	DT	O	the	det	28	SENT_352	[p19l932t2923r1034b2983],
26	TaqMan	NNP	O	TaqMan	nn	28	SENT_352	[p19l1061t2925r1349b3001],
27	PCR	NN	O	pcr	nn	28	SENT_352	[p19l1376t2924r1536b2984],
28	assay	NN	O	assay	prep_for	23	SENT_352	[p19l1564t2942r1764b3001],
29	.	.	O	.	_	0	SENT_352	[p19l1564t2942r1764b3001],

1	This	DT	O	this	det	2	SENT_353	[p19l1792t2923r1940b2983],
2	study	NN	O	study	nsubjpass	4	SENT_353	[p19l1972t2923r2151b3001],
3	was	VBD	O	be	auxpass	4	SENT_353	[p19l7t3045r144b3086],
4	supported	VBN	O	support	_	0	SENT_353	[p19l188t3026r560b3104],
5	by	IN	O	by	_	0	SENT_353	[p19l597t3026r686b3104],
6	a	DT	O	a	det	7	SENT_353	[p19l728t3045r764b3086],
7	grant	NN	O	grant	agent	4	SENT_353	[p19l803t3035r996b3104],
8	for	IN	O	for	_	0	SENT_353	[p19l1034t3026r1143b3087],
9	cancer	NN	O	cancer	nn	10	SENT_353	[p19l1181t3045r1428b3086],
10	research	NN	O	research	prep_for	7	SENT_353	[p19l1464t3026r1782b3086],
11	from	IN	O	from	_	0	SENT_353	[p19l1821t3026r2002b3087],
12	the	DT	O	the	det	13	SENT_353	[p19l2039t3026r2151b3086],
13	Ministry	NNP	ORGANIZATION	Ministry	prep_from	4	SENT_353	[p19l6t3129r348b3207],
14	of	IN	ORGANIZATION	of	_	0	SENT_353	[p19l391t3129r472b3190],
15	Education	NNP	ORGANIZATION	Education	prep_of	13	SENT_353	[p19l508t3129r939b3201],
16	,	,	O	,	_	0	SENT_353	[p19l508t3129r939b3201],
17	Culture	NNP	O	Culture	prep_of	13	SENT_353	[p19l980t3129r1306b3201],
18	,	,	O	,	_	0	SENT_353	[p19l980t3129r1306b3201],
19	Sports	NNP	O	Sports	prep_of	13	SENT_353	[p19l1348t3129r1627b3207],
20	,	,	O	,	_	0	SENT_353	[p19l1348t3129r1627b3207],
21	Science	NNP	O	Science	prep_of	13	SENT_353	[p19l1670t3129r1974b3190],
22	and	CC	O	and	_	0	SENT_353	[p19l2017t3129r2152b3189],
23	Technology	NNP	O	Technology	prep_of	13	SENT_353	[p19l6t3232r418b3310],
24	of	IN	O	of	_	0	SENT_353	[p19l444t3232r519b3293],
25	Japan	NNP	LOCATION	Japan	prep_of	13	SENT_353	[p19l537t3233r733b3310],
26	and	CC	O	and	_	0	SENT_353	[p19l759t3232r881b3292],
27	Astra	NNP	ORGANIZATION	Astra	nn	30	SENT_353	[p19l904t3233r1092b3292],
28	Zeneca	NNP	ORGANIZATION	Zeneca	nn	30	SENT_353	[p19l1114t3233r1364b3292],
29	Research	NNP	ORGANIZATION	Research	nn	30	SENT_353	[p19l1387t3232r1704b3292],
30	grant	NN	O	grant	conj_and	25	SENT_353	[p19l1728t3241r1905b3310],
31	2004	CD	DATE	2004	num	30	SENT_353	[p19l1929t3232r2120b3292],
32	.	.	O	.	_	0	SENT_353	[p19l1929t3232r2120b3292],

1	References	NNS	O	reference	_	0	SENT_354	[p19l6t3462r409b3524],

1	.	.	O	.	_	0	SENT_355	[p20l91t72r406b143],

1	Baselga	NNP	PERSON	Baselga	nn	2	SENT_356	[p20l91t72r406b143],
2	J	NNP	PERSON	J	_	0	SENT_356	[p20l440t74r495b137],
3	,	,	O	,	_	0	SENT_356	[p20l440t74r495b137],
4	Rischin	NNP	PERSON	Rischin	nn	5	SENT_356	[p20l530t73r797b127],
5	D	NNP	O	D	appos	2	SENT_356	[p20l833t74r913b137],
6	,	,	O	,	_	0	SENT_356	[p20l833t74r913b137],
7	Ranson	NNP	O	Ranson	nn	8	SENT_356	[p20l948t74r1205b127],
8	M	NNP	O	M	appos	2	SENT_356	[p20l1241t74r1334b137],
9	,	,	O	,	_	0	SENT_356	[p20l1241t74r1334b137],
10	et	FW	O	et	nn	11	SENT_356	[p20l1371t83r1432b127],
11	al	FW	O	al	appos	2	SENT_356	[p20l1465t73r1530b127],
12	:	:	O	:	_	0	SENT_356	[p20l1571t90r1579b127],
13	Phase	NN	O	phase	dep	2	SENT_356	[p20l1621t73r1821b127],
14	I	PRP	O	I	nsubj	15	SENT_356	[p20l1858t74r1881b126],
15	safety	VBP	O	safety	rcmod	13	SENT_356	[p20l1921t72r2153b143],
16	,	,	O	,	_	0	SENT_356	[p20l1921t72r2153b143],
17	pharmacokinetic	JJ	O	pharmacokinetic	dep	2	SENT_356	[p20l128t150r704b220],
18	,	,	O	,	_	0	SENT_356	[p20l128t150r704b220],
19	and	CC	O	and	_	0	SENT_356	[p20l738t150r853b204],
20	pharmacodynamic	JJ	O	pharmacodynamic	amod	21	SENT_356	[p20l885t150r1493b220],
21	trial	NN	O	trial	conj_and	13	SENT_356	[p20l1528t149r1661b204],
22	of	IN	O	of	_	0	SENT_356	[p20l1695t149r1765b204],
23	ZD1839	NN	O	zd1839	prep_of	21	SENT_356	[p20l1793t150r2086b214],
24	,	,	O	,	_	0	SENT_356	[p20l1793t150r2086b214],
25	a	DT	O	a	det	34	SENT_356	[p20l2121t167r2153b204],
26	selective	JJ	O	selective	amod	34	SENT_356	[p20l132t226r400b281],
27	oral	JJ	O	oral	amod	34	SENT_356	[p20l433t226r552b281],
28	epidermal	JJ	O	epidermal	amod	34	SENT_356	[p20l583t226r894b297],
29	growth	NN	O	growth	nn	34	SENT_356	[p20l926t227r1145b297],
30	factor	NN	O	factor	nn	34	SENT_356	[p20l1176t226r1358b281],
31	receptor	NN	O	receptor	nn	34	SENT_356	[p20l1386t235r1643b297],
32	tyrosine	NN	O	tyrosine	nn	34	SENT_356	[p20l1673t227r1922b297],
33	kinase	NN	O	kinase	nn	34	SENT_356	[p20l1953t227r2151b281],
34	inhibitor	NN	O	inhibitor	appos	23	SENT_356	[p20l130t304r417b368],
35	,	,	O	,	_	0	SENT_356	[p20l130t304r417b368],
36	in	IN	O	in	_	0	SENT_356	[p20l442t304r501b357],
37	patients	NNS	O	patient	prep_in	23	SENT_356	[p20l524t304r765b374],
38	with	IN	O	with	_	0	SENT_356	[p20l792t304r929b358],
39	five	CD	NUMBER	five	prep_with	37	SENT_356	[p20l954t303r1073b358],
40	selected	VBN	O	select	partmod	23	SENT_356	[p20l1101t303r1349b358],
41	solid	JJ	O	solid	amod	43	SENT_356	[p20l1376t303r1524b358],
42	tumor	NN	O	tumor	nn	43	SENT_356	[p20l1549t312r1735b358],
43	types	NNS	O	type	dobj	40	SENT_356	[p20l1758t312r1940b374],
44	.	.	O	.	_	0	SENT_356	[p20l1758t312r1940b374],

1	J	NNP	O	J	nn	3	SENT_357	[p20l1965t305r1994b358],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_357	[p20l2020t303r2152b359],
3	Oncol	NNP	PERSON	Oncol	_	0	SENT_357	[p20l131t381r318b437],
4	20	CD	NUMBER	20	num	3	SENT_357	[p20l342t382r433b436],
5	:	:	O	:	_	0	SENT_357	[p20l342t382r433b436],
6	4292-4302	CD	DATE	4292-4302	dep	3	SENT_357	[p20l460t382r817b446],
7	,	,	DATE	,	_	0	SENT_357	[p20l460t382r817b446],
8	2002	CD	DATE	2002	appos	6	SENT_357	[p20l839t382r1011b437],
9	.	.	O	.	_	0	SENT_357	[p20l839t382r1011b437],

1	.	.	O	.	_	0	SENT_358	[p20l92t505r101b515],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_359	[p20l129t460r416b515],
2	M	NNP	O	M	_	0	SENT_359	[p20l448t461r539b524],
3	,	,	O	,	_	0	SENT_359	[p20l448t461r539b524],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_359	[p20l572t461r745b515],
5	S	NNP	O	S	appos	2	SENT_359	[p20l782t460r844b524],
6	,	,	O	,	_	0	SENT_359	[p20l782t460r844b524],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_359	[p20l877t460r1185b515],
8	G	NNP	PERSON	G	appos	2	SENT_359	[p20l1220t460r1297b524],
9	,	,	O	,	_	0	SENT_359	[p20l1220t460r1297b524],
10	et	FW	O	et	nn	11	SENT_359	[p20l1331t470r1389b515],
11	al	FW	O	al	appos	2	SENT_359	[p20l1420t460r1500b515],
12	:	:	O	:	_	0	SENT_359	[p20l1420t460r1500b515],
13	Multi	JJ	O	multi	amod	14	SENT_359	[p20l1539t459r2151b515],
14	—	NN	O	—	dep	2	SENT_359	[p20l1539t459r2151b515],
15	institutional	JJ	O	institutional	amod	17	SENT_359	[p20l1539t459r2151b515],
16	randomized	JJ	O	randomized	amod	17	SENT_359	[p20l129t537r514b591],
17	phase	NN	O	phase	rcmod	14	SENT_359	[p20l546t537r730b607],
18	II	CD	NUMBER	ii	num	19	SENT_359	[p20l764t538r816b590],
19	trial	NN	O	trial	dobj	17	SENT_359	[p20l850t536r981b591],
20	of	IN	O	of	_	0	SENT_359	[p20l1015t536r1085b591],
21	gefitinib	NN	O	gefitinib	prep_of	19	SENT_359	[p20l1114t536r1390b607],
22	for	IN	O	for	prep	17	SENT_359	[p20l1425t536r1519b591],
23	previously	RB	DATE	previously	pcomp	22	SENT_359	[p20l1550t536r1895b607],
24	treated	VBN	O	treat	partmod	14	SENT_359	[p20l1929t537r2152b591],
25	patients	NNS	O	patient	dobj	24	SENT_359	[p20l128t614r369b684],
26	with	IN	O	with	_	0	SENT_359	[p20l395t614r532b668],
27	advanced	JJ	O	advanced	amod	32	SENT_359	[p20l558t614r850b668],
28	non-small	JJ	O	non-small	amod	32	SENT_359	[p20l873t613r1323b668],
29	—	NN	O	—	nn	32	SENT_359	[p20l873t613r1323b668],
30	cell	NN	O	cell	nn	32	SENT_359	[p20l873t613r1323b668],
31	lung	NN	O	lung	nn	32	SENT_359	[p20l1347t613r1483b684],
32	cancer	NN	O	cancer	prep_with	24	SENT_359	[p20l1509t631r1729b668],
33	.	.	O	.	_	0	SENT_359	[p20l1509t631r1729b668],

1	J	NNP	O	J	nn	3	SENT_360	[p20l1753t615r1782b668],
2	Clin	NNP	O	Clin	nn	3	SENT_360	[p20l1807t613r1939b669],
3	Oncol	NNP	O	Oncol	_	0	SENT_360	[p20l1964t613r2152b668],
4	21	CD	NUMBER	21	num	3	SENT_360	[p20l131t692r222b746],
5	:	:	O	:	_	0	SENT_360	[p20l131t692r222b746],
6	2237-2246	CD	DATE	2237-2246	dep	3	SENT_360	[p20l250t691r606b756],
7	,	,	DATE	,	_	0	SENT_360	[p20l250t691r606b756],
8	2003	CD	DATE	2003	appos	6	SENT_360	[p20l628t692r800b747],
9	.	.	O	.	_	0	SENT_360	[p20l628t692r800b747],

1	.	.	O	.	_	0	SENT_361	[p20l91t814r101b823],

1	Giaccone	NNP	PERSON	Giaccone	nn	2	SENT_362	[p20l130t769r453b823],
2	G	NNP	PERSON	G	_	0	SENT_362	[p20l490t769r569b833],
3	,	,	O	,	_	0	SENT_362	[p20l490t769r569b833],
4	Herbst	NNP	ORGANIZATION	Herbst	nn	5	SENT_362	[p20l604t769r833b823],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_362	[p20l868t769r991b833],
6	,	,	O	,	_	0	SENT_362	[p20l868t769r991b833],
7	Manegold	NNP	ORGANIZATION	Manegold	nn	8	SENT_362	[p20l1025t768r1372b839],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_362	[p20l1408t769r1482b833],
9	,	,	O	,	_	0	SENT_362	[p20l1408t769r1482b833],
10	et	FW	O	et	nn	11	SENT_362	[p20l1519t779r1579b823],
11	al	FW	O	al	appos	2	SENT_362	[p20l1612t769r1696b823],
12	:	:	O	:	_	0	SENT_362	[p20l1612t769r1696b823],
13	Gefitinib	NNP	O	Gefitinib	dep	2	SENT_362	[p20l1738t768r2051b823],
14	in	IN	O	in	_	0	SENT_362	[p20l2089t769r2152b822],
15	combination	NN	O	combination	prep_in	13	SENT_362	[p20l130t846r524b900],
16	with	IN	O	with	_	0	SENT_362	[p20l557t846r695b900],
17	gemcitabine	NN	O	gemcitabine	prep_with	15	SENT_362	[p20l728t846r1112b916],
18	and	CC	O	and	_	0	SENT_362	[p20l1147t846r1257b900],
19	cisplatin	NN	O	cisplatin	conj_and	17	SENT_362	[p20l1289t845r1557b916],
20	in	IN	O	in	_	0	SENT_362	[p20l1589t846r1648b899],
21	advanced	JJ	O	advanced	amod	24	SENT_362	[p20l1681t846r1978b900],
22	nonsmall-cell	JJ	O	nonsmall-cell	amod	24	SENT_362	[p20l2009t863r2150b900, p20l132t922r449b977],
23	lung	NN	O	lung	nn	24	SENT_362	[p20l483t922r624b993],
24	cancer	NN	O	cancer	prep_in	13	SENT_362	[p20l658t940r885b977],
25	:	:	O	:	_	0	SENT_362	[p20l658t940r885b977],
26	a	DT	O	a	det	27	SENT_362	[p20l925t940r958b977],
27	phase	NN	O	phase	dep	2	SENT_362	[p20l988t923r1171b993],
28	III	CD	NUMBER	iii	num	29	SENT_362	[p20l1205t924r1283b976],
29	trial	NN	O	trial	dep	27	SENT_362	[p20l1316t922r1446b977],
30	-	:	O	-	_	0	SENT_362	[p20l1481t955r1501b961],
31	INTACT	NN	O	intact	dep	2	SENT_362	[p20l1536t923r1829b978],
32	1	CD	NUMBER	1	dep	31	SENT_362	[p20l1870t924r1919b977],
33	.	.	O	.	_	0	SENT_362	[p20l1870t924r1919b977],

1	J	NNP	O	J	nn	3	SENT_363	[p20l1953t924r1982b977],
2	Clin	NNP	O	Clin	nn	3	SENT_363	[p20l2015t922r2152b978],
3	Oncol	NNP	O	Oncol	_	0	SENT_363	[p20l131t1000r318b1056],
4	22	CD	NUMBER	22	num	3	SENT_363	[p20l342t1001r433b1055],
5	:	:	O	:	_	0	SENT_363	[p20l342t1001r433b1055],
6	777-784	CD	NUMBER	777-784	dep	3	SENT_363	[p20l460t1001r739b1065],
7	,	,	O	,	_	0	SENT_363	[p20l460t1001r739b1065],
8	2004	CD	DATE	2004	appos	6	SENT_363	[p20l761t1001r932b1056],
9	.	.	O	.	_	0	SENT_363	[p20l761t1001r932b1056],

1	.	.	O	.	_	0	SENT_364	[p20l92t1123r101b1132],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_365	[p20l130t1078r260b1132],
2	MG	NN	PERSON	mg	_	0	SENT_365	[p20l288t1078r433b1142],
3	,	,	O	,	_	0	SENT_365	[p20l288t1078r433b1142],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_365	[p20l458t1077r659b1132],
5	RB	NN	O	rb	appos	2	SENT_365	[p20l686t1079r809b1142],
6	,	,	O	,	_	0	SENT_365	[p20l686t1079r809b1142],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_365	[p20l834t1078r1042b1132],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_365	[p20l1066t1078r1181b1142],
9	,	,	O	,	_	0	SENT_365	[p20l1066t1078r1181b1142],
10	et	FW	O	et	nn	11	SENT_365	[p20l1207t1088r1263b1132],
11	al	FW	O	al	appos	2	SENT_365	[p20l1286t1078r1361b1132],
12	:	:	O	:	_	0	SENT_365	[p20l1286t1078r1361b1132],
13	Efficacy	NN	O	efficacy	dep	2	SENT_365	[p20l1393t1077r1655b1148],
14	of	IN	O	of	_	0	SENT_365	[p20l1683t1077r1750b1132],
15	gefitinib	NN	O	gefitinib	prep_of	13	SENT_365	[p20l1772t1077r2055b1148],
16	,	,	O	,	_	0	SENT_365	[p20l1772t1077r2055b1148],
17	an	DT	O	a	det	18	SENT_365	[p20l2082t1095r2152b1132],
18	inhibitor	NN	O	inhibitor	appos	2	SENT_365	[p20l130t1155r424b1209],
19	of	IN	O	of	_	0	SENT_365	[p20l459t1154r529b1209],
20	the	DT	O	the	det	26	SENT_365	[p20l559t1155r658b1209],
21	epidermal	JJ	O	epidermal	amod	26	SENT_365	[p20l694t1154r1030b1225],
22	growth	NN	O	growth	nn	26	SENT_365	[p20l1066t1155r1302b1225],
23	factor	NN	O	factor	nn	26	SENT_365	[p20l1336t1154r1534b1209],
24	receptor	NN	O	receptor	nn	26	SENT_365	[p20l1566t1163r1846b1225],
25	tyrosine	NN	O	tyrosine	nn	26	SENT_365	[p20l1879t1155r2151b1225],
26	kinase	NN	O	kinase	prep_of	18	SENT_365	[p20l128t1232r348b1296],
27	,	,	O	,	_	0	SENT_365	[p20l128t1232r348b1296],
28	in	IN	O	in	_	0	SENT_365	[p20l370t1232r429b1285],
29	symptomatic	JJ	O	symptomatic	amod	30	SENT_365	[p20l454t1232r852b1302],
30	patients	NNS	O	patient	prep_in	2	SENT_365	[p20l876t1232r1116b1302],
31	with	IN	O	with	_	0	SENT_365	[p20l1141t1232r1278b1286],
32	non-small	JJ	O	non-small	amod	35	SENT_365	[p20l1301t1231r1612b1286],
33	cell	NN	O	cell	nn	35	SENT_365	[p20l1635t1231r1745b1286],
34	lung	NN	O	lung	nn	35	SENT_365	[p20l1769t1231r1904b1302],
35	cancer	NN	O	cancer	prep_with	30	SENT_365	[p20l1929t1249r2147b1286],
36	:	:	O	:	_	0	SENT_365	[p20l1929t1249r2147b1286],
37	a	DT	O	a	det	39	SENT_365	[p20l131t1327r163b1364],
38	randomized	JJ	O	randomized	amod	39	SENT_365	[p20l183t1310r552b1365],
39	trial	NN	O	trial	dep	30	SENT_365	[p20l572t1309r715b1365],
40	.	.	O	.	_	0	SENT_365	[p20l572t1309r715b1365],

1	JAMA	NN	O	jama	_	0	SENT_366	[p20l737t1310r948b1365],
2	290	CD	NUMBER	290	num	1	SENT_366	[p20l971t1310r1102b1365],
3	:	:	O	:	_	0	SENT_366	[p20l971t1310r1102b1365],
4	2149-2158	CD	DATE	2149-2158	dep	1	SENT_366	[p20l1130t1309r1486b1374],
5	,	,	DATE	,	_	0	SENT_366	[p20l1130t1309r1486b1374],
6	2003	CD	DATE	2003	appos	4	SENT_366	[p20l1508t1310r1680b1365],
7	.	.	O	.	_	0	SENT_366	[p20l1508t1310r1680b1365],

1	.	.	O	.	_	0	SENT_367	[p20l91t1387r340b1441],

1	Rusch	NNP	PERSON	Rusch	nn	2	SENT_368	[p20l91t1387r340b1441],
2	V	NNP	PERSON	V	_	0	SENT_368	[p20l375t1388r455b1451],
3	,	,	O	,	_	0	SENT_368	[p20l375t1388r455b1451],
4	Baselga	NNP	PERSON	Baselga	nn	5	SENT_368	[p20l489t1386r761b1457],
5	J	NNP	PERSON	J	appos	2	SENT_368	[p20l795t1388r848b1451],
6	,	,	O	,	_	0	SENT_368	[p20l795t1388r848b1451],
7	Cordon-Cardo	NNP	PERSON	Cordon-Cardo	nn	8	SENT_368	[p20l884t1387r1378b1442],
8	C	NNP	O	C	appos	2	SENT_368	[p20l1415t1387r1490b1451],
9	,	,	O	,	_	0	SENT_368	[p20l1415t1387r1490b1451],
10	et	FW	O	et	nn	11	SENT_368	[p20l1525t1397r1586b1441],
11	al	FW	O	al	appos	2	SENT_368	[p20l1618t1387r1702b1441],
12	:	:	O	:	_	0	SENT_368	[p20l1618t1387r1702b1441],
13	Differential	JJ	O	differential	amod	14	SENT_368	[p20l1743t1386r2151b1441],
14	expression	NN	O	expression	dep	2	SENT_368	[p20l130t1464r487b1534],
15	of	IN	O	of	_	0	SENT_368	[p20l521t1463r592b1518],
16	the	DT	O	the	det	20	SENT_368	[p20l621t1464r719b1518],
17	epidermal	JJ	O	epidermal	amod	20	SENT_368	[p20l754t1463r1086b1534],
18	growth	NN	O	growth	nn	20	SENT_368	[p20l1122t1464r1354b1534],
19	factor	NN	O	factor	nn	20	SENT_368	[p20l1388t1463r1584b1518],
20	receptor	NN	O	receptor	prep_of	14	SENT_368	[p20l1616t1471r1891b1534],
21	and	CC	O	and	_	0	SENT_368	[p20l1926t1464r2041b1518],
22	its	PRP$	O	its	poss	23	SENT_368	[p20l2075t1464r2150b1518],
23	ligands	NNS	O	ligand	conj_and	14	SENT_368	[p20l130t1540r361b1611],
24	in	IN	O	in	_	0	SENT_368	[p20l397t1541r457b1594],
25	primary	JJ	O	primary	amod	29	SENT_368	[p20l489t1541r745b1611],
26	non-small	JJ	O	non-small	amod	29	SENT_368	[p20l778t1540r1102b1595],
27	cell	NN	O	cell	nn	29	SENT_368	[p20l1136t1540r1251b1595],
28	lung	NN	O	lung	nn	29	SENT_368	[p20l1285t1540r1425b1611],
29	cancers	NNS	O	cancer	prep_in	23	SENT_368	[p20l1460t1558r1700b1595],
30	and	CC	O	and	_	0	SENT_368	[p20l1737t1541r1850b1595],
31	adjacent	JJ	O	adjacent	amod	33	SENT_368	[p20l1884t1541r2153b1611],
32	benign	JJ	O	benign	amod	33	SENT_368	[p20l128t1618r341b1688],
33	lung	NN	O	lung	prep_in	23	SENT_368	[p20l362t1617r517b1688],
34	.	.	O	.	_	0	SENT_368	[p20l362t1617r517b1688],

1	Cancer	NN	O	cancer	_	0	SENT_369	[p20l541t1618r761b1673],
2	Res	NNP	O	Res	dep	1	SENT_369	[p20l781t1619r895b1672],
3	53	CD	NUMBER	53	num	2	SENT_369	[p20l920t1617r1011b1672],
4	:	:	O	:	_	0	SENT_369	[p20l920t1617r1011b1672],
5	2379-2385	CD	DATE	2379-2385	dep	1	SENT_369	[p20l1039t1617r1395b1682],
6	,	,	DATE	,	_	0	SENT_369	[p20l1039t1617r1395b1682],
7	1993	CD	DATE	1993	appos	5	SENT_369	[p20l1424t1618r1589b1673],
8	.	.	O	.	_	0	SENT_369	[p20l1424t1618r1589b1673],

1	.	.	O	.	_	0	SENT_370	[p20l91t1740r101b1749],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_371	[p20l129t1695r327b1765],
2	TJ	NNP	PERSON	TJ	_	0	SENT_371	[p20l357t1696r454b1759],
3	,	,	O	,	_	0	SENT_371	[p20l357t1696r454b1759],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_371	[p20l482t1694r610b1749],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_371	[p20l640t1696r789b1759],
6	,	,	O	,	_	0	SENT_371	[p20l640t1696r789b1759],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_371	[p20l820t1694r1078b1749],
8	R	NNP	PERSON	R	appos	2	SENT_371	[p20l1105t1696r1177b1759],
9	,	,	O	,	_	0	SENT_371	[p20l1105t1696r1177b1759],
10	et	FW	O	et	nn	11	SENT_371	[p20l1206t1705r1262b1749],
11	al	FW	O	al	appos	2	SENT_371	[p20l1289t1695r1364b1749],
12	:	:	O	:	_	0	SENT_371	[p20l1289t1695r1364b1749],
13	Activating	VBG	O	activate	amod	14	SENT_371	[p20l1399t1695r1726b1765],
14	mutations	NNS	O	mutation	dep	2	SENT_371	[p20l1757t1695r2061b1749],
15	in	IN	O	in	_	0	SENT_371	[p20l2093t1695r2152b1748],
16	the	DT	O	the	det	19	SENT_371	[p20l129t1772r222b1826],
17	epidermal	JJ	O	epidermal	amod	19	SENT_371	[p20l250t1771r560b1842],
18	growth	NN	O	growth	nn	19	SENT_371	[p20l588t1772r807b1842],
19	factor	NN	O	factor	prep_in	14	SENT_371	[p20l833t1771r1015b1826],
20	receptor	NN	O	receptor	nn	22	SENT_371	[p20l1039t1780r1296b1842],
21	underlying	VBG	O	underlie	amod	22	SENT_371	[p20l1320t1771r1657b1842],
22	responsiveness	NN	O	responsiveness	dep	14	SENT_371	[p20l1684t1772r2150b1842],
23	of	IN	O	of	_	0	SENT_371	[p20l130t1848r198b1903],
24	non-small	JJ	O	non-small	amod	28	SENT_371	[p20l224t1848r676b1903],
25	—	NN	O	—	nn	28	SENT_371	[p20l224t1848r676b1903],
26	cell	NN	O	cell	nn	28	SENT_371	[p20l224t1848r676b1903],
27	lung	NN	O	lung	nn	28	SENT_371	[p20l708t1848r844b1919],
28	cancer	NN	O	cancer	prep_of	22	SENT_371	[p20l877t1866r1081b1903],
29	to	TO	O	to	_	0	SENT_371	[p20l1111t1857r1169b1903],
30	gefitinib	NN	O	gefitinib	prep_to	28	SENT_371	[p20l1203t1848r1485b1919],
31	.	.	O	.	_	0	SENT_371	[p20l1203t1848r1485b1919],

1	N	NN	O	n	nn	3	SENT_372	[p20l1517t1850r1572b1903],
2	Engl	NNP	O	Engl	nn	3	SENT_372	[p20l1603t1848r1749b1919],
3	J	NNP	O	J	nsubj	4	SENT_372	[p20l1781t1850r1809b1903],
4	Med	VBD	O	med	_	0	SENT_372	[p20l1841t1849r1983b1903],
5	350	CD	NUMBER	350	num	7	SENT_372	[p20l2017t1848r2147b1903],
6	:	:	O	:	_	0	SENT_372	[p20l2017t1848r2147b1903],
7	2129-2139	CD	DATE	2129-2139	dobj	4	SENT_372	[p20l131t1927r487b1991],
8	,	,	DATE	,	_	0	SENT_372	[p20l131t1927r487b1991],
9	2004	CD	DATE	2004	appos	7	SENT_372	[p20l509t1927r680b1982],
10	.	.	O	.	_	0	SENT_372	[p20l509t1927r680b1982],

1	.	.	O	.	_	0	SENT_373	[p20l92t2049r101b2058],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_374	[p20l129t2005r280b2058],
2	JG	NNP	O	JG	_	0	SENT_374	[p20l314t2004r423b2068],
3	,	,	O	,	_	0	SENT_374	[p20l314t2004r423b2068],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_374	[p20l455t2005r638b2058],
5	PA	NN	PERSON	pa	appos	2	SENT_374	[p20l672t2004r795b2068],
6	,	,	O	,	_	0	SENT_374	[p20l672t2004r795b2068],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_374	[p20l826t2005r945b2058],
8	JC	NNP	PERSON	JC	appos	2	SENT_374	[p20l979t2004r1084b2068],
9	,	,	O	,	_	0	SENT_374	[p20l979t2004r1084b2068],
10	et	FW	O	et	nn	11	SENT_374	[p20l1117t2014r1175b2058],
11	al	FW	O	al	appos	2	SENT_374	[p20l1206t2004r1285b2058],
12	:	:	O	:	_	0	SENT_374	[p20l1206t2004r1285b2058],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_374	[p20l1323t2004r1527b2058],
14	mutations	NNS	O	mutation	dep	2	SENT_374	[p20l1560t2004r1880b2058],
15	in	IN	O	in	_	0	SENT_374	[p20l1915t2004r1976b2057],
16	lung	NN	O	lung	nn	17	SENT_374	[p20l2009t2003r2151b2074],
17	cancer	NN	O	cancer	prep_in	14	SENT_374	[p20l130t2098r351b2135],
18	:	:	O	:	_	0	SENT_374	[p20l130t2098r351b2135],
19	correlation	NN	O	correlation	dep	2	SENT_374	[p20l389t2080r731b2135],
20	with	IN	O	with	_	0	SENT_374	[p20l763t2081r902b2135],
21	clinical	JJ	O	clinical	amod	22	SENT_374	[p20l934t2080r1165b2135],
22	response	NN	O	response	prep_with	19	SENT_374	[p20l1197t2098r1473b2151],
23	to	TO	O	to	_	0	SENT_374	[p20l1505t2089r1564b2135],
24	gefitinib	NN	O	gefitinib	nn	25	SENT_374	[p20l1598t2080r1863b2151],
25	therapy	NN	O	therapy	prep_to	22	SENT_374	[p20l1896t2081r2151b2151],
26	.	.	O	.	_	0	SENT_374	[p20l1896t2081r2151b2151],

1	Science	NNP	O	Science	_	0	SENT_375	[p20l131t2159r370b2214],
2	304	CD	NUMBER	304	num	1	SENT_375	[p20l395t2159r524b2213],
3	:	:	O	:	_	0	SENT_375	[p20l395t2159r524b2213],
4	1497-1500	CD	DATE	1497-1500	dep	1	SENT_375	[p20l559t2158r908b2223],
5	,	,	DATE	,	_	0	SENT_375	[p20l559t2158r908b2223],
6	2004	CD	DATE	2004	appos	4	SENT_375	[p20l930t2159r1102b2214],
7	.	.	O	.	_	0	SENT_375	[p20l930t2159r1102b2214],

1	.	.	O	.	_	0	SENT_376	[p20l92t2281r101b2290],

1	Pao	NNP	O	Pao	nn	2	SENT_377	[p20l129t2237r251b2290],
2	W	NNP	O	W	_	0	SENT_377	[p20l287t2237r384b2300],
3	,	,	O	,	_	0	SENT_377	[p20l287t2237r384b2300],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_377	[p20l417t2235r632b2290],
5	V	NNP	O	V	appos	2	SENT_377	[p20l666t2237r745b2300],
6	,	,	O	,	_	0	SENT_377	[p20l666t2237r745b2300],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_377	[p20l778t2236r1112b2290],
8	M	NNP	O	M	appos	2	SENT_377	[p20l1147t2237r1239b2300],
9	,	,	O	,	_	0	SENT_377	[p20l1147t2237r1239b2300],
10	et	FW	O	et	nn	11	SENT_377	[p20l1274t2246r1334b2290],
11	al	FW	O	al	appos	2	SENT_377	[p20l1366t2236r1449b2290],
12	:	:	O	:	_	0	SENT_377	[p20l1366t2236r1449b2290],
13	EGF	NN	ORGANIZATION	egf	nn	14	SENT_377	[p20l1490t2236r1644b2290],
14	receptor	NN	O	receptor	dep	2	SENT_377	[p20l1677t2244r1961b2306],
15	gene	NN	O	gene	nn	16	SENT_377	[p20l1996t2253r2151b2306],
16	mutation	NN	O	mutation	nsubj	18	SENT_377	[p20l130t2313r406b2367],
17	are	VBP	O	be	cop	18	SENT_377	[p20l434t2330r525b2367],
18	common	JJ	O	common	rcmod	14	SENT_377	[p20l553t2330r824b2367],
19	in	IN	O	in	_	0	SENT_377	[p20l851t2313r910b2366],
20	lung	NN	O	lung	nn	21	SENT_377	[p20l936t2312r1072b2383],
21	cancer	NN	O	cancer	prep_in	18	SENT_377	[p20l1100t2330r1303b2367],
22	from	IN	O	from	_	0	SENT_377	[p20l1329t2312r1479b2367],
23	‘	CD	NUMBER	‘	prep_from	21	SENT_377	[p20l1511t2313r1704b2367],
24	never	RB	O	never	advmod	21	SENT_377	[p20l1511t2313r1704b2367],
25	smokers	NNS	O	smoker	dep	21	SENT_377	[p20l1732t2313r2008b2367],
26	’	CD	NUMBER	’	tmod	18	SENT_377	[p20l1732t2313r2008b2367],
27	and	CC	O	and	_	0	SENT_377	[p20l2042t2313r2152b2367],
28	are	VBP	O	be	auxpass	29	SENT_377	[p20l131t2407r230b2444],
29	associated	VBN	O	associate	conj_and	18	SENT_377	[p20l268t2390r621b2444],
30	with	IN	O	with	_	0	SENT_377	[p20l656t2390r804b2444],
31	sensitivity	NN	O	sensitivity	prep_with	29	SENT_377	[p20l843t2390r1198b2460],
32	of	IN	O	of	_	0	SENT_377	[p20l1235t2389r1306b2444],
33	tumors	NNS	O	tumor	prep_of	31	SENT_377	[p20l1336t2398r1569b2444],
34	to	TO	O	to	_	0	SENT_377	[p20l1606t2398r1668b2444],
35	gefitinib	NN	O	gefitinib	prep_to	29	SENT_377	[p20l1705t2389r1997b2460],
36	and	CC	O	and	_	0	SENT_377	[p20l2035t2390r2152b2444],
37	elrotinib	NN	O	elrotinib	prep_to	29	SENT_377	[p20l130t2467r411b2523],
38	.	.	O	.	_	0	SENT_377	[p20l130t2467r411b2523],

1	Proc	NNP	PERSON	Proc	nn	5	SENT_378	[p20l434t2469r574b2523],
2	Natl	NNP	PERSON	Natl	nn	5	SENT_378	[p20l596t2467r729b2523],
3	Acad	NNP	PERSON	Acad	nn	5	SENT_378	[p20l751t2468r914b2522],
4	Sci	NNP	PERSON	Sci	nn	5	SENT_378	[p20l937t2468r1033b2523],
5	USA	NNP	LOCATION	USA	_	0	SENT_378	[p20l1055t2468r1209b2523],
6	101	CD	NUMBER	101	num	5	SENT_378	[p20l1239t2468r1362b2522],
7	:	:	O	:	_	0	SENT_378	[p20l1239t2468r1362b2522],
8	13306-13311	CD	NUMBER	13306-13311	dep	5	SENT_378	[p20l1397t2467r1825b2532],
9	,	,	O	,	_	0	SENT_378	[p20l1397t2467r1825b2532],
10	2004	CD	DATE	2004	appos	8	SENT_378	[p20l1847t2468r2019b2523],
11	.	.	O	.	_	0	SENT_378	[p20l1847t2468r2019b2523],

1	.	.	O	.	_	0	SENT_379	[p20l92t2591r101b2601],

1	Sordella	NN	O	sordellum	nn	2	SENT_380	[p20l131t2545r398b2601],
2	R	NN	O	r	_	0	SENT_380	[p20l429t2547r501b2610],
3	,	,	O	,	_	0	SENT_380	[p20l429t2547r501b2610],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_380	[p20l533t2545r664b2601],
5	DW	NNP	ORGANIZATION	DW	conj_and	2	SENT_380	[p20l697t2547r848b2610],
6	,	,	O	,	_	0	SENT_380	[p20l697t2547r848b2610],
7	Haber	NNP	O	Haber	nn	8	SENT_380	[p20l880t2546r1075b2601],
8	DA	NNP	O	DA	conj_and	2	SENT_380	[p20l1107t2546r1219b2600],
9	and	CC	O	and	_	0	SENT_380	[p20l1253t2546r1365b2600],
10	Settleman	NNP	O	Settleman	nn	11	SENT_380	[p20l1399t2545r1718b2601],
11	J	NNP	O	J	conj_and	2	SENT_380	[p20l1750t2547r1779b2601],
12	:	:	O	:	_	0	SENT_380	[p20l1787t2563r1796b2600],
13	Gefitinibsensitizing	JJ	O	gefitinibsensitizing	amod	15	SENT_380	[p20l1835t2545r2149b2601, p20l132t2623r500b2693],
14	EGFR	NN	O	egfr	nn	15	SENT_380	[p20l536t2623r746b2677],
15	mutations	NNS	O	mutation	nsubj	19	SENT_380	[p20l781t2623r1116b2677],
16	in	IN	O	in	_	0	SENT_380	[p20l1154t2623r1216b2676],
17	lung	NN	O	lung	nn	18	SENT_380	[p20l1251t2622r1399b2693],
18	cancer	NN	O	cancer	prep_in	15	SENT_380	[p20l1436t2640r1658b2677],
19	activate	VBP	O	activate	dep	2	SENT_380	[p20l1694t2623r1959b2677],
20	antiapoptotic	JJ	O	antiapoptotic	amod	21	SENT_380	[p20l1997t2623r2150b2677, p20l131t2700r417b2770],
21	pathways	NNS	O	pathway	dobj	19	SENT_380	[p20l439t2700r752b2770],
22	.	.	O	.	_	0	SENT_380	[p20l439t2700r752b2770],

1	Science	NNP	O	Science	_	0	SENT_381	[p20l777t2700r1016b2754],
2	305	CD	NUMBER	305	num	1	SENT_381	[p20l1040t2699r1169b2754],
3	:	:	O	:	_	0	SENT_381	[p20l1040t2699r1169b2754],
4	1163-1167	CD	DATE	1163-1167	dep	1	SENT_381	[p20l1204t2699r1554b2764],
5	,	,	DATE	,	_	0	SENT_381	[p20l1204t2699r1554b2764],
6	2004	CD	DATE	2004	appos	4	SENT_381	[p20l1576t2700r1747b2754],
7	.	.	O	.	_	0	SENT_381	[p20l1576t2700r1747b2754],

1	Tracy	NNP	PERSON	Tracy	nn	2	SENT_382	[p20l129t2778r313b2847],
2	S	NNP	PERSON	S	nsubj	16	SENT_382	[p20l348t2777r409b2841],
3	,	,	O	,	_	0	SENT_382	[p20l348t2777r409b2841],
4	Mukohara	NNP	PERSON	Mukohara	nn	5	SENT_382	[p20l440t2777r769b2831],
5	T	NN	PERSON	t	appos	2	SENT_382	[p20l800t2778r867b2841],
6	,	,	O	,	_	0	SENT_382	[p20l800t2778r867b2841],
7	Hansen	NNP	PERSON	Hansen	nn	8	SENT_382	[p20l899t2778r1136b2831],
8	M	NNP	O	M	appos	2	SENT_382	[p20l1168t2778r1258b2841],
9	,	,	O	,	_	0	SENT_382	[p20l1168t2778r1258b2841],
10	Meyerson	NNP	PERSON	Meyerson	nn	11	SENT_382	[p20l1289t2778r1607b2847],
11	M	NNP	O	M	appos	2	SENT_382	[p20l1639t2778r1728b2841],
12	,	,	O	,	_	0	SENT_382	[p20l1639t2778r1728b2841],
13	Johnson	NNP	PERSON	Johnson	appos	2	SENT_382	[p20l1760t2777r2021b2831],
14	BE	VB	O	be	cop	16	SENT_382	[p20l2053t2778r2152b2830],
15	and	CC	O	and	cc	16	SENT_382	[p20l131t2854r241b2908],
16	J	NNP	O	J	_	0	SENT_382	[p20l267t2855r295b2908],
17	anne	NN	O	anne	nn	18	SENT_382	[p20l299t2858r442b2908],
18	PA	NN	O	pa	dep	16	SENT_382	[p20l470t2854r584b2908],
19	:	:	O	:	_	0	SENT_382	[p20l470t2854r584b2908],
20	Gefitinib	NN	O	gefitinib	nsubj	21	SENT_382	[p20l616t2853r895b2908],
21	induces	VBZ	O	induce	parataxis	16	SENT_382	[p20l923t2854r1158b2908],
22	apoptosis	NN	O	apoptosis	dobj	21	SENT_382	[p20l1188t2854r1478b2924],
23	in	IN	O	in	_	0	SENT_382	[p20l1507t2854r1565b2907],
24	the	DT	O	the	det	26	SENT_382	[p20l1592t2854r1685b2908],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_382	[p20l1712t2854r1910b2908],
26	L858R	NN	O	l858r	prep_in	21	SENT_382	[p20l1936t2853r2152b2908],
27	non-small	JJ	O	non-small	amod	33	SENT_382	[p20l129t2930r455b2985],
28	cell	NN	O	cell	nn	33	SENT_382	[p20l489t2930r605b2985],
29	lung	NN	O	lung	nn	33	SENT_382	[p20l638t2930r780b3001],
30	cancer	NN	O	cancer	nn	33	SENT_382	[p20l815t2948r1027b2985],
31	cell	NN	O	cell	nn	33	SENT_382	[p20l1059t2930r1175b2985],
32	line	NN	O	line	nn	33	SENT_382	[p20l1209t2930r1329b2985],
33	H3255	NN	O	h3255	dep	26	SENT_382	[p20l1363t2930r1601b2985],
34	.	.	O	.	_	0	SENT_382	[p20l1363t2930r1601b2985],

1	Cancer	NN	O	cancer	_	0	SENT_383	[p20l1636t2931r1866b2986],
2	Res	NNP	O	Res	dep	1	SENT_383	[p20l1897t2932r2015b2985],
3	64	CD	NUMBER	64	num	2	SENT_383	[p20l2052t2930r2146b2985],
4	:	:	O	:	_	0	SENT_383	[p20l2052t2930r2146b2985],
5	7241-7244	CD	DATE	7241-7244	dep	1	SENT_383	[p20l130t3009r487b3073],
6	,	,	DATE	,	_	0	SENT_383	[p20l130t3009r487b3073],
7	2004	CD	DATE	2004	appos	5	SENT_383	[p20l509t3009r680b3064],
8	.	.	O	.	_	0	SENT_383	[p20l509t3009r680b3064],

1	Hirsch	NNP	PERSON	Hirsch	nn	2	SENT_384	[p20l129t3085r344b3140],
2	FR	NN	O	fr	_	0	SENT_384	[p20l376t3087r493b3150],
3	,	,	O	,	_	0	SENT_384	[p20l376t3087r493b3150],
4	Varella-Garcia	NNP	O	Varella-Garcia	nn	5	SENT_384	[p20l525t3085r1010b3140],
5	M	NNP	O	M	appos	2	SENT_384	[p20l1041t3087r1131b3150],
6	,	,	O	,	_	0	SENT_384	[p20l1041t3087r1131b3150],
7	Bunn	NNP	PERSON	Bunn	nn	9	SENT_384	[p20l1163t3087r1335b3140],
8	PA	NN	PERSON	pa	nn	9	SENT_384	[p20l1368t3086r1468b3139],
9	Jr	NNP	PERSON	Jr	appos	2	SENT_384	[p20l1500t3087r1578b3150],
10	,	,	O	,	_	0	SENT_384	[p20l1500t3087r1578b3150],
11	et	FW	O	et	nn	12	SENT_384	[p20l1611t3096r1669b3140],
12	al	FW	O	al	appos	2	SENT_384	[p20l1699t3085r1777b3140],
13	:	:	O	:	_	0	SENT_384	[p20l1699t3085r1777b3140],
14	Epidermal	JJ	O	epidermal	amod	17	SENT_384	[p20l1815t3085r2151b3156],
15	growth	NN	O	growth	nn	17	SENT_384	[p20l130t3163r365b3234],
16	factor	NN	O	factor	nn	17	SENT_384	[p20l400t3163r597b3218],
17	receptor	NN	O	receptor	dep	2	SENT_384	[p20l629t3171r908b3234],
18	in	IN	O	in	_	0	SENT_384	[p20l942t3163r1003b3217],
19	non-small	JJ	O	non-small	amod	23	SENT_384	[p20l1038t3163r1528b3218],
20	—	NN	O	—	nn	23	SENT_384	[p20l1038t3163r1528b3218],
21	cell	NN	O	cell	nn	23	SENT_384	[p20l1038t3163r1528b3218],
22	lung	NN	O	lung	nn	23	SENT_384	[p20l1563t3163r1709b3234],
23	carcinomas	NNS	O	carcinoma	prep_in	17	SENT_384	[p20l1745t3163r2147b3218],
24	:	:	O	:	_	0	SENT_384	[p20l1745t3163r2147b3218],
25	correlation	NN	O	correlation	dep	2	SENT_384	[p20l130t3239r468b3294],
26	between	IN	O	between	_	0	SENT_384	[p20l499t3240r760b3294],
27	gene	NN	O	gene	nn	29	SENT_384	[p20l793t3257r937b3310],
28	copy	NN	O	copy	nn	29	SENT_384	[p20l970t3257r1119b3310],
29	number	NN	O	number	prep_between	25	SENT_384	[p20l1152t3240r1392b3294],
30	and	CC	O	and	_	0	SENT_384	[p20l1423t3239r1533b3294],
31	protein	NN	O	protein	nn	32	SENT_384	[p20l1563t3240r1786b3310],
32	expression	NN	O	expression	prep_between	25	SENT_384	[p20l1818t3240r2152b3310],
33	and	CC	O	and	_	0	SENT_384	[p20l131t3316r241b3370],
34	impact	NN	O	impact	prep_between	25	SENT_384	[p20l262t3316r474b3387],
35	on	IN	O	on	_	0	SENT_384	[p20l495t3334r571b3371],
36	prognosis	NN	O	prognosis	prep_on	29	SENT_384	[p20l591t3316r913b3387],
37	.	.	O	.	_	0	SENT_384	[p20l591t3316r913b3387],

1	J	NNP	O	J	nn	3	SENT_385	[p20l935t3318r964b3371],
2	Clin	NNP	O	Clin	nn	3	SENT_385	[p20l987t3316r1118b3371],
3	Oncol	NNP	O	Oncol	_	0	SENT_385	[p20l1141t3316r1329b3371],
4	21	CD	NUMBER	21	num	3	SENT_385	[p20l1352t3317r1443b3370],
5	:	:	O	:	_	0	SENT_385	[p20l1352t3317r1443b3370],
6	3798-3807	CD	DATE	3798-3807	dep	3	SENT_385	[p20l1473t3316r1828b3381],
7	,	,	DATE	,	_	0	SENT_385	[p20l1473t3316r1828b3381],
8	2003	CD	DATE	2003	appos	6	SENT_385	[p20l1850t3316r2021b3371],
9	.	.	O	.	_	0	SENT_385	[p20l1850t3316r2021b3371],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nn	2	SENT_386	[p20l130t3394r439b3465],
2	F	NN	O	f	_	0	SENT_386	[p20l463t3395r526b3459],
3	,	,	O	,	_	0	SENT_386	[p20l463t3395r526b3459],
4	Hirsch	NNP	PERSON	Hirsch	nn	5	SENT_386	[p20l548t3394r755b3448],
5	FR	NN	O	fr	appos	2	SENT_386	[p20l778t3395r892b3459],
6	,	,	O	,	_	0	SENT_386	[p20l778t3395r892b3459],
7	Rossi	NNP	PERSON	Rossi	nn	8	SENT_386	[p20l914t3394r1086b3449],
8	E	NNP	O	E	appos	2	SENT_386	[p20l1110t3395r1176b3459],
9	,	,	O	,	_	0	SENT_386	[p20l1110t3395r1176b3459],
10	et	FW	O	et	nn	11	SENT_386	[p20l1200t3404r1256b3449],
11	al	FW	O	al	appos	2	SENT_386	[p20l1277t3394r1352b3448],
12	:	:	O	:	_	0	SENT_386	[p20l1277t3394r1352b3448],
13	Epidermal	JJ	O	epidermal	amod	17	SENT_386	[p20l1381t3394r1705b3465],
14	growth	NN	O	growth	nn	17	SENT_386	[p20l1729t3394r1948b3465],
15	factor	NN	O	factor	nn	17	SENT_386	[p20l1972t3394r2153b3449],
16	receptor	NN	O	receptor	nn	17	SENT_386	[p20l129t3479r385b3541],
17	gene	NN	O	gene	dep	2	SENT_386	[p20l410t3488r554b3541],
18	and	CC	O	and	_	0	SENT_386	[p20l582t3471r691b3525],
19	protein	NN	O	protein	nn	22	SENT_386	[p20l715t3471r936b3541],
20	and	CC	O	and	_	0	SENT_386	[p20l963t3471r1073b3525],
21	gefitinib	NN	O	gefitinib	conj_and	19	SENT_386	[p20l1098t3470r1359b3541],
22	sensitivity	NN	O	sensitivity	conj_and	17	SENT_386	[p20l1389t3471r1705b3541],
23	in	IN	O	in	_	0	SENT_386	[p20l1731t3471r1790b3524],
24	nonsmallcell	JJ	O	nonsmallcell	amod	26	SENT_386	[p20l1815t3470r2150b3525, p20l130t3547r240b3602],
25	lung	NN	O	lung	nn	26	SENT_386	[p20l262t3547r398b3618],
26	cancer	NN	O	cancer	prep_in	22	SENT_386	[p20l421t3564r641b3602],
27	.	.	O	.	_	0	SENT_386	[p20l421t3564r641b3602],

1	J	NNP	O	J	nn	4	SENT_387	[p20l663t3549r692b3602],
2	Natl	NNP	O	Natl	nn	4	SENT_387	[p20l713t3547r846b3602],
3	Cancer	NNP	O	Cancer	nn	4	SENT_387	[p20l869t3548r1089b3602],
4	Inst	NNP	O	Inst	_	0	SENT_387	[p20l1109t3549r1226b3602],
5	97	CD	NUMBER	97	num	4	SENT_387	[p20l1247t3548r1338b3603],
6	:	:	O	:	_	0	SENT_387	[p20l1247t3548r1338b3603],
7	643-655	CD	NUMBER	643-655	dep	4	SENT_387	[p20l1367t3547r1645b3612],
8	,	,	O	,	_	0	SENT_387	[p20l1367t3547r1645b3612],
9	2005	CD	DATE	2005	appos	7	SENT_387	[p20l1667t3547r1838b3602],
10	.	.	O	.	_	0	SENT_387	[p20l1667t3547r1838b3602],

1	Sasaki	NNP	PERSON	Sasaki	nn	2	SENT_388	[p20l132t3625r331b3680],
2	H	NNP	O	H	_	0	SENT_388	[p20l356t3627r431b3690],
3	,	,	O	,	_	0	SENT_388	[p20l356t3627r431b3690],
4	Shimizu	NNP	PERSON	Shimizu	nn	5	SENT_388	[p20l456t3625r712b3680],
5	S	NNP	O	S	appos	2	SENT_388	[p20l739t3626r799b3690],
6	,	,	O	,	_	0	SENT_388	[p20l739t3626r799b3690],
7	Endo	NNP	PERSON	Endo	nn	8	SENT_388	[p20l822t3625r985b3680],
8	K	NNP	PERSON	K	appos	2	SENT_388	[p20l1010t3627r1085b3690],
9	,	,	O	,	_	0	SENT_388	[p20l1010t3627r1085b3690],
10	et	FW	O	et	nn	11	SENT_388	[p20l1110t3636r1165b3680],
11	al	FW	O	al	appos	2	SENT_388	[p20l1187t3625r1262b3680],
12	:	:	O	:	_	0	SENT_388	[p20l1187t3625r1262b3680],
13	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_388	[p20l1291t3626r1490b3680],
14	and	CC	O	and	_	0	SENT_388	[p20l1515t3625r1625b3680],
15	ErbB2	NN	O	erbb2	nn	17	SENT_388	[p20l1649t3625r1851b3680],
16	mutation	NN	O	mutation	nn	17	SENT_388	[p20l1876t3625r2152b3680],
17	status	NN	O	status	dep	2	SENT_388	[p20l132t3710r298b3757],
18	in	IN	O	in	_	0	SENT_388	[p20l322t3702r379b3756],
19	Japanese	JJ	MISC	japanese	amod	22	SENT_388	[p20l400t3704r668b3773],
20	lung	NN	O	lung	nn	22	SENT_388	[p20l691t3702r823b3773],
21	cancer	NN	O	cancer	nn	22	SENT_388	[p20l846t3719r1043b3757],
22	patients	NNS	O	patient	prep_in	17	SENT_388	[p20l1063t3702r1314b3773],
23	.	.	O	.	_	0	SENT_388	[p20l1063t3702r1314b3773],

1	Int	NN	O	int	nn	3	SENT_389	[p20l1337t3704r1421b3756],
2	J	NN	O	j	nn	3	SENT_389	[p20l1440t3704r1469b3757],
3	Cancer	NN	O	cancer	_	0	SENT_389	[p20l1492t3703r1706b3757],
4	118	CD	NUMBER	118	dep	3	SENT_389	[p20l1734t3703r1855b3757],
5	:	:	O	:	_	0	SENT_389	[p20l1734t3703r1855b3757],
6	180-184	CD	NUMBER	180-184	dep	3	SENT_389	[p20l1889t3703r2153b3767],
7	,	,	O	,	_	0	SENT_389	[p20l1889t3703r2153b3767],
8	2006	CD	DATE	2006	appos	6	SENT_389	[p20l131t3779r302b3833],
9	.	.	O	.	_	0	SENT_389	[p20l131t3779r302b3833],

1	Endo	NNP	PERSON	Endo	nn	2	SENT_390	[p21l130t29r293b84],
2	K	NNP	PERSON	K	_	0	SENT_390	[p21l326t31r401b94],
3	,	,	O	,	_	0	SENT_390	[p21l326t31r401b94],
4	Konishi	NNP	PERSON	Konishi	nn	5	SENT_390	[p21l432t29r679b84],
5	A	NNP	O	A	appos	2	SENT_390	[p21l711t30r786b94],
6	,	,	O	,	_	0	SENT_390	[p21l711t30r786b94],
7	Sasaki	NNP	PERSON	Sasaki	nn	8	SENT_390	[p21l819t29r1020b84],
8	H	NNP	O	H	appos	2	SENT_390	[p21l1052t31r1128b94],
9	,	,	O	,	_	0	SENT_390	[p21l1052t31r1128b94],
10	et	FW	O	et	nn	11	SENT_390	[p21l1160t40r1216b84],
11	al	FW	O	al	appos	2	SENT_390	[p21l1245t29r1321b84],
12	:	:	O	:	_	0	SENT_390	[p21l1245t29r1321b84],
13	Epidermal	JJ	O	epidermal	amod	18	SENT_390	[p21l1358t29r1684b100],
14	growth	NN	O	growth	nn	18	SENT_390	[p21l1718t29r1938b100],
15	factor	NN	O	factor	nn	18	SENT_390	[p21l1970t29r2153b84],
16	receptor	NN	O	receptor	nn	18	SENT_390	[p21l129t114r401b177],
17	gene	NN	O	gene	nn	18	SENT_390	[p21l434t124r584b177],
18	mutation	NN	O	mutation	dep	2	SENT_390	[p21l618t106r910b161],
19	in	IN	O	in	_	0	SENT_390	[p21l944t106r1005b160],
20	non-small	JJ	O	non-small	amod	23	SENT_390	[p21l1039t106r1366b161],
21	cell	NN	O	cell	nn	23	SENT_390	[p21l1401t106r1518b161],
22	lung	NN	O	lung	nn	23	SENT_390	[p21l1552t106r1694b177],
23	cancer	NN	O	cancer	prep_in	18	SENT_390	[p21l1729t123r1944b161],
24	using	VBG	O	use	partmod	23	SENT_390	[p21l1976t106r2151b177],
25	highly	RB	O	highly	advmod	26	SENT_390	[p21l129t183r326b254],
26	sensitive	JJ	O	sensitive	amod	31	SENT_390	[p21l358t183r626b238],
27	and	CC	O	and	_	0	SENT_390	[p21l657t183r767b238],
28	fast	JJ	O	fast	conj_and	26	SENT_390	[p21l795t183r907b238],
29	TaqMan	NNP	O	TaqMan	nn	31	SENT_390	[p21l934t185r1197b254],
30	PCR	NN	O	pcr	nn	31	SENT_390	[p21l1225t184r1371b238],
31	assay	NN	O	assay	dobj	24	SENT_390	[p21l1401t200r1585b254],
32	.	.	O	.	_	0	SENT_390	[p21l1401t200r1585b254],

1	Lung	NN	O	lung	nn	2	SENT_391	[p21l1614t185r1777b254],
2	Cancer	NN	O	cancer	_	0	SENT_391	[p21l1807t184r2027b238],
3	50	CD	NUMBER	50	dep	2	SENT_391	[p21l2055t183r2146b238],
4	:	:	O	:	_	0	SENT_391	[p21l2055t183r2146b238],
5	375-384	CD	NUMBER	375-384	dep	2	SENT_391	[p21l132t261r409b326],
6	,	,	O	,	_	0	SENT_391	[p21l132t261r409b326],
7	2005	CD	DATE	2005	appos	5	SENT_391	[p21l431t261r602b316],
8	.	.	O	.	_	0	SENT_391	[p21l431t261r602b316],

1	Kawahara	NNP	PERSON	Kawahara	nn	2	SENT_392	[p21l130t338r446b392],
2	M	NNP	O	M	_	0	SENT_392	[p21l469t340r557b403],
3	,	,	O	,	_	0	SENT_392	[p21l469t340r557b403],
4	Furuse	NNP	PERSON	Furuse	nn	5	SENT_392	[p21l581t340r791b393],
5	K	NNP	PERSON	K	appos	2	SENT_392	[p21l817t340r892b403],
6	,	,	O	,	_	0	SENT_392	[p21l817t340r892b403],
7	Segawa	NNP	PERSON	Segawa	nn	8	SENT_392	[p21l918t338r1158b409],
8	Y	NN	PERSON	y	appos	2	SENT_392	[p21l1182t340r1257b403],
9	,	,	O	,	_	0	SENT_392	[p21l1182t340r1257b403],
10	et	FW	O	et	nn	11	SENT_392	[p21l1282t349r1337b393],
11	al	FW	O	al	appos	2	SENT_392	[p21l1360t338r1435b393],
12	:	:	O	:	_	0	SENT_392	[p21l1360t338r1435b393],
13	Phase	NN	O	phase	nn	15	SENT_392	[p21l1465t338r1645b393],
14	II	CD	NUMBER	ii	num	15	SENT_392	[p21l1671t340r1720b392],
15	study	NN	O	study	dep	2	SENT_392	[p21l1748t338r1912b409],
16	of	IN	O	of	_	0	SENT_392	[p21l1938t338r2006b393],
17	S-1	NN	O	s-1	prep_of	15	SENT_392	[p21l2028t338r2153b403],
18	,	,	O	,	_	0	SENT_392	[p21l2028t338r2153b403],
19	a	DT	O	a	det	22	SENT_392	[p21l131t432r164b469],
20	novel	JJ	O	novel	amod	22	SENT_392	[p21l197t415r380b470],
21	oral	JJ	O	oral	amod	22	SENT_392	[p21l416t415r543b470],
22	fluorouracil	NN	O	fluorouracil	appos	2	SENT_392	[p21l579t415r1003b480],
23	,	,	O	,	_	0	SENT_392	[p21l579t415r1003b480],
24	in	IN	O	in	_	0	SENT_392	[p21l1037t415r1098b469],
25	advanced	JJ	O	advanced	amod	28	SENT_392	[p21l1134t415r1448b470],
26	non-small-cell	JJ	O	non-small-cell	amod	28	SENT_392	[p21l1482t415r1971b470],
27	lung	NN	O	lung	nn	28	SENT_392	[p21l2006t415r2151b486],
28	cancer	NN	O	cancer	prep_in	2	SENT_392	[p21l130t509r350b547],
29	.	.	O	.	_	0	SENT_392	[p21l130t509r350b547],

1	Br	NN	O	br	nn	3	SENT_393	[p21l373t494r451b546],
2	J	NN	O	j	nn	3	SENT_393	[p21l470t494r499b547],
3	Cancer	NN	O	cancer	_	0	SENT_393	[p21l521t493r742b548],
4	85	CD	NUMBER	85	dep	3	SENT_393	[p21l764t492r854b547],
5	:	:	O	:	_	0	SENT_393	[p21l764t492r854b547],
6	939-943	CD	NUMBER	939-943	dep	3	SENT_393	[p21l882t493r1160b555],
7	,	,	O	,	_	0	SENT_393	[p21l882t493r1160b555],
8	2001	CD	DATE	2001	appos	6	SENT_393	[p21l1182t493r1354b547],
9	.	.	O	.	_	0	SENT_393	[p21l1182t493r1354b547],

1	ONCOLOGY	NNP	O	ONCOLOGY	nn	2	SENT_394	[p21l390t630r575b654],
2	REPORTS	NNS	O	report	_	0	SENT_394	[p21l585t630r729b654],
3	16	CD	NUMBER	16	num	5	SENT_394	[p21l751t630r787b654],
4	:	:	O	:	_	0	SENT_394	[p21l751t630r787b654],
5	533-541	CD	NUMBER	533-541	dep	2	SENT_394	[p21l807t630r926b658],
6	,	,	O	,	_	0	SENT_394	[p21l807t630r926b658],
7	2006	CD	DATE	2006	num	8	SENT_394	[p21l944t630r1008b654],
8	541	CD	NUMBER	541	appos	5	SENT_394	[p21l1710t635r1770b666],

1	Mitsudomi	JJ	ORGANIZATION	mitsudomi	amod	2	SENT_395	[p21l128t823r491b878],
2	T	NN	ORGANIZATION	t	_	0	SENT_395	[p21l526t824r595b888],
3	,	,	O	,	_	0	SENT_395	[p21l526t824r595b888],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_395	[p21l629t823r876b878],
5	T	NN	PERSON	t	appos	2	SENT_395	[p21l908t824r978b888],
6	,	,	O	,	_	0	SENT_395	[p21l908t824r978b888],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_395	[p21l1010t823r1224b878],
8	H	NN	PERSON	h	appos	2	SENT_395	[p21l1258t824r1336b888],
9	,	,	O	,	_	0	SENT_395	[p21l1258t824r1336b888],
10	et	FW	O	et	nn	11	SENT_395	[p21l1370t834r1429b878],
11	al	FW	O	al	appos	2	SENT_395	[p21l1460t823r1541b878],
12	:	:	O	:	_	0	SENT_395	[p21l1460t823r1541b878],
13	Mutations	NNS	O	mutation	nsubj	20	SENT_395	[p21l1580t823r1916b878],
14	of	IN	O	of	_	0	SENT_395	[p21l1953t823r2023b878],
15	the	DT	O	the	det	19	SENT_395	[p21l2052t823r2150b878],
16	epidermal	JJ	O	epidermal	amod	19	SENT_395	[p21l129t900r443b971],
17	growth	NN	O	growth	nn	19	SENT_395	[p21l476t900r697b971],
18	factor	NN	O	factor	nn	19	SENT_395	[p21l729t900r913b955],
19	gene	NN	O	gene	prep_of	13	SENT_395	[p21l944t917r1090b971],
20	predict	VBP	O	predict	dep	2	SENT_395	[p21l1121t900r1342b971],
21	prolonged	JJ	O	prolonged	amod	22	SENT_395	[p21l1371t900r1692b971],
22	survival	NN	O	survival	dobj	20	SENT_395	[p21l1726t900r1976b954],
23	after	IN	O	after	_	0	SENT_395	[p21l2010t900r2153b954],
24	gefitinib	NN	O	gefitinib	nn	25	SENT_395	[p21l129t977r393b1048],
25	treatment	NN	O	treatment	prep_after	20	SENT_395	[p21l426t985r724b1031],
26	in	IN	O	in	_	0	SENT_395	[p21l755t977r814b1031],
27	patients	NNS	O	patient	prep_in	25	SENT_395	[p21l845t977r1087b1048],
28	with	IN	O	with	_	0	SENT_395	[p21l1121t977r1259b1031],
29	non-small-cell	JJ	O	non-small-cell	amod	31	SENT_395	[p21l1291t977r1745b1032],
30	lung	NN	O	lung	nn	31	SENT_395	[p21l1777t977r1914b1048],
31	cancer	NN	O	cancer	prep_with	27	SENT_395	[p21l1948t994r2153b1031],
32	with	IN	O	with	_	0	SENT_395	[p21l129t1054r271b1108],
33	postoperative	JJ	O	postoperative	amod	34	SENT_395	[p21l304t1054r746b1125],
34	recurrence	NN	O	recurrence	prep_with	31	SENT_395	[p21l779t1071r1145b1109],
35	.	.	O	.	_	0	SENT_395	[p21l779t1071r1145b1109],

1	J	NNP	O	J	nn	3	SENT_396	[p21l1179t1055r1208b1108],
2	Clin	NNP	O	Clin	nn	3	SENT_396	[p21l1242t1054r1380b1109],
3	Oncol	NNP	O	Oncol	_	0	SENT_396	[p21l1414t1054r1609b1109],
4	23	CD	NUMBER	23	num	3	SENT_396	[p21l1644t1054r1739b1108],
5	:	:	O	:	_	0	SENT_396	[p21l1644t1054r1739b1108],
6	2513-2520	CD	DATE	2513-2520	dep	3	SENT_396	[p21l1779t1054r2152b1119],
7	,	,	DATE	,	_	0	SENT_396	[p21l1779t1054r2152b1119],
8	2005	CD	DATE	2005	appos	6	SENT_396	[p21l130t1131r301b1185],
9	.	.	O	.	_	0	SENT_396	[p21l130t1131r301b1185],

1	Takano	NNP	PERSON	Takano	nn	2	SENT_397	[p21l128t1208r360b1263],
2	T	NN	O	t	_	0	SENT_397	[p21l389t1209r455b1273],
3	,	,	O	,	_	0	SENT_397	[p21l389t1209r455b1273],
4	Ohe	NN	O	ohe	nn	5	SENT_397	[p21l483t1208r610b1263],
5	Y	NN	O	y	appos	2	SENT_397	[p21l639t1209r713b1273],
6	,	,	O	,	_	0	SENT_397	[p21l639t1209r713b1273],
7	Sakamoto	NNP	PERSON	Sakamoto	nn	8	SENT_397	[p21l742t1208r1050b1263],
8	H	NNP	O	H	appos	2	SENT_397	[p21l1079t1209r1154b1273],
9	,	,	O	,	_	0	SENT_397	[p21l1079t1209r1154b1273],
10	et	FW	O	et	nn	11	SENT_397	[p21l1182t1218r1238b1263],
11	al	FW	O	al	appos	2	SENT_397	[p21l1263t1208r1338b1262],
12	:	:	O	:	_	0	SENT_397	[p21l1263t1208r1338b1262],
13	Epidermal	JJ	O	epidermal	amod	18	SENT_397	[p21l1371t1208r1695b1279],
14	growth	NN	O	growth	nn	18	SENT_397	[p21l1724t1208r1943b1279],
15	factor	NN	O	factor	nn	18	SENT_397	[p21l1971t1208r2153b1263],
16	receptor	NN	O	receptor	nn	18	SENT_397	[p21l128t1294r393b1357],
17	gene	NN	O	gene	nn	18	SENT_397	[p21l425t1303r572b1357],
18	mutations	NNS	O	mutation	dep	2	SENT_397	[p21l606t1286r920b1341],
19	and	CC	O	and	_	0	SENT_397	[p21l956t1286r1068b1340],
20	increased	VBD	O	increase	conj_and	18	SENT_397	[p21l1100t1286r1404b1340],
21	copy	NN	O	copy	nn	22	SENT_397	[p21l1436t1303r1588b1357],
22	numbers	NNS	O	number	nsubj	23	SENT_397	[p21l1622t1286r1894b1340],
23	predict	VBP	O	predict	ccomp	20	SENT_397	[p21l1928t1286r2152b1357],
24	gefitinib	NN	O	gefitinib	nn	25	SENT_397	[p21l129t1363r403b1434],
25	sensitivity	NN	O	sensitivity	dobj	23	SENT_397	[p21l439t1363r771b1434],
26	in	IN	O	in	_	0	SENT_397	[p21l805t1363r865b1417],
27	patients	NNS	O	patient	prep_in	23	SENT_397	[p21l897t1363r1147b1434],
28	with	IN	O	with	_	0	SENT_397	[p21l1183t1363r1324b1417],
29	recurrent	JJ	O	recurrent	amod	32	SENT_397	[p21l1356t1371r1650b1417],
30	non-small-cell	JJ	O	non-small-cell	amod	32	SENT_397	[p21l1682t1363r2151b1418],
31	lung	NN	O	lung	nn	32	SENT_397	[p21l129t1440r265b1511],
32	cancer	NN	O	cancer	prep_with	27	SENT_397	[p21l288t1457r508b1494],
33	.	.	O	.	_	0	SENT_397	[p21l288t1457r508b1494],

1	J	NNP	O	J	nn	3	SENT_398	[p21l530t1441r559b1494],
2	Clin	NNP	O	Clin	nn	3	SENT_398	[p21l581t1440r714b1495],
3	Oncol	NNP	O	Oncol	_	0	SENT_398	[p21l736t1440r924b1495],
4	23	CD	NUMBER	23	num	3	SENT_398	[p21l947t1440r1038b1494],
5	:	:	O	:	_	0	SENT_398	[p21l947t1440r1038b1494],
6	6829-6837	CD	DATE	6829-6837	dep	3	SENT_398	[p21l1067t1440r1423b1505],
7	,	,	DATE	,	_	0	SENT_398	[p21l1067t1440r1423b1505],
8	2005	CD	DATE	2005	appos	6	SENT_398	[p21l1445t1440r1616b1494],
9	.	.	O	.	_	0	SENT_398	[p21l1445t1440r1616b1494],

1	Han	NNP	O	Han	nn	2	SENT_399	[p21l129t1518r257b1571],
2	SW	NNP	O	SW	_	0	SENT_399	[p21l286t1517r420b1582],
3	,	,	O	,	_	0	SENT_399	[p21l286t1517r420b1582],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_399	[p21l446t1517r584b1571],
5	TY	NNP	PERSON	TY	appos	2	SENT_399	[p21l610t1518r732b1582],
6	,	,	O	,	_	0	SENT_399	[p21l610t1518r732b1582],
7	Hwang	NNP	PERSON	Hwang	nn	8	SENT_399	[p21l758t1518r981b1588],
8	PG	NNP	O	PG	appos	2	SENT_399	[p21l1009t1518r1128b1582],
9	,	,	O	,	_	0	SENT_399	[p21l1009t1518r1128b1582],
10	et	FW	O	et	nn	11	SENT_399	[p21l1155t1527r1211b1572],
11	al	FW	O	al	appos	2	SENT_399	[p21l1235t1517r1310b1571],
12	:	:	O	:	_	0	SENT_399	[p21l1235t1517r1310b1571],
13	Predictive	JJ	O	predictive	amod	16	SENT_399	[p21l1343t1517r1657b1571],
14	and	CC	O	and	_	0	SENT_399	[p21l1687t1517r1796b1571],
15	prognostic	JJ	O	prognostic	amod	16	SENT_399	[p21l1822t1517r2150b1588],
16	impact	NN	O	impact	dep	2	SENT_399	[p21l129t1594r346b1665],
17	of	IN	O	of	_	0	SENT_399	[p21l378t1594r447b1649],
18	epidermal	JJ	O	epidermal	amod	22	SENT_399	[p21l475t1594r794b1665],
19	growth	NN	O	growth	nn	22	SENT_399	[p21l828t1594r1052b1665],
20	factor	NN	O	factor	nn	22	SENT_399	[p21l1085t1594r1272b1649],
21	receptor	NN	O	receptor	nn	22	SENT_399	[p21l1302t1602r1567b1665],
22	mutation	NN	O	mutation	prep_of	16	SENT_399	[p21l1598t1594r1882b1649],
23	in	IN	O	in	_	0	SENT_399	[p21l1914t1594r1974b1648],
24	nonsmall	JJ	O	nonsmall	amod	28	SENT_399	[p21l2007t1611r2149b1649, p21l131t1671r303b1725],
25	cell	NN	O	cell	nn	28	SENT_399	[p21l337t1671r452b1725],
26	lung	NN	O	lung	nn	28	SENT_399	[p21l486t1671r627b1742],
27	cancer	NN	O	cancer	nn	28	SENT_399	[p21l661t1688r873b1725],
28	patients	NNS	O	patient	prep_in	22	SENT_399	[p21l904t1671r1156b1742],
29	treated	VBN	O	treat	partmod	28	SENT_399	[p21l1191t1671r1413b1725],
30	with	IN	O	with	_	0	SENT_399	[p21l1446t1671r1588b1725],
31	gefitinib	NN	O	gefitinib	prep_with	29	SENT_399	[p21l1622t1671r1917b1742],
32	.	.	O	.	_	0	SENT_399	[p21l1622t1671r1917b1742],

1	J	NNP	O	J	nn	3	SENT_400	[p21l1952t1672r1980b1725],
2	Clin	NNP	O	Clin	nn	3	SENT_400	[p21l2014t1671r2152b1726],
3	Oncol	NNP	O	Oncol	_	0	SENT_400	[p21l130t1749r317b1804],
4	23	CD	NUMBER	23	num	3	SENT_400	[p21l341t1749r432b1804],
5	:	:	O	:	_	0	SENT_400	[p21l341t1749r432b1804],
6	2493-2501	CD	DATE	2493-2501	dep	3	SENT_400	[p21l460t1749r816b1814],
7	,	,	DATE	,	_	0	SENT_400	[p21l460t1749r816b1814],
8	2005	CD	DATE	2005	appos	6	SENT_400	[p21l838t1749r1010b1804],
9	.	.	O	.	_	0	SENT_400	[p21l838t1749r1010b1804],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_401	[p21l129t1826r267b1880],
2	KS	NN	O	k	_	0	SENT_401	[p21l289t1826r408b1891],
3	,	,	O	,	_	0	SENT_401	[p21l289t1826r408b1891],
4	J	NNP	O	J	nn	6	SENT_401	[p21l430t1827r459b1880],
5	eong	FW	O	eong	nn	6	SENT_401	[p21l461t1843r610b1897],
6	J	NNP	O	J	appos	2	SENT_401	[p21l634t1827r662b1880],
7	Y	NN	O	y	dep	6	SENT_401	[p21l665t1827r740b1891],
8	,	,	O	,	_	0	SENT_401	[p21l665t1827r740b1891],
9	Kim	NNP	PERSON	Kim	nn	10	SENT_401	[p21l762t1826r900b1880],
10	YC	NNP	O	YC	appos	2	SENT_401	[p21l923t1827r1050b1891],
11	,	,	O	,	_	0	SENT_401	[p21l923t1827r1050b1891],
12	et	FW	O	et	nn	13	SENT_401	[p21l1074t1837r1130b1881],
13	al	FW	O	al	appos	2	SENT_401	[p21l1150t1826r1226b1880],
14	:	:	O	:	_	0	SENT_401	[p21l1150t1826r1226b1880],
15	Predictors	NNS	O	predictor	dep	13	SENT_401	[p21l1255t1826r1568b1881],
16	of	IN	O	of	_	0	SENT_401	[p21l1594t1826r1662b1881],
17	the	DT	O	the	det	18	SENT_401	[p21l1680t1826r1773b1880],
18	response	NN	O	response	prep_of	15	SENT_401	[p21l1796t1843r2068b1897],
19	to	TO	O	to	_	0	SENT_401	[p21l2092t1834r2150b1881],
20	gefitinib	NN	O	gefitinib	prep_to	18	SENT_401	[p21l129t1903r392b1974],
21	in	IN	O	in	_	0	SENT_401	[p21l425t1903r484b1957],
22	refractory	JJ	O	refractory	amod	26	SENT_401	[p21l515t1903r823b1974],
23	non-small	JJ	O	non-small	amod	26	SENT_401	[p21l855t1903r1167b1958],
24	cell	NN	O	cell	nn	26	SENT_401	[p21l1200t1903r1310b1957],
25	lung	NN	O	lung	nn	26	SENT_401	[p21l1342t1903r1479b1974],
26	cancer	NN	O	cancer	prep_in	20	SENT_401	[p21l1512t1920r1733b1957],
27	.	.	O	.	_	0	SENT_401	[p21l1512t1920r1733b1957],

1	Clin	NNP	O	Clin	nn	3	SENT_402	[p21l1767t1903r1899b1958],
2	Cancer	NNP	O	Cancer	nn	3	SENT_402	[p21l1932t1904r2153b1958],
3	Res	NNP	O	Res	_	0	SENT_402	[p21l128t1982r242b2036],
4	11	CD	NUMBER	11	num	3	SENT_402	[p21l273t1982r358b2036],
5	:	:	O	:	_	0	SENT_402	[p21l273t1982r358b2036],
6	2244-2251	CD	DATE	2244-2251	dep	3	SENT_402	[p21l386t1981r743b2046],
7	,	,	DATE	,	_	0	SENT_402	[p21l386t1981r743b2046],
8	2005	CD	DATE	2005	appos	6	SENT_402	[p21l765t1981r936b2036],
9	.	.	O	.	_	0	SENT_402	[p21l765t1981r936b2036],

1	Taron	NNP	PERSON	Taron	nn	2	SENT_403	[p21l129t2059r314b2113],
2	M	NNP	PERSON	M	nsubjpass	27	SENT_403	[p21l345t2059r433b2123],
3	,	,	O	,	_	0	SENT_403	[p21l345t2059r433b2123],
4	Ichinose	NNP	PERSON	Ichinose	nn	5	SENT_403	[p21l464t2058r726b2113],
5	Y	NN	PERSON	y	appos	2	SENT_403	[p21l759t2059r834b2123],
6	,	,	O	,	_	0	SENT_403	[p21l759t2059r834b2123],
7	Rosell	NNP	PERSON	Rosell	nn	8	SENT_403	[p21l863t2058r1062b2113],
8	R	NNP	PERSON	R	appos	5	SENT_403	[p21l1093t2059r1164b2123],
9	,	,	O	,	_	0	SENT_403	[p21l1093t2059r1164b2123],
10	et	FW	O	et	nn	11	SENT_403	[p21l1196t2069r1252b2113],
11	al	FW	O	al	appos	5	SENT_403	[p21l1281t2058r1356b2112],
12	:	:	O	:	_	0	SENT_403	[p21l1281t2058r1356b2112],
13	Activating	VBG	O	activate	amod	14	SENT_403	[p21l1393t2058r1721b2129],
14	mutations	NNS	O	mutation	dep	11	SENT_403	[p21l1753t2058r2059b2113],
15	in	IN	O	in	_	0	SENT_403	[p21l2092t2058r2151b2112],
16	the	DT	O	the	det	19	SENT_403	[p21l128t2135r227b2189],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_403	[p21l261t2135r530b2206],
18	kinase	NN	O	kinase	nn	19	SENT_403	[p21l564t2135r775b2189],
19	domain	NN	O	domain	prep_in	14	SENT_403	[p21l811t2135r1057b2190],
20	of	IN	O	of	_	0	SENT_403	[p21l1091t2135r1161b2190],
21	the	DT	O	the	det	25	SENT_403	[p21l1190t2135r1288b2189],
22	epidermal	JJ	O	epidermal	amod	25	SENT_403	[p21l1324t2135r1655b2206],
23	growth	NN	O	growth	nn	25	SENT_403	[p21l1691t2135r1924b2206],
24	factor	NN	O	factor	nn	25	SENT_403	[p21l1958t2135r2153b2190],
25	receptor	NN	O	receptor	prep_of	14	SENT_403	[p21l128t2220r398b2283],
26	are	VBP	O	be	auxpass	27	SENT_403	[p21l432t2229r527b2266],
27	associated	VBN	O	associate	_	0	SENT_403	[p21l563t2212r899b2267],
28	with	IN	O	with	_	0	SENT_403	[p21l932t2212r1075b2266],
29	improved	JJ	O	improved	amod	30	SENT_403	[p21l1108t2212r1420b2283],
30	survival	NN	O	survival	prep_with	27	SENT_403	[p21l1456t2212r1716b2266],
31	in	IN	O	in	_	0	SENT_403	[p21l1750t2212r1811b2266],
32	gefitinibtreated	JJ	O	gefitinibtreated	amod	35	SENT_403	[p21l1845t2212r2149b2283, p21l128t2289r340b2343],
33	chemorefractory	JJ	O	chemorefractory	amod	35	SENT_403	[p21l362t2289r876b2360],
34	lung	NN	O	lung	nn	35	SENT_403	[p21l899t2289r1035b2360],
35	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	30	SENT_403	[p21l1059t2289r1617b2344],
36	.	.	O	.	_	0	SENT_403	[p21l1059t2289r1617b2344],

1	Clin	NNP	O	Clin	nn	3	SENT_404	[p21l1641t2289r1773b2344],
2	Cancer	NNP	O	Cancer	nn	3	SENT_404	[p21l1796t2290r2016b2344],
3	Res	NNP	O	Res	_	0	SENT_404	[p21l2036t2290r2150b2343],
4	11	CD	NUMBER	11	num	3	SENT_404	[p21l136t2368r221b2422],
5	:	:	O	:	_	0	SENT_404	[p21l136t2368r221b2422],
6	5878-5885	CD	DATE	5878-5885	dep	3	SENT_404	[p21l249t2367r606b2432],
7	,	,	DATE	,	_	0	SENT_404	[p21l249t2367r606b2432],
8	2005	CD	DATE	2005	appos	6	SENT_404	[p21l628t2367r799b2422],
9	.	.	O	.	_	0	SENT_404	[p21l628t2367r799b2422],

1	Greulich	NN	PERSON	greulich	nn	2	SENT_405	[p21l129t2444r400b2499],
2	H	NN	PERSON	h	_	0	SENT_405	[p21l425t2445r501b2509],
3	,	,	O	,	_	0	SENT_405	[p21l425t2445r501b2509],
4	Chen	NNP	PERSON	Chen	nn	5	SENT_405	[p21l526t2444r688b2499],
5	TH	NN	O	th	appos	2	SENT_405	[p21l713t2445r836b2509],
6	,	,	O	,	_	0	SENT_405	[p21l713t2445r836b2509],
7	Freg	NNP	O	Freg	nn	8	SENT_405	[p21l860t2445r1001b2515],
8	W	NNP	O	W	appos	2	SENT_405	[p21l1026t2445r1120b2509],
9	,	,	O	,	_	0	SENT_405	[p21l1026t2445r1120b2509],
10	et	FW	O	et	nn	11	SENT_405	[p21l1146t2455r1202b2499],
11	al	FW	O	al	appos	2	SENT_405	[p21l1224t2444r1300b2498],
12	:	:	O	:	_	0	SENT_405	[p21l1224t2444r1300b2498],
13	Oncogenic	JJ	O	oncogenic	amod	14	SENT_405	[p21l1331t2444r1666b2515],
14	transformation	NN	O	transformation	dep	2	SENT_405	[p21l1692t2444r2151b2499],
15	by	IN	O	by	_	0	SENT_405	[p21l128t2521r204b2592],
16	inhibitor-sensitive	JJ	O	inhibitor-sensitive	amod	19	SENT_405	[p21l237t2521r809b2576],
17	and-resistant	JJ	O	and-resistant	amod	19	SENT_405	[p21l843t2521r1244b2575],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_405	[p21l1274t2522r1474b2576],
19	mutants	NNS	O	mutant	prep_by	14	SENT_405	[p21l1506t2529r1772b2575],
20	.	.	O	.	_	0	SENT_405	[p21l1506t2529r1772b2575],

1	PLoS	NNP	O	PLoS	nn	2	SENT_406	[p21l1804t2521r1974b2576],
2	Med	NNP	O	Med	_	0	SENT_406	[p21l2009t2521r2152b2575],
3	2	CD	NUMBER	2	dep	2	SENT_406	[p21l130t2599r182b2652],
4	:	:	O	:	_	0	SENT_406	[p21l130t2599r182b2652],
5	e313	CD	NUMBER	e313	dep	2	SENT_406	[p21l209t2598r355b2652],
6	(	CD	NUMBER	(	num	7	SENT_406	[p21l383t2598r568b2669],
7	Epub	NN	O	epub	npadvmod	5	SENT_406	[p21l383t2598r568b2669],
8	ahead	RB	O	ahead	_	0	SENT_406	[p21l593t2598r773b2652],
9	of	IN	O	of	_	0	SENT_406	[p21l794t2598r862b2653],
10	print	NN	O	print	nn	11	SENT_406	[p21l877t2598r1070b2669],
11	)	NN	O	)	prep_ahead_of	5	SENT_406	[p21l877t2598r1070b2669],
12	,	,	O	,	_	0	SENT_406	[p21l877t2598r1070b2669],
13	2005	CD	DATE	2005	appos	11	SENT_406	[p21l1093t2598r1264b2652],
14	.	.	O	.	_	0	SENT_406	[p21l1093t2598r1264b2652],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_407	[p21l129t2675r461b2746],
2	S	NNP	LOCATION	S	_	0	SENT_407	[p21l485t2675r545b2740],
3	,	,	O	,	_	0	SENT_407	[p21l485t2675r545b2740],
4	Boggon	NNP	ORGANIZATION	Boggon	nn	5	SENT_407	[p21l566t2676r812b2746],
5	TJ	NNP	ORGANIZATION	TJ	appos	2	SENT_407	[p21l833t2676r930b2740],
6	,	,	O	,	_	0	SENT_407	[p21l833t2676r930b2740],
7	Dayaram	NNP	PERSON	Dayaram	nn	8	SENT_407	[p21l950t2676r1236b2746],
8	T	NN	PERSON	t	appos	2	SENT_407	[p21l1257t2676r1323b2740],
9	,	,	O	,	_	0	SENT_407	[p21l1257t2676r1323b2740],
10	et	FW	O	et	nn	11	SENT_407	[p21l1345t2686r1401b2730],
11	al	FW	O	al	appos	2	SENT_407	[p21l1420t2675r1495b2729],
12	:	:	O	:	_	0	SENT_407	[p21l1420t2675r1495b2729],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_407	[p21l1522t2676r1721b2730],
14	mutation	NN	O	mutation	dep	2	SENT_407	[p21l1742t2675r2019b2730],
15	and	CC	O	and	_	0	SENT_407	[p21l2042t2675r2152b2729],
16	resistance	NN	O	resistance	dep	2	SENT_407	[p21l128t2752r436b2806],
17	of	IN	O	of	_	0	SENT_407	[p21l469t2752r537b2807],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_407	[p21l563t2752r1016b2807],
19	lung	NN	O	lung	nn	20	SENT_407	[p21l1048t2752r1185b2823],
20	cancer	NN	O	cancer	prep_of	14	SENT_407	[p21l1218t2769r1422b2806],
21	to	TO	O	to	_	0	SENT_407	[p21l1452t2760r1510b2807],
22	gefitinib	NN	O	gefitinib	prep_to	20	SENT_407	[p21l1543t2752r1826b2823],
23	.	.	O	.	_	0	SENT_407	[p21l1543t2752r1826b2823],

1	N	NN	O	n	nn	3	SENT_408	[p21l1858t2753r1913b2806],
2	Engl	NNP	O	Engl	nn	3	SENT_408	[p21l1944t2752r2091b2823],
3	J	NNP	O	J	nsubj	4	SENT_408	[p21l2122t2753r2151b2806],
4	Med	VBD	O	med	_	0	SENT_408	[p21l128t2830r271b2885],
5	352	CD	NUMBER	352	num	7	SENT_408	[p21l294t2830r423b2885],
6	:	:	O	:	_	0	SENT_408	[p21l294t2830r423b2885],
7	786-792	CD	NUMBER	786-792	dobj	4	SENT_408	[p21l451t2830r730b2894],
8	,	,	O	,	_	0	SENT_408	[p21l451t2830r730b2894],
9	2005	CD	DATE	2005	appos	7	SENT_408	[p21l752t2830r923b2885],
10	.	.	O	.	_	0	SENT_408	[p21l752t2830r923b2885],

1	Janne	NNP	PERSON	Janne	nn	2	SENT_409	[p21l128t2908r307b2961],
2	PA	NN	PERSON	pa	_	0	SENT_409	[p21l340t2908r460b2972],
3	,	,	O	,	_	0	SENT_409	[p21l340t2908r460b2972],
4	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	5	SENT_409	[p21l493t2907r1043b2978],
5	S	NNP	LOCATION	S	appos	2	SENT_409	[p21l1076t2907r1137b2972],
6	,	,	O	,	_	0	SENT_409	[p21l1076t2907r1137b2972],
7	Yeap	NNP	PERSON	Yeap	nn	8	SENT_409	[p21l1169t2908r1333b2978],
8	BY	NNP	O	BY	appos	2	SENT_409	[p21l1366t2908r1496b2972],
9	,	,	O	,	_	0	SENT_409	[p21l1366t2908r1496b2972],
10	er	NNP	O	er	nn	11	SENT_409	[p21l1528t2918r1585b2962],
11	al	NNP	O	al	appos	2	SENT_409	[p21l1615t2907r1692b2961],
12	:	:	O	:	_	0	SENT_409	[p21l1615t2907r1692b2961],
13	Outcomes	NNS	O	outcome	dep	2	SENT_409	[p21l1731t2907r2049b2962],
14	of	IN	O	of	_	0	SENT_409	[p21l2084t2907r2153b2962],
15	patients	NNS	O	patient	prep_of	13	SENT_409	[p21l127t2984r367b3055],
16	with	IN	O	with	_	0	SENT_409	[p21l400t2984r536b3038],
17	advanced	JJ	O	advanced	amod	21	SENT_409	[p21l568t2984r860b3038],
18	non-small	JJ	O	non-small	amod	21	SENT_409	[p21l890t2984r1200b3039],
19	cell	NN	O	cell	nn	21	SENT_409	[p21l1231t2984r1341b3038],
20	lung	NN	O	lung	nn	21	SENT_409	[p21l1372t2984r1507b3055],
21	cancer	NN	O	cancer	prep_with	15	SENT_409	[p21l1539t3001r1742b3038],
22	treated	VBN	O	treat	partmod	13	SENT_409	[p21l1770t2984r1981b3038],
23	with	IN	O	with	_	0	SENT_409	[p21l2011t2984r2148b3038],
24	gefitinib	NN	O	gefitinib	nn	26	SENT_409	[p21l129t3061r390b3132],
25	(	CD	NUMBER	(	num	26	SENT_409	[p21l422t3061r724b3128],
26	ZD1839	NN	O	zd1839	prep_with	22	SENT_409	[p21l422t3061r724b3128],
27	,	,	O	,	_	0	SENT_409	[p21l422t3061r724b3128],
28	‘	CD	NUMBER	‘	num	30	SENT_409	[p21l758t3061r977b3115],
29	Iressa	NN	O	iressa	nn	30	SENT_409	[p21l758t3061r977b3115],
30	’	NN	O	’	appos	26	SENT_409	[p21l758t3061r977b3115],
31	on	IN	O	on	_	0	SENT_409	[p21l1013t3078r1089b3116],
32	an	DT	O	a	det	35	SENT_409	[p21l1119t3078r1189b3115],
33	expanded	JJ	O	expanded	amod	35	SENT_409	[p21l1218t3061r1516b3132],
34	access	NN	O	access	nn	35	SENT_409	[p21l1545t3078r1739b3115],
35	study	NN	O	study	prep_on	30	SENT_409	[p21l1772t3061r1955b3132],
36	.	.	O	.	_	0	SENT_409	[p21l1772t3061r1955b3132],

1	Lung	NN	O	lung	nn	2	SENT_410	[p21l1984t3062r2147b3132],
2	Cancer	NN	O	cancer	_	0	SENT_410	[p21l129t3140r349b3194],
3	44	CD	NUMBER	44	dep	2	SENT_410	[p21l368t3140r461b3194],
4	:	:	O	:	_	0	SENT_410	[p21l368t3140r461b3194],
5	221-230	CD	NUMBER	221-230	dep	2	SENT_410	[p21l489t3139r767b3204],
6	,	,	O	,	_	0	SENT_410	[p21l489t3139r767b3204],
7	2004	CD	DATE	2004	appos	5	SENT_410	[p21l789t3139r960b3194],
8	.	.	O	.	_	0	SENT_410	[p21l789t3139r960b3194],

1	Kosaka	NNP	PERSON	Kosaka	nn	2	SENT_411	[p21l128t3217r365b3272],
2	T	NN	O	t	_	0	SENT_411	[p21l395t3218r462b3282],
3	,	,	O	,	_	0	SENT_411	[p21l395t3218r462b3282],
4	Yatabe	NNP	PERSON	Yatabe	nn	5	SENT_411	[p21l494t3217r715b3272],
5	Y	NN	PERSON	y	conj_and	2	SENT_411	[p21l748t3218r823b3282],
6	,	,	O	,	_	0	SENT_411	[p21l748t3218r823b3282],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_411	[p21l854t3217r1059b3272],
8	H	NN	PERSON	h	conj_and	2	SENT_411	[p21l1091t3218r1166b3282],
9	,	,	O	,	_	0	SENT_411	[p21l1091t3218r1166b3282],
10	Kuwano	NNP	PERSON	Kuwano	nn	11	SENT_411	[p21l1198t3218r1462b3272],
11	H	NNP	O	H	conj_and	2	SENT_411	[p21l1495t3218r1571b3282],
12	,	,	O	,	_	0	SENT_411	[p21l1495t3218r1571b3282],
13	Takahashi	NNP	PERSON	Takahashi	nn	14	SENT_411	[p21l1602t3217r1925b3272],
14	T	NN	O	t	conj_and	2	SENT_411	[p21l1958t3218r2003b3271],
15	and	CC	O	and	_	0	SENT_411	[p21l2037t3217r2148b3272],
16	Mitsudomi	NN	LOCATION	mitsudomus	nn	17	SENT_411	[p21l128t3294r469b3349],
17	T	NN	O	t	conj_and	2	SENT_411	[p21l491t3295r553b3348],
18	:	:	O	:	_	0	SENT_411	[p21l491t3295r553b3348],
19	Mutations	NNS	O	mutation	dep	2	SENT_411	[p21l580t3294r894b3349],
20	of	IN	O	of	_	0	SENT_411	[p21l918t3294r985b3349],
21	the	DT	O	the	det	26	SENT_411	[p21l1002t3294r1095b3348],
22	epidermal	JJ	O	epidermal	amod	26	SENT_411	[p21l1118t3294r1428b3365],
23	growth	NN	O	growth	nn	26	SENT_411	[p21l1451t3294r1670b3365],
24	factor	NN	O	factor	nn	26	SENT_411	[p21l1692t3294r1873b3349],
25	receptor	NN	O	receptor	nn	26	SENT_411	[p21l1893t3302r2149b3365],
26	gene	NN	O	gene	prep_of	19	SENT_411	[p21l129t3388r272b3442],
27	in	IN	O	in	_	0	SENT_411	[p21l301t3371r358b3425],
28	lung	NN	O	lung	nn	29	SENT_411	[p21l386t3371r519b3442],
29	cancer	NN	O	cancer	prep_in	26	SENT_411	[p21l548t3388r761b3425],
30	:	:	O	:	_	0	SENT_411	[p21l548t3388r761b3425],
31	biological	JJ	O	biological	dep	2	SENT_411	[p21l793t3371r1097b3442],
32	and	CC	O	and	_	0	SENT_411	[p21l1126t3371r1234b3425],
33	clinical	JJ	O	clinical	amod	34	SENT_411	[p21l1262t3371r1483b3425],
34	implications	NNS	O	implication	dep	2	SENT_411	[p21l1511t3371r1904b3442],
35	.	.	O	.	_	0	SENT_411	[p21l1511t3371r1904b3442],

1	Cancer	NN	O	cancer	_	0	SENT_412	[p21l1933t3371r2150b3426],
2	Res	NNP	O	Res	dep	1	SENT_412	[p21l128t3450r241b3504],
3	64	CD	NUMBER	64	num	2	SENT_412	[p21l266t3449r357b3504],
4	:	:	O	:	_	0	SENT_412	[p21l266t3449r357b3504],
5	8919-8923	CD	DATE	8919-8923	dep	1	SENT_412	[p21l387t3449r741b3514],
6	,	,	DATE	,	_	0	SENT_412	[p21l387t3449r741b3514],
7	2004	CD	DATE	2004	appos	5	SENT_412	[p21l763t3449r934b3504],
8	.	.	O	.	_	0	SENT_412	[p21l763t3449r934b3504],

1	Pegram	NNP	PERSON	Pegram	nn	2	SENT_413	[p21l128t3527r370b3597],
2	M	NN	O	m	_	0	SENT_413	[p21l400t3527r467b3580],
3	and	CC	O	and	_	0	SENT_413	[p21l500t3526r611b3580],
4	Slamon	NN	PERSON	slamon	nn	5	SENT_413	[p21l644t3526r883b3581],
5	D	NN	O	d	conj_and	2	SENT_413	[p21l914t3527r985b3580],
6	:	:	O	:	_	0	SENT_413	[p21l914t3527r985b3580],
7	Biological	JJ	O	biological	amod	8	SENT_413	[p21l1022t3526r1352b3597],
8	rationale	NN	O	rationale	dep	2	SENT_413	[p21l1383t3526r1661b3581],
9	for	IN	O	for	_	0	SENT_413	[p21l1693t3526r1785b3581],
10	HER2/neu	NN	O	her2/neu	nn	13	SENT_413	[p21l1814t3526r2147b3581],
11	(	CD	NUMBER	(	num	13	SENT_413	[p21l131t3603r398b3670],
12	c-erB2	NN	O	c-erb2	nn	13	SENT_413	[p21l131t3603r398b3670],
13	)	NN	O	)	prep_for	8	SENT_413	[p21l131t3603r398b3670],
14	as	IN	O	as	_	0	SENT_413	[p21l435t3620r496b3657],
15	a	DT	O	a	det	16	SENT_413	[p21l532t3620r564b3657],
16	target	NN	O	target	prep_as	8	SENT_413	[p21l595t3611r778b3674],
17	for	IN	O	for	_	0	SENT_413	[p21l809t3603r902b3658],
18	monoclonal	JJ	O	monoclonal	amod	20	SENT_413	[p21l933t3603r1309b3658],
19	antibody	NN	O	antibody	nn	20	SENT_413	[p21l1343t3603r1620b3674],
20	therapy	NN	O	therapy	prep_for	16	SENT_413	[p21l1653t3603r1912b3674],
21	.	.	O	.	_	0	SENT_413	[p21l1653t3603r1912b3674],

1	Semin	NNP	ORGANIZATION	Semin	nn	2	SENT_414	[p21l1948t3603r2148b3658],
2	Oncol	NNP	ORGANIZATION	Oncol	_	0	SENT_414	[p21l129t3680r317b3735],
3	5	CD	NUMBER	5	number	4	SENT_414	[p21l340t3680r372b3734],
4	(	CD	NUMBER	(	num	5	SENT_414	[p21l400t3680r590b3751],
5	suppl	NN	O	suppl	dep	2	SENT_414	[p21l400t3680r590b3751],
6	9	CD	NUMBER	9	num	7	SENT_414	[p21l613t3681r691b3747],
7	)	NN	O	)	dep	2	SENT_414	[p21l613t3681r691b3747],
8	:	:	O	:	_	0	SENT_414	[p21l613t3681r691b3747],
9	13-19	CD	DATE	13-19	dep	2	SENT_414	[p21l726t3680r919b3745],
10	,	,	DATE	,	_	0	SENT_414	[p21l726t3680r919b3745],
11	2000	CD	DATE	2000	appos	9	SENT_414	[p21l941t3681r1112b3734],
12	.	.	O	.	_	0	SENT_414	[p21l941t3681r1112b3734],

1	Brabender	NNP	PERSON	Brabender	nn	2	SENT_415	[p21l128t3757r453b3811],
2	J	NNP	PERSON	J	_	0	SENT_415	[p21l475t3758r503b3811],
3	,	,	O	,	_	0	SENT_415	[p21l512t3802r524b3822],
4	Danenber	NNP	O	Danenber	nn	5	SENT_415	[p21l546t3757r849b3811],
5	KD	NN	O	kd	appos	2	SENT_415	[p21l871t3758r1003b3821],
6	,	,	O	,	_	0	SENT_415	[p21l871t3758r1003b3821],
7	Metzger	NNP	PERSON	Metzger	nn	8	SENT_415	[p21l1025t3758r1285b3828],
8	R	NNP	PERSON	R	appos	2	SENT_415	[p21l1306t3758r1377b3822],
9	,	,	O	,	_	0	SENT_415	[p21l1306t3758r1377b3822],
10	et	FW	O	et	nn	11	SENT_415	[p21l1401t3768r1457b3812],
11	al	FW	O	al	appos	2	SENT_415	[p21l1478t3757r1552b3811],
12	:	:	O	:	_	0	SENT_415	[p21l1478t3757r1552b3811],
13	Epidermal	JJ	O	epidermal	amod	15	SENT_415	[p21l1581t3757r1904b3828],
14	growth	NN	O	growth	nn	15	SENT_415	[p21l1929t3757r2148b3828],
15	factor	NN	O	factor	nsubjpass	26	SENT_415	[p22l129t10r310b65],
16	and	CC	O	and	_	0	SENT_415	[p22l338t10r448b64],
17	HER2-neu	NN	O	her2-neu	nn	19	SENT_415	[p22l475t11r807b64],
18	mRNA	NN	O	mrna	nn	19	SENT_415	[p22l835t10r1059b64],
19	expression	NN	O	expression	nsubjpass	26	SENT_415	[p22l1087t10r1419b81],
20	in	IN	O	in	_	0	SENT_415	[p22l1447t10r1506b64],
21	non-small	JJ	O	non-small	amod	24	SENT_415	[p22l1533t10r1844b65],
22	cell	NN	O	cell	nn	24	SENT_415	[p22l1873t10r1982b64],
23	lung	NN	O	lung	nn	24	SENT_415	[p22l2011t10r2147b81],
24	cancer	NN	O	cancer	prep_in	15	SENT_415	[p22l129t105r328b143],
25	is	VBZ	O	be	auxpass	26	SENT_415	[p22l350t88r397b143],
26	correlated	VBN	O	correlate	dep	2	SENT_415	[p22l422t88r725b143],
27	with	IN	O	with	_	0	SENT_415	[p22l748t88r882b143],
28	survival	NN	O	survival	prep_with	26	SENT_415	[p22l907t88r1167b143],
29	.	.	O	.	_	0	SENT_415	[p22l907t88r1167b143],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_416	[p22l1191t88r1321b143],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_416	[p22l1344t89r1560b143],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_416	[p22l1581t89r1693b143],
4	7	CD	NUMBER	7	num	3	SENT_416	[p22l1718t89r1770b143],
5	:	:	O	:	_	0	SENT_416	[p22l1718t89r1770b143],
6	1850-1855	CD	DATE	1850-1855	dep	3	SENT_416	[p22l1806t88r2149b153],
7	,	,	DATE	,	_	0	SENT_416	[p22l1806t88r2149b153],
8	2001	CD	DATE	2001	appos	6	SENT_416	[p22l129t166r301b219],
9	.	.	O	.	_	0	SENT_416	[p22l129t166r301b219],

1	Yarden	NNP	PERSON	Yarden	nn	2	SENT_417	[p22l129t242r356b296],
2	Y	NN	PERSON	y	_	0	SENT_417	[p22l381t243r435b296],
3	and	CC	O	and	_	0	SENT_417	[p22l462t242r571b296],
4	Sliwkowski	NNP	O	Sliwkowski	nn	5	SENT_417	[p22l597t242r962b297],
5	MX	NNP	O	MX	conj_and	2	SENT_417	[p22l986t243r1127b296],
6	:	:	O	:	_	0	SENT_417	[p22l986t243r1127b296],
7	Untangling	VBG	O	untangle	dep	2	SENT_417	[p22l1157t242r1506b313],
8	the	DT	O	the	det	11	SENT_417	[p22l1531t242r1624b296],
9	erbB2	NN	O	erbb2	nn	11	SENT_417	[p22l1650t242r1838b296],
10	signaling	NN	O	signaling	nn	11	SENT_417	[p22l1866t242r2147b313],
11	network	NN	O	network	dobj	7	SENT_417	[p22l128t320r401b375],
12	.	.	O	.	_	0	SENT_417	[p22l128t320r401b375],

1	Nat	NNP	O	Nat	nn	5	SENT_418	[p22l423t321r535b375],
2	Rev	NN	O	rev	nn	5	SENT_418	[p22l555t321r679b375],
3	Mol	NNP	O	Mol	nn	5	SENT_418	[p22l701t320r829b375],
4	Cell	NNP	O	Cell	nn	5	SENT_418	[p22l852t320r978b375],
5	Biol	NNP	O	Biol	_	0	SENT_418	[p22l1001t320r1133b375],
6	2	CD	NUMBER	2	dep	5	SENT_418	[p22l1156t321r1208b375],
7	:	:	O	:	_	0	SENT_418	[p22l1156t321r1208b375],
8	127-137	CD	NUMBER	127-137	dep	5	SENT_418	[p22l1243t320r1514b385],
9	,	,	O	,	_	0	SENT_418	[p22l1243t320r1514b385],
10	2001	CD	DATE	2001	appos	8	SENT_418	[p22l1536t321r1707b375],
11	.	.	O	.	_	0	SENT_418	[p22l1536t321r1707b375],

1	Shigematsu	NN	PERSON	shigematsu	nn	2	SENT_419	[p22l130t397r482b468],
2	H	NN	PERSON	h	_	0	SENT_419	[p22l503t398r577b461],
3	,	,	O	,	_	0	SENT_419	[p22l503t398r577b461],
4	Takahashi	NNP	PERSON	Takahashi	nn	5	SENT_419	[p22l596t397r906b451],
5	T	NN	O	t	appos	2	SENT_419	[p22l927t398r993b462],
6	,	,	O	,	_	0	SENT_419	[p22l927t398r993b462],
7	Nomura	NNP	ORGANIZATION	Nomura	nn	8	SENT_419	[p22l1012t398r1262b452],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_419	[p22l1281t398r1369b462],
9	,	,	O	,	_	0	SENT_419	[p22l1281t398r1369b462],
10	et	FW	O	et	nn	11	SENT_419	[p22l1389t408r1444b452],
11	al	FW	O	al	appos	8	SENT_419	[p22l1462t397r1521b451],
12	2	CD	NUMBER	2	num	14	SENT_419	[p22l1545t414r1554b451],
13	Somatic	JJ	O	somatic	amod	14	SENT_419	[p22l1583t397r1827b452],
14	mutations	NNS	O	mutation	dep	2	SENT_419	[p22l1849t397r2146b452],
15	of	IN	O	of	_	0	SENT_419	[p22l129t474r197b529],
16	HER2	NN	O	her2	nn	18	SENT_419	[p22l224t475r419b528],
17	kinase	NN	O	kinase	nn	18	SENT_419	[p22l450t474r651b528],
18	domain	NN	O	domain	prep_of	14	SENT_419	[p22l685t474r920b529],
19	in	IN	O	in	_	0	SENT_419	[p22l952t474r1011b528],
20	lung	NN	O	lung	nn	21	SENT_419	[p22l1044t474r1181b545],
21	adenocarciomas	NNS	O	adenocarcioma	prep_in	18	SENT_419	[p22l1216t474r1744b529],
22	.	.	O	.	_	0	SENT_419	[p22l1216t474r1744b529],

1	Cancer	NN	O	cancer	_	0	SENT_420	[p22l1778t475r2001b529],
2	Res	NNP	O	Res	dep	1	SENT_420	[p22l2031t475r2146b528],
3	65	CD	NUMBER	65	num	2	SENT_420	[p22l130t552r221b607],
4	:	:	O	:	_	0	SENT_420	[p22l130t552r221b607],
5	1642-1646	CD	DATE	1642-1646	dep	1	SENT_420	[p22l255t552r604b617],
6	,	,	DATE	,	_	0	SENT_420	[p22l255t552r604b617],
7	2005	CD	DATE	2005	appos	5	SENT_420	[p22l627t552r798b607],
8	.	.	O	.	_	0	SENT_420	[p22l627t552r798b607],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nn	2	SENT_421	[p22l129t630r437b700],
2	F	NN	O	f	nsubjpass	19	SENT_421	[p22l464t630r527b694],
3	,	,	O	,	_	0	SENT_421	[p22l464t630r527b694],
4	Garcia	NNP	PERSON	Garcia	nn	5	SENT_421	[p22l553t629r759b684],
5	MV	NNP	O	MV	appos	2	SENT_421	[p22l784t630r929b694],
6	,	,	O	,	_	0	SENT_421	[p22l784t630r929b694],
7	Shigematsu	NNP	PERSON	Shigematsu	nn	8	SENT_421	[p22l956t629r1316b700],
8	H	NNP	PERSON	H	appos	5	SENT_421	[p22l1343t630r1418b694],
9	,	,	O	,	_	0	SENT_421	[p22l1343t630r1418b694],
10	et	FW	O	et	nn	11	SENT_421	[p22l1445t640r1500b684],
11	al	FW	O	al	appos	5	SENT_421	[p22l1524t629r1599b683],
12	:	:	O	:	_	0	SENT_421	[p22l1524t629r1599b683],
13	Increased	VBN	O	increase	amod	16	SENT_421	[p22l1631t629r1929b683],
14	HER2	NN	O	her2	nn	16	SENT_421	[p22l1954t630r2147b683],
15	gene	NN	O	gene	nn	16	SENT_421	[p22l129t723r281b777],
16	copy	NN	O	copy	dep	11	SENT_421	[p22l317t723r474b777],
17	number	NN	O	number	tmod	16	SENT_421	[p22l509t706r762b760],
18	is	VBZ	O	be	auxpass	19	SENT_421	[p22l795t706r845b760],
19	associated	VBN	O	associate	_	0	SENT_421	[p22l883t706r1227b761],
20	with	IN	O	with	_	0	SENT_421	[p22l1261t706r1406b760],
21	response	NN	O	response	prep_with	19	SENT_421	[p22l1439t723r1731b777],
22	to	TO	O	to	_	0	SENT_421	[p22l1766t714r1827b761],
23	gefitinib	NN	O	gefitinib	nn	24	SENT_421	[p22l1863t706r2146b777],
24	therapy	NN	O	therapy	prep_to	19	SENT_421	[p22l128t783r360b854],
25	in	IN	O	in	_	0	SENT_421	[p22l387t783r446b837],
26	epidermal	JJ	O	epidermal	dep	27	SENT_421	[p22l473t783r782b854],
27	growth	NN	O	growth	amod	32	SENT_421	[p22l810t783r1029b854],
28	factor-positive	JJ	O	factor-positive	amod	32	SENT_421	[p22l1055t783r1508b854],
29	non-small-cell	JJ	O	non-small-cell	amod	32	SENT_421	[p22l1535t783r1984b838],
30	lung	NN	O	lung	nn	32	SENT_421	[p22l2011t783r2147b854],
31	cancer	NN	O	cancer	nn	32	SENT_421	[p22l129t877r331b914],
32	patients	NNS	O	patient	prep_in	24	SENT_421	[p22l351t860r611b931],
33	.	.	O	.	_	0	SENT_421	[p22l351t860r611b931],

1	J	NNP	O	J	nn	3	SENT_422	[p22l633t861r662b914],
2	Clin	NNP	O	Clin	nn	3	SENT_422	[p22l684t860r816b915],
3	Oncol	NNP	O	Oncol	_	0	SENT_422	[p22l839t860r1026b915],
4	23	CD	NUMBER	23	num	3	SENT_422	[p22l1050t860r1141b914],
5	:	:	O	:	_	0	SENT_422	[p22l1050t860r1141b914],
6	5007-5018	CD	DATE	5007-5018	dep	3	SENT_422	[p22l1169t860r1525b925],
7	,	,	DATE	,	_	0	SENT_422	[p22l1169t860r1525b925],
8	2005	CD	DATE	2005	appos	6	SENT_422	[p22l1546t860r1718b914],
9	.	.	O	.	_	0	SENT_422	[p22l1546t860r1718b914],

1	Tsao	NNP	PERSON	Tsao	nn	2	SENT_423	[p22l128t938r277b992],
2	MS	NN	O	m	_	0	SENT_423	[p22l305t937r436b1002],
3	,	,	O	,	_	0	SENT_423	[p22l305t937r436b1002],
4	Sakurada	NNP	ORGANIZATION	Sakurada	nn	5	SENT_423	[p22l464t937r752b992],
5	A	NNP	ORGANIZATION	A	appos	2	SENT_423	[p22l778t938r853b1002],
6	,	,	O	,	_	0	SENT_423	[p22l778t938r853b1002],
7	Cutz	NNP	O	Cutz	nn	9	SENT_423	[p22l880t938r1024b992],
8	J	NNP	O	J	nn	9	SENT_423	[p22l1051t938r1080b991],
9	C	NNP	O	C	appos	2	SENT_423	[p22l1083t937r1152b1002],
10	,	,	O	,	_	0	SENT_423	[p22l1083t937r1152b1002],
11	et	FW	O	et	nn	12	SENT_423	[p22l1180t947r1235b992],
12	al	FW	O	al	appos	2	SENT_423	[p22l1260t937r1335b991],
13	:	:	O	:	_	0	SENT_423	[p22l1260t937r1335b991],
14	Erlotinib	NNP	O	Erlotinib	dep	2	SENT_423	[p22l1367t937r1642b992],
15	in	IN	O	in	_	0	SENT_423	[p22l1671t937r1729b991],
16	lung	NN	O	lung	prep_in	14	SENT_423	[p22l1756t937r1892b1008],
17	cancermolecular	JJ	O	cancermolecular	amod	16	SENT_423	[p22l1921t954r2145b991, p22l128t1014r450b1069],
18	and	CC	O	and	_	0	SENT_423	[p22l483t1014r595b1068],
19	clinical	JJ	O	clinical	amod	20	SENT_423	[p22l628t1014r863b1068],
20	predictors	NNS	O	predictor	dep	2	SENT_423	[p22l895t1014r1215b1085],
21	of	IN	O	of	_	0	SENT_423	[p22l1251t1014r1319b1069],
22	outcome	NN	O	outcome	prep_of	20	SENT_423	[p22l1348t1022r1641b1069],
23	.	.	O	.	_	0	SENT_423	[p22l1348t1022r1641b1069],

1	N	NN	O	n	nn	3	SENT_424	[p22l1674t1015r1729b1068],
2	Engl	NNP	O	Engl	nn	3	SENT_424	[p22l1761t1014r1910b1085],
3	J	NNP	O	J	nsubj	4	SENT_424	[p22l1943t1015r1972b1068],
4	Med	VBD	O	med	_	0	SENT_424	[p22l2004t1014r2148b1068],
5	353	CD	NUMBER	353	dobj	4	SENT_424	[p22l131t1092r259b1147],
6	:	:	O	:	_	0	SENT_424	[p22l131t1092r259b1147],
7	133-144	CD	NUMBER	133-144	num	8	SENT_424	[p22l294t1092r759b1156],
8	,2005	CD	NUMBER	,2005	dep	5	SENT_424	[p22l294t1092r759b1156],
9	.	.	O	.	_	0	SENT_424	[p22l294t1092r759b1156],

